Query 020431
Match_columns 326
No_of_seqs 201 out of 1991
Neff 7.4
Searched_HMMs 46136
Date Fri Mar 29 09:41:15 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/020431.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/020431hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0527 LysC Aspartokinases [A 100.0 8.7E-63 1.9E-67 483.2 31.8 285 28-326 103-387 (447)
2 PLN02551 aspartokinase 100.0 1.7E-59 3.7E-64 468.5 31.3 299 15-326 139-449 (521)
3 PRK09034 aspartate kinase; Rev 100.0 2.6E-57 5.6E-62 448.8 32.2 295 17-326 94-389 (454)
4 PRK06291 aspartate kinase; Pro 100.0 4.9E-57 1.1E-61 448.4 33.4 299 15-326 96-402 (465)
5 PRK09084 aspartate kinase III; 100.0 9.9E-57 2.1E-61 443.8 33.2 299 14-326 84-388 (448)
6 PRK09436 thrA bifunctional asp 100.0 1.3E-56 2.8E-61 469.9 33.9 304 14-326 92-400 (819)
7 PRK09466 metL bifunctional asp 100.0 9.8E-56 2.1E-60 460.7 30.6 295 15-326 101-395 (810)
8 PRK09181 aspartate kinase; Val 100.0 8.1E-54 1.8E-58 423.8 29.5 282 16-326 113-406 (475)
9 TIGR00656 asp_kin_monofn aspar 100.0 5.6E-53 1.2E-57 412.7 32.7 282 30-326 60-341 (401)
10 PRK05925 aspartate kinase; Pro 100.0 2.4E-52 5.2E-57 410.2 32.7 292 18-326 83-376 (440)
11 TIGR00657 asp_kinases aspartat 100.0 2.3E-52 5.1E-57 412.9 32.3 282 32-326 101-382 (441)
12 KOG0456 Aspartate kinase [Amin 100.0 1.3E-53 2.8E-58 397.3 20.2 298 11-310 162-540 (559)
13 PRK08841 aspartate kinase; Val 100.0 2.4E-51 5.2E-56 398.6 27.6 268 31-307 61-379 (392)
14 PRK08961 bifunctional aspartat 100.0 6.9E-49 1.5E-53 415.0 31.6 295 15-326 93-402 (861)
15 PRK06635 aspartate kinase; Rev 100.0 4.1E-48 9E-53 378.7 29.9 280 32-326 62-344 (404)
16 PRK08210 aspartate kinase I; R 100.0 2.8E-47 6.1E-52 372.7 30.8 278 30-325 65-342 (403)
17 PRK07431 aspartate kinase; Pro 100.0 4.1E-46 8.8E-51 380.3 31.6 288 29-326 59-352 (587)
18 cd04245 AAK_AKiii-YclM-BS AAK_ 100.0 1.6E-46 3.5E-51 350.2 21.2 196 16-215 93-288 (288)
19 cd04257 AAK_AK-HSDH AAK_AK-HSD 100.0 1E-45 2.2E-50 346.4 21.1 200 14-215 90-294 (294)
20 cd04258 AAK_AKiii-LysC-EC AAK_ 100.0 1.4E-45 3.1E-50 344.5 21.5 200 15-215 87-292 (292)
21 cd04243 AAK_AK-HSDH-like AAK_A 100.0 1.6E-45 3.4E-50 344.9 21.1 200 14-215 89-293 (293)
22 cd04247 AAK_AK-Hom3 AAK_AK-Hom 100.0 3.7E-45 8.1E-50 343.2 20.8 201 15-216 99-305 (306)
23 PRK08373 aspartate kinase; Val 100.0 2.7E-44 5.7E-49 341.8 26.4 241 31-305 97-340 (341)
24 cd04244 AAK_AK-LysC-like AAK_A 100.0 7.7E-45 1.7E-49 341.4 20.5 200 14-215 91-298 (298)
25 cd04259 AAK_AK-DapDC AAK_AK-Da 100.0 3.7E-44 8.1E-49 335.8 20.8 199 15-215 85-295 (295)
26 TIGR02078 AspKin_pair Pyrococc 100.0 2.5E-41 5.4E-46 319.7 23.0 230 32-304 93-326 (327)
27 cd04248 AAK_AK-Ectoine AAK_AK- 100.0 1.2E-41 2.6E-46 316.1 19.5 175 29-215 126-304 (304)
28 cd04261 AAK_AKii-LysC-BS AAK_A 100.0 8E-37 1.7E-41 279.2 20.2 181 31-215 59-239 (239)
29 cd04260 AAK_AKi-DapG-BS AAK_AK 100.0 8.3E-37 1.8E-41 279.9 19.9 182 30-215 63-244 (244)
30 cd04234 AAK_AK AAK_AK: Amino A 100.0 3.6E-37 7.8E-42 279.4 17.1 199 14-215 15-227 (227)
31 cd04246 AAK_AK-DapG-like AAK_A 100.0 3.2E-36 7E-41 275.2 20.4 180 32-215 60-239 (239)
32 cd02115 AAK Amino Acid Kinases 100.0 2.8E-29 6.1E-34 229.6 19.0 180 31-214 61-248 (248)
33 PRK14558 pyrH uridylate kinase 99.9 1.7E-25 3.6E-30 203.5 19.2 182 11-216 20-230 (231)
34 cd04242 AAK_G5K_ProB AAK_G5K_P 99.9 2.9E-24 6.2E-29 197.8 16.7 159 34-207 65-234 (251)
35 cd04239 AAK_UMPK-like AAK_UMPK 99.9 3.9E-24 8.5E-29 194.3 16.8 174 11-208 18-213 (229)
36 PF00696 AA_kinase: Amino acid 99.9 2.3E-25 5E-30 203.0 6.7 112 90-203 125-242 (242)
37 PRK00358 pyrH uridylate kinase 99.9 1E-23 2.2E-28 191.7 17.1 174 11-208 20-215 (231)
38 PRK12314 gamma-glutamyl kinase 99.9 4.7E-23 1E-27 191.1 19.1 191 11-216 28-264 (266)
39 PRK14557 pyrH uridylate kinase 99.9 4.3E-23 9.4E-28 189.1 15.8 162 32-217 67-239 (247)
40 cd04254 AAK_UMPK-PyrH-Ec UMP k 99.9 4.6E-23 1E-27 187.5 15.6 155 36-214 67-230 (231)
41 TIGR02075 pyrH_bact uridylate 99.9 1.5E-22 3.3E-27 184.4 15.3 155 36-214 68-232 (233)
42 PRK13402 gamma-glutamyl kinase 99.9 1.5E-21 3.2E-26 188.1 16.7 193 10-217 23-258 (368)
43 COG0528 PyrH Uridylate kinase 99.9 5.3E-21 1.2E-25 170.4 18.6 181 11-215 25-237 (238)
44 PRK14556 pyrH uridylate kinase 99.9 5.1E-21 1.1E-25 174.4 18.3 181 11-215 35-247 (249)
45 PRK05429 gamma-glutamyl kinase 99.8 2.4E-20 5.1E-25 180.7 16.6 193 11-217 27-262 (372)
46 cd04253 AAK_UMPK-PyrH-Pf AAK_U 99.8 2.7E-20 6E-25 168.2 15.7 138 34-207 61-204 (221)
47 TIGR01027 proB glutamate 5-kin 99.8 3.2E-20 6.9E-25 179.2 16.7 193 11-217 19-254 (363)
48 TIGR02076 pyrH_arch uridylate 99.8 1.2E-19 2.7E-24 163.9 16.1 140 34-208 60-205 (221)
49 cd04241 AAK_FomA-like AAK_FomA 99.8 8.7E-20 1.9E-24 168.0 14.0 145 49-207 83-236 (252)
50 PRK14058 acetylglutamate/acety 99.8 1.2E-19 2.7E-24 168.5 14.7 169 33-216 68-267 (268)
51 cd04250 AAK_NAGK-C AAK_NAGK-C: 99.8 3.2E-19 7E-24 166.7 13.5 151 43-208 93-263 (279)
52 PRK00942 acetylglutamate kinas 99.8 1.5E-18 3.3E-23 162.4 13.5 160 38-216 98-282 (283)
53 cd04249 AAK_NAGK-NC AAK_NAGK-N 99.8 1.1E-18 2.4E-23 160.7 11.8 156 34-207 67-236 (252)
54 TIGR00761 argB acetylglutamate 99.8 1.3E-18 2.7E-23 158.3 11.3 141 43-199 75-228 (231)
55 COG0263 ProB Glutamate 5-kinas 99.8 1.9E-17 4.1E-22 155.2 17.5 194 10-218 24-261 (369)
56 cd04238 AAK_NAGK-like AAK_NAGK 99.8 4.6E-18 1E-22 156.9 12.1 147 43-207 77-239 (256)
57 PLN02512 acetylglutamate kinas 99.8 1.6E-17 3.5E-22 157.3 14.8 155 48-215 129-308 (309)
58 cd04251 AAK_NAGK-UC AAK_NAGK-U 99.7 1.1E-17 2.4E-22 154.5 12.4 158 33-208 64-244 (257)
59 cd04255 AAK_UMPK-MosAB AAK_UMP 99.7 2.6E-17 5.6E-22 152.2 14.3 182 13-207 47-245 (262)
60 CHL00202 argB acetylglutamate 99.7 2.7E-17 5.8E-22 154.0 14.3 159 42-215 101-283 (284)
61 PTZ00489 glutamate 5-kinase; P 99.7 9.9E-17 2.1E-21 148.4 17.1 169 36-217 72-260 (264)
62 cd04256 AAK_P5CS_ProBA AAK_P5C 99.7 5.8E-17 1.3E-21 151.6 15.2 168 36-214 94-283 (284)
63 PLN02418 delta-1-pyrroline-5-c 99.7 4.5E-17 9.7E-22 169.6 15.0 170 35-216 90-283 (718)
64 COG1608 Predicted archaeal kin 99.7 2.6E-16 5.7E-21 140.4 11.0 153 48-215 83-251 (252)
65 COG0548 ArgB Acetylglutamate k 99.6 5.5E-15 1.2E-19 135.4 14.1 151 41-207 79-246 (265)
66 TIGR01092 P5CS delta l-pyrroli 99.6 1.6E-14 3.5E-19 150.7 15.1 162 39-216 88-275 (715)
67 cd04236 AAK_NAGS-Urea AAK_NAGS 99.5 1.4E-13 3E-18 127.6 12.5 140 48-203 100-253 (271)
68 cd04252 AAK_NAGK-fArgBP AAK_NA 99.5 4.7E-13 1E-17 123.1 14.3 144 41-203 72-230 (248)
69 cd04915 ACT_AK-Ectoine_2 ACT d 99.5 1.4E-13 3E-18 101.0 8.6 65 241-306 2-66 (66)
70 PRK12353 putative amino acid k 99.5 5E-13 1.1E-17 126.8 14.7 121 90-215 176-313 (314)
71 cd04235 AAK_CK AAK_CK: Carbama 99.5 6.8E-13 1.5E-17 124.8 15.4 119 90-214 172-307 (308)
72 cd04918 ACT_AK1-AT_2 ACT domai 99.5 2.4E-13 5.2E-18 99.3 8.3 63 242-305 2-64 (65)
73 cd04919 ACT_AK-Hom3_2 ACT doma 99.4 4.6E-13 1E-17 97.5 8.6 66 241-306 1-66 (66)
74 cd04922 ACT_AKi-HSDH-ThrA_2 AC 99.4 1E-12 2.2E-17 95.5 8.6 66 241-306 1-66 (66)
75 cd04237 AAK_NAGS-ABP AAK_NAGS- 99.4 1.6E-12 3.5E-17 121.6 11.9 147 42-207 94-263 (280)
76 TIGR00746 arcC carbamate kinas 99.4 5.7E-12 1.2E-16 119.0 15.2 200 11-215 23-309 (310)
77 PRK05279 N-acetylglutamate syn 99.4 2.2E-12 4.8E-17 128.0 12.7 157 42-217 101-292 (441)
78 cd04921 ACT_AKi-HSDH-ThrA-like 99.4 2.8E-12 6E-17 97.1 10.3 80 241-320 1-80 (80)
79 cd04937 ACT_AKi-DapG-BS_2 ACT 99.4 3E-12 6.6E-17 93.1 8.3 63 241-305 1-63 (64)
80 PRK12686 carbamate kinase; Rev 99.4 6.1E-12 1.3E-16 118.5 11.8 122 90-215 174-311 (312)
81 cd04916 ACT_AKiii-YclM-BS_2 AC 99.3 4.9E-12 1.1E-16 91.8 8.7 66 241-306 1-66 (66)
82 cd04917 ACT_AKiii-LysC-EC_2 AC 99.3 5E-12 1.1E-16 91.8 8.2 63 241-305 1-63 (64)
83 cd04920 ACT_AKiii-DAPDC_2 ACT 99.3 3.9E-12 8.5E-17 92.4 7.5 63 242-306 1-63 (63)
84 TIGR01890 N-Ac-Glu-synth amino 99.3 1.4E-11 3E-16 121.9 13.7 157 42-217 93-280 (429)
85 KOG1154 Gamma-glutamyl kinase 99.3 8.8E-12 1.9E-16 110.9 9.6 157 39-211 92-261 (285)
86 PLN02551 aspartokinase 99.3 1.6E-11 3.4E-16 123.7 12.8 123 182-308 380-511 (521)
87 cd04924 ACT_AK-Arch_2 ACT doma 99.3 1.2E-11 2.7E-16 89.6 8.7 64 241-304 1-64 (66)
88 PRK12454 carbamate kinase-like 99.3 2E-11 4.3E-16 114.9 11.9 121 90-215 176-312 (313)
89 cd04240 AAK_UC AAK_UC: Unchara 99.3 1.1E-11 2.3E-16 110.8 8.9 102 89-207 81-186 (203)
90 PRK06291 aspartate kinase; Pro 99.3 1.8E-11 4E-16 122.2 9.6 123 183-306 336-463 (465)
91 PRK12354 carbamate kinase; Rev 99.2 1.8E-10 3.9E-15 108.2 14.6 122 90-217 166-301 (307)
92 COG0527 LysC Aspartokinases [A 99.2 6E-11 1.3E-15 117.3 11.4 120 183-306 322-446 (447)
93 PRK09181 aspartate kinase; Val 99.2 4.3E-11 9.4E-16 119.4 10.3 125 182-311 343-471 (475)
94 PRK09436 thrA bifunctional asp 99.2 7.5E-11 1.6E-15 124.9 11.8 125 183-308 330-463 (819)
95 PF13840 ACT_7: ACT domain ; P 99.2 8.5E-11 1.8E-15 85.9 7.4 63 237-302 2-65 (65)
96 PRK09034 aspartate kinase; Rev 99.2 1.3E-10 2.8E-15 115.7 10.0 121 184-307 324-451 (454)
97 PRK07431 aspartate kinase; Pro 99.2 1.6E-10 3.4E-15 118.7 10.7 132 183-316 283-421 (587)
98 PRK09411 carbamate kinase; Rev 99.1 7.6E-10 1.6E-14 103.3 13.6 118 90-215 167-296 (297)
99 PRK09084 aspartate kinase III; 99.1 7E-10 1.5E-14 110.3 12.3 119 183-306 321-447 (448)
100 PRK12352 putative carbamate ki 99.1 5.1E-10 1.1E-14 106.0 10.7 120 90-215 177-314 (316)
101 cd04892 ACT_AK-like_2 ACT doma 99.0 9.9E-10 2.2E-14 78.4 8.1 64 242-305 1-64 (65)
102 cd04936 ACT_AKii-LysC-BS-like_ 99.0 1E-09 2.2E-14 78.5 8.0 62 242-305 1-62 (63)
103 cd04923 ACT_AK-LysC-DapG-like_ 99.0 1.4E-09 3E-14 77.8 8.0 62 242-305 1-62 (63)
104 TIGR00656 asp_kin_monofn aspar 99.0 1.4E-09 2.9E-14 106.8 10.1 121 183-306 275-400 (401)
105 PRK04531 acetylglutamate kinas 99.0 5.7E-09 1.2E-13 102.0 14.1 113 92-216 122-249 (398)
106 TIGR00657 asp_kinases aspartat 98.9 3.8E-09 8.2E-14 105.0 10.6 120 183-305 316-440 (441)
107 cd04912 ACT_AKiii-LysC-EC-like 98.9 9.3E-09 2E-13 77.1 9.8 71 241-319 1-74 (75)
108 PLN02825 amino-acid N-acetyltr 98.9 6.2E-09 1.4E-13 104.5 10.7 109 53-178 111-235 (515)
109 PRK08961 bifunctional aspartat 98.9 3.9E-09 8.5E-14 112.8 9.8 121 182-307 336-462 (861)
110 cd04932 ACT_AKiii-LysC-EC_1 AC 98.9 1.5E-08 3.3E-13 76.1 9.6 71 241-319 1-74 (75)
111 PRK05925 aspartate kinase; Pro 98.9 7.2E-09 1.6E-13 102.7 9.9 117 186-308 316-436 (440)
112 PRK09466 metL bifunctional asp 98.9 8.7E-09 1.9E-13 108.9 11.0 123 183-308 332-456 (810)
113 PRK06635 aspartate kinase; Rev 98.9 1E-08 2.2E-13 100.8 10.4 121 183-305 275-402 (404)
114 cd04868 ACT_AK-like ACT domain 98.9 9.2E-09 2E-13 71.8 7.1 60 242-301 1-60 (60)
115 cd04934 ACT_AK-Hom3_1 CT domai 98.8 2.1E-08 4.6E-13 74.9 9.0 64 241-306 1-65 (73)
116 PRK08210 aspartate kinase I; R 98.8 1.2E-08 2.5E-13 100.3 9.8 138 163-305 260-401 (403)
117 cd04933 ACT_AK1-AT_1 ACT domai 98.8 2.7E-08 5.9E-13 75.2 8.9 63 241-305 1-69 (78)
118 cd04935 ACT_AKiii-DAPDC_1 ACT 98.8 5.6E-08 1.2E-12 73.0 9.4 64 241-306 1-67 (75)
119 COG2054 Uncharacterized archae 98.8 8.8E-09 1.9E-13 88.6 5.4 83 126-216 118-210 (212)
120 cd04890 ACT_AK-like_1 ACT doma 98.6 1.5E-07 3.2E-12 67.6 7.8 60 243-304 2-61 (62)
121 COG0549 ArcC Carbamate kinase 98.5 6.6E-07 1.4E-11 82.3 11.0 116 90-215 175-311 (312)
122 cd04891 ACT_AK-LysC-DapG-like_ 98.5 3.7E-07 8.1E-12 64.2 7.4 57 242-300 1-60 (61)
123 cd04913 ACT_AKii-LysC-BS-like_ 98.5 4.5E-07 9.8E-12 66.6 7.8 61 241-303 1-64 (75)
124 cd04914 ACT_AKi-DapG-BS_1 ACT 98.3 3E-06 6.5E-11 62.1 8.0 57 242-302 2-58 (67)
125 cd04910 ACT_AK-Ectoine_1 ACT d 97.8 0.00011 2.3E-09 54.5 6.9 65 242-306 2-66 (71)
126 cd04911 ACT_AKiii-YclM-BS_1 AC 97.5 0.00041 8.9E-09 52.1 7.1 73 242-319 2-75 (76)
127 PRK08841 aspartate kinase; Val 97.4 0.00078 1.7E-08 66.1 9.0 76 230-326 247-322 (392)
128 PF01842 ACT: ACT domain; Int 97.0 0.0012 2.7E-08 46.9 4.9 53 251-303 7-64 (66)
129 COG3830 ACT domain-containing 97.0 0.0028 6E-08 48.8 6.5 76 240-319 2-79 (90)
130 cd04888 ACT_PheB-BS C-terminal 96.3 0.02 4.3E-07 42.0 7.2 53 252-304 8-63 (76)
131 COG3603 Uncharacterized conser 96.1 0.036 7.8E-07 44.8 7.9 71 230-303 52-122 (128)
132 KOG2436 Acetylglutamate kinase 96.0 0.011 2.3E-07 58.8 5.6 118 41-176 170-301 (520)
133 KOG0456 Aspartate kinase [Amin 96.0 0.0079 1.7E-07 58.0 4.1 93 228-325 380-475 (559)
134 cd02116 ACT ACT domains are co 95.3 0.081 1.8E-06 34.6 6.2 48 253-300 7-59 (60)
135 PF13740 ACT_6: ACT domain; PD 95.1 0.11 2.5E-06 38.5 6.9 59 242-305 3-63 (76)
136 cd04908 ACT_Bt0572_1 N-termina 95.0 0.15 3.2E-06 36.7 7.2 52 251-302 8-59 (66)
137 PRK04435 hypothetical protein; 94.8 0.21 4.5E-06 42.3 8.7 62 239-303 67-131 (147)
138 PRK13562 acetolactate synthase 94.5 0.16 3.4E-06 38.8 6.5 52 251-302 9-67 (84)
139 CHL00100 ilvH acetohydroxyacid 94.4 0.26 5.7E-06 42.9 8.5 57 243-302 4-66 (174)
140 cd04870 ACT_PSP_1 CT domains f 93.7 0.28 6E-06 36.2 6.4 57 243-302 1-62 (75)
141 cd04882 ACT_Bt0572_2 C-termina 93.2 0.4 8.6E-06 33.6 6.4 52 251-302 6-59 (65)
142 PRK08178 acetolactate synthase 92.8 0.49 1.1E-05 37.1 6.7 58 242-302 9-71 (96)
143 PRK11152 ilvM acetolactate syn 92.8 0.5 1.1E-05 35.5 6.5 52 251-302 10-66 (76)
144 COG4747 ACT domain-containing 92.2 1.8 3.8E-05 35.3 9.3 109 186-303 18-129 (142)
145 PRK00194 hypothetical protein; 92.1 0.39 8.3E-06 36.6 5.4 37 241-280 3-39 (90)
146 PRK11895 ilvH acetolactate syn 91.8 0.4 8.7E-06 41.2 5.7 53 251-303 9-67 (161)
147 PRK06737 acetolactate synthase 91.7 0.51 1.1E-05 35.4 5.4 52 251-302 9-66 (76)
148 cd04883 ACT_AcuB C-terminal AC 91.6 1.6 3.5E-05 31.3 8.0 52 251-302 8-63 (72)
149 cd04889 ACT_PDH-BS-like C-term 91.1 0.92 2E-05 31.1 6.0 50 251-300 5-55 (56)
150 cd04893 ACT_GcvR_1 ACT domains 91.1 1.1 2.4E-05 33.3 6.8 34 243-279 3-36 (77)
151 cd04909 ACT_PDH-BS C-terminal 91.0 0.95 2.1E-05 32.4 6.2 52 251-302 8-64 (69)
152 cd04872 ACT_1ZPV ACT domain pr 90.8 1.3 2.9E-05 33.6 7.2 36 242-280 2-37 (88)
153 cd04869 ACT_GcvR_2 ACT domains 90.6 1.7 3.7E-05 32.0 7.5 34 244-280 2-35 (81)
154 TIGR00119 acolac_sm acetolacta 90.2 0.79 1.7E-05 39.3 5.9 52 251-302 8-65 (157)
155 cd04875 ACT_F4HF-DF N-terminal 90.1 2.1 4.6E-05 31.2 7.5 33 243-278 1-33 (74)
156 cd04903 ACT_LSD C-terminal ACT 89.7 1.3 2.7E-05 31.2 5.9 52 251-302 6-61 (71)
157 cd04886 ACT_ThrD-II-like C-ter 89.3 1.9 4.2E-05 30.3 6.7 52 251-302 5-66 (73)
158 cd04880 ACT_AAAH-PDT-like ACT 87.5 1.9 4.1E-05 31.5 5.7 50 252-302 7-66 (75)
159 COG0440 IlvH Acetolactate synt 87.3 1.1 2.3E-05 38.6 4.7 54 251-304 11-70 (163)
160 cd04874 ACT_Af1403 N-terminal 85.5 4.1 8.9E-05 28.6 6.5 51 251-301 7-61 (72)
161 cd04878 ACT_AHAS N-terminal AC 84.5 3.8 8.2E-05 28.7 5.9 51 251-301 7-63 (72)
162 cd04879 ACT_3PGDH-like ACT_3PG 84.5 3.7 8.1E-05 28.5 5.9 52 251-302 6-61 (71)
163 PF13291 ACT_4: ACT domain; PD 84.3 5.5 0.00012 29.3 6.9 57 242-301 7-67 (80)
164 cd04877 ACT_TyrR N-terminal AC 83.7 6 0.00013 28.8 6.8 45 252-297 8-52 (74)
165 PRK11589 gcvR glycine cleavage 83.3 4.3 9.4E-05 35.9 6.9 60 240-304 7-68 (190)
166 TIGR00655 PurU formyltetrahydr 83.2 3.3 7.2E-05 38.9 6.4 34 243-279 2-35 (280)
167 cd04881 ACT_HSDH-Hom ACT_HSDH_ 83.0 7.6 0.00017 27.6 7.1 52 251-302 7-65 (79)
168 cd04901 ACT_3PGDH C-terminal A 81.9 1.3 2.8E-05 31.5 2.5 52 251-302 6-59 (69)
169 PF13710 ACT_5: ACT domain; PD 81.5 3 6.6E-05 29.8 4.3 50 253-302 1-56 (63)
170 PRK06027 purU formyltetrahydro 80.4 7.2 0.00016 36.7 7.6 36 241-279 6-41 (286)
171 PRK13010 purU formyltetrahydro 80.2 4.9 0.00011 37.9 6.4 35 241-278 9-43 (289)
172 cd04887 ACT_MalLac-Enz ACT_Mal 79.8 10 0.00022 27.2 6.8 52 251-302 6-60 (74)
173 cd04905 ACT_CM-PDT C-terminal 79.0 9.8 0.00021 28.1 6.6 52 251-302 8-68 (80)
174 cd04925 ACT_ACR_2 ACT domain-c 78.9 18 0.00039 26.4 8.0 44 243-289 2-47 (74)
175 cd04871 ACT_PSP_2 ACT domains 78.8 2.2 4.9E-05 32.3 3.0 34 243-278 1-34 (84)
176 PRK08577 hypothetical protein; 78.8 13 0.00029 30.6 8.0 60 240-302 55-122 (136)
177 PRK13011 formyltetrahydrofolat 78.7 10 0.00022 35.7 8.1 35 241-278 7-41 (286)
178 cd04884 ACT_CBS C-terminal ACT 78.2 7.9 0.00017 27.9 5.8 29 251-279 6-34 (72)
179 cd04902 ACT_3PGDH-xct C-termin 77.9 5 0.00011 28.6 4.6 52 251-302 6-61 (73)
180 cd04929 ACT_TPH ACT domain of 77.1 11 0.00023 28.0 6.2 51 252-302 8-65 (74)
181 PF11760 CbiG_N: Cobalamin syn 77.1 3.8 8.3E-05 31.3 3.8 49 90-142 26-78 (84)
182 cd04904 ACT_AAAH ACT domain of 76.9 10 0.00022 27.8 6.1 51 252-302 8-65 (74)
183 cd04873 ACT_UUR-ACR-like ACT d 76.8 18 0.00039 25.2 7.3 45 243-290 2-48 (70)
184 cd04927 ACT_ACR-like_2 Second 76.7 19 0.00042 26.5 7.5 66 243-311 2-74 (76)
185 cd04900 ACT_UUR-like_1 ACT dom 75.1 22 0.00047 25.7 7.4 31 243-276 3-33 (73)
186 cd04931 ACT_PAH ACT domain of 73.7 19 0.00041 27.7 7.0 51 252-302 22-80 (90)
187 COG0462 PrsA Phosphoribosylpyr 73.1 30 0.00066 33.0 9.5 95 36-147 98-195 (314)
188 COG1058 CinA Predicted nucleot 72.6 20 0.00044 33.2 8.1 68 47-140 22-89 (255)
189 cd04896 ACT_ACR-like_3 ACT dom 72.2 38 0.00082 25.2 8.3 33 243-278 2-34 (75)
190 PRK08198 threonine dehydratase 71.9 21 0.00045 35.1 8.6 61 238-301 324-394 (404)
191 cd04876 ACT_RelA-SpoT ACT dom 71.3 21 0.00046 23.8 6.4 50 252-301 6-61 (71)
192 PRK11589 gcvR glycine cleavage 69.6 18 0.0004 31.9 6.9 32 242-276 96-127 (190)
193 COG2150 Predicted regulator of 69.1 26 0.00057 30.1 7.4 63 239-302 91-157 (167)
194 cd04899 ACT_ACR-UUR-like_2 C-t 67.6 24 0.00051 24.8 6.1 34 243-279 2-35 (70)
195 cd04906 ACT_ThrD-I_1 First of 66.2 28 0.0006 26.2 6.4 51 250-302 7-64 (85)
196 COG4747 ACT domain-containing 66.0 34 0.00074 28.0 7.0 56 243-303 5-62 (142)
197 cd04926 ACT_ACR_4 C-terminal 65.2 33 0.00071 24.8 6.5 40 251-290 8-49 (72)
198 cd04895 ACT_ACR_1 ACT domain-c 63.0 14 0.00031 27.3 4.1 59 242-303 2-67 (72)
199 cd04885 ACT_ThrD-I Tandem C-te 62.3 42 0.0009 23.9 6.5 51 251-302 5-61 (68)
200 COG4492 PheB ACT domain-contai 59.6 31 0.00067 28.8 5.8 52 251-302 79-137 (150)
201 cd04897 ACT_ACR_3 ACT domain-c 58.1 75 0.0016 23.6 8.6 65 242-309 2-73 (75)
202 cd00885 cinA Competence-damage 57.4 68 0.0015 27.6 8.1 69 46-140 19-87 (170)
203 PF02254 TrkA_N: TrkA-N domain 57.1 39 0.00085 26.3 6.2 69 39-147 3-71 (116)
204 cd04930 ACT_TH ACT domain of t 56.7 44 0.00096 26.9 6.4 38 252-289 49-89 (115)
205 PRK03673 hypothetical protein; 55.8 62 0.0013 32.0 8.4 69 46-140 21-89 (396)
206 PRK06349 homoserine dehydrogen 55.6 25 0.00055 34.9 5.8 52 251-302 355-412 (426)
207 PRK03670 competence damage-ind 54.5 66 0.0014 29.7 7.9 70 46-140 20-89 (252)
208 PTZ00145 phosphoribosylpyropho 54.5 85 0.0018 31.5 9.1 36 34-69 211-247 (439)
209 PTZ00445 p36-lilke protein; Pr 52.7 67 0.0015 29.0 7.4 27 47-73 30-56 (219)
210 TIGR01127 ilvA_1Cterm threonin 50.4 72 0.0016 30.9 8.0 61 239-302 303-373 (380)
211 cd05014 SIS_Kpsf KpsF-like pro 49.1 70 0.0015 25.3 6.6 79 116-203 1-81 (128)
212 PF00994 MoCF_biosynth: Probab 48.1 1E+02 0.0022 25.3 7.5 68 46-139 17-84 (144)
213 PRK01215 competence damage-ind 47.1 96 0.0021 28.8 7.9 69 46-140 23-91 (264)
214 COG0499 SAM1 S-adenosylhomocys 46.7 54 0.0012 32.1 6.1 77 53-149 161-241 (420)
215 PRK03659 glutathione-regulated 46.2 1E+02 0.0022 32.1 8.7 116 38-193 404-524 (601)
216 COG0011 Uncharacterized conser 45.0 1.5E+02 0.0033 23.4 7.7 71 244-319 7-79 (100)
217 PRK06382 threonine dehydratase 44.7 1.1E+02 0.0023 30.2 8.2 62 238-302 327-398 (406)
218 TIGR00719 sda_beta L-serine de 44.6 49 0.0011 29.5 5.3 47 252-298 156-206 (208)
219 PRK03092 ribose-phosphate pyro 44.3 2.5E+02 0.0055 26.5 10.4 34 36-69 83-117 (304)
220 TIGR00177 molyb_syn molybdenum 43.7 1.7E+02 0.0038 24.1 8.3 65 47-137 28-92 (144)
221 PRK02269 ribose-phosphate pyro 43.1 3E+02 0.0066 26.2 12.9 93 35-144 98-194 (320)
222 PF09413 DUF2007: Domain of un 43.1 67 0.0015 22.6 5.0 46 257-302 11-64 (67)
223 COG1778 Low specificity phosph 42.7 23 0.00051 30.4 2.7 52 143-206 10-61 (170)
224 PRK05788 cobalamin biosynthesi 42.3 26 0.00056 33.5 3.3 45 111-155 83-132 (315)
225 COG3602 Uncharacterized protei 42.1 37 0.00081 27.5 3.6 65 235-302 64-128 (134)
226 COG0303 MoeA Molybdopterin bio 41.5 99 0.0022 30.6 7.4 71 48-146 205-275 (404)
227 PRK07334 threonine dehydratase 41.0 1.3E+02 0.0028 29.6 8.2 58 242-302 327-394 (403)
228 smart00852 MoCF_biosynth Proba 41.0 1.2E+02 0.0026 24.5 6.8 69 45-139 17-85 (135)
229 PRK00549 competence damage-ind 39.4 1.4E+02 0.0029 29.7 8.0 69 46-140 20-88 (414)
230 cd04928 ACT_TyrKc Uncharacteri 38.4 74 0.0016 23.2 4.5 29 244-275 4-32 (68)
231 cd04817 PA_VapT_like PA_VapT_l 37.8 1.6E+02 0.0035 24.5 7.1 65 111-177 52-128 (139)
232 COG0077 PheA Prephenate dehydr 37.5 1.9E+02 0.0042 27.1 8.2 126 161-302 122-261 (279)
233 PRK11092 bifunctional (p)ppGpp 37.3 2.5E+02 0.0055 30.0 10.0 69 230-301 610-689 (702)
234 PRK11790 D-3-phosphoglycerate 37.1 58 0.0013 32.2 5.0 52 251-302 345-398 (409)
235 PRK13581 D-3-phosphoglycerate 36.2 2E+02 0.0043 29.4 8.9 51 252-302 460-514 (526)
236 PF12122 DUF3582: Protein of u 36.0 1.1E+02 0.0025 24.0 5.5 59 253-314 8-67 (101)
237 PRK11898 prephenate dehydratas 34.9 3E+02 0.0066 25.7 9.3 126 160-302 122-264 (283)
238 PRK03562 glutathione-regulated 34.1 2E+02 0.0044 30.1 8.7 28 37-66 403-430 (621)
239 PRK06545 prephenate dehydrogen 33.5 91 0.002 30.1 5.7 60 240-302 289-353 (359)
240 TIGR00200 cinA_nterm competenc 33.5 2.2E+02 0.0048 28.3 8.4 68 47-140 21-88 (413)
241 PF06153 DUF970: Protein of un 33.3 1.7E+02 0.0037 23.5 6.2 50 257-306 12-66 (109)
242 TIGR02667 moaB_proteo molybden 32.7 2.3E+02 0.005 24.1 7.4 71 44-138 20-90 (163)
243 PHA01735 hypothetical protein 32.7 1.2E+02 0.0027 22.2 4.7 49 18-71 8-58 (76)
244 TIGR01327 PGDH D-3-phosphoglyc 31.4 2.1E+02 0.0045 29.3 8.1 51 252-302 459-513 (525)
245 PF00289 CPSase_L_chain: Carba 31.2 18 0.00038 29.0 0.2 29 38-68 6-34 (110)
246 PRK02458 ribose-phosphate pyro 31.1 4.8E+02 0.01 24.9 12.0 36 34-69 101-137 (323)
247 cd04819 PA_2 PA_2: Protease-as 30.7 1.4E+02 0.0031 24.1 5.6 41 113-153 42-85 (127)
248 PF08544 GHMP_kinases_C: GHMP 29.9 1.9E+02 0.0041 20.8 5.8 50 256-305 34-84 (85)
249 TIGR02726 phenyl_P_delta pheny 29.8 45 0.00097 28.7 2.5 50 143-205 9-59 (169)
250 TIGR00106 uncharacterized prot 29.6 2.7E+02 0.0059 21.6 6.7 63 253-320 16-78 (97)
251 cd00886 MogA_MoaB MogA_MoaB fa 29.4 3.2E+02 0.0069 22.7 7.7 68 47-138 21-88 (152)
252 TIGR01251 ribP_PPkin ribose-ph 29.4 1.3E+02 0.0028 28.5 5.8 94 36-146 95-190 (308)
253 smart00460 TGc Transglutaminas 29.2 68 0.0015 22.2 3.0 24 42-67 9-32 (68)
254 PRK01259 ribose-phosphate pyro 28.2 1.4E+02 0.003 28.3 5.8 93 34-143 92-186 (309)
255 PRK11899 prephenate dehydratas 27.8 1.9E+02 0.0041 27.1 6.6 51 252-302 202-261 (279)
256 PF11823 DUF3343: Protein of u 27.6 1.8E+02 0.0039 21.0 5.2 48 255-302 11-61 (73)
257 PF09413 DUF2007: Domain of un 27.0 62 0.0014 22.8 2.5 33 39-71 3-35 (67)
258 cd02129 PA_hSPPL_like PA_hSPPL 26.8 2.9E+02 0.0063 22.4 6.7 63 115-177 44-109 (120)
259 cd00758 MoCF_BD MoCF_BD: molyb 26.7 3.4E+02 0.0074 21.9 7.8 66 46-137 19-84 (133)
260 PRK04923 ribose-phosphate pyro 25.8 5.6E+02 0.012 24.4 9.5 34 36-69 100-135 (319)
261 COG0329 DapA Dihydrodipicolina 25.7 3.2E+02 0.0069 25.7 7.7 54 48-109 27-80 (299)
262 cd00952 CHBPH_aldolase Trans-o 25.0 1.6E+02 0.0034 27.9 5.5 79 49-146 32-111 (309)
263 PF11713 Peptidase_C80: Peptid 24.5 1.2E+02 0.0025 25.9 4.1 35 243-277 105-142 (157)
264 PF01841 Transglut_core: Trans 24.5 64 0.0014 24.7 2.4 28 41-70 53-80 (113)
265 TIGR00691 spoT_relA (p)ppGpp s 24.4 2.9E+02 0.0062 29.4 7.8 67 231-300 595-669 (683)
266 PF13721 SecD-TM1: SecD export 23.7 3.3E+02 0.0071 21.3 6.3 44 259-304 49-93 (101)
267 PRK10872 relA (p)ppGpp synthet 23.4 3.3E+02 0.0071 29.4 8.0 68 231-301 651-730 (743)
268 PF01910 DUF77: Domain of unkn 22.8 2.5E+02 0.0054 21.6 5.3 63 252-319 13-75 (92)
269 PRK00934 ribose-phosphate pyro 22.7 2.7E+02 0.0058 26.0 6.6 92 34-142 90-181 (285)
270 PRK14324 glmM phosphoglucosami 22.5 5.8E+02 0.013 25.3 9.3 53 15-67 155-207 (446)
271 COG1707 ACT domain-containing 22.1 2.7E+02 0.0058 24.3 5.8 51 252-302 10-65 (218)
272 PRK08526 threonine dehydratase 22.0 2.4E+02 0.0051 27.8 6.3 61 239-302 324-394 (403)
273 PLN02317 arogenate dehydratase 21.3 2.7E+02 0.0059 27.4 6.4 51 252-302 291-364 (382)
274 COG2716 GcvR Glycine cleavage 21.0 1.1E+02 0.0024 26.6 3.3 31 242-275 93-123 (176)
275 PRK10622 pheA bifunctional cho 21.0 5.3E+02 0.012 25.3 8.5 51 252-302 305-364 (386)
276 cd02133 PA_C5a_like PA_C5a_lik 20.9 4.3E+02 0.0093 21.6 6.9 47 130-177 63-109 (143)
277 PF13511 DUF4124: Domain of un 20.7 96 0.0021 21.3 2.4 28 131-158 4-33 (60)
278 PRK07199 phosphoribosylpyropho 20.6 7.2E+02 0.016 23.4 12.5 96 34-146 93-191 (301)
279 PRK10629 EnvZ/OmpR regulon mod 20.4 2.7E+02 0.0058 22.9 5.3 47 256-304 50-97 (127)
No 1
>COG0527 LysC Aspartokinases [Amino acid transport and metabolism]
Probab=100.00 E-value=8.7e-63 Score=483.22 Aligned_cols=285 Identities=39% Similarity=0.583 Sum_probs=264.6
Q ss_pred cCCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEec
Q 020431 28 SGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIAT 107 (326)
Q Consensus 28 ~~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~ 107 (326)
.++.+++.+|+++|+||++|+++|+.+|+++|++|.+++++++++.+++.+++..++...+...+.++++ .+.|||++
T Consensus 103 ~~~~~~~~~D~ilS~GE~~Sa~lla~~L~~~Gv~A~~~~~~~~~i~t~~~~~~a~i~~~~~~~~l~~~~~--~~~v~Vv~ 180 (447)
T COG0527 103 LGEVSPRERDELLSLGERLSAALLAAALNALGVDARSLDGRQAGIATDSNHGNARILDEDSERRLLRLLE--EGKVPVVA 180 (447)
T ss_pred ccCCCHHHHHHHHhhchHHHHHHHHHHHHhCCCceEEEchHHceeeecCcccccccchhhhhhhHHHHhc--CCcEEEec
Confidence 3678999999999999999999999999999999999999999999998888776665444333776776 89999999
Q ss_pred CccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchh
Q 020431 108 GFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPR 187 (326)
Q Consensus 108 Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~ 187 (326)
||+|.+++|+++|||||||||+|++||.+++|+++.||||||||||+|||++|+|+++++|||+||.||+++|++|+||+
T Consensus 181 GF~G~~~~G~~tTLGRGGSD~SA~~laa~l~Ad~~~I~TDVdGI~TaDPRiVp~Ar~i~~isyeEa~ELA~~GAkVLHpr 260 (447)
T COG0527 181 GFQGINEDGETTTLGRGGSDYSAAALAAALGADEVEIWTDVDGVYTADPRIVPDARLLPEISYEEALELAYLGAKVLHPR 260 (447)
T ss_pred CceeecCCCCEEEeCCCcHHHHHHHHHHHcCCCEEEEEECCCCCccCCCCCCCcceEcCccCHHHHHHHHHCCchhcCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHh
Q 020431 188 TIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKD 267 (326)
Q Consensus 188 a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~ 267 (326)
|++|++++|||++|+|+++|+.+||+|..+.... .+.+++|+..+|+++|++.|..|...+|+.+++|.+|++
T Consensus 261 av~pa~~~~Ip~~i~~t~~p~~~GTlI~~~~~~~-------~~~v~gIa~~~~~~~i~v~~~~~~~~~g~~a~vf~~l~~ 333 (447)
T COG0527 261 AVEPAMRSGIPLRIKNTFNPDAPGTLITAETESD-------EPVVKGIALDDNVALITVSGPGMNGMVGFAARVFGILAE 333 (447)
T ss_pred HHHHHHhcCCcEEEEecCCCCCCceEEecCCcCC-------CCceEEEEeCCCeEEEEEEccCccccccHHHHHHHHHHH
Confidence 9999999999999999999999999998864321 257999999999999999999999999999999999999
Q ss_pred CCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 268 VGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 268 ~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
+||+++||+|+.++.+++|++++.+.+++.+.|++.+..... +++++.++|+|+
T Consensus 334 ~~i~v~~I~q~~~~~~i~~~v~~~~~~~a~~~l~~~~~~~~~-----~v~~~~~~a~vs 387 (447)
T COG0527 334 AGINVDLITQSISEVSISFTVPESDAPRALRALLEEKLELLA-----EVEVEEGLALVS 387 (447)
T ss_pred cCCcEEEEEeccCCCeEEEEEchhhHHHHHHHHHHHHhhhcc-----eEEeeCCeeEEE
Confidence 999999999999999999999999999999999998866554 799999999874
No 2
>PLN02551 aspartokinase
Probab=100.00 E-value=1.7e-59 Score=468.53 Aligned_cols=299 Identities=25% Similarity=0.425 Sum_probs=259.6
Q ss_pred HHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhH
Q 020431 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESE 89 (326)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~ 89 (326)
.+...++.|+++++ ++.+++.+|+++|+||+||+++++.+|+++|++|.+++++++++++++.|++..++ ..+.
T Consensus 139 ~~~~~~~~l~~ll~~i~~~~~~~~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~lda~~~gi~t~~~~~~a~i~-~~~~ 217 (521)
T PLN02551 139 VVEKLLDELEQLLKGIAMMKELTPRTRDYLVSFGERMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADIL-EATY 217 (521)
T ss_pred HHHHHHHHHHHHHHhhhhhcccchHHHHHHHhHHHHHHHHHHHHHHHHCCCCcEEechHHcceEecCCCCccchh-hhhH
Confidence 35566777777765 47889999999999999999999999999999999999999988888888876665 3444
Q ss_pred HHHHHHhhc---CCCcEEEecCccccC-CCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEE
Q 020431 90 KRLEKWFSQ---SPSNTIIATGFIAST-PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (326)
Q Consensus 90 ~~i~~~l~~---~~~~ipVv~Gfi~~~-~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i 165 (326)
+.+.+.+.. ..+.|||++||+|.+ .+|+++|||||||||+|+++|.+|+|+++.+|||||||||+|||++|+|+++
T Consensus 218 ~~l~~~l~~~~~~~~~v~Vv~GFig~~~~~G~~ttLGRGGSD~sA~~la~~L~A~~v~I~tDV~Gi~taDPr~v~~A~~l 297 (521)
T PLN02551 218 PAVAKRLHGDWIDDPAVPVVTGFLGKGWKTGAITTLGRGGSDLTATTIGKALGLREIQVWKDVDGVLTCDPRIYPNAVPV 297 (521)
T ss_pred HHHHHHHHhhhccCCeEEEEcCccccCCCCCcEEecCCChHHHHHHHHHHHcCCCEEEEEeCCCceeCCCCCCCCCceEe
Confidence 555555421 245899999999999 8999999999999999999999999999999999999999999999999999
Q ss_pred eeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEE
Q 020431 166 RTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVN 245 (326)
Q Consensus 166 ~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~Is 245 (326)
++|||+||.||+++|++|+||+|+.||++++||++|+|+++|+.+||+|..... + ....+++|+..+|+++|+
T Consensus 298 ~~lsy~Ea~elA~~GakVlhp~ai~pa~~~~Ipi~vknt~~p~~~GT~I~~~~~-~------~~~~v~~It~~~~v~li~ 370 (521)
T PLN02551 298 PYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPTAPGTLITKTRD-M------SKAVLTSIVLKRNVTMLD 370 (521)
T ss_pred cccCHHHHHHHHhCCCcccCHHHHHHHHHCCceEEEEecCCCCCCCcEEecccc-c------CCCcccceecCCCeEEEE
Confidence 999999999999999999999999999999999999999999999999976421 1 234699999999999999
Q ss_pred EecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHH---HHHhcCCCCcceEEEcCe
Q 020431 246 VEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKF---REALNAGRLSQVCLSFWL 322 (326)
Q Consensus 246 ivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f---~~~~~~~~~~~v~~~~~~ 322 (326)
|.|.+|.+.+|+++++|+.|+++||+|+||+ +|+.+|||++++++... .+.+.+.+ ..++. .+.++++++++
T Consensus 371 i~~~~m~~~~g~~arvf~~l~~~~I~Vd~Is--sSe~sIs~~v~~~~~~~-~~~i~~~l~~l~~el~--~~~~V~v~~~v 445 (521)
T PLN02551 371 IVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSISLTLDPSKLWS-RELIQQELDHLVEELE--KIAVVNLLQGR 445 (521)
T ss_pred EecCCCCCcccHHHHHHHHHHHcCCcEEEEe--ccCCEEEEEEehhHhhh-hhhHHHHHHHHHHHhh--cCCeEEEeCCE
Confidence 9999999999999999999999999999998 56899999999998755 32332222 22333 37889999999
Q ss_pred eecC
Q 020431 323 CDYT 326 (326)
Q Consensus 323 ~~~~ 326 (326)
++|+
T Consensus 446 AiIS 449 (521)
T PLN02551 446 SIIS 449 (521)
T ss_pred EEEE
Confidence 9874
No 3
>PRK09034 aspartate kinase; Reviewed
Probab=100.00 E-value=2.6e-57 Score=448.82 Aligned_cols=295 Identities=23% Similarity=0.378 Sum_probs=258.9
Q ss_pred HHHHHHHHhhhcCCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHh
Q 020431 17 RSTYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWF 96 (326)
Q Consensus 17 ~~~~~~l~~~~~~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l 96 (326)
...++.|..++ .+.+++.+|.++|+||+||+.+++.+|+++|+++.+++++++++++++++++..++.. +.+.+..++
T Consensus 94 ~~~l~~l~~~~-~~~~~~~~d~l~s~GE~~S~~l~a~~L~~~g~~a~~~~~~~~~~~t~~~~~~a~i~~~-~~~~~~~~~ 171 (454)
T PRK09034 94 EEILEHLANLA-SRNPDRLLDAFKARGEDLNAKLIAAYLNYEGIPARYVDPKEAGIIVTDEPGNAQVLPE-SYDNLKKLR 171 (454)
T ss_pred HHHHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCcEEEchHHceEEecCCcCceeEcHh-hHHHHHHHH
Confidence 33445555444 3577889999999999999999999999999999999999998888888887665542 456666666
Q ss_pred hcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHH
Q 020431 97 SQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEM 176 (326)
Q Consensus 97 ~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l 176 (326)
. .+.|||++||+|.+.+|+++|+|||||||+|+++|.+|+|+++.+|||||||||+|||++|+|+++++|||+||.||
T Consensus 172 ~--~~~v~Vv~GFig~~~~g~~ttlgRggSD~tA~~la~~l~A~~~~i~tdV~Gi~taDPr~v~~A~~l~~lsy~Ea~el 249 (454)
T PRK09034 172 D--RDEKLVIPGFFGVTKDGQIVTFSRGGSDITGAILARGVKADLYENFTDVDGIYAANPRIVKNPKSIKEITYREMREL 249 (454)
T ss_pred h--cCCEEEecCccccCCCCCEEecCCCcHHHHHHHHHHHcCCCEEEEEecCCccCcCCCCCCCCCeECCccCHHHHHHH
Confidence 5 66799999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCccc
Q 020431 177 SYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPG 256 (326)
Q Consensus 177 ~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~ 256 (326)
+++|+++|||+|+.||++++||++|+|+++|+.+||+|....... ....+++|+..+|+++|++.|.+|.+.+|
T Consensus 250 a~~Gakvlhp~ai~~a~~~~Ipi~v~~~~~p~~~GT~I~~~~~~~------~~~~Vk~It~~~~i~~Itv~~~~~~~~~g 323 (454)
T PRK09034 250 SYAGFSVFHDEALIPAYRGGIPINIKNTNNPEDPGTLIVPDRDNK------NKNPITGIAGDKGFTSIYISKYLMNREVG 323 (454)
T ss_pred HhCCcccCCHHHHHHHHHcCCCEEEEcCCCCCCCccEEEeccccC------ccccceEEEecCCEEEEEEccCCCCCCcc
Confidence 999999999999999999999999999999998999997642211 12469999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHH-HHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 257 TANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVA-EALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 257 i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av-~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
+++++|+.|+++||+|+|++ +|+.++||++++.+..++. +.+..+|..++ ....+.++.++|+|+
T Consensus 324 ~~a~if~~la~~~I~Vd~i~--ss~~sis~~v~~~~~~~a~~~~l~~el~~~~---~~~~I~~~~~va~Vs 389 (454)
T PRK09034 324 FGRKVLQILEDHGISYEHMP--SGIDDLSIIIRERQLTPKKEDEILAEIKQEL---NPDELEIEHDLAIIM 389 (454)
T ss_pred HHHHHHHHHHHcCCeEEEEc--CCCcEEEEEEeHHHhhHHHHHHHHHHHHHhh---CCceEEEeCCEEEEE
Confidence 99999999999999999997 7899999999999887765 66666665554 356799999999874
No 4
>PRK06291 aspartate kinase; Provisional
Probab=100.00 E-value=4.9e-57 Score=448.43 Aligned_cols=299 Identities=40% Similarity=0.614 Sum_probs=270.3
Q ss_pred HHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCC---ch
Q 020431 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPD---FS 86 (326)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~---~~ 86 (326)
.++..++.|++++. ++.+++.+|+++|+||+||+++++.+|+++|++|.++++++++++++++++...++ +.
T Consensus 96 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~~Sa~l~~~~L~~~Gi~a~~l~~~~~~i~t~~~~~~~~~~~~~~~ 175 (465)
T PRK06291 96 TIDSRIEELEKALVGVSYLGELTPRSRDYILSFGERLSAPILSGALRDLGIKSVALTGGEAGIITDSNFGNARPLPKTYE 175 (465)
T ss_pred HHHHHHHHHHHHHHHHHHhccCChHHHHHHHhhhHHHHHHHHHHHHHhCCCCeEEEchHHCcEEecCCCCceeechhhHH
Confidence 46667788888776 36788999999999999999999999999999999999999988888777765443 33
Q ss_pred hhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEe
Q 020431 87 ESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILR 166 (326)
Q Consensus 87 ~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~ 166 (326)
...+.++.+++ .+.|||++||+|.+++|.++|+||||||++|+++|.+|+|+++++||||||||++||+++|+|++++
T Consensus 176 ~~~~~~~~ll~--~~~vpVv~Gfig~~~~g~~~tlgrggsD~~A~~~A~~l~a~~~~i~tdV~Gi~~~dP~~~~~a~~i~ 253 (465)
T PRK06291 176 RVKERLEPLLK--EGVIPVVTGFIGETEEGIITTLGRGGSDYSAAIIGAALDADEIWIWTDVDGVMTTDPRIVPEARVIP 253 (465)
T ss_pred HHHHHHHHHhh--cCcEEEEeCcEEcCCCCCEEEecCCChHHHHHHHHHhcCCCEEEEEECCCCCCCCCCCCCCCCeEcc
Confidence 44456677776 7899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEE
Q 020431 167 TLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNV 246 (326)
Q Consensus 167 ~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~Isi 246 (326)
+++|+||.+++++|++++||+|+.+|+++|||++|.|+++|+.+||+|..... . ....+++|+..+|+++|++
T Consensus 254 ~l~~~ea~~l~~~G~~v~~~~a~~~~~~~~i~i~i~~~~~~~~~gt~i~~~~~-~------~~~~V~~It~~~~valIsI 326 (465)
T PRK06291 254 KISYIEAMELSYFGAKVLHPRTIEPAMEKGIPVRVKNTFNPEFPGTLITSDSE-S------SKRVVKAVTLIKNVALINI 326 (465)
T ss_pred ccCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEecCCCCCCCceEEEeccc-c------cCcccceEEeeCCEEEEEE
Confidence 99999999999999999999999999999999999999999999999976422 1 1246999999999999999
Q ss_pred ecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 247 EGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 247 vG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
+|.+|.+.+|+++++|+.|+++||+|+||+|++|+.+++|+|++++.+++++.||+.|... ..+.++++.++++|+
T Consensus 327 ~g~~m~~~~g~~arvf~~L~~~gI~V~mIsq~sse~sIsf~V~~~d~~~av~~L~~~~~~~----~~~~i~~~~~~a~Is 402 (465)
T PRK06291 327 SGAGMVGVPGTAARIFSALAEEGVNVIMISQGSSESNISLVVDEADLEKALKALRREFGEG----LVRDVTFDKDVCVVA 402 (465)
T ss_pred eCCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCCceEEEEEeHHHHHHHHHHHHHHHHHh----cCcceEEeCCEEEEE
Confidence 9999999999999999999999999999999999999999999999999999999988754 367899999999873
No 5
>PRK09084 aspartate kinase III; Validated
Probab=100.00 E-value=9.9e-57 Score=443.78 Aligned_cols=299 Identities=28% Similarity=0.465 Sum_probs=264.1
Q ss_pred HHHHHHHHHHHhhhcC---CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHH
Q 020431 14 EFIRSTYNFLSNVDSG---HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEK 90 (326)
Q Consensus 14 ~~i~~~~~~l~~~~~~---~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~ 90 (326)
+.++..++.|++++++ +.+++.+|.++|+||+||+++++.+|+++|++|.+++++++ +.+++.+++..+++..+..
T Consensus 84 ~~i~~~~~~l~~l~~~~~~~~~~~~~d~i~s~GE~lSa~l~~~~L~~~Gi~a~~l~~~~~-i~t~~~~~~~~~~~~~~~~ 162 (448)
T PRK09084 84 EEIERLLENITVLAEAASLATSPALTDELVSHGELMSTLLFVELLRERGVQAEWFDVRKV-MRTDDRFGRAEPDVAALAE 162 (448)
T ss_pred HHHHHHHHHHHHHHHhhhhcCChhhhhhhhhHHHHHHHHHHHHHHHhCCCCcEEEchHHe-EEecCCCCcccccHHHHHH
Confidence 4577889999999876 47889999999999999999999999999999999999999 4566677777787766655
Q ss_pred HHHHHhhc--CCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeee
Q 020431 91 RLEKWFSQ--SPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTL 168 (326)
Q Consensus 91 ~i~~~l~~--~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~l 168 (326)
.+.+.+.. ..+ |||++||+|.+.+|.++|+||||||++|+++|.+|+|+++++|||||||||+|||++|+|+++++|
T Consensus 163 ~~~~~~~~~~~~~-v~Vv~Gf~g~~~~G~~ttLgRggSD~~a~~~a~~l~a~~~~i~tdv~Gi~t~dP~~~~~a~~i~~i 241 (448)
T PRK09084 163 LAQEQLLPLLAEG-VVVTQGFIGSDEKGRTTTLGRGGSDYSAALLAEALNASRVEIWTDVPGIYTTDPRIVPAAKRIDEI 241 (448)
T ss_pred HHHHHHHHhhcCC-cEEecCeeecCCCCCEeecCCCchHHHHHHHHHHcCCCEEEEEECCCccccCCCCCCCCCeEcccC
Confidence 55544432 145 999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEec
Q 020431 169 SYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEG 248 (326)
Q Consensus 169 s~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG 248 (326)
+|+||.||+++|++++||+++.++++++||++|+|+++|+.+||+|..... ....+++|+..+|+++|++.|
T Consensus 242 s~~ea~ela~~Ga~vlh~~~~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~--------~~~~v~~it~~~~i~lItv~~ 313 (448)
T PRK09084 242 SFEEAAEMATFGAKVLHPATLLPAVRSNIPVFVGSSKDPEAGGTWICNDTE--------NPPLFRAIALRRNQTLLTLHS 313 (448)
T ss_pred CHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEEeCCCCCCCceEEecCCC--------CCCeeEEEEeeCCEEEEEEec
Confidence 999999999999999999999999999999999999999989999976421 123699999999999999999
Q ss_pred CCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccH-HHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 249 TGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEV-KAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 249 ~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~-~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
.+|.+.+|+++++|+.|++++|+|+||+ +|+.+|||++++++. .++...+.+++..++. .+.+++++.++++|+
T Consensus 314 ~~~~~~~g~~a~if~~l~~~~I~Vd~I~--sse~sIs~~i~~~~~~~~~~~~~~~~l~~el~--~~~~i~~~~~va~Is 388 (448)
T PRK09084 314 LNMLHARGFLAEVFGILARHKISVDLIT--TSEVSVSLTLDTTGSTSTGDTLLTQALLTELS--QLCRVEVEEGLALVA 388 (448)
T ss_pred CCCCccccHHHHHHHHHHHcCCeEEEEe--ccCcEEEEEEechhhhhhhhHHHHHHHHHHHh--cCCeEEEECCeEEEE
Confidence 9999999999999999999999999999 468999999999874 4455556666665654 478899999999874
No 6
>PRK09436 thrA bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional
Probab=100.00 E-value=1.3e-56 Score=469.89 Aligned_cols=304 Identities=39% Similarity=0.634 Sum_probs=280.3
Q ss_pred HHHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhh
Q 020431 14 EFIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSES 88 (326)
Q Consensus 14 ~~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~ 88 (326)
++|+..|+.|+++++ ++.+++.+|+++|+||+||+++++.+|+++|++|.+++++++++ +++.+++..+++..+
T Consensus 92 ~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~i~-t~~~~~~~~~~~~~~ 170 (819)
T PRK09436 92 AKVDQEFAQLKDILHGISLLGECPDSVNAAIISRGERLSIAIMAAVLEARGHDVTVIDPRELLL-ADGHYLESTVDIAES 170 (819)
T ss_pred HHHHHHHHHHHHHHHHHHhhccCChhhhhheeeHHHHHHHHHHHHHHHhCCCCeEEECHHHeEE-ecCCCCCceechHhh
Confidence 457777888888776 47789999999999999999999999999999999999999854 566777777887778
Q ss_pred HHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeee
Q 020431 89 EKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTL 168 (326)
Q Consensus 89 ~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~l 168 (326)
++.+++++.. .+.|||++||+|.+.+|+++|+||||||++|+++|.+++|+.+++|||||||||+||+.+|+|++++++
T Consensus 171 ~~~i~~~~~~-~~~v~Vv~Gfig~~~~G~~ttlGRgGSD~~A~~~A~~l~A~~~~i~tdVdGvyt~DP~~~~~A~~i~~i 249 (819)
T PRK09436 171 TRRIAASFIP-ADHVILMPGFTAGNEKGELVTLGRNGSDYSAAILAACLDADCCEIWTDVDGVYTADPRVVPDARLLKSL 249 (819)
T ss_pred HHHHHHHHhc-CCcEEEecCcccCCCCCCEEEeCCCCchHHHHHHHHHcCCCEEEEEECCCceECCCCCCCCCCeEeeEe
Confidence 8888888752 478999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEec
Q 020431 169 SYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEG 248 (326)
Q Consensus 169 s~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG 248 (326)
+|+|+.+++++|++++||+|+.+|+++|||++|+|+++|+.+||+|+.... + ....+++|+.++|+++|+++|
T Consensus 250 sy~ea~el~~~G~kvlhp~a~~~a~~~~Ipi~i~n~~~p~~~GT~I~~~~~-~------~~~~Vk~It~~~dvalIsV~G 322 (819)
T PRK09436 250 SYQEAMELSYFGAKVLHPRTIAPIAQFQIPCLIKNTFNPQAPGTLIGAESD-E------DSLPVKGISNLNNMAMFNVSG 322 (819)
T ss_pred cHHHHHHHHhcCCccchHHHHHHHHHCCceEEEccCCCCCCCceEEEecCc-c------cccccceEEEeCCEEEEEEEc
Confidence 999999999999999999999999999999999999999999999976421 1 235699999999999999999
Q ss_pred CCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 249 TGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 249 ~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
.+|...+|+++++|+.|+++||+|+|++|++|+.+|||+|++++.+++++.||++|..++....++++++.+++++|+
T Consensus 323 ~gm~~~~G~~arIf~~La~~gI~V~mIsqssSe~sIsf~V~~~d~~~av~~L~~~f~~el~~~~~~~i~~~~~valIs 400 (819)
T PRK09436 323 PGMKGMVGMASRVFAALSRAGISVVLITQSSSEYSISFCVPQSDAAKAKRALEEEFALELKEGLLEPLEVEENLAIIS 400 (819)
T ss_pred CCCCCCcCHHHHHHHHHHHCCCcEEEEEcCCCCceEEEEEeHHHHHHHHHHHHHHHHHHhccCCcceEEEeCCEEEEE
Confidence 999999999999999999999999999999999999999999999999999999998888888899999999999874
No 7
>PRK09466 metL bifunctional aspartate kinase II/homoserine dehydrogenase II; Provisional
Probab=100.00 E-value=9.8e-56 Score=460.72 Aligned_cols=295 Identities=27% Similarity=0.407 Sum_probs=264.3
Q ss_pred HHHHHHHHHHhhhcCCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHH
Q 020431 15 FIRSTYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEK 94 (326)
Q Consensus 15 ~i~~~~~~l~~~~~~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~ 94 (326)
.++..++.|++++.++++++.+|+++|+||+||+++++.+|+++|+++.++++++++. +++. +...++...+++++++
T Consensus 101 ~i~~~~~~l~~~l~~~~~~~~~d~ils~GE~~Sa~lla~~L~~~G~~a~~ld~~~~i~-~~~~-~~~~i~~~~~~~~l~~ 178 (810)
T PRK09466 101 RLISDLERLAALLDGGINDAQYAEVVGHGEVWSARLMAALLNQQGLPAAWLDARSFLR-AERA-AQPQVDEGLSYPLLQQ 178 (810)
T ss_pred HHHHHHHHHHHHhhccCCchhhhheecHHHHHHHHHHHHHHHhCCCCcEEEcHHHhee-cCCC-CCcccchhhhHHHHHH
Confidence 3667788999999899999999999999999999999999999999999999999844 4333 2345666667788988
Q ss_pred HhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHH
Q 020431 95 WFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAW 174 (326)
Q Consensus 95 ~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~ 174 (326)
++....+.|||++||+|.+.+|+++|+|||||||+|+++|.+|+|++++||||||||||+|||++|+|+++++|||+||.
T Consensus 179 ~~~~~~~~v~Vv~GF~g~~~~G~~ttLGRGGSD~tA~~la~~l~A~~v~i~tDV~Gi~taDPr~v~~A~~i~~isy~Ea~ 258 (810)
T PRK09466 179 LLAQHPGKRLVVTGFISRNEAGETVLLGRNGSDYSATLIGALAGVERVTIWSDVAGVYSADPRKVKDACLLPLLRLDEAS 258 (810)
T ss_pred HHhccCCeEEEeeCccccCCCCCEEEcCCChHHHHHHHHHHHcCCCEEEEEeCCCccccCCcccCCCceEcccCCHHHHH
Confidence 88744558999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCc
Q 020431 175 EMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGV 254 (326)
Q Consensus 175 ~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~ 254 (326)
||+++|++|+||+|++|++++|||++|+|+++|+.+||+|..... ....++.|+..+|+++|++.+.++.+.
T Consensus 259 ela~~GakVlHp~ti~pa~~~~Ipi~V~ntf~p~~~GT~I~~~~~--------~~~~v~~It~~~~v~~i~i~~~~~~g~ 330 (810)
T PRK09466 259 ELARLAAPVLHARTLQPVSGSDIDLQLRCSYQPEQGSTRIERVLA--------SGTGARIVTSLDDVCLIELQVPASHDF 330 (810)
T ss_pred HHHHcCccccCHHHHHHHHHcCCeEEEecCCCCCCCceEEecCcc--------cccceeeeeccCCEEEEEEecCCcCCc
Confidence 999999999999999999999999999999999999999975311 123578999999999999999888889
Q ss_pred ccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 255 PGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 255 ~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
+|+.+++|+.|++++|+++||+|++++.+++|.++..+.+++.+.|++.. ..++++++.++|+|+
T Consensus 331 ~g~~~~if~~l~~~~I~v~~i~~~~s~~sis~~i~~~~~~~~~~~l~~~~-------~~~~i~v~~~~a~Vs 395 (810)
T PRK09466 331 KLAQKELDQLLKRAQLRPLAVGVHPDRQLLQLAYTSEVADSALKLLDDAA-------LPGELKLREGLALVA 395 (810)
T ss_pred chHHHHHHHHHHHCCCeEEEEEecCCCcEEEEEEeHHHHHHHHHHHHhhc-------CCCcEEEeCCeEEEE
Confidence 99999999999999999999999999999999999888888888887742 127899999999874
No 8
>PRK09181 aspartate kinase; Validated
Probab=100.00 E-value=8.1e-54 Score=423.84 Aligned_cols=282 Identities=20% Similarity=0.279 Sum_probs=240.8
Q ss_pred HHHHHHHHHhhhc------CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhH
Q 020431 16 IRSTYNFLSNVDS------GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESE 89 (326)
Q Consensus 16 i~~~~~~l~~~~~------~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~ 89 (326)
++..++.+.+++. ++++++.+|.++|+||+||+++|+.+|+++|++|.++++..+.. ++ ++ .+.
T Consensus 113 ~~~~l~~l~~~l~~~~~~l~e~~~~~~D~l~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~~~-~~--------~~-~~~ 182 (475)
T PRK09181 113 ARACLIDLQRLCAYGHFSLDEHLLTVREMLASIGEAHSAFNTALLLQNRGVNARFVDLTGWDD-DD--------PL-TLD 182 (475)
T ss_pred HHHHHHHHHHHHhcCcchhhccChhHhHHHhhHhHHHHHHHHHHHHHhCCCCeEEeccccccC-Cc--------cc-chH
Confidence 4666777777654 57899999999999999999999999999999999998865532 11 11 134
Q ss_pred HHHHHHhhc--CCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCC--CCCeEE
Q 020431 90 KRLEKWFSQ--SPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKV--SEAVIL 165 (326)
Q Consensus 90 ~~i~~~l~~--~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~--~~a~~i 165 (326)
+++++.++. ..+.|||++||+ .+.+|+++|||||||||+|+++|.+|+|+++.+||||+ |||+|||++ |+|+++
T Consensus 183 ~~i~~~l~~~~~~~~v~Vv~GF~-~~~~G~itTLGRGGSDyTAailAa~L~A~~~~IwTDV~-I~taDPriV~~~~A~~i 260 (475)
T PRK09181 183 ERIKKAFKDIDVTKELPIVTGYA-KCKEGLMRTFDRGYSEMTFSRIAVLTGADEAIIHKEYH-LSSADPKLVGEDKVVPI 260 (475)
T ss_pred HHHHHHHhhhccCCcEEEecCCc-CCCCCCEEecCCChHHHHHHHHHHHcCCCEEEEeCCCc-cccCCCCcCCCCCCeEc
Confidence 667766652 246899999996 57789999999999999999999999999999999996 999999999 699999
Q ss_pred eeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEE
Q 020431 166 RTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVN 245 (326)
Q Consensus 166 ~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~Is 245 (326)
++|||+||.||+++|++|+||+|++||++++||++|+|+++|+.+||+|..... . ....+++|+..+|+++|+
T Consensus 261 ~~lsy~Ea~ELA~~GAkVLHp~ti~pa~~~~Ipi~V~nt~~p~~~GT~I~~~~~-~------~~~~ik~It~~~~~~~i~ 333 (475)
T PRK09181 261 GRTNYDVADQLANLGMEAIHPKAAKGLRQAGIPLRIKNTFEPEHPGTLITKDYV-S------EQPRVEIIAGSDKVFALE 333 (475)
T ss_pred CccCHHHHHHHHHcCchhcCHHHHHHHHHcCCeEEEecCCCCCCCCeEEecCcc-c------ccccceeEeccCCEEEEE
Confidence 999999999999999999999999999999999999999999999999976421 1 124589999999999999
Q ss_pred EecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccc-c-HHHHHHHHHHHHHHHhcCCCCcceEEEcCee
Q 020431 246 VEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEK-E-VKAVAEALESKFREALNAGRLSQVCLSFWLC 323 (326)
Q Consensus 246 ivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~-d-~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~ 323 (326)
+.|.+|...+|+.+++|+.|++++|+|+|++ +|+.++||+++.+ + ..++++.|+++|. .+++++ ++++
T Consensus 334 i~~~~~~~~~g~~~~if~~l~~~~i~v~~i~--ss~~sis~~v~~~~~~~~~~~~~L~~~~~-------~~~i~~-~~~a 403 (475)
T PRK09181 334 VFDQDMVGEDGYDLEILEILTRHKVSYISKA--TNANTITHYLWGSLKTLKRVIAELEKRYP-------NAEVTV-RKVA 403 (475)
T ss_pred EcCCCCCCcchHHHHHHHHHHHcCCeEEEEE--ecCcEEEEEEcCChHHHHHHHHHHHHhcC-------CceEEE-CCce
Confidence 9999999999999999999999999999998 5689999999988 3 5667777776542 235664 8888
Q ss_pred ecC
Q 020431 324 DYT 326 (326)
Q Consensus 324 ~~~ 326 (326)
+|+
T Consensus 404 ~Vs 406 (475)
T PRK09181 404 IVS 406 (475)
T ss_pred EEE
Confidence 763
No 9
>TIGR00656 asp_kin_monofn aspartate kinase, monofunctional class. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. The protein slr0657 from Synechocystis PCC6803 is extended by a duplication of the C-terminal region corresponding to the beta chain. Incorporation of a second copy of the C-terminal domain may be quite common in this subgroup of aspartokinases.
Probab=100.00 E-value=5.6e-53 Score=412.73 Aligned_cols=282 Identities=35% Similarity=0.533 Sum_probs=256.9
Q ss_pred CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCc
Q 020431 30 HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGF 109 (326)
Q Consensus 30 ~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gf 109 (326)
..++..+|.++++||++|+++++++|+++|+++.++++.+..+++++++++..+....+++.+.++++ .+.|||++||
T Consensus 60 ~~~~~~~~~i~~~Ge~~s~~~~~~~l~~~g~~a~~l~~~~~~~~t~~~~~~~~~~~~~~~~~l~~~l~--~~~vpVi~g~ 137 (401)
T TIGR00656 60 AITPRERDELVSHGERLSSALFSGALRDLGVKAIWLDGGEAGIITDDNFGNAKIDIIATEERLLPLLE--EGIIVVVAGF 137 (401)
T ss_pred CCChHHHHHHhhHHHHHHHHHHHHHHHhCCCceEEeccccceEEeCCCCCceEeeecchHHHHHHHHh--CCCEEEecCc
Confidence 34677789999999999999999999999999999999998888877776555555555588899988 8899999999
Q ss_pred cccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhH
Q 020431 110 IASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTI 189 (326)
Q Consensus 110 i~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~ 189 (326)
+|.+.+|.++++||||||++|+.+|.+|+|+++++||||||||++||+++|+|+++++++|+||.+|+++|++++||+|+
T Consensus 138 ~~~~~~g~~~~lgrg~sD~~A~~lA~~l~A~~l~i~tdV~Gv~~~DP~~~~~a~~i~~ls~~ea~~l~~~G~~v~~~~a~ 217 (401)
T TIGR00656 138 QGATEKGYTTTLGRGGSDYTAALLAAALKADRVDIYTDVPGVYTTDPRVVEAAKRIDKISYEEALELATFGAKVLHPRTV 217 (401)
T ss_pred ceeCCCCCEeecCCCcHHHHHHHHHHHcCCCEEEEEECCCCCCcCCCCCCCCcEECCccCHHHHHHHHHcCCcccCHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCC
Q 020431 190 IPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVG 269 (326)
Q Consensus 190 ~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~ 269 (326)
++|++++||++|.|+++|+ +||+|.++.. ....+++|+.++|+++|+++|.+|.+.+|+++++|+.|++++
T Consensus 218 ~~a~~~~i~i~i~~~~~~~-~gT~I~~~~~--------~~~~v~~I~~~~~va~vsv~g~~~~~~~g~~~~if~~L~~~~ 288 (401)
T TIGR00656 218 EPAMRSGVPIEVRSSFDPE-EGTLITNSME--------NPPLVKGIALRKNVTRVTVHGLGMLGKRGFLARIFGALAERN 288 (401)
T ss_pred HHHHHCCCeEEEEECCCCC-CCeEEEeCcc--------cCCceEEEEEECCEEEEEEecCCCCCCccHHHHHHHHHHHcC
Confidence 9999999999999999988 8999976421 123699999999999999999999999999999999999999
Q ss_pred CcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 270 ANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 270 I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
|+++|++|+.|+.+++|+|++++.+++++.||+.|... .+..++++.++++|+
T Consensus 289 I~i~~i~~~~s~~~Is~~V~~~d~~~a~~~L~~~~~~~----~~~~i~~~~~~a~Is 341 (401)
T TIGR00656 289 INVDLISQTPSETSISLTVDETDADEAVRALKDQSGAA----GLDRVEVEEGLAKVS 341 (401)
T ss_pred CcEEEEEcCCCCceEEEEEeHHHHHHHHHHHHHHHHhc----CCceEEEeCCeEEEE
Confidence 99999999889999999999999999999999976332 267789999988763
No 10
>PRK05925 aspartate kinase; Provisional
Probab=100.00 E-value=2.4e-52 Score=410.19 Aligned_cols=292 Identities=23% Similarity=0.379 Sum_probs=249.6
Q ss_pred HHHHHHHhhh-cCCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHh
Q 020431 18 STYNFLSNVD-SGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWF 96 (326)
Q Consensus 18 ~~~~~l~~~~-~~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l 96 (326)
..++.|++++ .++.+++.+|+++|+||+||+++++.+|+++|++|.+++++++ +.++++|++..++...+.+.+.+..
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~d~i~s~GE~~Sa~l~a~~L~~~Gi~a~~ld~~~~-i~t~~~~~~a~~~~~~~~~~~~~~~ 161 (440)
T PRK05925 83 PWWERLEHFEDVEEISSEDQARILAIGEDISASLICAYCCTYVLPLEFLEARQV-ILTDDQYLRAVPDLALMQTAWHELA 161 (440)
T ss_pred HHHHHHHHHHHhCcCCchhhhhheehhHHHHHHHHHHHHHhCCCCeEEEcHHHh-EeecCCccccccCHHHHHHHHHHhh
Confidence 3445566665 3677889999999999999999999999999999999999998 5566677777788766766666544
Q ss_pred hcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHH
Q 020431 97 SQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEM 176 (326)
Q Consensus 97 ~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l 176 (326)
. ..+.|||++||+|.+.+|+++|+||||||++|+++|.+++|+.+++|||||||||+||+++|+|+++++++|+|+.++
T Consensus 162 ~-~~~~v~Vv~GF~g~~~~G~~ttLgrGgsD~~AallA~~l~Ad~~~i~TdVdGvytaDP~~~~~A~~i~~is~~ea~el 240 (440)
T PRK05925 162 L-QEDAIYIMQGFIGANSSGKTTVLGRGGSDFSASLIAELCKAREVRIYTDVNGIYTMDPKIIKDAQLIPELSFEEMQNL 240 (440)
T ss_pred c-cCCcEEEecCcceeCCCCCEEEeccCcHHHHHHHHHHHcCCCEEEEEEcCCccCCCCcCCCCCCeEeeEECHHHHHHH
Confidence 3 256899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCccc
Q 020431 177 SYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPG 256 (326)
Q Consensus 177 ~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~ 256 (326)
+++|++++||+++++|+++|||++|.|+++|+.+||+|.+..... .....+++|+.++|+++|++.+.. ..++
T Consensus 241 a~~Ga~vl~~~~~~~a~~~~Ipi~I~~~~~p~~~GT~i~~~~~~~-----~~~~~ik~It~~~~~~~i~v~~~~--~~~~ 313 (440)
T PRK05925 241 ASFGAKVLHPPMLKPCVRAGIPIFVTSTFDVTKGGTWIYASDKEV-----SYEPRIKALSLKQNQALWSVDYNS--LGLV 313 (440)
T ss_pred HhCCCCcCCHHHHHHHHHCCCcEEEecCCCCCCCccEEecCCccc-----cCCCceEEEEEeCCEEEEEEecCC--cchh
Confidence 999999999999999999999999999999999999997642111 023469999999999999997643 3578
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccH-HHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 257 TANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEV-KAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 257 i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~-~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
+++++|+.|+++||++++++ +++.++||++++++. ..+++.|..+ + ..+.+++++.++++|+
T Consensus 314 ~~~~if~~l~~~~I~vd~i~--s~~~sis~~i~~~~~~~~~~~~l~~~----l--~~~~~i~~~~~~a~Vs 376 (440)
T PRK05925 314 RLEDVLGILRSLGIVPGLVM--AQNLGVYFTIDDDDISEEYPQHLTDA----L--SAFGTVSCEGPLALIT 376 (440)
T ss_pred HHHHHHHHHHHcCCcEEEEe--ccCCEEEEEEechhccHHHHHHHHHH----h--cCCceEEEECCEEEEE
Confidence 89999999999999999986 447899999999875 3355555443 2 2467899999999874
No 11
>TIGR00657 asp_kinases aspartate kinase. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. This may be a feature of a number of closely related forms, including a paralog from B. subtilis.
Probab=100.00 E-value=2.3e-52 Score=412.93 Aligned_cols=282 Identities=35% Similarity=0.531 Sum_probs=253.7
Q ss_pred ChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccc
Q 020431 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (326)
Q Consensus 32 ~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~ 111 (326)
+++.+|.++|+||+||+++++++|+++|++++++++.+.++++++++++..+......+.++++++ .+.|||++||+|
T Consensus 101 ~~~~~d~ils~GE~~s~~l~~~~l~~~Gi~a~~l~~~~~~l~t~~~~~~~~~~~~~~~~~l~~~l~--~~~vpVv~G~~g 178 (441)
T TIGR00657 101 KPREMDRILSFGERLSAALLSAALEELGVKAVSLLGGEAGILTDSNFGRARVIIEILTERLEPLLE--EGIIPVVAGFQG 178 (441)
T ss_pred CcchHhheecHHHHHHHHHHHHHHHhCCCCCEEEEcCcceEEecCCCCceeecHhhhHHHHHHHHh--cCCEEEEeCcEe
Confidence 467889999999999999999999999999999999999888877776543234445688999988 789999999999
Q ss_pred cCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHH
Q 020431 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (326)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~ 191 (326)
.+.+|+++++||||||++|+.+|.+|+|+++++||||||||++||+.+|+++++++++|+|+.+|+++|++++||+|+++
T Consensus 179 ~~~~g~~~~lgrggsD~~A~~lA~~l~a~~l~~~tDV~Gv~~~DP~~~~~a~~i~~is~~ea~el~~~G~~v~~~~a~~~ 258 (441)
T TIGR00657 179 ATEKGETTTLGRGGSDYTAALLAAALKADECEIYTDVDGIYTTDPRIVPDARRIDEISYEEMLELASFGAKVLHPRTLEP 258 (441)
T ss_pred eCCCCCEeecCCCchHHHHHHHHHHcCCCEEEEEECCCCCCcCCCCCCCCCeECCccCHHHHHHHHhcCCcccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCc
Q 020431 192 VMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGAN 271 (326)
Q Consensus 192 a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~ 271 (326)
+++++||++|.|+++|+.+||+|.+..... ....+++|+..+++++|++.|.+|.. +|+++++|+.|+++||+
T Consensus 259 ~~~~~i~i~i~~~~~~~~~GT~I~~~~~~~------~~~~i~~It~~~~v~~Isv~g~~~~~-~g~la~if~~L~~~~I~ 331 (441)
T TIGR00657 259 AMRAKIPIVVKSTFNPEAPGTLIVASTKEM------EEPIVKGLSLDRNQARVTVSGLGMKG-PGFLARVFGALAEAGIN 331 (441)
T ss_pred HHHcCCeEEEecCCCCCCCceEEEeCCCcc------ccCccceEEEeCCEEEEEEECCCCCC-ccHHHHHHHHHHHcCCe
Confidence 999999999999999988999998643211 22468999999999999999999998 99999999999999999
Q ss_pred EEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 272 VIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 272 v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
|++++|++|+.+|+|++++++.+++.+.|.. ......+..+.++.++++++
T Consensus 332 I~~i~q~~se~sIs~~I~~~~~~~a~~~L~~----~~~~~~~~~I~~~~~~a~Vs 382 (441)
T TIGR00657 332 VDLITQSSSETSISFTVDKEDADQAKTLLKS----ELNLSALSSVEVEKGLAKVS 382 (441)
T ss_pred EEEEEecCCCceEEEEEEHHHHHHHHHHHHH----HHHhcCcceEEEcCCeEEEE
Confidence 9999999999999999999999988887744 22345577899999998874
No 12
>KOG0456 consensus Aspartate kinase [Amino acid transport and metabolism]
Probab=100.00 E-value=1.3e-53 Score=397.27 Aligned_cols=298 Identities=27% Similarity=0.399 Sum_probs=249.9
Q ss_pred hhHHHHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCc
Q 020431 11 LSYEFIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDF 85 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~ 85 (326)
+|...+..+.+.|+++++ +|.+++.+|+++|+||.||+|.|+++|+..|++|..+|+.+++.++-+.+...+..+
T Consensus 162 ~d~~v~~~~le~leq~Lk~i~mm~Elt~RTrD~lvs~GE~lS~rf~aA~lnd~G~kar~~D~~~I~~~~~d~~t~~d~~~ 241 (559)
T KOG0456|consen 162 VDPAVIAKLLEGLEQLLKGIAMMKELTLRTRDYLVSFGECLSTRFFAAYLNDIGHKARQYDAFEIGFITTDDFTNDDILE 241 (559)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHHHhcchhhhhHhhhhhhHHHHHHHHHHHHhcCccceeechhheeccccccccchhHHH
Confidence 456677788888999887 599999999999999999999999999999999999999999777644443222211
Q ss_pred hhhHHHHHHHhh-c--CCCcEEEecCccc-cCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCC
Q 020431 86 SESEKRLEKWFS-Q--SPSNTIIATGFIA-STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSE 161 (326)
Q Consensus 86 ~~~~~~i~~~l~-~--~~~~ipVv~Gfi~-~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~ 161 (326)
......-+++. . ..+.|||++||.| ....|-.+++||||+|.+|+.+|.+||++++.+|+|||||+|+||+++|.
T Consensus 242 -a~~~av~k~~~~~~aken~VPVvTGf~Gk~~~tg~lt~lGRG~sDl~At~i~~al~~~EiQVWKdVDGv~T~DP~~~p~ 320 (559)
T KOG0456|consen 242 -ATYPAVSKLLSGDWAKENAVPVVTGFLGKGWPTGALTTLGRGGSDLTATTIGKALGLDEIQVWKDVDGVLTCDPRIYPG 320 (559)
T ss_pred -HHHHHHHHhcccccccCCccceEeeccccCccccceecccCCchhhHHHHHHHHcCchhhhhhhhcCceEecCCccCCC
Confidence 11111122222 2 3568999999999 66889999999999999999999999999999999999999999999999
Q ss_pred CeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCC--------------------C
Q 020431 162 AVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVD--------------------E 221 (326)
Q Consensus 162 a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~--------------------~ 221 (326)
|++++.+|++||.||+|+|+.|+||-++.++.+.+||++|.|..+|.++||.|.++.+- .
T Consensus 321 Ar~vp~lT~dEAaELaYfGaqVlHP~sM~~~~~~~IPvRvKN~~NP~~~GTvI~~d~~m~k~~~TsI~lK~nv~mldI~S 400 (559)
T KOG0456|consen 321 ARLVPYLTFDEAAELAYFGAQVLHPFSMRPAREGRIPVRVKNSYNPTAPGTVITPDRDMSKAGLTSIVLKRNVTMLDIAS 400 (559)
T ss_pred ccccCccCHHHHHHHHhhhhhhccccccchhhccCcceEeecCCCCCCCceEeccchhhhhccceEEEEeccEEEEEecc
Confidence 99999999999999999999999999999999999999999999999999999876320 0
Q ss_pred C---------------------------------cc------------hh-------hccCCeeeEEeecCeEEEEEecC
Q 020431 222 N---------------------------------ED------------EQ-------IIDSPVKGFATIDNLALVNVEGT 249 (326)
Q Consensus 222 ~---------------------------------~~------------~~-------~~~~~v~~I~~~~~ia~IsivG~ 249 (326)
+ .+ .| .+-..+-.+...++.++||++|.
T Consensus 401 tr~l~q~GFLAkvFti~ek~~isVDvvaTSEV~iSltL~~~~~~sreliq~~l~~a~eeL~ki~~vdll~~~sIiSLiGn 480 (559)
T KOG0456|consen 401 TRMLGQHGFLAKVFTIFEKLGISVDVVATSEVSISLTLDPSKLDSRELIQGELDQAVEELEKIAVVDLLKGRSIISLIGN 480 (559)
T ss_pred cchhhhhhHHHHHHHHHHHhCcEEEEEEeeeEEEEEecChhhhhhHHHHHhhHHHHHHHHHHhhhhhhhccchHHhhhhh
Confidence 0 00 00 00111223344568899999998
Q ss_pred CCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcC
Q 020431 250 GMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNA 310 (326)
Q Consensus 250 ~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~ 310 (326)
|++..+++.+.|..|++.||||.|||||+|+.+|||+|++++..++++.||++|+..+..
T Consensus 481 -vq~ss~i~~rmF~~l~e~giNvqMISQGAskvNIS~ivne~ea~k~v~~lH~~~~e~~~~ 540 (559)
T KOG0456|consen 481 -VQNSSGILERMFCVLAENGINVQMISQGASKVNISCIVNEKEAEKCVQALHKAFFETLDL 540 (559)
T ss_pred -hhhhhHHHHHHHHHHHhcCcceeeeccccccceEEEEEChHHHHHHHHHHHHHHcCCCCc
Confidence 999999999999999999999999999999999999999999999999999999877533
No 13
>PRK08841 aspartate kinase; Validated
Probab=100.00 E-value=2.4e-51 Score=398.56 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=232.3
Q ss_pred CChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCcc
Q 020431 31 ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFI 110 (326)
Q Consensus 31 ~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi 110 (326)
.+++.+|.++|+||++|+.+++.+|+++|+++.+++++++++++++.++...+... ..+.++++++ .+.|||++||+
T Consensus 61 ~~~~~~d~l~s~GE~~s~~lla~~L~~~Gi~a~~l~~~~~~i~t~~~~~~~~i~~~-~~~~i~~ll~--~~~vpVv~Gf~ 137 (392)
T PRK08841 61 PTARELDVLLSAGEQVSMALLAMTLNKLGYAARSLTGAQANIVTDNQHNDATIKHI-DTSTITELLE--QDQIVIVAGFQ 137 (392)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEehhHcCEEecCCCCCceechh-hHHHHHHHHh--CCCEEEEeCCc
Confidence 35677899999999999999999999999999999999987777766654434332 3478888888 78999999999
Q ss_pred ccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHH
Q 020431 111 ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTII 190 (326)
Q Consensus 111 ~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~ 190 (326)
|.+++|+++|+||||||++|+.+|.+|+|+++++||||||||++||+++|+|+++++++|+||.||+++|++++||+|++
T Consensus 138 g~~~~g~~ttlgrggsD~tAa~lA~~L~Ad~l~i~TDVdGVyt~DP~~v~~A~~i~~is~~ea~ela~~Ga~vlhp~ai~ 217 (392)
T PRK08841 138 GRNENGDITTLGRGGSDTTAVALAGALNADECQIFTDVDGVYTCDPRVVKNARKLDVIDFPSMEAMARKGAKVLHLPSVQ 217 (392)
T ss_pred ccCCCCCEEEeCCCChHHHHHHHHHHcCCCEEEEEeCCCCCCcCCCCCCCCceEcccccHHHHHHHHhcCccccCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCEEEEeccCCCCCceEEeCCCCC---------CC---------cc---------------------------h
Q 020431 191 PVMRYDIPIVIRNIFNLSVPGIMICRPPVD---------EN---------ED---------------------------E 225 (326)
Q Consensus 191 ~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~---------~~---------~~---------------------------~ 225 (326)
+|+++|||++|.|++++ .+||+|..+... .+ .+ .
T Consensus 218 ~a~~~~Ipi~i~n~~~~-~~GT~I~~~~~~~~i~~i~~~~~~~~i~v~~~~~~~i~~~l~~~~i~v~~i~~~~~~~~~~v 296 (392)
T PRK08841 218 HAWKHSVPLRVLSSFEV-GEGTLIKGEAGTQAVCGIALQRDLALIEVESESLPSLTKQCQMLGIEVWNVIEEADRAQIVI 296 (392)
T ss_pred HHHHCCCeEEEEecCCC-CCCeEEEeccCCCcEEEEEEeCCeEEEEeccchHHHHHHHHHHcCCCEEEEEecCCcEEEEE
Confidence 99999999999999986 579999643210 00 00 0
Q ss_pred -----h-hccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHH
Q 020431 226 -----Q-IIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEA 299 (326)
Q Consensus 226 -----~-~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~ 299 (326)
. ........+...+|+++|+++|.++ ||+.+++|++|++++||+.+++ +|+.+|||+|+++|.+++++.
T Consensus 297 ~~~~~~~~~~~~~~~i~~~~~~a~vsvVG~~~---~gv~~~~~~aL~~~~I~i~~i~--~s~~~is~vv~~~~~~~av~~ 371 (392)
T PRK08841 297 KQDACAKLKLVFDDKIRNSESVSLLTLVGLEA---NGMVEHACNLLAQNGIDVRQCS--TEPQSSMLVLDPANVDRAANI 371 (392)
T ss_pred CHHHHHHHHHhCcccEEEeCCEEEEEEECCCC---hHHHHHHHHHHHhCCCCEEEEE--CCCcEEEEEEeHHHHHHHHHH
Confidence 0 0011122477778999999999874 9999999999999999999998 578999999999999999999
Q ss_pred HHHHHHHH
Q 020431 300 LESKFREA 307 (326)
Q Consensus 300 Lh~~f~~~ 307 (326)
||++|+..
T Consensus 372 lH~~f~~~ 379 (392)
T PRK08841 372 LHKTYVTS 379 (392)
T ss_pred HHHHHcCC
Confidence 99999765
No 14
>PRK08961 bifunctional aspartate kinase/diaminopimelate decarboxylase protein; Provisional
Probab=100.00 E-value=6.9e-49 Score=415.01 Aligned_cols=295 Identities=32% Similarity=0.450 Sum_probs=252.6
Q ss_pred HHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCC-------CCC
Q 020431 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSN-------QVD 82 (326)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g-------~~~ 82 (326)
.++..++.|+++++ ++.+++.+|.++|+||+||+.+++.+|+++|+++.+++++++++++++.++ +..
T Consensus 93 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~~~~~~~~~~~~~~~~~~~~ 172 (861)
T PRK08961 93 VLAERLAALQRLLDGIRALTRASLRWQAEVLGQGELLSTTLGAAYLEASGLDMGWLDAREWLTALPQPNQSEWSQYLSVS 172 (861)
T ss_pred HHHHHHHHHHHHHHHHHHhccCChhhhheEEEehHHHHHHHHHHHHHhCCCCcEEEcHHHhEeecCccccccccccccce
Confidence 56677888888874 577899999999999999999999999999999999999999766652211 111
Q ss_pred CCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCC
Q 020431 83 PDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEA 162 (326)
Q Consensus 83 ~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a 162 (326)
++.......++.+++ ..+.|||++||+|.+.+|.++|+||||||++|+++|.+|+|+++++|||||||||+||+++|+|
T Consensus 173 ~~~~~~~~~~~~~~~-~~~~v~Vv~Gf~g~~~~g~~ttLgrggsD~~A~~iA~~l~a~~~~i~tdv~Gv~t~dP~~~~~a 251 (861)
T PRK08961 173 CQWQSDPALRERFAA-QPAQVLITQGFIARNADGGTALLGRGGSDTSAAYFAAKLGASRVEIWTDVPGMFSANPKEVPDA 251 (861)
T ss_pred ecHhhHHHHHHHHhc-cCCeEEEeCCcceeCCCCCEEEEeCCchHHHHHHHHHHcCCCEEEEEeCCCccccCCCCCCCCc
Confidence 212112234444443 2346999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeE
Q 020431 163 VILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLA 242 (326)
Q Consensus 163 ~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia 242 (326)
++++++||+|+.+|++.|++++||+|+++|+++|||++|.|+++|+.+||+|..+.. ....+++|+.++|++
T Consensus 252 ~~i~~ls~~e~~el~~~g~~v~~~~a~~~a~~~~i~i~v~~~~~~~~~gT~I~~~~~--------~~~~v~~It~~~~v~ 323 (861)
T PRK08961 252 RLLTRLDYDEAQEIATTGAKVLHPRSIKPCRDAGIPMAILDTERPDLSGTSIDGDAE--------PVPGVKAISRKNGIV 323 (861)
T ss_pred eEecccCHHHHHHHHHCCCeEECHHHHHHHHHCCCCEEEEeCCCCCCCccEEeCCCC--------CCCcceeEEEECCEE
Confidence 999999999999999999999999999999999999999999999889999976421 234699999999999
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHH---HHHHHHHHHHHHHhcCCCCcceEEE
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVK---AVAEALESKFREALNAGRLSQVCLS 319 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~---~av~~Lh~~f~~~~~~~~~~~v~~~ 319 (326)
+|++.+.+|.+.+|+++++|+.|++++|+|+||+ +|+.++||++++.+.. ++++.+.+++. .++.+.++
T Consensus 324 lItv~~~~~~~~~g~~a~if~~la~~~I~Vd~I~--sse~sis~~i~~~~~~~~~~~~~~l~~~l~------~~~~i~~~ 395 (861)
T PRK08961 324 LVSMETIGMWQQVGFLADVFTLFKKHGLSVDLIS--SSETNVTVSLDPSENLVNTDVLAALSADLS------QICRVKII 395 (861)
T ss_pred EEEEecCCccccccHHHHHHHHHHHcCCeEEEEE--cCCCEEEEEEccccccchHHHHHHHHHHHh------hcCcEEEe
Confidence 9999999999999999999999999999999998 5789999999998753 56666665542 36779999
Q ss_pred cCeeecC
Q 020431 320 FWLCDYT 326 (326)
Q Consensus 320 ~~~~~~~ 326 (326)
+++|+|+
T Consensus 396 ~~va~IS 402 (861)
T PRK08961 396 VPCAAVS 402 (861)
T ss_pred CCeEEEE
Confidence 9999874
No 15
>PRK06635 aspartate kinase; Reviewed
Probab=100.00 E-value=4.1e-48 Score=378.75 Aligned_cols=280 Identities=30% Similarity=0.470 Sum_probs=246.9
Q ss_pred ChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccc
Q 020431 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (326)
Q Consensus 32 ~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~ 111 (326)
++..++.++++||++|+++++.+|+++|+++.++++.+++++++.+++..++. ....+.++++++ .+.|||++||+|
T Consensus 62 ~~~~~~~~~~~Ge~~~~~~~~~~l~~~g~~a~~l~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~l~--~~~ipVi~g~~~ 138 (404)
T PRK06635 62 DPRELDMLLSTGEQVSVALLAMALQSLGVKARSFTGWQAGIITDSAHGKARIT-DIDPSRIREALD--EGDVVVVAGFQG 138 (404)
T ss_pred CHHHHHHHhhhhHHHHHHHHHHHHHhCCCCeEEeChhhCCEEecCCCCceEee-ecCHHHHHHHHh--CCCEEEecCccE
Confidence 56778999999999999999999999999999999999977776666543321 112478888988 789999999999
Q ss_pred cCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHH
Q 020431 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (326)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~ 191 (326)
.+++|+++++||||||++|+++|.+|+|+++++||||||||++||+.+|+++++++++|+|+.++++.|++++||+|+++
T Consensus 139 ~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tDV~Gv~~~dP~~~~~a~~i~~i~~~e~~~l~~~g~~~~~~~a~~~ 218 (404)
T PRK06635 139 VDEDGEITTLGRGGSDTTAVALAAALKADECEIYTDVDGVYTTDPRIVPKARKLDKISYEEMLELASLGAKVLHPRSVEY 218 (404)
T ss_pred eCCCCCEEecCCCChHHHHHHHHHHhCCCEEEEEEcCCCCCcCCCCCCCCceECCccCHHHHHHHHHcCCcccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCc
Q 020431 192 VMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGAN 271 (326)
Q Consensus 192 a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~ 271 (326)
++++|+|++|.|++++ ..||.|...... ......+++|+..+++++|+++| |.+.+|+++++|++|+++||+
T Consensus 219 ~~~~~i~~~i~~~~~~-~~gT~i~~~~~~-----~~~~~~i~~I~~~~~v~~Isv~g--~~~~~g~l~~i~~~L~~~~I~ 290 (404)
T PRK06635 219 AKKYNVPLRVRSSFSD-NPGTLITGEEEE-----IMEQPVVTGIAFDKDEAKVTVVG--VPDKPGIAAQIFGALAEANIN 290 (404)
T ss_pred HHHcCceEEEEcCCCC-CCCCEEeeCCcc-----ccccCceEEEEecCCeEEEEECC--CCCCccHHHHHHHHHHHcCCe
Confidence 9999999999999986 579999764320 01235689999999999999998 889999999999999999999
Q ss_pred EEEEEecCCc---cEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 272 VIMISQASSE---HSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 272 v~~Isq~~se---~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
+++++|+.++ .+++|++++++.+++++.||+ +..+. .+..+++..++++++
T Consensus 291 i~~is~s~~~~~~~~is~~v~~~~~~~a~~~L~~-~~~~~---~~~~i~~~~~ia~is 344 (404)
T PRK06635 291 VDMIVQNVSEDGKTDITFTVPRDDLEKALELLEE-VKDEI---GAESVTYDDDIAKVS 344 (404)
T ss_pred EEEEEecCCCCCceeEEEEEcHHHHHHHHHHHHH-HHHHc---CcceEEEcCCeEEEE
Confidence 9999998766 899999999999999999998 43333 255688888888763
No 16
>PRK08210 aspartate kinase I; Reviewed
Probab=100.00 E-value=2.8e-47 Score=372.75 Aligned_cols=278 Identities=26% Similarity=0.407 Sum_probs=239.2
Q ss_pred CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCc
Q 020431 30 HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGF 109 (326)
Q Consensus 30 ~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gf 109 (326)
..+++.+|.++++||++|+++++++|+++|+++.++++.+..+++++.++...+... ..+.++++++ .+.|||++||
T Consensus 65 ~~~~~~~~~l~~~Ge~~s~~~~~~~l~~~Gi~a~~l~~~~~~~~t~~~~~~~~v~~~-~~~~l~~~l~--~~~vpVi~G~ 141 (403)
T PRK08210 65 EISKREQDLLMSCGEIISSVVFSNMLNENGIKAVALTGGQAGIITDDNFTNAKIIEV-NPDRILEALE--EGDVVVVAGF 141 (403)
T ss_pred CCChHHHHHHHhHhHHHHHHHHHHHHHhCCCCeEEechHHccEEccCCCCceeeehh-hHHHHHHHHh--cCCEEEeeCe
Confidence 346778899999999999999999999999999999999987777766543323221 2378888887 7899999999
Q ss_pred cccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhH
Q 020431 110 IASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTI 189 (326)
Q Consensus 110 i~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~ 189 (326)
+|.+++|+++|+||||||++|+.+|.+|+|++++|||||||||++||+.+|+++++++|+|+|+.+++++|++++||+|+
T Consensus 142 ~~~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~i~tDV~GV~~~dP~~~~~a~~i~~ls~~ea~~l~~~G~~v~~~~a~ 221 (403)
T PRK08210 142 QGVTENGDITTLGRGGSDTTAAALGVALKAEYVDIYTDVDGIMTADPRIVEDARLLDVVSYNEVFQMAYQGAKVIHPRAV 221 (403)
T ss_pred eecCCCCCEEEeCCCchHHHHHHHHHHcCCCEEEEEECCCCCCcCCCCcCCCCeECCccCHHHHHHHHHCCccccCHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCC
Q 020431 190 IPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVG 269 (326)
Q Consensus 190 ~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~ 269 (326)
++|++++||++|+|++++ .+||+|.++....... +.....+++|+..+|+++|++.+..+ .+|+++++|+.|+++|
T Consensus 222 ~~~~~~~i~i~i~~~~~~-~~gT~I~~~~~~~~~~-~~~~~~v~~It~~~~i~~isv~~~~~--~~g~la~If~~L~~~~ 297 (403)
T PRK08210 222 EIAMQANIPLRIRSTYSD-SPGTLITSLGDAKGGI-DVEERLITGIAHVSNVTQIKVKAKEN--AYDLQQEVFKALAEAG 297 (403)
T ss_pred HHHHHCCCeEEEEecCCC-cCCcEEEecCcccccc-ccccCceEEEEEcCCcEEEEEecCCC--cchHHHHHHHHHHHcC
Confidence 999999999999999984 4699998653211000 01235799999999999999987654 3999999999999999
Q ss_pred CcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeec
Q 020431 270 ANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDY 325 (326)
Q Consensus 270 I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~ 325 (326)
|+|++++|+ ..+++|+++.++.+++.+.|++. ..++.+++++++|
T Consensus 298 I~i~~i~~~--~~~is~~v~~~~~~~a~~~l~~~---------~~~v~~~~~~a~i 342 (403)
T PRK08210 298 ISVDFINIF--PTEVVFTVSDEDSEKAKEILENL---------GLKPSVRENCAKV 342 (403)
T ss_pred CeEEEEEec--CceEEEEEcHHHHHHHHHHHHHh---------CCcEEEeCCcEEE
Confidence 999999986 34799999999999888777762 1268888888876
No 17
>PRK07431 aspartate kinase; Provisional
Probab=100.00 E-value=4.1e-46 Score=380.26 Aligned_cols=288 Identities=27% Similarity=0.419 Sum_probs=244.3
Q ss_pred CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecC
Q 020431 29 GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATG 108 (326)
Q Consensus 29 ~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~G 108 (326)
.+.+....|.++++||++|+.+++.+|+++|++++++++.++++++++.+|..++... ..+.++++++ .+.|||++|
T Consensus 59 ~~~~~~~~~~~ls~Ge~~s~~l~~~~l~~~gi~a~~l~~~~~~~~~~~~~~~~~i~~~-~~~~l~~~l~--~g~vpVv~g 135 (587)
T PRK07431 59 SNPPRREMDMLLSTGEQVSIALLSMALHELGQPAISLTGAQVGIVTESEHGRARILEI-KTDRIQRHLD--AGKVVVVAG 135 (587)
T ss_pred cCCCHHHHHHHHHHhHHHHHHHHHHHHHHCCCCeEEechhHcCeEecCCCCceeeeec-cHHHHHHHHh--CCCeEEecC
Confidence 3456678899999999999999999999999999999999998887766554322221 2268888888 789999999
Q ss_pred ccccCCC--CCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccch
Q 020431 109 FIASTPD--NIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHP 186 (326)
Q Consensus 109 fi~~~~~--g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~ 186 (326)
|+|.+.+ |+++|+||||||++|+++|.+|+|+++++||||||||++||+++|+|+++++++|+|+.+|+++|+++|||
T Consensus 136 ~~g~~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~i~TDVdGVyt~DP~~~~~a~~i~~i~~~e~~el~~~G~~v~~~ 215 (587)
T PRK07431 136 FQGISLSSNLEITTLGRGGSDTSAVALAAALGADACEIYTDVPGVLTTDPRLVPEAQLMDEISCDEMLELASLGASVLHP 215 (587)
T ss_pred CcCCCCCCCCCEeecCCCchHHHHHHHHHHcCCCEEEEEeCCCccCcCCCCCCCCCeECCCcCHHHHHHHHhCCCceEhH
Confidence 9987644 88999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcch-hhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHH
Q 020431 187 RTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDE-QIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAV 265 (326)
Q Consensus 187 ~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~-~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L 265 (326)
+|+++++++|||++|+|++. +..||+|.+......... ......+++++..+|++++++. ++.+.+|+++++|+.|
T Consensus 216 ~a~~~~~~~~i~i~i~~~~~-~~~GT~i~~~~~~~~~~~~~~~~~~i~gi~~~~~~a~itl~--~~~~~~g~~a~if~~l 292 (587)
T PRK07431 216 RAVEIARNYGVPLVVRSSWS-DAPGTLVTSPPPRPRSLGGLELGKPVDGVELDEDQAKVALL--RVPDRPGIAAQLFEEL 292 (587)
T ss_pred HHHHHHHHcCCcEEEecCCC-CCCCeEEEeCCcccccccchhcccccceEEEecCceEEEEe--cCCCcccHHHHHHHHH
Confidence 99999999999999999984 558999976432110000 0013468999999999999997 5888999999999999
Q ss_pred HhCCCcEEEEEecCCc---cEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEcCeeecC
Q 020431 266 KDVGANVIMISQASSE---HSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 266 ~~~~I~v~~Isq~~se---~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~~~~~~~ 326 (326)
+++||+|+||+|++++ .+|||++++++..++.+.|.+ +..++.. +++++.+++|+|+
T Consensus 293 ~~~~I~v~~i~qs~~~~~~~~isf~i~~~d~~~~~~~l~~-l~~~~~~---~~i~~~~~~a~Is 352 (587)
T PRK07431 293 AAQGVNVDLIIQSIHEGNSNDIAFTVAENELKKAEAVAEA-IAPALGG---AEVLVETNVAKLS 352 (587)
T ss_pred HHcCCcEEEEEeccCCCCCccEEEEEeHHHHHHHHHHHHH-HHHHcCC---CcEEEeCCeEEEE
Confidence 9999999999997654 899999999999988777764 5444433 6799999999874
No 18
>cd04245 AAK_AKiii-YclM-BS AAK_AKiii-YclM-BS: Amino Acid Kinase Superfamily (AAK), AKiii-YclM-BS; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. In Bacillus subtilis (BS), YclM is reported to be a single polypeptide of 50 kD. The Bacillus subtilis 168 AKIII is induced by lysine and repressed by threonine, and it is synergistically inhibited by lysine and threonine.
Probab=100.00 E-value=1.6e-46 Score=350.21 Aligned_cols=196 Identities=28% Similarity=0.467 Sum_probs=178.1
Q ss_pred HHHHHHHHHhhhcCCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHH
Q 020431 16 IRSTYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKW 95 (326)
Q Consensus 16 i~~~~~~l~~~~~~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~ 95 (326)
+...++.+.+++. +.+++.+|.++|+||+||+++++.+|+++|+++.++++++++++++++++...++.. +.+.+.++
T Consensus 93 i~~~~~~l~~~~~-~~~~~~~d~i~s~GE~lSa~ll~~~L~~~Gi~a~~ld~~~~~i~t~~~~~~a~~~~~-~~~~~~~~ 170 (288)
T cd04245 93 IAEILENLANLDY-ANPDYLLDALKARGEYLNAQLMAAYLNYQGIDARYVIPKDAGLVVTDEPGNAQILPE-SYQKIKKL 170 (288)
T ss_pred HHHHHHHHHHhhc-cCCHHHHHHHHHHhHHHHHHHHHHHHHHCCCCeEEEcHHHCceeecCCccccccchh-hHHHHHHH
Confidence 3344455555443 467889999999999999999999999999999999999998888888877666553 56788888
Q ss_pred hhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHH
Q 020431 96 FSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWE 175 (326)
Q Consensus 96 l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~ 175 (326)
++ .+.|||++||+|.+.+|+++++|||||||+|+++|.+|+|+++.+|||||||||+|||++|+|+.+++|||+||.+
T Consensus 171 ~~--~~~v~Vv~Gf~g~~~~G~~ttLgRggSD~tAal~A~~l~A~~v~i~tdVdGvytaDPr~v~~A~~i~~lsy~EA~e 248 (288)
T cd04245 171 RD--SDEKLVIPGFYGYSKNGDIKTFSRGGSDITGAILARGFQADLYENFTDVDGIYAANPRIVANPKPISEMTYREMRE 248 (288)
T ss_pred Hh--CCCEEEEeCccccCCCCCEEEcCCCchHHHHHHHHHHcCCCEEEEEeCCCceECCCCCCCCCCeEeCccCHHHHHH
Confidence 87 6789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 176 MSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 176 l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
|+++|+++|||+|+.+|++++||++|+|+++|+.+||+|.
T Consensus 249 la~~GakVlhp~ai~~a~~~~Ipi~v~n~~~p~~~GT~I~ 288 (288)
T cd04245 249 LSYAGFSVFHDEALIPAIEAGIPINIKNTNHPEAPGTLIV 288 (288)
T ss_pred HHHCCCcccCHHHHHHHHHCCCcEEEeeCCCCCCCCceeC
Confidence 9999999999999999999999999999999999999984
No 19
>cd04257 AAK_AK-HSDH AAK_AK-HSDH: Amino Acid Kinase Superfamily (AAK), AK-HSDH; this CD includes the N-terminal catalytic domain of aspartokinase (AK) of the bifunctional enzyme AK - homoserine dehydrogenase (HSDH). These aspartokinases are found in bacteria (E. coli AKI-HSDHI, ThrA and E. coli AKII-HSDHII, MetL) and higher plants (Z. mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. ThrA and MetL are involved in threonine and methionine biosynthesis, respectively. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathway end products. Maize AK-HSDH is a Thr-sensitive 180-kD enzyme. Arabidopsis AK-HSDH is an alanine-act
Probab=100.00 E-value=1e-45 Score=346.36 Aligned_cols=200 Identities=49% Similarity=0.798 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhh
Q 020431 14 EFIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSES 88 (326)
Q Consensus 14 ~~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~ 88 (326)
+.|+..++.|++++. ++.+++.+|.++|+||+||+++++.+|+++|+++.+++++++ +.+++.++...++...+
T Consensus 90 ~~i~~~~~~l~~~l~~~~~~~~~~~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~t~~~~~~a~~~~~~~ 168 (294)
T cd04257 90 SALGNDLEELKDLLEGIYLLGELPDSIRAKVLSFGERLSARLLSALLNQQGLDAAWIDAREL-IVTDGGYLNAVVDIELS 168 (294)
T ss_pred HHHHHHHHHHHHHHHHHHhhccCChhHhhhheeHHHHHHHHHHHHHHHhCCCCeEEEchHHe-eEecCCCCceEechHhh
Confidence 346677888888776 578899999999999999999999999999999999999997 55666677777877777
Q ss_pred HHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeee
Q 020431 89 EKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTL 168 (326)
Q Consensus 89 ~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~l 168 (326)
.+.+++++... +.|||++||+|.+.+|.++|+||||||++|+++|..++|+++++||||||||++||+.+|+|++++++
T Consensus 169 ~~~l~~~~~~~-~~v~Vv~Gfig~~~~G~~ttlGRGGSD~~A~~lA~~l~a~~l~i~tdVdGvyt~DP~~~~~A~~i~~i 247 (294)
T cd04257 169 KERIKAWFSSN-GKVIVVTGFIASNPQGETTTLGRNGSDYSAAILAALLDADQVEIWTDVDGVYSADPRKVKDARLLPSL 247 (294)
T ss_pred HHHHHHHHhcC-CCEEEecCcccCCCCCCEEECCCCchHHHHHHHHHHhCCCEEEEEeCCCccCCCCCCCCCCCeEecee
Confidence 78899888732 78999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 169 SYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 169 s~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
+|+|+.+++++|++++||+|+++++++|||++|+|+++|+.+||+|+
T Consensus 248 s~~ea~~l~~~Gakv~h~~~~~~a~~~~Ipi~i~~~~~p~~~GT~I~ 294 (294)
T cd04257 248 SYQEAMELSYFGAKVLHPKTIQPVAKKNIPILIKNTFNPEAPGTLIS 294 (294)
T ss_pred CHHHHHHHHhCCCcccCHHHHHHHHHCCCCEEEeeCCCCCCCCCEeC
Confidence 99999999999999999999999999999999999999999999984
No 20
>cd04258 AAK_AKiii-LysC-EC AAK_AKiii-LysC-EC: Amino Acid Kinase Superfamily (AAK), AKiii-LysC-EC: this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive aspartokinase isoenzyme AKIII. AKIII is a monofunctional class enzyme (LysC) found in some bacteria such as E. coli. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. In E. coli, LysC is reported to be a homodimer of 50 kD subunits.
Probab=100.00 E-value=1.4e-45 Score=344.47 Aligned_cols=200 Identities=31% Similarity=0.574 Sum_probs=184.4
Q ss_pred HHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhH
Q 020431 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESE 89 (326)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~ 89 (326)
.|+..+++|+++++ ++++++.+|.++|+||+||+++++.+|+++|+++.+++++++ +.++++++...++...+.
T Consensus 87 ~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~t~~~~~~a~~~~~~~~ 165 (292)
T cd04258 87 KLEELLEELTQLAEGAALLGELSPASRDELLSFGERMSSLLFSEALREQGVPAEWFDVRTV-LRTDSRFGRAAPDLNALA 165 (292)
T ss_pred HHHHHHHHHHHHHhhhccccccChHhHhHhhhHHHHHHHHHHHHHHHhCCCCeEEEchHHe-EEecCCCccccccHHHHH
Confidence 46778889998885 467889999999999999999999999999999999999999 556677787888887777
Q ss_pred HHHHHHhhc-CCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeee
Q 020431 90 KRLEKWFSQ-SPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTL 168 (326)
Q Consensus 90 ~~i~~~l~~-~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~l 168 (326)
+.+...++. ..+.|||++||+|.+.+|+++|+||||||++|+++|.+++|+++++||||||||++||+++|+|++++.+
T Consensus 166 ~~~~~~~~~~~~~~v~Vv~Gf~g~~~~G~~ttLGrggsD~~a~~~a~~l~a~~~~i~tdv~Gv~~~dP~~~~~a~~i~~i 245 (292)
T cd04258 166 ELAAKLLKPLLAGTVVVTQGFIGSTEKGRTTTLGRGGSDYSAALLAEALHAEELQIWTDVAGIYTTDPRICPAARAIKEI 245 (292)
T ss_pred HHHHHHHHHhhcCCEEEECCccccCCCCCEEecCCCchHHHHHHHHHHcCCCEEEEEECCCccCCCCCCCCCCCeEecee
Confidence 777776653 2568999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 169 SYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 169 s~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
+|+||.+|+++|++++||+|+.++++++||++|+|+++|+.+||+|.
T Consensus 246 sy~Ea~ela~~Gakvlhp~a~~~~~~~~ipi~i~~~~~p~~~GT~I~ 292 (292)
T cd04258 246 SFAEAAEMATFGAKVLHPATLLPAIRKNIPVFVGSSKDPEAGGTLIT 292 (292)
T ss_pred CHHHHHHHHHCCCcccCHHHHHHHHHcCCcEEEEeCCCCCCCCceeC
Confidence 99999999999999999999999999999999999999999999984
No 21
>cd04243 AAK_AK-HSDH-like AAK_AK-HSDH-like: Amino Acid Kinase Superfamily (AAK), AK-HSDH-like; this family includes the N-terminal catalytic domain of aspartokinase (AK) of the bifunctional enzyme AK- homoserine dehydrogenase (HSDH). These aspartokinases are found in such bacteria as E. coli (AKI-HSDHI, ThrA and AKII-HSDHII, MetL) and in higher plants (Z. mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. ThrA and MetL are involved in threonine and methionine biosynthesis, respectively. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathway end products. Maize AK-HSDH is a Thr-sensitive 180-kD enzyme. Arabidopsis AK-
Probab=100.00 E-value=1.6e-45 Score=344.93 Aligned_cols=200 Identities=43% Similarity=0.738 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhh
Q 020431 14 EFIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSES 88 (326)
Q Consensus 14 ~~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~ 88 (326)
+.|+..++.|+++++ ++++++.+|.++|+||+||+++++.+|+++|++|.++++++++ .+++.++...+++..+
T Consensus 89 ~~i~~~~~~l~~~l~~~~~~~~~s~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~ld~~~~i-~t~~~~~~~~~~~~~s 167 (293)
T cd04243 89 AALDSLLERLKDLLEGIRLLGELSDKTRAEVLSFGELLSSRLMSAYLQEQGLPAAWLDARELL-LTDDGFLNAVVDLKLS 167 (293)
T ss_pred HHHHHHHHHHHHHHHhhhhhccCCchhhhHheeHHHHHHHHHHHHHHHhCCCCcEEEcHHHeE-EecCCCCcchhhhHHH
Confidence 457777888888875 4678999999999999999999999999999999999999984 4555677777777777
Q ss_pred HHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeee
Q 020431 89 EKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTL 168 (326)
Q Consensus 89 ~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~l 168 (326)
++.++.++..+ +.|||++||+|.+.+|+++|+||||||++|+++|.+++|+++++||||||||++||+++|+|++++++
T Consensus 168 ~~~~~~~~~~~-~~v~Vv~Gfig~~~~G~~ttLGRggsD~~A~~~a~~l~a~~~~i~tdvdGiyt~dP~~~~~a~~i~~l 246 (293)
T cd04243 168 KERLAQLLAEH-GKVVVTQGFIASNEDGETTTLGRGGSDYSAALLAALLDAEEVEIWTDVDGVYTADPRKVPDARLLKEL 246 (293)
T ss_pred HHHHHHHHhcC-CCEEEecCccccCCCCCEEEeCCCCcHHHHHHHHHHcCCCEEEEEeCCCccCCCCCCCCCCCeEecee
Confidence 78899888721 78999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 169 SYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 169 s~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
+|+|+.+++++|++++||+|+++++++|||++|+|+++|+.+||+|+
T Consensus 247 s~~ea~~l~~~Gakvl~p~ai~~a~~~~i~i~i~~~~~p~~~GT~I~ 293 (293)
T cd04243 247 SYDEAMELAYFGAKVLHPRTIQPAIRKNIPIFIKNTFNPEAPGTLIS 293 (293)
T ss_pred CHHHHHHHHhCCCcccCHHHHHHHHHCCCcEEEecCCCCCCCCCEeC
Confidence 99999999999999999999999999999999999999999999984
No 22
>cd04247 AAK_AK-Hom3 AAK_AK-Hom3: Amino Acid Kinase Superfamily (AAK), AK-Hom3; this CD includes the N-terminal catalytic domain of the aspartokinase HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae and other related AK domains. Aspartokinase, the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single aspartokinase isoenzyme type, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies show that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size.
Probab=100.00 E-value=3.7e-45 Score=343.20 Aligned_cols=201 Identities=29% Similarity=0.512 Sum_probs=172.7
Q ss_pred HHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCC-chhh
Q 020431 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPD-FSES 88 (326)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~-~~~~ 88 (326)
.++..++.|++++. ++.+++.+|.++|+||+||+++++.+|+++|+++.++++++++. ++......... ....
T Consensus 99 ~i~~~~~~l~~~l~~~~~l~~~~~~~~d~i~s~GE~lSa~l~a~~L~~~Gi~a~~ld~~~~i~-~~~~~~~~~~~~~~~~ 177 (306)
T cd04247 99 EINKECELLRKYLEAAKILSEISPRTKDLVISTGEKLSCRFMAAVLRDRGVDAEYVDLSHIVD-LDFSIEALDQTFYDEL 177 (306)
T ss_pred HHHHHHHHHHHHHHHHHhhhhcchHHHHHHhhHHHHHHHHHHHHHHHhCCCCeEEEcHHHhee-cCCCccccccchhHHH
Confidence 35667888887765 57889999999999999999999999999999999999999853 43321011111 1222
Q ss_pred HHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeee
Q 020431 89 EKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTL 168 (326)
Q Consensus 89 ~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~l 168 (326)
.+.+.+.+....+.|||++||+|.+.+|+++||||||||++|+++|..|+|+++++|||||||||+||+++|+|+++++|
T Consensus 178 ~~~~~~~~~~~~~~v~Vv~GFig~~~~G~~ttLGRgGsD~~A~~la~~l~a~~v~i~tdVdGvyt~DP~~~~~a~~i~~i 257 (306)
T cd04247 178 AQVLGEKITACENRVPVVTGFFGNVPGGLLSQIGRGYTDLCAALCAVGLNADELQIWKEVDGIFTADPRKVPTARLLPSI 257 (306)
T ss_pred HHHHHHHhhccCCceEEeeccEecCCCCCeEEeCCCchHHHHHHHHHHcCCCEEEEeecCCeeECCCCCCCCCCeEeccc
Confidence 23333334323467999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeC
Q 020431 169 SYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICR 216 (326)
Q Consensus 169 s~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~ 216 (326)
+|+||.+|+++|++|+||+|+.||+++|||++|+|+++|+.+||+|.+
T Consensus 258 s~~ea~el~~~GakVlHp~ti~pa~~~~Ipi~i~nt~~P~~~GT~I~~ 305 (306)
T cd04247 258 TPEEAAELTYYGSEVIHPFTMEQVIKARIPIRIKNVENPRGEGTVIYP 305 (306)
T ss_pred CHHHHHHHHhCcCcccCHHHHHHHHHcCCcEEEecCCCCCCCCcEEcC
Confidence 999999999999999999999999999999999999999999999976
No 23
>PRK08373 aspartate kinase; Validated
Probab=100.00 E-value=2.7e-44 Score=341.76 Aligned_cols=241 Identities=27% Similarity=0.389 Sum_probs=208.0
Q ss_pred CChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhH---HHHHHHhhcCCCcEEEec
Q 020431 31 ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESE---KRLEKWFSQSPSNTIIAT 107 (326)
Q Consensus 31 ~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~---~~i~~~l~~~~~~ipVv~ 107 (326)
++++.+|+++|+||+||+.+++.+|+++|+++.+++++++ +.+++.+++..++...+. +.+.++++ .+.|||++
T Consensus 97 ~~~~~~D~ils~GE~lSa~lla~~L~~~Gi~a~~l~~~~~-i~t~~~~~~a~i~~~~s~~~~~~l~~~l~--~g~VpVv~ 173 (341)
T PRK08373 97 PSEALRDYILSFGERLSAVLFAEALENEGIKGKVVDPWEI-LEAKGSFGNAFIDIKKSKRNVKILYELLE--RGRVPVVP 173 (341)
T ss_pred CChHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEeHHHh-eeecCCccceeechhhhhhhHHHHHHHHh--CCcEEEEe
Confidence 4578899999999999999999999999999999999998 556677777666654433 56666776 78999999
Q ss_pred CccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchh
Q 020431 108 GFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPR 187 (326)
Q Consensus 108 Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~ 187 (326)
||++ +.+|.++|+||||||++|+.+|.+|+|+++++||||||||++||+.+|+|++++++||+||.+++++|++++||+
T Consensus 174 Gf~g-~~~G~~ttLGRGGSD~tA~~lA~~L~A~~v~i~TDVdGVytaDP~~v~~A~~i~~isy~Ea~ela~~Gakvlhp~ 252 (341)
T PRK08373 174 GFIG-NLNGFRATLGRGGSDYSAVALGVLLNAKAVLIMSDVEGIYTADPKLVPSARLIPYLSYDEALIAAKLGMKALHWK 252 (341)
T ss_pred CCcc-CCCCeEEEcCCCchHHHHHHHHHHcCCCEEEEEECCCccCCCCCCCCCCCeEcccCCHHHHHHHHHCcChhhhHH
Confidence 9998 889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHh
Q 020431 188 TIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKD 267 (326)
Q Consensus 188 a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~ 267 (326)
|++++++ +||++|+|++++ .+||+|..+.. ....+.++ ...|.|.|+++|. .+.++
T Consensus 253 ai~~a~~-~Ipi~v~~t~~~-~~GT~I~~~~~--------~~~~~~~~-~~~~~~~i~~~~~--~~~~~----------- 308 (341)
T PRK08373 253 AIEPVKG-KIPIIFGRTRDW-RMGTLVSNESS--------GMPILVHK-VGEEHAEILVVGV--EEEIG----------- 308 (341)
T ss_pred HHHHHHc-CCcEEEecCCCC-CCCcEEecCCC--------CCceEEEE-ecCCEEEEEEecc--CCCCC-----------
Confidence 9999999 999999999987 47999976432 12457777 7889999999983 23222
Q ss_pred CCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 268 VGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 268 ~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
+. .+. -....+.+.|+.++...+++.+|...+
T Consensus 309 --~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (341)
T PRK08373 309 --YP--VYE--EGEFWFKIKVPKEELIEALREIHRRVF 340 (341)
T ss_pred --CC--cee--cCCceEEEecCHHHHHHHHHHHHHHhh
Confidence 22 222 347889999999999999999999653
No 24
>cd04244 AAK_AK-LysC-like AAK_AK-LysC-like: Amino Acid Kinase Superfamily (AAK), AK-LysC-like; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive AK isoenzyme found in higher plants. The lysine-sensitive AK isoenzyme is a monofunctional protein. It is involved in the overall regulation of the aspartate pathway and can be synergistically inhibited by S-adenosylmethionine. Also included in this CD is an uncharacterized LysC-like AK found in Euryarchaeota and some bacteria. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP.
Probab=100.00 E-value=7.7e-45 Score=341.40 Aligned_cols=200 Identities=41% Similarity=0.636 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCC---c
Q 020431 14 EFIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPD---F 85 (326)
Q Consensus 14 ~~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~---~ 85 (326)
+.|..++++|++++. ++.+++.+|.++|+||+||+++++.+|+++|++|.+++++++++++++.+++..++ .
T Consensus 91 ~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~l~~~~~~i~t~~~~~~a~~~~~~~ 170 (298)
T cd04244 91 SIIDSLLEELEKLLYGIAYLGELTPRSRDYIVSFGERLSAPIFSAALRSLGIKARALDGGEAGIITDDNFGNARPLPATY 170 (298)
T ss_pred HHHHHHHHHHHHHHHHHHhhhcCCchHhhHhccHhHHHHHHHHHHHHHhCCCCeEEEcHHHcceeecCcccccccchhHH
Confidence 457778888888876 46788999999999999999999999999999999999999987777766554332 3
Q ss_pred hhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEE
Q 020431 86 SESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (326)
Q Consensus 86 ~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i 165 (326)
...+..+..+++ .+.|||++||+|.+.+|+++|+||||||++|+.+|.+|+|+++++||||||||++||+++|+|+++
T Consensus 171 ~~i~~~l~~ll~--~~~vpVv~Gfig~~~~g~~ttlgRggsD~~A~~~A~~l~a~~l~i~tdV~Gv~~~dP~~~~~a~~i 248 (298)
T cd04244 171 ERVRKRLLPMLE--DGKIPVVTGFIGATEDGAITTLGRGGSDYSATIIGAALDADEIWIWKDVDGVMTADPRIVPEARTI 248 (298)
T ss_pred HHHHHHHHHHhh--cCCEEEEeCccccCCCCCEEEecCCChHHHHHHHHHHcCCCEEEEEECCCCCCCCCCCCCCCCeEc
Confidence 233344555555 689999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 166 RTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 166 ~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
+++||+||.+|+++|++++||+|+++|+++|||++|+|+++|+.+||+|+
T Consensus 249 ~~lsy~Ea~el~~~Ga~vlhp~ai~~a~~~~Ipi~i~n~~~p~~~GT~I~ 298 (298)
T cd04244 249 PRLSYAEAMELAYFGAKVLHPRTVEPAMEKGIPVRVKNTFNPEAPGTLIT 298 (298)
T ss_pred CccCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEeeCCCCCCCCCEeC
Confidence 99999999999999999999999999999999999999999999999984
No 25
>cd04259 AAK_AK-DapDC AAK_AK-DapDC: Amino Acid Kinase Superfamily (AAK), AK-DapDC; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the bifunctional enzyme AK - DAP decarboxylase (DapDC) found in some bacteria. Aspartokinase is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. DapDC, which is the lysA gene product, catalyzes the decarboxylation of DAP to lysine.
Probab=100.00 E-value=3.7e-44 Score=335.76 Aligned_cols=199 Identities=34% Similarity=0.543 Sum_probs=178.9
Q ss_pred HHHHHHHHHHhhhc-----CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCC-------CC
Q 020431 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQ-------VD 82 (326)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~-------~~ 82 (326)
.|+..++.|++++. ++++++.+|.++|+||+||+++++.+|+++|+++.++++++++++++ .+|. ..
T Consensus 85 ~i~~~~~~l~~~l~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~i~~~~-~~~~~~~~~~~a~ 163 (295)
T cd04259 85 LLANDLAQLQRWLTGISLLKQASPRTRAEVLALGELMSTRLGAAYLEAQGLKVKWLDARELLTATP-TLGGETMNYLSAR 163 (295)
T ss_pred HHHHHHHHHHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEcHHHheeecc-cccccccccccce
Confidence 46677888888764 47889999999999999999999999999999999999999966543 4443 23
Q ss_pred CCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCC
Q 020431 83 PDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEA 162 (326)
Q Consensus 83 ~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a 162 (326)
++...+.+++.+.+.. .+.|||++||+|.+.+|+++|+||||||++|+.+|.+++|+++++||||||||++||+.+|+|
T Consensus 164 v~~~~~~~~l~~~l~~-~~~v~Vv~GFig~~~~G~~ttLGrggsD~tA~~lA~~l~A~~l~i~TdV~Gvyt~DP~~~~~a 242 (295)
T cd04259 164 CESEYADALLQKRLAD-GAQLIITQGFIARNAHGETVLLGRGGSDTSAAYFAAKLQAARCEIWTDVPGLFTANPHEVPHA 242 (295)
T ss_pred ehhhhhHHHHHHHHhc-CCceeEeCCceeeCCCCCEEEECCCChHHHHHHHHHHcCCCEEEEEECCCccccCCCCCCCCC
Confidence 3334566788888762 367999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 163 VILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 163 ~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
+++++++|+||.+++++|++++||+|+++++++|||++|+|+++|+.+||+|+
T Consensus 243 ~~i~~ls~~ea~~l~~~Ga~v~h~~a~~~a~~~~ipi~i~~~~~p~~~GT~I~ 295 (295)
T cd04259 243 RLLKRLDYDEAQEIATMGAKVLHPRCIPPARRANIPMVVRSTERPELSGTLIT 295 (295)
T ss_pred eEeceeCHHHHHHHHHcCCcccCHHHHHHHHHCCCCEEEEeCCCCCCCCcEeC
Confidence 99999999999999999999999999999999999999999999999999984
No 26
>TIGR02078 AspKin_pair Pyrococcus aspartate kinase subunit, putative. This family consists of proteins restricted to and found as paralogous pairs (typically close together) in species of Pyrococcus, a hyperthermophilic archaeal genus. Members are always found close to other genes of threonine biosynthesis and appear to represent the Pyrococcal form of aspartate kinase. Alignment to aspartokinase III from E. coli shows that 300 N-terminal and 20 C-terminal amino acids are homologous, but the form in Pyrococcus lacks ~ 100 amino acids in between.
Probab=100.00 E-value=2.5e-41 Score=319.74 Aligned_cols=230 Identities=26% Similarity=0.390 Sum_probs=195.1
Q ss_pred ChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhH---HHHHHHhhcCCCcEEEecC
Q 020431 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESE---KRLEKWFSQSPSNTIIATG 108 (326)
Q Consensus 32 ~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~---~~i~~~l~~~~~~ipVv~G 108 (326)
++..+|+++|+||+||+++++. |+++.+++++++ +.+++.+|+..+++..+. +.+.++++ .+.|||++|
T Consensus 93 ~~~~~d~I~s~GE~lSa~Lla~-----gi~a~~vd~~~~-i~t~~~~~~a~~~~~~~~~~~~~l~~~l~--~g~IpVv~G 164 (327)
T TIGR02078 93 KEALRDYILSLGERLSAVIFAE-----GINGKVVDPWDI-FFAKGDFGNAFIDIKKSKRNAKILYEVLE--SGKIPVIPG 164 (327)
T ss_pred ChHHHHHHHHHHHHHHHHHHHc-----cCCcEEEcHHHH-hccCCcCCceeechhhhHhhHHHHHHHHh--CCcEEEEeC
Confidence 5678999999999999999886 899999999998 456667777777765544 34445555 789999999
Q ss_pred ccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhh
Q 020431 109 FIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRT 188 (326)
Q Consensus 109 fi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a 188 (326)
|++ +.+|.++|+||||||++|+++|.+|+|+++++||||||||++||+.+|+|+++++++|+||.+++++|++++||+|
T Consensus 165 f~~-~~~G~~ttlGRGgSD~~Aa~lA~~L~A~~v~i~TDVdGVytaDP~~v~~A~~i~~lsy~Ea~ela~~Gakvlhp~a 243 (327)
T TIGR02078 165 FYG-NLNGYRVTLGRGGSDYSAVALGVLLNSKLVAIMSDVEGIFTADPKLVPSARLIPYLSYEEIKIAAKLGMKALQWKA 243 (327)
T ss_pred Ccc-CCCCeEEEcCCCChHHHHHHHHHhcCCCEEEEEECCCccCCCCCCcCCCceEccccCHHHHHHHHHCCchhhHHHH
Confidence 998 8899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEeecC-eEEEEEecCCCCCcccHHHHHHHHHHh
Q 020431 189 IIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDN-LALVNVEGTGMAGVPGTANAIFGAVKD 267 (326)
Q Consensus 189 ~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~~~-ia~IsivG~~~~~~~~i~a~if~~L~~ 267 (326)
+++++++|||++|+|+++|. +||+|+.... ....+.++++ ++.|++..
T Consensus 244 ~~~a~~~~Ipi~I~~t~~~~-~GT~I~~~~~-----------~~~~i~~~~~~i~~v~~~~------------------- 292 (327)
T TIGR02078 244 ADLAKEYKIPVLFGRTRDWR-MGTLISNRSS-----------GMPLMVYKDGELLVVNVRR------------------- 292 (327)
T ss_pred HHHHHHCCCeEEEEeCCCcC-CCcEEecCCC-----------CCcEEEEccCcEEEEEEee-------------------
Confidence 99999999999999999986 7999976422 2334777877 77777721
Q ss_pred CCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHH
Q 020431 268 VGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKF 304 (326)
Q Consensus 268 ~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f 304 (326)
.++-..+. -.+..+++.|+.++...+++.+|...
T Consensus 293 -~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (327)
T TIGR02078 293 -EISYPVIE--EGEFWKKYKVPKEDGIEIIRELHRKV 326 (327)
T ss_pred -cccccccc--cCCceEEEecCHHHHHHHHHHHHhhh
Confidence 12222222 34678999999999999999999854
No 27
>cd04248 AAK_AK-Ectoine AAK_AK-Ectoine: Amino Acid Kinase Superfamily (AAK), AK-Ectoine; this CD includes the N-terminal catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and other various halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase and L-aspartate-semialdehyde dehydrogenase. The M. alcaliphilum and the V. cholerae aspartokinases are encoded on the ectABCask operon.
Probab=100.00 E-value=1.2e-41 Score=316.15 Aligned_cols=175 Identities=21% Similarity=0.339 Sum_probs=154.2
Q ss_pred CCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhc--CCCcEEEe
Q 020431 29 GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQ--SPSNTIIA 106 (326)
Q Consensus 29 ~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~--~~~~ipVv 106 (326)
++++++.+|.++|+||+||+.+++.+|+++|++|.++++..+.. .+ ... +. +++.+.+.. ..+.|||+
T Consensus 126 ~e~~~~~rd~l~S~GE~~Sa~l~a~~L~~~Gi~A~~vD~~~~~~-~~----~~t-~~----~~i~~~~~~~~~~~~v~Iv 195 (304)
T cd04248 126 AEHLLAARELLASLGEAHSAFNTALLLQNRGVNARFVDLSGWRD-SG----DMT-LD----ERISEAFRDIDPRDELPIV 195 (304)
T ss_pred hhCCHHHHHHHhhhCHHHHHHHHHHHHHHCCCCeEEECcccccc-cC----CCC-cH----HHHHHHHHhhccCCcEEEe
Confidence 48899999999999999999999999999999999998875522 11 111 22 344444431 25689999
Q ss_pred cCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCC--CCCeEEeeecHHHHHHHhhcCCccc
Q 020431 107 TGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKV--SEAVILRTLSYQEAWEMSYFGANVL 184 (326)
Q Consensus 107 ~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~--~~a~~i~~ls~~e~~~l~~~g~~v~ 184 (326)
+|| +.+.+|.++|+|||||||+|+.+|.+++|++++|||||+ |||+|||++ ++|++++++||+||.||+++|++++
T Consensus 196 tGF-~~~~~G~itTLGRGGSDyTAs~iAa~l~A~ev~I~TDV~-i~taDPriV~~~~A~~i~~lsY~EA~ELA~~GakvL 273 (304)
T cd04248 196 TGY-AKCAEGLMREFDRGYSEMTFSRIAVLTGASEAIIHKEFH-LSSADPKLVGEDKARPIGRTNYDVADQLANLGMEAI 273 (304)
T ss_pred CCc-cCCCCCCEEEcCCCcHHHHHHHHHHHcCCCEEEEECCCc-eecCCCCccCCCCceEeCccCHHHHHHHHHcChhhc
Confidence 999 567899999999999999999999999999999999995 999999999 5899999999999999999999999
Q ss_pred chhhHHHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 185 HPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 185 ~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
||+|++++++++||++|+|+++|+.+||+|+
T Consensus 274 HP~ai~pa~~~~IPi~Vkntf~P~~~GTlIt 304 (304)
T cd04248 274 HPKAAKGLRQAGIPLRVKNTFEPDHPGTLIT 304 (304)
T ss_pred CHHHHHHHHHcCCeEEEecCCCCCCCCceeC
Confidence 9999999999999999999999999999984
No 28
>cd04261 AAK_AKii-LysC-BS AAK_AKii-LysC-BS: Amino Acid Kinase Superfamily (AAK), AKii; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine, and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase isoenzyme type, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In this organism and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regulated by the concerted action of lysine and
Probab=100.00 E-value=8e-37 Score=279.22 Aligned_cols=181 Identities=33% Similarity=0.481 Sum_probs=165.0
Q ss_pred CChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCcc
Q 020431 31 ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFI 110 (326)
Q Consensus 31 ~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi 110 (326)
.+.+..+.+++.||++++.++++.|+++|++++++++.++.+++.+.++..++... ..+.++++++ .+.|||++||+
T Consensus 59 ~~~~~~~~i~a~Ge~~~~~l~~~~l~~~g~~a~~l~~~~~~l~~~~~~~~~~i~~~-~~~~l~~ll~--~~~ipVi~G~~ 135 (239)
T cd04261 59 PPARELDVLLSTGEQVSIALLAMALNRLGIKAISLTGWQAGILTDGHHGKARIIDI-DPDRIRELLE--EGDVVIVAGFQ 135 (239)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEechhhCCEEecCCCCcceechh-hHHHHHHHHH--cCCeEEEcCcc
Confidence 45678889999999999999999999999999999999987776655533233221 2378889998 78999999999
Q ss_pred ccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHH
Q 020431 111 ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTII 190 (326)
Q Consensus 111 ~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~ 190 (326)
+.+++|.+++++||++|++|+.+|.+|+|+++++||||||||++||+.+|+++++++++|+|+.++++.|++++||+|++
T Consensus 136 ~~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~lii~tdV~GVy~~dP~~~~~a~~i~~i~~~ea~~l~~~G~~~~~~~a~~ 215 (239)
T cd04261 136 GINEDGDITTLGRGGSDTSAVALAAALGADRCEIYTDVDGVYTADPRIVPKARKLDEISYDEMLEMASLGAKVLHPRSVE 215 (239)
T ss_pred ccCCCCCEEecCCCChHHHHHHHHHHcCCCEEEEEeCCCCCCCCCCCCCCCceEccccCHHHHHHHHhccccccCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCEEEEeccCCCCCceEEe
Q 020431 191 PVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 191 ~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
++.++|||++|.|+++|+ +||+|+
T Consensus 216 ~~~~~~i~i~I~n~~~~~-~gt~i~ 239 (239)
T cd04261 216 LAKKYGVPLRVLSSFSEE-PGTLIT 239 (239)
T ss_pred HHHHcCCeEEEecCCCCC-CCcEeC
Confidence 999999999999999999 999984
No 29
>cd04260 AAK_AKi-DapG-BS AAK_AKi-DapG-BS: Amino Acid Kinase Superfamily (AAK), AKi-DapG; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the diaminopimelate-sensitive aspartokinase isoenzyme AKI (DapG), a monofunctional class enzyme found in Bacilli (Bacillus subtilis 168), Clostridia, and Actinobacteria bacterial species. In Bacillus subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and two bet
Probab=100.00 E-value=8.3e-37 Score=279.93 Aligned_cols=182 Identities=34% Similarity=0.509 Sum_probs=165.3
Q ss_pred CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCc
Q 020431 30 HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGF 109 (326)
Q Consensus 30 ~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gf 109 (326)
..+++.++.++++||.+++++++++|+++|+++..+++.++++++.+.++..++... ..+.++++++ .+.|||++||
T Consensus 63 ~~t~~~~~~~~~~Ge~~~~~~~~~~l~~~Gi~a~~l~~~~~~lit~~~~~~~~v~~~-~~~~l~~ll~--~g~VPVv~g~ 139 (244)
T cd04260 63 DISPRELDLLMSCGEIISAVVLTSTLRAQGLKAVALTGAQAGILTDDNYSNAKIIKV-NPKKILSALK--EGDVVVVAGF 139 (244)
T ss_pred CCCHHHHHHHHHHhHHHHHHHHHHHHHhCCCCeEEechHHcCEEecCCCCceeeecc-CHHHHHHHHh--CCCEEEecCC
Confidence 456778899999999999999999999999999999999988877665543222111 1267888888 8899999999
Q ss_pred cccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhH
Q 020431 110 IASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTI 189 (326)
Q Consensus 110 i~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~ 189 (326)
++.+++|++++++|||||++|+.+|.+|+|+++++||||||||++||+.+++++++++|+|+|+.++++.|++++||+|+
T Consensus 140 ~~~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tDV~GVy~~dP~~~~~a~~i~~i~~~e~~~l~~~g~~v~~~~a~ 219 (244)
T cd04260 140 QGVTEDGEVTTLGRGGSDTTAAALGAALNAEYVEIYTDVDGIMTADPRVVPNARILDVVSYNEVFQMAHQGAKVIHPRAV 219 (244)
T ss_pred cccCCCCCEEEeCCCchHHHHHHHHHHcCCCEEEEEECCCcCCcCCCCCCCCCeEcccCCHHHHHHHHHcCchhcCHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 190 IPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 190 ~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
++++++++|++|.|+++|+ +||+|+
T Consensus 220 ~~~~~~~i~v~I~~~~~~~-~gt~i~ 244 (244)
T cd04260 220 EIAMQANIPIRIRSTMSEN-PGTLIT 244 (244)
T ss_pred HHHHHcCCeEEEecCCCCC-CCCEeC
Confidence 9999999999999999988 899984
No 30
>cd04234 AAK_AK AAK_AK: Amino Acid Kinase Superfamily (AAK), Aspartokinase (AK); this CD includes the N-terminal catalytic domain of aspartokinase (4-L-aspartate-4-phosphotransferase;). AK is the first enzyme in the biosynthetic pathway of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. It also catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind amino acids leading to allosteric regulation of the enzyme. In Escherichia coli, three different aspartokinase isoenzymes are regulated specifically by lysine, methionine, and threonine. AK-HSDHI (ThrA) and AK-HSDHII (MetL) are bifunctional enzymes that consist of an N-terminal AK and a C-terminal homoserine dehyd
Probab=100.00 E-value=3.6e-37 Score=279.44 Aligned_cols=199 Identities=39% Similarity=0.656 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhhhc-----------CCCChhHHh--HhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCC
Q 020431 14 EFIRSTYNFLSNVDS-----------GHATESFTD--FVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQ 80 (326)
Q Consensus 14 ~~i~~~~~~l~~~~~-----------~~~~~~~~d--~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~ 80 (326)
+.++...+.+.++-. +..+....+ .++|.||.+|+++++++|+++|+++.++++.++++++++. +.
T Consensus 15 ~~~~~~~~~i~~l~~g~~vvvV~Sg~~~~t~~l~~~~~~~s~Ge~~~~~l~~~~l~~~Gi~a~~l~~~~~~~~~~~~-~~ 93 (227)
T cd04234 15 ERIKRVADIIKAYEKGNRVVVVVSAMGGVTDLLIELALLLSFGERLSARLLAAALRDRGIKARSLDARQAGITTDDN-HG 93 (227)
T ss_pred HHHHHHHHHHHHhhcCCCEEEEEcCCCcccHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCeEEeCHHHCCEEcCCc-cc
Confidence 466677777776511 123444333 6888999999999999999999999999999998876543 22
Q ss_pred CCCCchhhHHHHHHHhhcCC-CcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCC
Q 020431 81 VDPDFSESEKRLEKWFSQSP-SNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKV 159 (326)
Q Consensus 81 ~~~~~~~~~~~i~~~l~~~~-~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~ 159 (326)
.........+.++++++ . +.|||++||++.+++|++++++|||||++|+.+|.+|+|+++++||||||||++||+.+
T Consensus 94 ~~~~~~~~~~~l~~~l~--~~~~vpVv~g~i~~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tdV~Gvy~~dP~~~ 171 (227)
T cd04234 94 AARIIEISYERLKELLA--EIGKVPVVTGFIGRNEDGEITTLGRGGSDYSAAALAAALGADEVEIWTDVDGIYTADPRIV 171 (227)
T ss_pred hhhHHHHHHHHHHHHHh--hCCCEEEecCceecCCCCCEEEeeCCCcHHHHHHHHHHhCCCEEEEEECCCccCCCCCCCC
Confidence 22334445688999988 7 99999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCCCCceEEe
Q 020431 160 SEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 160 ~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
|+++++++++|+|+.++++.|+++|||+|+++|.++|+|++|.|+++|+..||+|+
T Consensus 172 ~~a~~i~~i~~~e~~~l~~~G~~~~~~~a~~~a~~~~i~i~i~~~~~~~~~gT~I~ 227 (227)
T cd04234 172 PEARLIPEISYDEALELAYFGAKVLHPRAVEPARKANIPIRVKNTFNPEAPGTLIT 227 (227)
T ss_pred CCceEcCcCCHHHHHHHHhCCccccCHHHHHHHHHcCCeEEEEeCCCCCCCCCEeC
Confidence 99999999999999999999999999999999999999999999999988999984
No 31
>cd04246 AAK_AK-DapG-like AAK_AK-DapG-like: Amino Acid Kinase Superfamily (AAK), AK-DapG-like; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the diaminopimelate-sensitive aspartokinase isoenzyme AKI (DapG), a monofunctional enzymes found in Bacilli (Bacillus subtilis 168), Clostridia, and Actinobacteria bacterial species, as well as, the catalytic AK domain of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis 168, the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related isoenzymes. In Bacillus subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. The role of the AKI isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulati
Probab=100.00 E-value=3.2e-36 Score=275.18 Aligned_cols=180 Identities=33% Similarity=0.513 Sum_probs=164.2
Q ss_pred ChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccc
Q 020431 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (326)
Q Consensus 32 ~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~ 111 (326)
+....+.+++.||+++++++++.|+++|+++.++++.++.+.+..+++..++.. ...+.++++++ .+.|||++||+|
T Consensus 60 ~~~~~~~i~~~Ge~~~~~~~~~~l~~~g~~a~~l~~~~~~l~~~~~~~~~~~~~-~~~~~l~~ll~--~g~ipVi~g~~~ 136 (239)
T cd04246 60 SPRELDMLLSTGEQISAALLAMALNRLGIKAISLTGWQAGILTDDHHGNARIID-IDPKRILEALE--EGDVVVVAGFQG 136 (239)
T ss_pred CHHHHHHHHHHhHHHHHHHHHHHHHhCCCCeEEeccccCCEEecCCCCceeech-hhHHHHHHHHh--cCCEEEEcCccc
Confidence 567789999999999999999999999999999999998666655554333322 23488899998 789999999999
Q ss_pred cCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHH
Q 020431 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (326)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~ 191 (326)
.+++|.+++++|||+|++|+.+|.+|+|+++++||||||||++||+.+|+++++++++|+|+.++++.|++++||+|+++
T Consensus 137 ~~~~g~~~~l~~g~~D~~A~~lA~~l~A~~li~~tdV~GVy~~dP~~~~~a~~i~~l~~~e~~~l~~~G~~~~~~~a~~~ 216 (239)
T cd04246 137 VNEDGEITTLGRGGSDTTAVALAAALKADRCEIYTDVDGVYTADPRIVPKARKLDVISYDEMLEMASLGAKVLHPRSVEL 216 (239)
T ss_pred cCCCCCEEecCCCChHHHHHHHHHHcCCCEEEEEECCCCCCCCCCCCCCCCeEcccCCHHHHHHHHhCCCcccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCEEEEeccCCCCCceEEe
Q 020431 192 VMRYDIPIVIRNIFNLSVPGIMIC 215 (326)
Q Consensus 192 a~~~~I~v~I~n~~~~~~~GT~I~ 215 (326)
++++|||++|.|+++|+ +||+|+
T Consensus 217 a~~~gi~i~i~~~~~~~-~gt~i~ 239 (239)
T cd04246 217 AKKYNVPLRVRSSFSEN-PGTLIT 239 (239)
T ss_pred HHHCCCeEEEecCCCCC-CCcEeC
Confidence 99999999999999998 999984
No 32
>cd02115 AAK Amino Acid Kinases (AAK) superfamily, catalytic domain; present in such enzymes like N-acetylglutamate kinase (NAGK), carbamate kinase (CK), aspartokinase (AK), glutamate-5-kinase (G5K) and UMP kinase (UMPK). The AAK superfamily includes kinases that phosphorylate a variety of amino acid substrates. These kinases catalyze the formation of phosphoric anhydrides, generally with a carboxylate, and use ATP as the source of the phosphoryl group; are involved in amino acid biosynthesis. Some of these kinases control the process via allosteric feed-back inhibition.
Probab=99.97 E-value=2.8e-29 Score=229.64 Aligned_cols=180 Identities=37% Similarity=0.498 Sum_probs=157.1
Q ss_pred CChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCcc
Q 020431 31 ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFI 110 (326)
Q Consensus 31 ~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi 110 (326)
.++...+.+++.||.++++++++.|+++|+++..+++.++.+.+++ ++..........+.++++++ .+.|||++||.
T Consensus 61 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~gi~a~~~~~~~~~~~~~~-~~~~g~~~~~~~~~l~~~l~--~~~ipVv~g~~ 137 (248)
T cd02115 61 ITDRETDALAAMGEGMSNLLIAAALEQHGIKAVPLDLTQAGFASPN-QGHVGKITKVSTDRLKSLLE--NGILPILSGFG 137 (248)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEchHHcCeEeCC-CCCcccceeeCHHHHHHHHh--CCcEEEecCeE
Confidence 4567788999999999999999999999999999999998776643 33322223334488999998 79999999998
Q ss_pred ccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHH
Q 020431 111 ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTII 190 (326)
Q Consensus 111 ~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~ 190 (326)
+.+.+ +..+++|++||++|+.+|.+|+|++++|||||||||++||+++++++++++++++|+.++++.|..++||+++.
T Consensus 138 ~~~~~-~~~~~~~~~sD~~A~~lA~~l~A~~li~~tdV~Gv~~~dP~~~~~a~~i~~i~~~e~~~l~~~g~~~~k~~a~~ 216 (248)
T cd02115 138 GTDEK-ETGTLGRGGSDSTAALLAAALKADRLVILTDVDGVYTADPRKVPDAKLLSELTYEEAAELAYAGAMVLKPKAAD 216 (248)
T ss_pred eccCC-ceeeecCCCHHHHHHHHHHHcCCCEEEEEecCCeeecCCCCcCCcCeECCcCCHHHHHHHHHcCCCccCHHHHH
Confidence 87765 67778999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCEEEEeccC--------CCCCceEE
Q 020431 191 PVMRYDIPIVIRNIFN--------LSVPGIMI 214 (326)
Q Consensus 191 ~a~~~~I~v~I~n~~~--------~~~~GT~I 214 (326)
++.++|++++|.|+.+ ++..||+|
T Consensus 217 ~~~~~~~~v~I~~~~~~~~l~~~~~~~~GT~I 248 (248)
T cd02115 217 PAARAGIPVRIANTENPGALALFTPDGGGTLI 248 (248)
T ss_pred HHHHcCCcEEEEeCCCcccccccCCCCCCCCC
Confidence 9999999999999887 34556654
No 33
>PRK14558 pyrH uridylate kinase; Provisional
Probab=99.94 E-value=1.7e-25 Score=203.52 Aligned_cols=182 Identities=23% Similarity=0.322 Sum_probs=147.0
Q ss_pred hhHHHHHHHHHHHHhhhc-----------C---------CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccce
Q 020431 11 LSYEFIRSTYNFLSNVDS-----------G---------HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREV 70 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~-----------~---------~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~ 70 (326)
++.+.|+...++|.++.+ + ..++...|.+...||+|++.+++..|.++|++++++++.
T Consensus 20 ~~~~~i~~la~~i~~~~~~g~~viiV~GgGs~~~g~~~~~~~~~~~d~ig~~~~~ln~~~~~~~l~~~gi~a~~~~~~-- 97 (231)
T PRK14558 20 FDPERVNYLVNEIKSVVEYGFKIGIVIGAGNLFRGVELKELSPTRADQIGMLGTVINALYLKDIFEKSGLKAVIVSQI-- 97 (231)
T ss_pred cCHHHHHHHHHHHHHHHHCCCeEEEEECccHHHHHHhccCCChHHHHHHHHHHHHHHHHHHHHHHHHcCCCeEEeccc--
Confidence 677788888887776532 1 234556788888899999999999999999999999862
Q ss_pred eeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCc
Q 020431 71 LIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDG 150 (326)
Q Consensus 71 ~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~G 150 (326)
. .... + .....+.+..+++ .+.|||++||.+ ... +.+|++|+++|..++|+++++||||||
T Consensus 98 ~--~~~~-----~-~~~~~~~i~~ll~--~g~vpV~~G~~~---~~~------~~~D~~a~~lA~~l~a~~l~~~tdVdG 158 (231)
T PRK14558 98 V--NLPS-----V-EPINYDDIELYFR--AGYIVIFAGGTS---NPF------FTTDTAAALRAVEMKADILIKATKVDG 158 (231)
T ss_pred c--ccch-----h-hhhhHHHHHHHHH--CCCEEEEECCCC---CCC------CCcHHHHHHHHHHcCCCEEEEEecCCe
Confidence 1 1111 1 1223478888888 889999999853 111 235999999999999999999999999
Q ss_pred ccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCC---------CCceEEeC
Q 020431 151 VYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLS---------VPGIMICR 216 (326)
Q Consensus 151 v~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~---------~~GT~I~~ 216 (326)
||++||+++|+|+++++++++|+.++ |++++||+++++|.++|+|++|.|+++++ ..||.|.+
T Consensus 159 vy~~dP~~~~~a~~i~~i~~~e~~~~---g~~~~d~~a~~~a~~~gi~v~I~ng~~~~~l~~~l~g~~~GT~i~~ 230 (231)
T PRK14558 159 IYDKDPKKFPDAKKIDHLTFSEAIKM---GLKVMDTEAFSICKKYGITILVINFFEPGNLLKALKGENVGTLVVP 230 (231)
T ss_pred eEccCCCCCCCCeEcccccHHHHHHc---CcccccHHHHHHHHHCCCCEEEEeCCCCCHHHHHHCCCCCcEEeCC
Confidence 99999999999999999999998876 78999999999999999999999987543 35777754
No 34
>cd04242 AAK_G5K_ProB AAK_G5K_ProB: Glutamate-5-kinase (G5K) catalyzes glutamate-dependent ATP cleavage; G5K transfers the terminal phosphoryl group of ATP to the gamma-carboxyl group of glutamate, in the first and controlling step of proline (and, in mammals, ornithine) biosynthesis. G5K is subject to feedback allosteric inhibition by proline or ornithine. In microorganisms and plants, proline plays an important role as an osmoprotectant and, in mammals, ornithine biosynthesis is crucial for proper ammonia detoxification, since a G5K mutation has been shown to cause human hyperammonaemia. Microbial G5K generally consists of two domains: a catalytic G5K domain and one PUA (pseudo uridine synthases and archaeosine-specific transglycosylases) domain, and some lack the PUA domain. G5K requires free Mg for activity, it is tetrameric, and it aggregates to higher forms in a proline-dependent way. G5K lacking the PUA domain remains tetrameric, active, and proline-inhibitable, but the Mg requir
Probab=99.92 E-value=2.9e-24 Score=197.75 Aligned_cols=159 Identities=18% Similarity=0.281 Sum_probs=130.5
Q ss_pred hHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccC
Q 020431 34 SFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (326)
Q Consensus 34 ~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~ 113 (326)
..++.++|+||..+.++++..|+++|+++. +++ .+++.++.... +....+.++++++ .+.|||+++
T Consensus 65 ~~~~~~~~~Gq~~l~~~~~~~l~~~Gi~~~-----q~l-~t~~~~~~~~~-~~~~~~~i~~ll~--~g~iPVv~~----- 130 (251)
T cd04242 65 PEKQALAAVGQSLLMALYEQLFAQYGIKVA-----QIL-LTRDDFEDRKR-YLNARNTLETLLE--LGVIPIINE----- 130 (251)
T ss_pred hHHHHHHHHhHHHHHHHHHHHHHHcCCeEE-----EEE-EehhHhcchHH-HHHHHHHHHHHHH--CCCEEEEcC-----
Confidence 456889999999999999999999999963 332 34433322111 2223467888888 889999964
Q ss_pred CCCCccc--ccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeec--HHHHHHHh-----hcCCccc
Q 020431 114 PDNIPTT--LKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS--YQEAWEMS-----YFGANVL 184 (326)
Q Consensus 114 ~~g~~~~--lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls--~~e~~~l~-----~~g~~v~ 184 (326)
++.+++ ++||++|++|+.+|.+|+|++++|||||||||++||+.+|+++++++++ ++|+.+++ .+++++|
T Consensus 131 -~d~v~~~~~~~~~~D~~A~~lA~~l~Ad~liilTDVdGvy~~dP~~~~~a~~i~~i~~~~~e~~~~~~~~~~~~~tggm 209 (251)
T cd04242 131 -NDTVATEEIRFGDNDRLSALVAGLVNADLLILLSDVDGLYDKNPRENPDAKLIPEVEEITDEIEAMAGGSGSSVGTGGM 209 (251)
T ss_pred -CCCeeeeccccCChHHHHHHHHHHcCCCEEEEecCcCEEEeCCCCCCCCCeEEEEecCChHHHHHHhcccCcCcccCCc
Confidence 233444 7899999999999999999999999999999999999999999999999 99999985 5778999
Q ss_pred ch--hhHHHHHhCCCCEEEEeccCC
Q 020431 185 HP--RTIIPVMRYDIPIVIRNIFNL 207 (326)
Q Consensus 185 ~~--~a~~~a~~~~I~v~I~n~~~~ 207 (326)
+| +++..+.++|++++|.|+..|
T Consensus 210 ~~Kl~a~~~a~~~gi~v~I~~g~~~ 234 (251)
T cd04242 210 RTKLKAARIATEAGIPVVIANGRKP 234 (251)
T ss_pred HHHHHHHHHHHHCCCcEEEEcCCCC
Confidence 99 688999999999999998755
No 35
>cd04239 AAK_UMPK-like AAK_UMPK-like: UMP kinase (UMPK)-like, the microbial/chloroplast uridine monophosphate kinase (uridylate kinase) enzyme that catalyzes UMP phosphorylation and plays a key role in pyrimidine nucleotide biosynthesis. Regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinases of E. coli (Ec) and Pyrococcus furiosus (Pf) are known to function as homohexamers, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial UMPKs have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Als
Probab=99.92 E-value=3.9e-24 Score=194.26 Aligned_cols=174 Identities=21% Similarity=0.256 Sum_probs=142.5
Q ss_pred hhHHHHHHHHHHHHhhhc---------C-------------CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEccc
Q 020431 11 LSYEFIRSTYNFLSNVDS---------G-------------HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTR 68 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~---------~-------------~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~ 68 (326)
++.++|+...+.+.++.+ + ..++...+.+.+.||++++.+|+..|.++|+++..+++.
T Consensus 18 ~~~~~i~~~a~~i~~~~~~g~~vvvV~ggG~~a~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~l~~~Gi~a~~~~~~ 97 (229)
T cd04239 18 IDPEVLKEIAREIKEVVDLGVEVAIVVGGGNIARGYIAAARGMPRATADYIGMLATVMNALALQDALEKLGVKTRVMSAI 97 (229)
T ss_pred CCHHHHHHHHHHHHHHHHCCCEEEEEECCChHHhhHHHhhcCCChhhHHHHHHHHHHHHHHHHHHHHHHcCCCEEEeCHH
Confidence 556777777777765431 1 123455678888999999999999999999999999998
Q ss_pred ceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeecc
Q 020431 69 EVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDV 148 (326)
Q Consensus 69 ~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV 148 (326)
++...+. ..+. +.+.++++ .+.|||++||.+.. . +.||++|+.+|..++|+++++||||
T Consensus 98 ~~~~~~~------~~~~----~~l~~~l~--~g~ipVi~g~~g~~-----~----~~sD~~A~~lA~~l~a~~li~~tdV 156 (229)
T cd04239 98 PMQGVAE------PYIR----RRAIRHLE--KGRIVIFGGGTGNP-----G----FTTDTAAALRAEEIGADVLLKATNV 156 (229)
T ss_pred HHhhhhc------cccH----HHHHHHHh--CCCEEEEeCccCCC-----C----CCcHHHHHHHHHHcCCCEEEEEECC
Confidence 7743321 1123 67888888 88999999996422 1 2479999999999999999999999
Q ss_pred CcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCC
Q 020431 149 DGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLS 208 (326)
Q Consensus 149 ~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~ 208 (326)
||||++||+.+|+|+++++++++|+.+++. +++|+.+++++.++|++++|.|+++|+
T Consensus 157 dGvy~~dP~~~~~a~~i~~i~~~e~~~~~~---~~~~~~a~~~~~~~~i~v~I~~g~~~~ 213 (229)
T cd04239 157 DGVYDADPKKNPDAKKYDRISYDELLKKGL---KVMDATALTLCRRNKIPIIVFNGLKPG 213 (229)
T ss_pred CcccCCCCCCCCCCeEEeEEcHHHHHHHhc---CCccHHHHHHHHHCCCeEEEECCCChh
Confidence 999999999999999999999999988863 889999999999999999999987653
No 36
>PF00696 AA_kinase: Amino acid kinase family Match to Glutamate-5-kinases, C-terminal end of the alignment Match to Aspartate kinases; InterPro: IPR001048 This entry contains proteins with various specificities and includes the aspartate, glutamate and uridylate kinase families. In prokaryotes and plants the synthesis of the essential amino acids lysine and threonine is predominantly regulated by feed-back inhibition of aspartate kinase (AK) and dihydrodipicolinate synthase (DHPS). In Escherichia coli, thrA, metLM, and lysC encode aspartokinase isozymes that show feedback inhibition by threonine, methionine, and lysine, respectively []. The lysine-sensitive isoenzyme of aspartate kinase from spinach leaves has a subunit composition of 4 large and 4 small subunits []. In plants although the control of carbon fixation and nitrogen assimilation has been studied in detail, relatively little is known about the regulation of carbon and nitrogen flow into amino acids. The metabolic regulation of expression of an Arabidopsis thaliana aspartate kinase/homoserine dehydrogenase (AK/HSD) gene, which encodes two linked key enzymes in the biosynthetic pathway of aspartate family amino acids has been studied []. The conversion of aspartate into either the storage amino acid asparagine or aspartate family amino acids may be subject to a coordinated, reciprocal metabolic control, and this biochemical branch point is a part of a larger, coordinated regulatory mechanism of nitrogen and carbon storage and utilization.; GO: 0008652 cellular amino acid biosynthetic process; PDB: 2X2W_B 2WXB_B 1B7B_C 2J4L_F 2J4K_E 2J4J_F 2OGX_B 3QUO_A 3D40_A 3D41_A ....
Probab=99.91 E-value=2.3e-25 Score=203.05 Aligned_cols=112 Identities=35% Similarity=0.488 Sum_probs=107.9
Q ss_pred HHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeec
Q 020431 90 KRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS 169 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls 169 (326)
+.++++++ .+.|||++||.+.+.+|++++++++++|++|+.||.+|+|++++|||||||||++||+.+|+++++++|+
T Consensus 125 ~~i~~~l~--~~~ipVv~g~~~~~~~g~~~~~~~~~sD~~A~~lA~~l~A~~li~~tdV~Gv~~~dP~~~~~~~~i~~l~ 202 (242)
T PF00696_consen 125 EAIRELLE--QGIIPVVSGFAGIDDDGEVTTLGNVSSDYIAALLAAALGADKLIFLTDVDGVYTADPRIVPDARLIPELS 202 (242)
T ss_dssp HHHHHHHH--TTSEEEEESEEEEETTSTEEEEEEETHHHHHHHHHHHTTCSEEEEEESSSSEBSSSTTTSTTSEBESEEE
T ss_pred HHHHHHHH--CCCEEEEeCCcccCCCCCcccCCCCCHHHHHHHHHHHhCchhhhhhhhcCceeecCCCCCCCCeeeeEee
Confidence 88999998 7999999999989999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHh------hcCCcccchhhHHHHHhCCCCEEEEe
Q 020431 170 YQEAWEMS------YFGANVLHPRTIIPVMRYDIPIVIRN 203 (326)
Q Consensus 170 ~~e~~~l~------~~g~~v~~~~a~~~a~~~~I~v~I~n 203 (326)
++|+.+++ +.|++++||.|++++++++++++|+|
T Consensus 203 ~~e~~~l~~~~~~~~~gm~~k~~~a~~~~~~~~~~v~I~n 242 (242)
T PF00696_consen 203 YDEAEELASKSGDVTGGMKPKHPAALEAAEEGGIPVHIIN 242 (242)
T ss_dssp HHHHHHHHHHTTSSTTTHHHHHHHHHHHHHHTTSEEEEEE
T ss_pred HHHHHHHHhcCCCCCCCHHHHHHHHHHHHHcCCCcEEEeC
Confidence 99999999 78899999999999999999999986
No 37
>PRK00358 pyrH uridylate kinase; Provisional
Probab=99.91 E-value=1e-23 Score=191.69 Aligned_cols=174 Identities=22% Similarity=0.290 Sum_probs=136.2
Q ss_pred hhHHHHHHHHHHHHhhhc---------C--C-----------CChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEccc
Q 020431 11 LSYEFIRSTYNFLSNVDS---------G--H-----------ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTR 68 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~---------~--~-----------~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~ 68 (326)
++.+.++...+.+.++.. + . .++...+.+.+.+++++++++++.|.++|+++..+++.
T Consensus 20 ~~~~~i~~~~~~i~~~~~~g~~vvlV~gGG~~a~~~~~~~~~~~~~~~~~~~~~~~~l~~~ll~~~l~~~Gi~a~~~~~~ 99 (231)
T PRK00358 20 IDPEVLDRIAEEIKEVVELGVEVAIVVGGGNIFRGYIGAAAGMDRATADYMGMLATVMNALALQDALERAGVDTRVQSAI 99 (231)
T ss_pred CCHHHHHHHHHHHHHHHHCCCeEEEEECCCHHHHHHHHhhcCCChhhHHHHHHHHHHHHHHHHHHHHHHcCCCeEEechh
Confidence 466777777776665432 1 0 11233566777899999999999999999999977664
Q ss_pred ceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeecc
Q 020431 69 EVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDV 148 (326)
Q Consensus 69 ~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV 148 (326)
.+...+. .+ ..+.+.++++ .+.|||++|+.+ .. .+.+|++|+++|.+|+|+++++||||
T Consensus 100 ~~~~~~~--------~~--~~~~~~~~l~--~g~vPVv~g~~~-----~~----~~ssD~~A~~lA~~l~A~~li~~tdV 158 (231)
T PRK00358 100 PMPQVAE--------PY--IRRRAIRHLE--KGRVVIFAAGTG-----NP----FFTTDTAAALRAEEIGADVLLKATNV 158 (231)
T ss_pred hcccccC--------cc--cHHHHHHHHH--CCCEEEEECCCC-----CC----CCCchHHHHHHHHHcCCCEEEEeeCc
Confidence 4422211 11 1256778888 889999988632 11 12479999999999999999999999
Q ss_pred CcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCC
Q 020431 149 DGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLS 208 (326)
Q Consensus 149 ~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~ 208 (326)
||||++||+.+|+|+++++++++|+.++ |++++|+.++++|.++|++++|.|+++|+
T Consensus 159 dGVy~~dP~~~~~a~~i~~i~~~e~~~~---g~~~~d~~a~~~a~~~~i~v~I~~g~~~~ 215 (231)
T PRK00358 159 DGVYDADPKKDPDAKKYDRLTYDEVLEK---GLKVMDATAISLARDNKIPIIVFNMNKPG 215 (231)
T ss_pred CceEcCCCCCCCCCEEeeEecHHHHHHc---CCcchhHHHHHHHHHcCCcEEEECCCCch
Confidence 9999999999999999999999987666 88999999999999999999999987553
No 38
>PRK12314 gamma-glutamyl kinase; Provisional
Probab=99.91 E-value=4.7e-23 Score=191.13 Aligned_cols=191 Identities=17% Similarity=0.230 Sum_probs=144.3
Q ss_pred hhHHHHHHHHHHHHhhhc----------C--------------CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEc
Q 020431 11 LSYEFIRSTYNFLSNVDS----------G--------------HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMD 66 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~----------~--------------~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~ 66 (326)
++.++|+...+.+.++.. + +...+.++.+.|.||.++.+++..+|+++|+++
T Consensus 28 ~~~~~i~~~~~~I~~~~~~g~~vvlV~Sga~~~g~~~l~~~~~~~~~~~~~a~aa~Gq~~l~~~~~~~~~~~g~~~---- 103 (266)
T PRK12314 28 INLERIEQLVFVISDLMNKGKEVILVSSGAIGAGLTKLKLDKRPTSLAEKQALAAVGQPELMSLYSKFFAEYGIVV---- 103 (266)
T ss_pred cCHHHHHHHHHHHHHHHHCCCeEEEEeeCcccccceeeccccCCCCHHHHHHHHHHhHHHHHHHHHHHHHHcCCeE----
Confidence 577788888777775432 1 112356789999999999999999999999964
Q ss_pred ccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCccccc----CCcchHHHHHHHHhhccceE
Q 020431 67 TREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLK----RDGSDFSAAIMGALLRAHQV 142 (326)
Q Consensus 67 ~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lg----rggsD~~A~~lA~~l~a~~~ 142 (326)
+++ +.+++.|+..+. +....+.++++++ .|.|||+.+ ++.+++.+ +|++|++|+++|.+++|+.+
T Consensus 104 -~q~-llT~~~~~~~~~-~~~~~~~l~~ll~--~g~IPVv~~------nd~v~~~~~~~~~~~~D~~Aa~lA~~l~Ad~l 172 (266)
T PRK12314 104 -AQI-LLTRDDFDSPKS-RANVKNTFESLLE--LGILPIVNE------NDAVATDEIDTKFGDNDRLSAIVAKLVKADLL 172 (266)
T ss_pred -EEE-EEecccccchHH-HHHHHHHHHHHHH--CCCEEEEcC------CCCeeeccccceecchHHHHHHHHHHhCCCEE
Confidence 455 334444432211 2334578888888 889999964 23333333 78999999999999999999
Q ss_pred EEeeccCcccccCCCCCCCCeEEeeecH--HHHHHHhhc-----CCccc--chhhHHHHHhCCCCEEEEeccCCC-----
Q 020431 143 TIWTDVDGVYSADPRKVSEAVILRTLSY--QEAWEMSYF-----GANVL--HPRTIIPVMRYDIPIVIRNIFNLS----- 208 (326)
Q Consensus 143 ~~~tDV~Gv~~~dP~~~~~a~~i~~ls~--~e~~~l~~~-----g~~v~--~~~a~~~a~~~~I~v~I~n~~~~~----- 208 (326)
+|||||||||++||+.+|+|++++++++ .|..+++.. |.++| +++++..|.++|++++|.|+.+|+
T Consensus 173 iilTDVdGVy~~dP~~~~~a~~i~~I~~~~~~~~~~~~~~~~~~~tGGM~~Kl~aa~~a~~~gv~v~I~~g~~~~~i~~~ 252 (266)
T PRK12314 173 IILSDIDGLYDKNPRINPDAKLRSEVTEITEEILALAGGAGSKFGTGGMVTKLKAAKFLMEAGIKMVLANGFNPSDILDF 252 (266)
T ss_pred EEEeCCCcccCCCCCCCCCCeEEEEecCCCHHHHHHhccCCCCcccCchHHHHHHHHHHHHCCCeEEEEcCCCchHHHHH
Confidence 9999999999999999999999999986 556555432 33445 557999999999999999987553
Q ss_pred ----CCceEEeC
Q 020431 209 ----VPGIMICR 216 (326)
Q Consensus 209 ----~~GT~I~~ 216 (326)
..||+|.+
T Consensus 253 l~g~~~GT~i~~ 264 (266)
T PRK12314 253 LEGESIGTLFAP 264 (266)
T ss_pred HcCCCCceEEcc
Confidence 46998865
No 39
>PRK14557 pyrH uridylate kinase; Provisional
Probab=99.90 E-value=4.3e-23 Score=189.08 Aligned_cols=162 Identities=17% Similarity=0.262 Sum_probs=127.9
Q ss_pred ChhHHhHhhccchHHHHHHHHHHHHHc-CCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCcc
Q 020431 32 TESFTDFVVGHGELWSAQMLAAVVRKN-GIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFI 110 (326)
Q Consensus 32 ~~~~~d~i~~~GE~~s~~~~~~~L~~~-Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi 110 (326)
+....|.+.+.||+||+.++...|++. +..+ .+.++..++... . +....++.+.++ .|.|||++||.
T Consensus 67 ~~~~~D~ig~~g~~lna~ll~~~l~~~~~~~~--------~i~t~~~~~~~~-~-~~~~~~~~~~l~--~g~VvV~~G~~ 134 (247)
T PRK14557 67 DRVEADNIGTLGTIINSLMLRGVLTSKTNKEV--------RVMTSIPFNAVA-E-PYIRLRAVHHLD--NGYIVIFGGGN 134 (247)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHhhhCCce--------eEEecccccccc-c-hhhHHHHHHHHh--CCCEEEEECCc
Confidence 345668999999999999999999984 4443 333433332211 1 112244666676 78899999987
Q ss_pred ccCCCCCcccccCCcchHHHHHHHHhhccceEEEee-ccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhH
Q 020431 111 ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWT-DVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTI 189 (326)
Q Consensus 111 ~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~t-DV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~ 189 (326)
+. +.++ +|++|+++|..++|+.+++|| ||||||++||+++|+|+++++++|.|+. ..+.++|+++|+
T Consensus 135 g~---~~~s------tD~lAallA~~l~Ad~li~~ttdVdGvY~~DP~~~~~Ak~i~~i~~~e~~---~~~~~~~~~~A~ 202 (247)
T PRK14557 135 GQ---PFVT------TDYPSVQRAIEMNSDAILVAKQGVDGVFTSDPKHNKSAKMYRKLNYNDVV---RQNIQVMDQAAL 202 (247)
T ss_pred CC---CccC------hHHHHHHHHHHhCCCEEEEecCCcCEeECCCCCCCCCCEEeeEEChhhhc---ccCHHHHHHHHH
Confidence 63 3344 599999999999999999995 9999999999999999999999999873 456789999999
Q ss_pred HHHHhCCCCEEEEeccCCC---------CCceEEeCC
Q 020431 190 IPVMRYDIPIVIRNIFNLS---------VPGIMICRP 217 (326)
Q Consensus 190 ~~a~~~~I~v~I~n~~~~~---------~~GT~I~~~ 217 (326)
++|.++|+|++|.|+.+|+ ..||+|.+.
T Consensus 203 ~~a~~~gi~v~I~ng~~~~~l~~~l~g~~~GT~i~~~ 239 (247)
T PRK14557 203 LLARDYNLPAHVFNFDEPGVMRRICLGEHVGTLINDD 239 (247)
T ss_pred HHHHHCCCcEEEEeCCCChHHHHHHcCCCCcEEEecC
Confidence 9999999999999987553 469999764
No 40
>cd04254 AAK_UMPK-PyrH-Ec UMP kinase (UMPK)-Ec, the microbial/chloroplast uridine monophosphate kinase (uridylate kinase) enzyme that catalyzes UMP phosphorylation and plays a key role in pyrimidine nucleotide biosynthesis; regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinase of E. coli (Ec) is known to function as a homohexamer, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial and chloroplast UMPKs (this CD) have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Members of this CD be
Probab=99.90 E-value=4.6e-23 Score=187.51 Aligned_cols=155 Identities=24% Similarity=0.278 Sum_probs=130.3
Q ss_pred HhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCC
Q 020431 36 TDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPD 115 (326)
Q Consensus 36 ~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~ 115 (326)
.|.+.+.|+++++.++++.|+++|+++..+++.++.... ...+. +.++++++ .+.|||++||.|
T Consensus 67 ~d~~g~~~~~~n~~ll~~~L~~~Gv~a~~l~~~~~~~~~------~~~~~----~~l~~~l~--~g~ipV~~g~~G---- 130 (231)
T cd04254 67 ADYMGMLATVINALALQDALESLGVKTRVMSAIPMQGVA------EPYIR----RRAIRHLE--KGRVVIFAGGTG---- 130 (231)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHcCCCeEEEcHHHhhhhh------cccCH----HHHHHHHH--CCCEEEEECCcC----
Confidence 455667799999999999999999999999998762211 11344 78888888 789999998854
Q ss_pred CCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhC
Q 020431 116 NIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRY 195 (326)
Q Consensus 116 g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~ 195 (326)
...+ .+|++|+++|.+|+|+++++||||||||++||+.+|+++++++++++|+.+ .|++++|+.++++|.++
T Consensus 131 -~~~~----~~D~~a~~lA~~l~a~~l~~~tdVdGvy~~dp~~~~~a~~i~~i~~~~~~~---~~~~~~d~~a~~~a~~~ 202 (231)
T cd04254 131 -NPFF----TTDTAAALRAIEINADVILKATKVDGVYDADPKKNPNAKRYDHLTYDEVLS---KGLKVMDATAFTLCRDN 202 (231)
T ss_pred -CCCC----CcHHHHHHHHHHcCCCEEEEEeCCCEEEecCCCCCCCcEEeeEecHHHHHh---cchhhhHHHHHHHHHHC
Confidence 2111 259999999999999999999999999999999999999999999999866 47889999999999999
Q ss_pred CCCEEEEeccCCC---------CCceEE
Q 020431 196 DIPIVIRNIFNLS---------VPGIMI 214 (326)
Q Consensus 196 ~I~v~I~n~~~~~---------~~GT~I 214 (326)
|++++|.|+.+|+ ..||+|
T Consensus 203 gi~~~I~~g~~~~~l~~~l~g~~~GT~i 230 (231)
T cd04254 203 NLPIVVFNINEPGNLLKAVKGEGVGTLI 230 (231)
T ss_pred CCeEEEEeCCCccHHHHHHCCCCCCEEe
Confidence 9999999987553 357776
No 41
>TIGR02075 pyrH_bact uridylate kinase. This protein, also called UMP kinase, converts UMP to UDP by adding a phosphate from ATP. It is the first step in pyrimidine biosynthesis. GTP is an allosteric activator. In a large fraction of all bacterial genomes, the gene tends to be located immediately downstream of elongation factor Ts and upstream of ribosome recycling factor. A related protein family, believed to be equivalent in function and found in the archaea and in spirochetes, is described by a separate model, TIGR02076.
Probab=99.89 E-value=1.5e-22 Score=184.39 Aligned_cols=155 Identities=22% Similarity=0.275 Sum_probs=130.3
Q ss_pred HhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCC
Q 020431 36 TDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPD 115 (326)
Q Consensus 36 ~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~ 115 (326)
.|.+.+.++++++++|+..|.++|+++..+++.++.. .... ...+.++++++ .|.|||+.|+.+.
T Consensus 68 ~d~~g~~~~~l~~~l~~~~L~~~Gi~a~~l~~~~~~~-~~~~---------~~~~~i~~ll~--~g~VpV~~g~~g~--- 132 (233)
T TIGR02075 68 ADYMGMLATVINGLALRDALEKLGVKTRVLSAISMPQ-ICES---------YIRRKAIKHLE--KGKVVIFSGGTGN--- 132 (233)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCCCcEEeccccCCC-Cccc---------cCHHHHHHHHH--CCCEEEEECCCCC---
Confidence 5778888999999999999999999999999987651 1111 12377888888 7899999987542
Q ss_pred CCcccccCCcchHHHHHHHHhhccceEEEeec-cCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHh
Q 020431 116 NIPTTLKRDGSDFSAAIMGALLRAHQVTIWTD-VDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMR 194 (326)
Q Consensus 116 g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tD-V~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~ 194 (326)
.. ..+|++|+++|..|+|+++++||| |||||++||+++|+++++++++++|+.++ |++++|+.++++|.+
T Consensus 133 ~~------~s~D~~a~~lA~~l~a~~li~~td~VdGvy~~dp~~~~~a~~i~~i~~~e~~~~---~~~~~d~~~~~~a~~ 203 (233)
T TIGR02075 133 PF------FTTDTAAALRAIEINADVILKGTNGVDGVYTADPKKNKDAKKYETITYNEALKK---NLKVMDLTAFALARD 203 (233)
T ss_pred CC------CCchHHHHHHHHHcCCCEEEEeecccCeEEcCCCCCCCCCeECcEecHHHHHhc---CHHHHHHHHHHHHHH
Confidence 11 125999999999999999999999 99999999999999999999999998764 778999999999999
Q ss_pred CCCCEEEEeccCCC---------CCceEE
Q 020431 195 YDIPIVIRNIFNLS---------VPGIMI 214 (326)
Q Consensus 195 ~~I~v~I~n~~~~~---------~~GT~I 214 (326)
+|++++|.|+.+|+ ..||.|
T Consensus 204 ~~i~v~i~~g~~~~~l~~~l~g~~~GT~i 232 (233)
T TIGR02075 204 NNLPIVVFNIDEPGALKKVILGKGIGTLV 232 (233)
T ss_pred CCCeEEEEeCCCcchHHHHHCCCCCCEEe
Confidence 99999999987543 457766
No 42
>PRK13402 gamma-glutamyl kinase; Provisional
Probab=99.87 E-value=1.5e-21 Score=188.11 Aligned_cols=193 Identities=17% Similarity=0.244 Sum_probs=150.5
Q ss_pred hhhHHHHHHHHHHHHhhhcC-----------------------CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEc
Q 020431 10 ELSYEFIRSTYNFLSNVDSG-----------------------HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMD 66 (326)
Q Consensus 10 ~~~~~~i~~~~~~l~~~~~~-----------------------~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~ 66 (326)
.|+.+++....+++..+... ...-..++.+.+.||.++.+.+...|.++|+++..
T Consensus 23 ~l~~~~i~~la~~I~~l~~~G~~vvlVsSGava~G~~~l~~~~~~~~~~~qalaavGq~~l~~~~~~~f~~~g~~~aq-- 100 (368)
T PRK13402 23 GCSSHYLLGLVQQIVYLKDQGHQVVLVSSGAVAAGYHKLGFIDRPSVPEKQAMAAAGQGLLMATWSKLFLSHGFPAAQ-- 100 (368)
T ss_pred CcCHHHHHHHHHHHHHHHHCCCEEEEEeCChhhcCccccCCCCCCCccHHHHHHHhhHHHHHHHHHHHHHHCCCeEEE--
Confidence 47788888877777765531 01234567888999999999999999999998843
Q ss_pred ccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCccc--ccCCcchHHHHHHHHhhccceEEE
Q 020431 67 TREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTT--LKRDGSDFSAAIMGALLRAHQVTI 144 (326)
Q Consensus 67 ~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~--lgrggsD~~A~~lA~~l~a~~~~~ 144 (326)
+++ +.+.+.. +-.+...+..++++++ .+.|||+.. ++.+++ +++|++|++|+++|.+++|+.+++
T Consensus 101 ---vLl-T~~d~~~-~~~y~n~~~~l~~LL~--~g~IPIine------nD~v~~~el~~GdnD~lAa~vA~~l~Ad~Lii 167 (368)
T PRK13402 101 ---LLL-THGDLRD-RERYINIRNTINVLLE--RGILPIINE------NDAVTTDRLKVGDNDNLSAMVAALADADTLII 167 (368)
T ss_pred ---EEE-ecchhhh-HHHHHHHHHHHHHHHH--CCcEEEEeC------CCcEeecccccCChHHHHHHHHHHhCCCEEEE
Confidence 323 3222211 1123344678888888 889999852 223343 778999999999999999999999
Q ss_pred eeccCcccccCCCCCCCCeEEeeecH--HHHHHHh-----hcCCcccch--hhHHHHHhCCCCEEEEeccCC--------
Q 020431 145 WTDVDGVYSADPRKVSEAVILRTLSY--QEAWEMS-----YFGANVLHP--RTIIPVMRYDIPIVIRNIFNL-------- 207 (326)
Q Consensus 145 ~tDV~Gv~~~dP~~~~~a~~i~~ls~--~e~~~l~-----~~g~~v~~~--~a~~~a~~~~I~v~I~n~~~~-------- 207 (326)
||||||||++||+.+|+|++++++++ +|+.+++ ..|+++|+| .++..|.++|++++|.|+..|
T Consensus 168 lTDVdGvy~~dP~~~p~a~~I~~I~~i~~e~~~l~~~~~s~~gtGGM~~Kl~Aa~~a~~~gi~v~I~~g~~~~~l~~~l~ 247 (368)
T PRK13402 168 LSDIDGLYDQNPRTNPDAKLIKQVTEINAEIYAMAGGAGSNVGTGGMRTKIQAAKIAMSHGIETFIGNGFTADIFNQLLK 247 (368)
T ss_pred EecCCeEEeCCCCCCCCCEEEEEeccCcHHHHHHhcccccCcCcCCchHHHHHHHHHHHcCCcEEEEcCCCchHHHHHhc
Confidence 99999999999999999999999997 7777776 367899999 589999999999999998765
Q ss_pred -CCCceEEeCC
Q 020431 208 -SVPGIMICRP 217 (326)
Q Consensus 208 -~~~GT~I~~~ 217 (326)
+..||+|.+.
T Consensus 248 g~~~GT~i~~~ 258 (368)
T PRK13402 248 GQNPGTYFTPE 258 (368)
T ss_pred CCCCceEEecC
Confidence 3469999764
No 43
>COG0528 PyrH Uridylate kinase [Nucleotide transport and metabolism]
Probab=99.87 E-value=5.3e-21 Score=170.36 Aligned_cols=181 Identities=23% Similarity=0.281 Sum_probs=146.3
Q ss_pred hhHHHHHHHHHHHHhhhcC----------------------CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEccc
Q 020431 11 LSYEFIRSTYNFLSNVDSG----------------------HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTR 68 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~~----------------------~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~ 68 (326)
.+.++++.+.++|.++.+. -.+....|++=...-+++|.++.+.|.+.|+++..+++.
T Consensus 25 id~~~i~~~a~~i~~~~~~g~eV~iVvGGGni~Rg~~~~~~g~~r~~~D~mGmlaTvmNal~L~~aL~~~~~~~~v~sai 104 (238)
T COG0528 25 IDPEVLDRIANEIKELVDLGVEVAVVVGGGNIARGYIGAAAGMDRVTADYMGMLATVMNALALQDALERLGVDTRVQSAI 104 (238)
T ss_pred CCHHHHHHHHHHHHHHHhcCcEEEEEECCCHHHHhHHHHHcCCchhhhhHHHHHHHHHHHHHHHHHHHhcCCcceecccc
Confidence 6788899988888888851 134455666666777889999999999999999999886
Q ss_pred ceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeec-
Q 020431 69 EVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTD- 147 (326)
Q Consensus 69 ~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tD- 147 (326)
....+. .+.+++...++++ .++|+|..| | +.+-.++| |++|+++|..++|+-++..|+
T Consensus 105 ~~~~~~----------e~~~~~~A~~~l~--~grVvIf~g--G-tg~P~fTT------Dt~AALrA~ei~ad~ll~atn~ 163 (238)
T COG0528 105 AMPQVA----------EPYSRREAIRHLE--KGRVVIFGG--G-TGNPGFTT------DTAAALRAEEIEADVLLKATNK 163 (238)
T ss_pred cCcccc----------CccCHHHHHHHHH--cCCEEEEeC--C-CCCCCCch------HHHHHHHHHHhCCcEEEEeccC
Confidence 663211 1234477777888 899999876 2 33333443 999999999999999999995
Q ss_pred cCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCC---------CCceEEe
Q 020431 148 VDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLS---------VPGIMIC 215 (326)
Q Consensus 148 V~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~---------~~GT~I~ 215 (326)
|||||++||+++|+|+.+++|||.|+.++ +.++|||.|+.++++++||++++|.+++. ..||+|.
T Consensus 164 VDGVY~~DPkk~pdA~~~~~Lty~e~l~~---~l~vmD~tA~~l~~~~~i~i~Vfn~~~~~~l~~~~~ge~~gT~V~ 237 (238)
T COG0528 164 VDGVYDADPKKDPDAKKYDTLTYDEVLKI---GLKVMDPTAFSLARDNGIPIIVFNINKPGNLKRALKGEEVGTIVE 237 (238)
T ss_pred CCceeCCCCCCCCCceecccCCHHHHHHh---cCeeecHHHHHHHHHcCCcEEEEeCCCCccHHHHHcCCCCceEec
Confidence 99999999999999999999999998877 58999999999999999999999976543 4577764
No 44
>PRK14556 pyrH uridylate kinase; Provisional
Probab=99.87 E-value=5.1e-21 Score=174.38 Aligned_cols=181 Identities=18% Similarity=0.248 Sum_probs=146.1
Q ss_pred hhHHHHHHHHHHHHhhhc-C------------------C----CChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcc
Q 020431 11 LSYEFIRSTYNFLSNVDS-G------------------H----ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDT 67 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~-~------------------~----~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~ 67 (326)
++.++++.+.+++.++.+ + . .+....|++=.-+-+++|.++.+.|.+.|+++..+++
T Consensus 35 ~d~~~~~~~a~~i~~~~~~g~~i~iVvGGGni~Rg~~~~~~~~~~r~~~D~~GmlaT~iNal~l~~~l~~~~~~~~v~sa 114 (249)
T PRK14556 35 INVESAQPIINQIKTLTNFGVELALVVGGGNILRGGRANFGNKIRRATADSMGMIATMINALALRDMLISEGVDAEVFSA 114 (249)
T ss_pred cCHHHHHHHHHHHHHHHhCCcEEEEEECCCHHHhCchhhccCCCchhhhhHHHHHHHHHHHHHHHHHHHHcCCCeEEeec
Confidence 677888888888887775 1 1 3334677877788999999999999999999999887
Q ss_pred cceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeec
Q 020431 68 REVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTD 147 (326)
Q Consensus 68 ~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tD 147 (326)
-...- + +.+ .+++.+.+.++ .|.|+|+.|+.| ++.++ +|++|+++|..++|+.+++|||
T Consensus 115 ~~~~~-----~----~e~-~~~~~~~~~l~--~g~vvi~~gg~G---~p~~S------tD~lAallA~~l~Ad~Lii~Td 173 (249)
T PRK14556 115 KGVDG-----L----LKV-ASAHEFNQELA--KGRVLIFAGGTG---NPFVT------TDTTASLRAVEIGADALLKATT 173 (249)
T ss_pred cccCc-----C----CCC-CCHHHHHHHHh--CCCEEEEECCCC---CCcCC------cHHHHHHHHHHcCCCEEEEEeC
Confidence 44311 1 111 14477778887 788999888754 34444 3999999999999999999999
Q ss_pred cCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCCC---------CCceEEe
Q 020431 148 VDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLS---------VPGIMIC 215 (326)
Q Consensus 148 V~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~~---------~~GT~I~ 215 (326)
|||||++||+++|+|+++++++|.|+.+. +.++|++.+++++.++|+|++|.|+.+|+ ..||+|.
T Consensus 174 VDGVYd~DP~~~p~A~~i~~I~~~e~~~~---~l~vmd~~A~~~a~~~gIpi~I~ng~~~~~L~~~l~Ge~~GT~i~ 247 (249)
T PRK14556 174 VNGVYDKDPNKYSDAKRFDKVTFSEVVSK---ELNVMDLGAFTQCRDFGIPIYVFDLTQPNALVDAVLDSKYGTWVT 247 (249)
T ss_pred CCccCCCCCCCCCCceEeeEEchhhhccc---chHhHHHHHHHHHHHCCCcEEEECCCCchHHHHHHcCCCCceEEE
Confidence 99999999999999999999999987653 56899999999999999999999987543 4688874
No 45
>PRK05429 gamma-glutamyl kinase; Provisional
Probab=99.85 E-value=2.4e-20 Score=180.71 Aligned_cols=193 Identities=19% Similarity=0.235 Sum_probs=146.3
Q ss_pred hhHHHHHHHHHHHHhhhc---------C-------------C--CChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEc
Q 020431 11 LSYEFIRSTYNFLSNVDS---------G-------------H--ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMD 66 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~---------~-------------~--~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~ 66 (326)
|+.++++...+++.++.. + + ..-...+.+.|.||..+++++...|+++|+++..+
T Consensus 27 l~~~~i~~la~~I~~l~~~g~~vViV~sGai~~g~~~l~l~~~~~~~~~~qa~aavGq~~L~~~~~~~l~~~gi~~~qi- 105 (372)
T PRK05429 27 LDRARIAELARQIAALRAAGHEVVLVSSGAVAAGRERLGLPERPKTLAEKQAAAAVGQSRLMQAYEELFARYGITVAQI- 105 (372)
T ss_pred cCHHHHHHHHHHHHHHHHCCCeEEEEcccHhhhhHhhcCCCCCCCchHHHHHHHHHhHHHHHHHHHHHHHHCCCCEEEE-
Confidence 667778777777665442 1 0 12235578889999999999999999999997653
Q ss_pred ccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecC-ccccCCCCCcccccCCcchHHHHHHHHhhccceEEEe
Q 020431 67 TREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATG-FIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIW 145 (326)
Q Consensus 67 ~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~G-fi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~ 145 (326)
+ .+.+.+.. ...+....+.++.+++ .+.|||++. +...+ ..+++|++|++|+++|.+++|+.++|+
T Consensus 106 ----l-~t~~d~~~-~~~~ln~~~~i~~Ll~--~g~IPVi~~nd~v~~-----~~l~~gd~D~~Aa~lA~~l~Ad~Liil 172 (372)
T PRK05429 106 ----L-LTRDDLED-RERYLNARNTLRTLLE--LGVVPIINENDTVAT-----DEIKFGDNDTLSALVANLVEADLLILL 172 (372)
T ss_pred ----E-eehhHhhh-hhHhhhHHHHHHHHHH--CCCEEEEcCCCccce-----ecccccChHHHHHHHHHHcCCCEEEEe
Confidence 2 22222211 1122233577888887 889999963 21111 125678999999999999999999999
Q ss_pred eccCcccccCCCCCCCCeEEeeecH--HHHHHHhh-----cCCcccch--hhHHHHHhCCCCEEEEeccCC---------
Q 020431 146 TDVDGVYSADPRKVSEAVILRTLSY--QEAWEMSY-----FGANVLHP--RTIIPVMRYDIPIVIRNIFNL--------- 207 (326)
Q Consensus 146 tDV~Gv~~~dP~~~~~a~~i~~ls~--~e~~~l~~-----~g~~v~~~--~a~~~a~~~~I~v~I~n~~~~--------- 207 (326)
|||||||++||+.+|++++++++++ +|+.+++. .|+++|+| .++..+.++|++++|.|+..+
T Consensus 173 TDVdGVy~~dP~~~p~a~~I~~i~~~~~e~~~~~~~~~~~~gtGGM~~Kl~aa~~a~~~Gi~v~I~~g~~~~~l~~~l~g 252 (372)
T PRK05429 173 TDVDGLYTADPRKNPDAKLIPEVEEITDELEAMAGGAGSGLGTGGMATKLEAARIATRAGIPVVIASGREPDVLLRLLAG 252 (372)
T ss_pred cCCCeeEcCCCCCCCCceEEEEeccCCHHHHHHhcCCCCCcCcCCcHHHHHHHHHHHHCCCeEEEEcCCCccHHHHHhcC
Confidence 9999999999999999999999998 67888853 67889999 689999999999999998654
Q ss_pred CCCceEEeCC
Q 020431 208 SVPGIMICRP 217 (326)
Q Consensus 208 ~~~GT~I~~~ 217 (326)
+..||.|.+.
T Consensus 253 ~~~GT~i~~~ 262 (372)
T PRK05429 253 EAVGTLFLPQ 262 (372)
T ss_pred CCCCEEEeeC
Confidence 2469999865
No 46
>cd04253 AAK_UMPK-PyrH-Pf AAK_UMPK-PyrH-Pf: UMP kinase (UMPK)-Pf, the mostly archaeal uridine monophosphate kinase (uridylate kinase) enzymes that catalyze UMP phosphorylation and play a key role in pyrimidine nucleotide biosynthesis; regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinase of Pyrococcus furiosus (Pf) is known to function as a homohexamer, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial UMPKs have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs (this CD) appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Members of thi
Probab=99.85 E-value=2.7e-20 Score=168.20 Aligned_cols=138 Identities=22% Similarity=0.228 Sum_probs=113.0
Q ss_pred hHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccC
Q 020431 34 SFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (326)
Q Consensus 34 ~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~ 113 (326)
...|.+...+++++++++...+. +|++++.+ +. +.+.++++ .+.|||++||++
T Consensus 61 ~~~d~~g~~~~~ln~~~~~~~l~-~~~~~~~~------------------~~----~~~~~~l~--~g~vpv~~G~~~-- 113 (221)
T cd04253 61 AFLDEIGIMATRLNARLLIAALG-DAYPPVPT------------------SY----EEALEAMF--TGKIVVMGGTEP-- 113 (221)
T ss_pred HHHHHhcCHHHHHHHHHHHHHHh-cCCCcCCC------------------CH----HHHHHHHH--cCCeEEEECCCC--
Confidence 34566666778888888777776 66654322 12 45667777 789999999964
Q ss_pred CCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhc-----CC-cccchh
Q 020431 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF-----GA-NVLHPR 187 (326)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~-----g~-~v~~~~ 187 (326)
+ .+ +|++|+++|..++|+.+++||||||||++||+.+|+|+++++++++|+.+++.. |+ .++|+.
T Consensus 114 --~-~s------~D~~a~~lA~~l~a~~li~~tdVdGVy~~dP~~~~~a~~i~~i~~~e~~~~~~~~~~~~g~~~~~d~~ 184 (221)
T cd04253 114 --G-QS------TDAVAALLAERLGADLLINATNVDGVYSKDPRKDPDAKKFDRLSADELIDIVGKSSWKAGSNEPFDPL 184 (221)
T ss_pred --C-Cc------cHHHHHHHHHHcCCCEEEEEeCCCeeECCCCCCCCCCeEeeEeCHHHHHHHccCCCcCCCCCcchHHH
Confidence 2 22 499999999999999999999999999999999999999999999999999765 44 578999
Q ss_pred hHHHHHhCCCCEEEEeccCC
Q 020431 188 TIIPVMRYDIPIVIRNIFNL 207 (326)
Q Consensus 188 a~~~a~~~~I~v~I~n~~~~ 207 (326)
+++++.++|++++|.|+.+|
T Consensus 185 a~~~~~~~gi~~~I~~g~~p 204 (221)
T cd04253 185 AAKIIERSGIKTIVVDGRDP 204 (221)
T ss_pred HHHHHHHCCCeEEEECCCCc
Confidence 99999999999999998754
No 47
>TIGR01027 proB glutamate 5-kinase. Bacterial ProB proteins hit the full length of this model, but the ProB-like domain of delta 1-pyrroline-5-carboxylate synthetase does not hit the C-terminal 100 residues of this model. The noise cutoff is set low enough to hit delta 1-pyrroline-5-carboxylate synthetase and other partial matches to this family.
Probab=99.84 E-value=3.2e-20 Score=179.18 Aligned_cols=193 Identities=17% Similarity=0.236 Sum_probs=145.7
Q ss_pred hhHHHHHHHHHHHHhhhc---------C------------C---CChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEc
Q 020431 11 LSYEFIRSTYNFLSNVDS---------G------------H---ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMD 66 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~---------~------------~---~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~ 66 (326)
++.++|+...+++.++.. + + ..-..++.+.+.|+.++.+++...|.++|+++..
T Consensus 19 ~~~~~i~~la~~I~~l~~~g~~vvlV~sG~~~~g~~~lg~~~~~~~l~~~qa~aa~Gq~~l~~~~~~~l~~~Gi~~aq-- 96 (363)
T TIGR01027 19 LDRSHIAELVEQVAALHAAGHEVVIVSSGAIAAGFEALGLPERPKTLAEKQALAAVGQVRLMQLYEQLFSQYGIKVAQ-- 96 (363)
T ss_pred cCHHHHHHHHHHHHHHHHCCCeEEEEeCcHHhcCccccCCCCCccchHHHHHHHHhChHHHHHHHHHHHHHcCCeEEE--
Confidence 677778777777765443 0 0 1113567889999999999999999999998633
Q ss_pred ccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEec-CccccCCCCCcccccCCcchHHHHHHHHhhccceEEEe
Q 020431 67 TREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIAT-GFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIW 145 (326)
Q Consensus 67 ~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~-Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~ 145 (326)
+++ +.+.+.+ +..+...+..+..+++ .+.|||++ ++... .+.+++|++|++|+++|.+++|+.++|+
T Consensus 97 ---ill-t~~d~~~-~~~~lna~~~i~~Ll~--~g~iPVi~end~v~-----~~~l~~gd~D~lAa~lA~~l~Ad~liil 164 (363)
T TIGR01027 97 ---ILL-TRADFSD-RERYLNARNTLEALLE--LGVVPIINENDTVA-----TEEIKFGDNDTLSALVAILVGADLLVLL 164 (363)
T ss_pred ---EEE-eccchhh-HHHHHHHHHHHHHHHh--CCCEEEEeCCCcee-----eeecCcCChHHHHHHHHHHcCCCEEEEE
Confidence 333 3322211 1123345577888887 78999996 33211 1336778899999999999999999999
Q ss_pred eccCcccccCCCCCCCCeEEeeecHH--HHHHHh-----hcCCcccchh--hHHHHHhCCCCEEEEeccCCC--------
Q 020431 146 TDVDGVYSADPRKVSEAVILRTLSYQ--EAWEMS-----YFGANVLHPR--TIIPVMRYDIPIVIRNIFNLS-------- 208 (326)
Q Consensus 146 tDV~Gv~~~dP~~~~~a~~i~~ls~~--e~~~l~-----~~g~~v~~~~--a~~~a~~~~I~v~I~n~~~~~-------- 208 (326)
|||||||++||+.+|+|++++++++. +..+++ ..|+++|+|+ |+..|.++|++++|.|+..|+
T Consensus 165 TDVdGVy~~dP~~~p~A~~I~~i~~~~~~~~~i~~~~~~~~gtGGM~~Kl~Aa~~a~~~gi~v~I~~g~~~~~l~~~l~g 244 (363)
T TIGR01027 165 TDVDGLYDADPRTNPDAKLIPVVEEITDLLLGVAGDSGSSVGTGGMRTKLQAADLATRAGVPVIIASGSKPEKIADALEG 244 (363)
T ss_pred eCCCcccCCCCCCCCCCeEEEEeccCcHHHHHhhcCCCcCcCcCCchHHHHHHHHHHHCCCeEEEEeCCCccHHHHHhcC
Confidence 99999999999999999999999864 455564 3678899997 889999999999999987543
Q ss_pred -CCceEEeCC
Q 020431 209 -VPGIMICRP 217 (326)
Q Consensus 209 -~~GT~I~~~ 217 (326)
..||.|.+.
T Consensus 245 ~~~GT~i~~~ 254 (363)
T TIGR01027 245 APVGTLFHAQ 254 (363)
T ss_pred CCCcEEEeeC
Confidence 469999764
No 48
>TIGR02076 pyrH_arch uridylate kinase, putative. This family consists of the archaeal and spirochete proteins most closely related to bacterial uridylate kinases (TIGR02075), an enzyme involved in pyrimidine biosynthesis. Members are likely, but not known, to be functionally equivalent to their bacterial counterparts. However, substantial sequence differences suggest that regulatory mechanisms may be different; the bacterial form is allosterically regulated by GTP.
Probab=99.83 E-value=1.2e-19 Score=163.87 Aligned_cols=140 Identities=23% Similarity=0.241 Sum_probs=112.9
Q ss_pred hHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccC
Q 020431 34 SFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (326)
Q Consensus 34 ~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~ 113 (326)
...|.+...+++++++++...|...++++...+ . ....+.+. .+.+||++||++
T Consensus 60 ~~~~~~g~~~~~ln~~~l~~ll~~~~~~~~~~~------------------~----~~~~~~l~--~g~ipv~~G~~~-- 113 (221)
T TIGR02076 60 TFLDEIGIDATRLNAMLLIAALGDDAYPKVPEN------------------F----EEALEAMS--LGKIVVMGGTHP-- 113 (221)
T ss_pred HHHHHhhhHHHHHHHHHHHHHHHhcCCCCcCCC------------------H----HHHHHHHH--cCCEEEEcCCCC--
Confidence 345667777899999998888877777654321 1 22344555 678999999862
Q ss_pred CCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhh---cCCc---ccchh
Q 020431 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY---FGAN---VLHPR 187 (326)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~---~g~~---v~~~~ 187 (326)
| ++ +|++|+++|.+++|+++++||||||||++||+++|+|+++++++++|+.+++. +|++ .+++.
T Consensus 114 --~-~s------~D~~A~~lA~~l~A~~li~ltdVdGvy~~dP~~~~~a~~i~~i~~~e~~~~~~~~~~~~g~~~~~~~~ 184 (221)
T TIGR02076 114 --G-HT------TDAVAALLAEFSKADLLINATNVDGVYDKDPKKDPDAKKFDKLTPEELVEIVGSSSVKAGSNEVVDPL 184 (221)
T ss_pred --C-CC------cHHHHHHHHHHcCCCEEEEEeCCCcccCCCCCCCCCCeEeeEECHHHHHHHhcCCCccCCCCceeHHH
Confidence 2 22 49999999999999999999999999999999999999999999999999876 3333 67889
Q ss_pred hHHHHHhCCCCEEEEeccCCC
Q 020431 188 TIIPVMRYDIPIVIRNIFNLS 208 (326)
Q Consensus 188 a~~~a~~~~I~v~I~n~~~~~ 208 (326)
+++.+.+.+++++|.|+.+|+
T Consensus 185 a~~~~~~~~i~v~I~~g~~~~ 205 (221)
T TIGR02076 185 AAKIIERSKIRTIVVNGRDPE 205 (221)
T ss_pred HHHHHHHCCCcEEEECCCCcc
Confidence 999999999999999987553
No 49
>cd04241 AAK_FomA-like AAK_FomA-like: This CD includes a fosfomycin biosynthetic gene product, FomA, and similar proteins found in a wide range of organisms. Together, the fomA and fomB genes in the fosfomycin biosynthetic gene cluster of Streptomyces wedmorensis confer high-level fosfomycin resistance. FomA and FomB proteins converted fosfomycin to fosfomycin monophosphate and fosfomycin diphosphate in the presence of ATP and a magnesium ion, indicating that FomA and FomB catalyzed phosphorylations of fosfomycin and fosfomycin monophosphate, respectively. FomA and related sequences in this CD are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.82 E-value=8.7e-20 Score=167.97 Aligned_cols=145 Identities=15% Similarity=0.191 Sum_probs=121.2
Q ss_pred HHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchH
Q 020431 49 QMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDF 128 (326)
Q Consensus 49 ~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~ 128 (326)
..+++.|.++|+++.++++.+++....++. ..++. +.++++++ .+.|||++|+++.+.+|++.+++ +|+
T Consensus 83 ~~~~~~l~~~g~~a~~l~~~~~~~~~~g~~--~~~~~----~~l~~ll~--~g~iPVi~~~~~~~~~~~~~~~~---~D~ 151 (252)
T cd04241 83 SIVVDALLEAGVPAVSVPPSSFFVTENGRI--VSFDL----EVIKELLD--RGFVPVLHGDVVLDEGGGITILS---GDD 151 (252)
T ss_pred HHHHHHHHHCCCCeEEEChHHeEEecCCee--eeecH----HHHHHHHh--CCCEEEEcCCeEecCCCCeEEeC---hHH
Confidence 467889999999999999999866543211 23444 88999998 89999999998888888777664 899
Q ss_pred HHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhc-------CCcccchh--hHHHHHhCCCCE
Q 020431 129 SAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF-------GANVLHPR--TIIPVMRYDIPI 199 (326)
Q Consensus 129 ~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~-------g~~v~~~~--a~~~a~~~~I~v 199 (326)
+|+.+|.+|+|++++|||||||||++|| |+++++++++++|+.++... ..++|.++ ++..+.++|+++
T Consensus 152 ~A~~lA~~l~A~~li~ltdv~Gv~~~~P---~~~~~i~~i~~~~~~~~~~~~~~~~~~~tGGm~~Kl~aa~~a~~~Gv~v 228 (252)
T cd04241 152 IVVELAKALKPERVIFLTDVDGVYDKPP---PDAKLIPEIDVGSLEDILAALGSAGTDVTGGMAGKIEELLELARRGIEV 228 (252)
T ss_pred HHHHHHHHcCCCEEEEEeCCCeeECCCC---CCCeEcceeCccchHHHHHhcCcCCccccCCHHHHHHHHHHHHhcCCeE
Confidence 9999999999999999999999999999 89999999999888888642 35688885 777778899999
Q ss_pred EEEeccCC
Q 020431 200 VIRNIFNL 207 (326)
Q Consensus 200 ~I~n~~~~ 207 (326)
+|.++.++
T Consensus 229 ~I~~g~~~ 236 (252)
T cd04241 229 YIFNGDKP 236 (252)
T ss_pred EEEeCCCH
Confidence 99998754
No 50
>PRK14058 acetylglutamate/acetylaminoadipate kinase; Provisional
Probab=99.82 E-value=1.2e-19 Score=168.51 Aligned_cols=169 Identities=14% Similarity=0.201 Sum_probs=133.5
Q ss_pred hhHHhH-hhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCC-------------------CCCC-CCCCchhhHHH
Q 020431 33 ESFTDF-VVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPT-------------------SSNQ-VDPDFSESEKR 91 (326)
Q Consensus 33 ~~~~d~-i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~-------------------~~g~-~~~~~~~~~~~ 91 (326)
++..+. ..+.| +++..++ +.|.++|++|+++++.++.+++.. ..|+ .+++. +.
T Consensus 68 ~~~l~~~~~a~~-~ln~~lv-~~L~~~Gv~a~~l~~~~~~l~~~~~~~~~~~~~~g~~~~~d~g~~g~v~~v~~----~~ 141 (268)
T PRK14058 68 RETLEVFIMAMA-LINKQLV-ERLQSLGVNAVGLSGLDGGLLEGKRKKAVRVVEEGKKKIIRGDYTGKIEEVNT----DL 141 (268)
T ss_pred HHHHHHHHHHHH-HHHHHHH-HHHHhCCCCccccCcccCCEEEEEEecccccccCCcceeccCCceeEEEEECH----HH
Confidence 344444 45778 7777775 599999999999999987554211 1111 23444 88
Q ss_pred HHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHH
Q 020431 92 LEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQ 171 (326)
Q Consensus 92 i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~ 171 (326)
++.+++ .+.|||++|+ +.+..|+..++ ++|++|+.+|.+|+|++++|||||||||++||. +++++++++++
T Consensus 142 i~~ll~--~g~iPVi~~~-~~~~~g~~~~i---~~D~~A~~lA~~l~A~~li~ltdv~Gv~~~~p~---~~~~i~~i~~~ 212 (268)
T PRK14058 142 LKLLLK--AGYLPVVAPP-ALSEEGEPLNV---DGDRAAAAIAGALKAEALVLLSDVPGLLRDPPD---EGSLIERITPE 212 (268)
T ss_pred HHHHHH--CCCEEEEeCc-eECCCCcEEec---CHHHHHHHHHHHcCCCEEEEEeCChhhccCCCC---CCcCccCcCHH
Confidence 999998 8899999997 55677887766 489999999999999999999999999999984 57899999999
Q ss_pred HHHHHhhcCCcccchh--hHHHHHhCCC-CEEEEeccCCC-------CCceEEeC
Q 020431 172 EAWEMSYFGANVLHPR--TIIPVMRYDI-PIVIRNIFNLS-------VPGIMICR 216 (326)
Q Consensus 172 e~~~l~~~g~~v~~~~--a~~~a~~~~I-~v~I~n~~~~~-------~~GT~I~~ 216 (326)
|+.++.....++|.|+ ++..+.++|+ +++|.++..++ ..||+|.+
T Consensus 213 e~~~l~~~~tGgM~~Kl~aa~~a~~~Gv~~v~I~~g~~~~~l~~~l~G~GT~I~~ 267 (268)
T PRK14058 213 EAEELSKAAGGGMKKKVLMAAEAVEGGVGRVIIADANVDDPISAALAGEGTVIVN 267 (268)
T ss_pred HHHHHhhccCCccHHHHHHHHHHHHcCCCEEEEEcCCCcchHHHHhCCCceEEec
Confidence 9999887778889885 6777788899 79999886553 35898864
No 51
>cd04250 AAK_NAGK-C AAK_NAGK-C: N-Acetyl-L-glutamate kinase - cyclic (NAGK-C) catalyzes the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of arginine biosynthesis found in some bacteria and photosynthetic organisms using the non-acetylated, cyclic route of ornithine biosynthesis. In this pathway, glutamate is first N-acetylated and then phosphorylated by NAGK to give phosphoryl NAG, which is converted to NAG-ornithine. There are two variants of this pathway. In one, typified by the pathway in Thermotoga maritima and Pseudomonas aeruginosa, the acetyl group is recycled by reversible transacetylation from acetylornithine to glutamate. The phosphorylation of NAG by NAGK is feedback inhibited by arginine. In photosynthetic organisms, NAGK is the target of the nitrogen-signaling protein PII. Hexameric formation of NAGK domains appears to be essential to both arginine inhibition and NAGK-PII complex formation. NAGK-C are members of the Amino A
Probab=99.80 E-value=3.2e-19 Score=166.67 Aligned_cols=151 Identities=15% Similarity=0.205 Sum_probs=123.4
Q ss_pred chHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCC--------------C-CCCCchhhHHHHHHHhhcCCCcEEEec
Q 020431 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSN--------------Q-VDPDFSESEKRLEKWFSQSPSNTIIAT 107 (326)
Q Consensus 43 GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g--------------~-~~~~~~~~~~~i~~~l~~~~~~ipVv~ 107 (326)
|+ ++.. +++.|+++|++++++++.+.++++.++++ . ..++. +.++++++ .+.|||++
T Consensus 93 g~-ln~~-l~~~L~~~Gv~a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~i~~----~~i~~ll~--~g~IPVi~ 164 (279)
T cd04250 93 GK-VNKE-IVSLINRAGGKAVGLSGKDGNLIKAKKKDATVIEEIIDLGFVGEVTEVNP----ELLETLLE--AGYIPVIA 164 (279)
T ss_pred Cc-hHHH-HHHHHHHcCCCcceeecCCCCEEEEEECcccccCCCcccCcccceEEEcH----HHHHHHHH--CCCeEEEc
Confidence 74 5555 59999999999999999987666654433 1 12333 88899998 88999999
Q ss_pred CccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhc--CCcccc
Q 020431 108 GFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF--GANVLH 185 (326)
Q Consensus 108 Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~--g~~v~~ 185 (326)
| ++.++.|++.+++ +|.+|+.+|.+|+|++++|||||||||++||. +++++++++++|+.+++.. ..++|.
T Consensus 165 ~-~~~~~~g~~~~~~---~D~~A~~lA~~l~A~~li~ltdv~Gv~~~~p~---~~~~i~~i~~~e~~~l~~~~~~tGgm~ 237 (279)
T cd04250 165 P-VGVGEDGETYNIN---ADTAAGAIAAALKAEKLILLTDVAGVLDDPND---PGSLISEISLKEAEELIADGIISGGMI 237 (279)
T ss_pred C-CccCCCCcEEEeC---HHHHHHHHHHHhCCCEEEEEECCcccccCCCC---CccccccCCHHHHHHHHHcCCCCCchH
Confidence 9 5888888888774 89999999999999999999999999999985 4799999999999999753 457888
Q ss_pred hh--hHHHHHhCCCC-EEEEeccCCC
Q 020431 186 PR--TIIPVMRYDIP-IVIRNIFNLS 208 (326)
Q Consensus 186 ~~--a~~~a~~~~I~-v~I~n~~~~~ 208 (326)
++ ++..+.+.|++ ++|.|+..|+
T Consensus 238 ~Kl~~a~~a~~~g~~~v~I~~g~~~~ 263 (279)
T cd04250 238 PKVEACIEALEGGVKAAHIIDGRVPH 263 (279)
T ss_pred HHHHHHHHHHHhCCCEEEEeCCCCCc
Confidence 85 66677778886 9999887553
No 52
>PRK00942 acetylglutamate kinase; Provisional
Probab=99.78 E-value=1.5e-18 Score=162.41 Aligned_cols=160 Identities=19% Similarity=0.220 Sum_probs=126.5
Q ss_pred HhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCC---------CC-CCCCchhhHHHHHHHhhcCCCcEEEec
Q 020431 38 FVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSS---------NQ-VDPDFSESEKRLEKWFSQSPSNTIIAT 107 (326)
Q Consensus 38 ~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~---------g~-~~~~~~~~~~~i~~~l~~~~~~ipVv~ 107 (326)
.+++ | +++. .+.+.|+++|++++.+++.+..+++...+ |. ..++. +.++++++ .|.|||++
T Consensus 98 ~a~~-G-~l~~-~i~~~L~~~Gv~a~~l~~~~~~~~ta~~~~~~~~~~~~g~i~~i~~----~~l~~ll~--~g~vpVv~ 168 (283)
T PRK00942 98 MVLA-G-KVNK-ELVSLINKHGGKAVGLSGKDGGLITAKKLEEDEDLGFVGEVTPVNP----ALLEALLE--AGYIPVIS 168 (283)
T ss_pred HHHc-C-chHH-HHHHHHHhCCCCccceeeccCCEEEEEECCCCCCCccccceEEECH----HHHHHHHH--CCCEEEEc
Confidence 3444 7 4554 45699999999999999998877765333 21 12333 88999998 88999999
Q ss_pred CccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcC--Ccccc
Q 020431 108 GFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLH 185 (326)
Q Consensus 108 Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g--~~v~~ 185 (326)
+ ++.+.+|++++++ +|++|+.||.+|+|++++|||||||||++ +++++++++++|+.+++..+ .++|.
T Consensus 169 ~-~~~~~~g~~~~l~---~D~~A~~lA~~l~A~~li~~tdv~Gv~~~------~~~~i~~i~~~e~~~~~~~~~~tggm~ 238 (283)
T PRK00942 169 P-IGVGEDGETYNIN---ADTAAGAIAAALGAEKLILLTDVPGVLDD------KGQLISELTASEAEELIEDGVITGGMI 238 (283)
T ss_pred C-cEECCCCcEEEEC---HHHHHHHHHHHcCCCEEEEEECCcccccC------CCcccccCCHHHHHHHHHcCCCCCchH
Confidence 7 5889999998885 89999999999999999999999999986 47899999999999998654 46777
Q ss_pred hh--hHHHHHhCCC-CEEEEeccCC----------CCCceEEeC
Q 020431 186 PR--TIIPVMRYDI-PIVIRNIFNL----------SVPGIMICR 216 (326)
Q Consensus 186 ~~--a~~~a~~~~I-~v~I~n~~~~----------~~~GT~I~~ 216 (326)
|+ ++..+.++|+ +++|.|+..+ +..||.|.+
T Consensus 239 ~Kl~~a~~~~~~gv~~v~I~~g~~~~~ll~~~~~~~~~GT~i~~ 282 (283)
T PRK00942 239 PKVEAALDAARGGVRSVHIIDGRVPHALLLELFTDEGIGTMIVP 282 (283)
T ss_pred HHHHHHHHHHHhCCCEEEEeCCCCCchHHHHHhcCCCcceEEec
Confidence 75 5666667887 5999987544 346888865
No 53
>cd04249 AAK_NAGK-NC AAK_NAGK-NC: N-Acetyl-L-glutamate kinase - noncyclic (NAGK-NC) catalyzes the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of microbial arginine biosynthesis using the acetylated, noncyclic route of ornithine biosynthesis. There are two variants of this pathway. In one, typified by the pathway in Escherichia coli, glutamate is acetylated by acetyl-CoA and acetylornithine is deacylated hydrolytically. In this pathway, feedback inhibition by arginine occurs at the initial acetylation of glutamate and not at the phosphorylation of NAG by NAGK. Homodimeric NAGK-NC are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.78 E-value=1.1e-18 Score=160.68 Aligned_cols=156 Identities=17% Similarity=0.182 Sum_probs=121.0
Q ss_pred hHHhHhhcc-chHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCC-------C-CCCCchhhHHHHHHHhhcCCCcEE
Q 020431 34 SFTDFVVGH-GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSN-------Q-VDPDFSESEKRLEKWFSQSPSNTI 104 (326)
Q Consensus 34 ~~~d~i~~~-GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g-------~-~~~~~~~~~~~i~~~l~~~~~~ip 104 (326)
...+.+.+. ++.++.+++...+ ++|++++++++.+.++++..+++ . .+++. +.++++++ .+.||
T Consensus 67 ~~l~~~~~~~~~~~n~~lv~~l~-~~Gv~a~~l~~~~~~~~~~~~~~~~~~~~G~v~~i~~----~~l~~ll~--~g~ip 139 (252)
T cd04249 67 EQIPYITGALAGTANKQLMAQAI-KAGLKPVGLSLADGGMTAVTQLDPELGAVGKATANDP----SLLNDLLK--AGFLP 139 (252)
T ss_pred HHHHHHHHHHcCcccHHHHHHHH-hCCCCceeeeccCCCEEEEEEcCCCCCcccceEEEcH----HHHHHHHH--CCCEE
Confidence 344454443 6677777766665 89999999999988666543322 1 12344 88999998 88999
Q ss_pred EecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcC--Cc
Q 020431 105 IATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--AN 182 (326)
Q Consensus 105 Vv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g--~~ 182 (326)
|++|+ +.+++|++++++ +|++|+.+|.+|+|+ ++|||||||||+.|| +++++++++|+.++...| ..
T Consensus 140 Vi~~~-g~~~~g~~~~~~---~D~~A~~lA~~l~A~-~i~ltdv~Gv~~~~~------~~i~~i~~~e~~~~~~~g~~~g 208 (252)
T cd04249 140 IISSI-GADDQGQLMNVN---ADQAATAIAQLLNAD-LVLLSDVSGVLDADK------QLISELNAKQAAELIEQGVITD 208 (252)
T ss_pred EECCC-EECCCCCEeeec---HHHHHHHHHHHcCCC-EEEEeCCcccCCCCC------cCccccCHHHHHHHHhcCCCcC
Confidence 99985 889999999886 899999999999999 689999999998765 688999999999997654 35
Q ss_pred ccch---hhHHHHHhCCCCEEEEeccCC
Q 020431 183 VLHP---RTIIPVMRYDIPIVIRNIFNL 207 (326)
Q Consensus 183 v~~~---~a~~~a~~~~I~v~I~n~~~~ 207 (326)
+|.+ .|++.+.+.+++++|.++..+
T Consensus 209 Gm~~kl~~a~~~~~~~~~~v~I~~g~~~ 236 (252)
T cd04249 209 GMIVKVNAALDAAQSLRRGIDIASWQYP 236 (252)
T ss_pred CcHHHHHHHHHHHHhCCCeEEEEeCCCc
Confidence 5655 466777777789999988654
No 54
>TIGR00761 argB acetylglutamate kinase. This model describes N-acetylglutamate kinases (ArgB) of many prokaryotes and the N-acetylglutamate kinase domains of multifunctional proteins from yeasts. This enzyme is the second step in the "acetylated" ornithine biosynthesis pathway. A related group of enzymes representing the first step of the pathway contain a homologous domain and are excluded from this model.
Probab=99.78 E-value=1.3e-18 Score=158.31 Aligned_cols=141 Identities=16% Similarity=0.246 Sum_probs=114.4
Q ss_pred chHHHHHHHHHHHHHcCCceEEEcccceeeccCCCC--------CC-CCCCchhhHHHHHHHhhcCCCcEEEecCccccC
Q 020431 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSS--------NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (326)
Q Consensus 43 GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~--------g~-~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~ 113 (326)
+++++..+ .+.|+++|++++++++.+..+++...+ |. ..++. +.++++++ .+.|||++|+ +.+
T Consensus 75 ~g~~~~~i-~~~L~~~G~~a~~l~~~~~~~it~~~~~~~~~~~~g~i~~i~~----~~i~~~l~--~g~IPVi~~~-~~~ 146 (231)
T TIGR00761 75 IGQVNKEL-VALLNKHGINAIGLTGGDGQLFTARSLDKEDLGYVGEIKKVNK----ALLEALLK--AGYIPVISSL-ALT 146 (231)
T ss_pred hcchHHHH-HHHHHhCCCCcccccCCCCCEEEEEECCCccCCcccceEEEcH----HHHHHHHH--CCCeEEECCC-ccC
Confidence 44566544 569999999999999998755543221 11 12333 88999998 8899999995 888
Q ss_pred CCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcC--Ccccchh--hH
Q 020431 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHPR--TI 189 (326)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g--~~v~~~~--a~ 189 (326)
.+|++++++ +|++|+.||.+|+|++++|||||||||++||+ +++++++++|+.++++.| .++|.++ ++
T Consensus 147 ~~g~~~~l~---sD~~A~~lA~~l~A~~li~ltdv~Gv~~~d~~-----~~i~~i~~~e~~~l~~~~~~tggm~~Kl~~a 218 (231)
T TIGR00761 147 AEGQALNVN---ADTAAGALAAALGAEKLVLLTDVPGILNGDGQ-----SLISEIPLEEIEQLIEQGIITGGMIPKVNAA 218 (231)
T ss_pred CCCcEEEeC---HHHHHHHHHHHcCCCEEEEEECCCCeecCCCC-----eeccccCHHHHHHHHHcCCCCCchHHHHHHH
Confidence 889999885 89999999999999999999999999999874 799999999999999866 5789885 67
Q ss_pred HHHHhCCCCE
Q 020431 190 IPVMRYDIPI 199 (326)
Q Consensus 190 ~~a~~~~I~v 199 (326)
..+.+.|++-
T Consensus 219 ~~a~~~gv~~ 228 (231)
T TIGR00761 219 LEALRGGVKS 228 (231)
T ss_pred HHHHHcCCCE
Confidence 7777788863
No 55
>COG0263 ProB Glutamate 5-kinase [Amino acid transport and metabolism]
Probab=99.77 E-value=1.9e-17 Score=155.18 Aligned_cols=194 Identities=15% Similarity=0.247 Sum_probs=154.7
Q ss_pred hhhHHHHHHHHHHHHhhhcC------------------------CCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEE
Q 020431 10 ELSYEFIRSTYNFLSNVDSG------------------------HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWM 65 (326)
Q Consensus 10 ~~~~~~i~~~~~~l~~~~~~------------------------~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l 65 (326)
.|+..+++.+..++.++... +..-+.+-.+.|.|+....+.+...|..+|+++
T Consensus 24 ~l~~~~l~~l~~~ia~L~~~G~eVilVSSGAiaaG~~~Lg~~~rp~~l~~kQA~AAVGQ~~Lm~~y~~~f~~~g~~v--- 100 (369)
T COG0263 24 GLDRSKLEELVRQVAALHKAGHEVVLVSSGAIAAGRTRLGLPKRPKTLAEKQAAAAVGQVRLMQLYEELFARYGIKV--- 100 (369)
T ss_pred CcCHHHHHHHHHHHHHHHhCCCEEEEEccchhhhChhhcCCCCCCcchHHHHHHHHhCHHHHHHHHHHHHHhcCCee---
Confidence 47788888888888887751 222255667889999999999999999999964
Q ss_pred cccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCccc--ccCCcchHHHHHHHHhhccceEE
Q 020431 66 DTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTT--LKRDGSDFSAAIMGALLRAHQVT 143 (326)
Q Consensus 66 ~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~--lgrggsD~~A~~lA~~l~a~~~~ 143 (326)
.++.++.++ +.+ +..|.+.+..+..+++ .|.|||+ |+|..+.+ +..|++|.++++.|...+||.++
T Consensus 101 --~QiLLTr~D-~~~-r~ry~Nar~Tl~~Ll~--~gvVPII------NENDtva~~EikfGDND~LsA~VA~lv~ADlLv 168 (369)
T COG0263 101 --GQILLTRDD-FSD-RRRYLNARNTLSALLE--LGVVPII------NENDTVATEEIKFGDNDTLSALVAILVGADLLV 168 (369)
T ss_pred --eEEEeehhh-hhh-HHHHHHHHHHHHHHHH--CCceeee------cCCCceeeeeeeecCCchHHHHHHHHhCCCEEE
Confidence 455444332 211 2245667788999998 8999998 67766655 55678899999999999999999
Q ss_pred EeeccCcccccCCCCCCCCeEEeeecH--HHHHHHhh-----cCCcccchh--hHHHHHhCCCCEEEEeccCCC------
Q 020431 144 IWTDVDGVYSADPRKVSEAVILRTLSY--QEAWEMSY-----FGANVLHPR--TIIPVMRYDIPIVIRNIFNLS------ 208 (326)
Q Consensus 144 ~~tDV~Gv~~~dP~~~~~a~~i~~ls~--~e~~~l~~-----~g~~v~~~~--a~~~a~~~~I~v~I~n~~~~~------ 208 (326)
++||+||+||+||+.+|+|+++++++- .|...++. .|.++|..| |++.|.++|++++|.++.+++
T Consensus 169 lLsDiDGLyd~nPr~~pdAk~i~~V~~it~ei~~~aggsgs~~GTGGM~TKl~AA~iA~~aG~~~iI~~g~~~~~i~~~~ 248 (369)
T COG0263 169 LLSDIDGLYDANPRTNPDAKLIPEVEEITPEIEAMAGGSGSELGTGGMRTKLEAAKIATRAGVPVIIASGSKPDVILDAL 248 (369)
T ss_pred EEEccCcccCCCCCCCCCCeeehhhcccCHHHHHHhcCCCCCCCcccHHHHHHHHHHHHHcCCcEEEecCCCcchHHHHH
Confidence 999999999999999999999998863 46767764 678899885 999999999999999998754
Q ss_pred ---CCceEEeCCC
Q 020431 209 ---VPGIMICRPP 218 (326)
Q Consensus 209 ---~~GT~I~~~~ 218 (326)
..||.+.+..
T Consensus 249 ~~~~~GT~F~~~~ 261 (369)
T COG0263 249 EGEAVGTLFEPQA 261 (369)
T ss_pred hCCCCccEEecCC
Confidence 4699998653
No 56
>cd04238 AAK_NAGK-like AAK_NAGK-like: N-Acetyl-L-glutamate kinase (NAGK)-like . Included in this CD are the Escherichia coli and Pseudomonas aeruginosa type NAGKs which catalyze the phosphorylation of N-acetyl-L-glutamate (NAG) by ATP in the second step of arginine biosynthesis found in bacteria and photosynthetic organisms using either the acetylated, noncyclic (NC), or non-acetylated, cyclic (C) route of ornithine biosynthesis. Also included in this CD is a distinct group of uncharacterized (UC) bacterial and archeal NAGKs. Members of this CD belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.76 E-value=4.6e-18 Score=156.91 Aligned_cols=147 Identities=16% Similarity=0.205 Sum_probs=118.4
Q ss_pred chHHHHHHHHHHHHHcCCceEEEcccceeeccCCCC----------CC-CCCCchhhHHHHHHHhhcCCCcEEEecCccc
Q 020431 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSS----------NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (326)
Q Consensus 43 GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~----------g~-~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~ 111 (326)
| +++.. +++.|+++|++++++++.+..++++.+. |. ..++. +.++.+++ .+.|||++| ++
T Consensus 77 g-~ln~~-i~~~L~~~Gv~a~~l~~~~~~~~~~~~~~~~~~~~~~~g~i~~i~~----~~l~~ll~--~g~ipVv~~-~~ 147 (256)
T cd04238 77 G-KVNKE-LVSLLNRAGGKAVGLSGKDGGLIKAEKKEEKDIDLGFVGEVTEVNP----ELLETLLE--AGYIPVIAP-IA 147 (256)
T ss_pred C-chHHH-HHHHHHhCCCCCCCcccccCCEEEEEECCCCCCCcccccceEEECH----HHHHHHHH--CCCEEEECC-cE
Confidence 6 55555 4999999999999999999866655332 22 13444 88899998 889999999 58
Q ss_pred cCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhc--CCcccchh--
Q 020431 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF--GANVLHPR-- 187 (326)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~--g~~v~~~~-- 187 (326)
.++.|++++++ +|++|+.+|..|+|++++|||||+|||++ +++++++++++|+.++... ..+.|.|+
T Consensus 148 ~~~~g~~~~~~---~D~~A~~lA~~l~a~~li~ltdv~Gv~~~------~~~~i~~i~~~e~~~~~~~~~~~ggm~~Kl~ 218 (256)
T cd04238 148 VDEDGETYNVN---ADTAAGAIAAALKAEKLILLTDVPGVLDD------PGSLISELTPKEAEELIEDGVISGGMIPKVE 218 (256)
T ss_pred ECCCCcEEEEC---HHHHHHHHHHHcCCCEEEEEeCCccccCC------CCCccccCCHHHHHHHHHcCCCCCChHHHHH
Confidence 88889988875 89999999999999999999999999987 3789999999999998753 35788785
Q ss_pred hHHHHHhCCC-CEEEEeccCC
Q 020431 188 TIIPVMRYDI-PIVIRNIFNL 207 (326)
Q Consensus 188 a~~~a~~~~I-~v~I~n~~~~ 207 (326)
++..+.+.|+ +++|.|+..+
T Consensus 219 ~a~~~~~~g~~~v~I~~g~~~ 239 (256)
T cd04238 219 AALEALEGGVRKVHIIDGRVP 239 (256)
T ss_pred HHHHHHHhCCCEEEEeCCCCC
Confidence 5666666776 5999987654
No 57
>PLN02512 acetylglutamate kinase
Probab=99.75 E-value=1.6e-17 Score=157.26 Aligned_cols=155 Identities=17% Similarity=0.205 Sum_probs=123.4
Q ss_pred HHHHHHHHHHcCCceEEEcccceeeccCCCC---------CC-CCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCC
Q 020431 48 AQMLAAVVRKNGIDCKWMDTREVLIVNPTSS---------NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNI 117 (326)
Q Consensus 48 ~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~---------g~-~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~ 117 (326)
.+.+++.|+++|++++++++.+..+++..++ |. ..++. +.++.+++ .+.|||++|+ +.++.|+
T Consensus 129 n~~lv~~L~~~Gv~av~l~g~d~~~i~a~~~~~~~~~~~~G~i~~v~~----~~i~~lL~--~g~IPVi~~~-~~d~~g~ 201 (309)
T PLN02512 129 NKSLVSLINKAGGTAVGLSGKDGRLLRARPSPNSADLGFVGEVTRVDP----TVLRPLVD--DGHIPVIATV-AADEDGQ 201 (309)
T ss_pred HHHHHHHHHHcCCCeEEeehhhCCEEEEEEcCcCccccccceeeecCH----HHHHHHHh--CCCEEEEeCc-eECCCCC
Confidence 5568899999999999999988654543322 11 13444 88999998 8999999996 8888888
Q ss_pred cccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcC--Ccccchh--hHHHHH
Q 020431 118 PTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHPR--TIIPVM 193 (326)
Q Consensus 118 ~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g--~~v~~~~--a~~~a~ 193 (326)
..++ ++|.+|+.||.+|+|++++|||||||||+++| ++++++++++++|+.++...| .++|.|| ++..+.
T Consensus 202 ~~~i---~~D~~A~~lA~~L~Ad~li~lTdV~GV~~~~~---~~~~lI~~i~~~e~~~l~~~~~vtGGM~~Kl~aa~~a~ 275 (309)
T PLN02512 202 AYNI---NADTAAGEIAAALGAEKLILLTDVAGVLEDKD---DPGSLVKELDIKGVRKLIADGKIAGGMIPKVECCVRSL 275 (309)
T ss_pred Eecc---CHHHHHHHHHHHcCCCEEEEEeCCcceeCCCC---CCcCCCcccCHHHHHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 8877 48999999999999999999999999999864 347899999999999987543 5789886 556667
Q ss_pred hCCCC-EEEEeccCCC----------CCceEEe
Q 020431 194 RYDIP-IVIRNIFNLS----------VPGIMIC 215 (326)
Q Consensus 194 ~~~I~-v~I~n~~~~~----------~~GT~I~ 215 (326)
+.|++ ++|.++..++ ..||.|.
T Consensus 276 ~~Gv~~v~I~~g~~~~~ll~~l~~~~~~GT~I~ 308 (309)
T PLN02512 276 AQGVKTAHIIDGRVPHSLLLEILTDEGAGTMIT 308 (309)
T ss_pred HcCCCEEEEecCCCCChHHHHHhcCCCCeeEEe
Confidence 78996 8999875442 3477774
No 58
>cd04251 AAK_NAGK-UC AAK_NAGK-UC: N-Acetyl-L-glutamate kinase - uncharacterized (NAGK-UC). This domain is similar to Escherichia coli and Pseudomonas aeruginosa NAGKs which catalyze the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of microbial arginine biosynthesis. These uncharacterized domain sequences are found in some bacteria (Deinococci and Chloroflexi) and archea and belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.74 E-value=1.1e-17 Score=154.51 Aligned_cols=158 Identities=14% Similarity=0.187 Sum_probs=123.2
Q ss_pred hhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCC-------------------CCC-CCCCchhhHHHH
Q 020431 33 ESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTS-------------------SNQ-VDPDFSESEKRL 92 (326)
Q Consensus 33 ~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~-------------------~g~-~~~~~~~~~~~i 92 (326)
++..+.+....+.++..+ ++.|+++|++++++++.+..++..+. .|. ..++. +.+
T Consensus 64 ~~~l~~~~~a~~~ln~~i-v~~L~~~Gi~a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~G~v~~v~~----~~i 138 (257)
T cd04251 64 KETLEVFVMVMGLINKKI-VARLHSLGVKAVGLTGLDGRLLEAKRKEIVRVNERGRKMIIRGGYTGKVEKVNS----DLI 138 (257)
T ss_pred HHHHHHHHHHHHHHHHHH-HHHHHhCCCCceecccccCCEEEEEEeecccccccCcccccCCcceEEEEEEcH----HHH
Confidence 444455554447777775 55999999999999998875443221 111 12344 889
Q ss_pred HHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHH
Q 020431 93 EKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQE 172 (326)
Q Consensus 93 ~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e 172 (326)
+.+++ .+.|||++++ +.+.+|++.+++ +|++|+.+|.+|+|++++|||||+|||++ ++++++++++|
T Consensus 139 ~~ll~--~g~vpVi~~~-~~~~~G~~~~i~---~D~~A~~lA~~L~A~~li~~tdv~Gv~~~-------~~~i~~i~~~e 205 (257)
T cd04251 139 EALLD--AGYLPVVSPV-AYSEEGEPLNVD---GDRAAAAIAAALKAERLILLTDVEGLYLD-------GRVIERITVSD 205 (257)
T ss_pred HHHHh--CCCeEEEeCc-EECCCCcEEecC---HHHHHHHHHHHcCCCEEEEEeCChhheeC-------CcccCccCHHH
Confidence 99998 8999999887 667889988884 89999999999999999999999999963 78999999999
Q ss_pred HHHHhhcCCcccchh--hHHHHHhCCCC-EEEEeccCCC
Q 020431 173 AWEMSYFGANVLHPR--TIIPVMRYDIP-IVIRNIFNLS 208 (326)
Q Consensus 173 ~~~l~~~g~~v~~~~--a~~~a~~~~I~-v~I~n~~~~~ 208 (326)
+.++...-.++|.|+ ++..+.++|++ ++|.++..|+
T Consensus 206 ~~~l~~~~~ggm~~Kl~aa~~a~~~gv~~v~i~~g~~~~ 244 (257)
T cd04251 206 AESLLEKAGGGMKRKLLAAAEAVEGGVREVVIGDARADS 244 (257)
T ss_pred HHHHHhhCCCchHHHHHHHHHHHHcCCCEEEEecCCCcc
Confidence 999976566788885 77777888884 7888876543
No 59
>cd04255 AAK_UMPK-MosAB AAK_UMPK-MosAB: This CD includes the alpha and beta subunits of the Mo storage protein (MosA and MosB) which are related to uridine monophosphate kinase (UMPK) enzymes that catalyze the phosphorylation of UMP by ATP, yielding UDP, and playing a key role in pyrimidine nucleotide biosynthesis. The Mo storage protein from the nitrogen-fixing bacterium, Azotobacter vinelandii, is characterized as an alpha4-beta4 octamer containing a polynuclear molybdenum-oxide cluster which is ATP-dependent to bind Mo and pH-dependent to release Mo. These and related bacterial sequences in this CD are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.74 E-value=2.6e-17 Score=152.19 Aligned_cols=182 Identities=14% Similarity=0.161 Sum_probs=121.8
Q ss_pred HHHHHHHHHHHHhhhcCCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEc------ccc-eeeccC--CCCCCCCC
Q 020431 13 YEFIRSTYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMD------TRE-VLIVNP--TSSNQVDP 83 (326)
Q Consensus 13 ~~~i~~~~~~l~~~~~~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~------~~~-~~~~~~--~~~g~~~~ 83 (326)
.+.|+...++|.++..+ .+.++.+|+--.+|....+..+.|++....+ ... ..+..+ ..+|...+
T Consensus 47 ~~~i~~la~~i~~~~~~------~~vilV~GGG~~~r~~~~~~~~~g~~~~~~~~~~~aa~~ln~lv~~~~l~~~g~~~i 120 (262)
T cd04255 47 AEAVLPLVEEIVALRPE------HKLLILTGGGTRARHVYSIGLDLGMPTGVLAKLGASVSEQNAEMLATLLAKHGGSKV 120 (262)
T ss_pred HHHHHHHHHHHHHHhCC------CcEEEEECCHHHHHHHHHHHHHcCCCchHHHHHHHHHHHHHHHHHHHHHHHcCCCcc
Confidence 56788888888887641 3566666666666643343445666554432 111 111111 11222111
Q ss_pred CchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCc------chHHHHHHHHhhccceEEEeeccCcccccCCC
Q 020431 84 DFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG------SDFSAAIMGALLRAHQVTIWTDVDGVYSADPR 157 (326)
Q Consensus 84 ~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrgg------sD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~ 157 (326)
- ....+.++++++ .+.|||++|+.+.+ ..++.+|+| +|++|+++|..++|+++++||||||||++||+
T Consensus 121 ~-~~~~~~l~~lL~--~g~vPVi~g~~~~~---~~~i~~~~g~~~~~~~D~~Aa~lA~~l~ad~li~~TdVdGVy~~dP~ 194 (262)
T cd04255 121 G-HGDLLQLPTFLK--AGRAPVISGMPPYG---LWEHPAEEGRIPPHRTDVGAFLLAEVIGARNLIFVKDEDGLYTADPK 194 (262)
T ss_pred c-cccHHHHHHHHH--CCCeEEEeCCcCCC---eeeecCCCccCCCCCcHHHHHHHHHHhCCCEEEEEeccCeeECCCCC
Confidence 0 011257888888 89999999996533 223444444 89999999999999999999999999999999
Q ss_pred CCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhC--CCCEEEEeccCC
Q 020431 158 KVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRY--DIPIVIRNIFNL 207 (326)
Q Consensus 158 ~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~--~I~v~I~n~~~~ 207 (326)
.+|+|+++++++++|+.++.. +..+|...+...+... .++++|.|+..|
T Consensus 195 ~~~~a~~i~~i~~~~~~~~~~-~~~~~~~~~~~~l~aa~~~~~v~I~~g~~~ 245 (262)
T cd04255 195 KNKKAEFIPEISAAELLKKDL-DDLVLERPVLDLLQNARHVKEVQIVNGLVP 245 (262)
T ss_pred CCCCCeEccEeCHHHHHHHhc-CCCCCcHHHHHHHHHhCCCCcEEEEeCCCC
Confidence 999999999999988877642 3335666666666533 358999998755
No 60
>CHL00202 argB acetylglutamate kinase; Provisional
Probab=99.74 E-value=2.7e-17 Score=154.04 Aligned_cols=159 Identities=16% Similarity=0.208 Sum_probs=126.0
Q ss_pred cchHHHHHHHHHHHHHcCCceEEEcccceeeccCCC-----C---CC-CCCCchhhHHHHHHHhhcCCCcEEEecCcccc
Q 020431 42 HGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTS-----S---NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIAS 112 (326)
Q Consensus 42 ~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~-----~---g~-~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~ 112 (326)
.|+. .+.+++.|.++|++|+++++.+..+++..+ + |. .+++. +.++.+++ .|.|||++|+ +.
T Consensus 101 ~g~l--n~~lv~~L~~~Gv~av~l~~~d~~~i~a~~~~~~d~~~~G~i~~v~~----~~i~~ll~--~g~iPVi~~~-~~ 171 (284)
T CHL00202 101 AGKV--NKDLVGSINANGGKAVGLCGKDANLIVARASDKKDLGLVGEIQQVDP----QLIDMLLE--KNYIPVIASV-AA 171 (284)
T ss_pred hhHH--HHHHHHHHHhCCCCeeeeeeccCCEEEEEeCCCcccccceeEEecCH----HHHHHHHH--CCCEEEECCC-cc
Confidence 3666 778899999999999999999876553211 1 22 23455 88999998 8899999995 88
Q ss_pred CCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcC--Ccccchh--h
Q 020431 113 TPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHPR--T 188 (326)
Q Consensus 113 ~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g--~~v~~~~--a 188 (326)
+..|++.+++ +|++|+.+|.+|+|++++|||||+|||+.+ . .| .+++++++++|+.++...| .++|.|+ +
T Consensus 172 ~~~g~~~ni~---~D~~A~~lA~~l~Ad~li~lTdv~Gv~~~~-~-d~-~~~i~~i~~~e~~~l~~~g~~tGGM~~Kl~a 245 (284)
T CHL00202 172 DHDGQTYNIN---ADVVAGEIAAKLNAEKLILLTDTPGILADI-N-DP-NSLISTLNIKEARNLASTGIISGGMIPKVNC 245 (284)
T ss_pred CCCCcEEecC---HHHHHHHHHHHhCCCEEEEEeCChhhcCCC-C-CC-CCccccccHHHHHHHHhcCCCCCCHHHHHHH
Confidence 8889988875 899999999999999999999999999842 1 12 3799999999999998654 5789885 6
Q ss_pred HHHHHhCCCC-EEEEeccCCC----------CCceEEe
Q 020431 189 IIPVMRYDIP-IVIRNIFNLS----------VPGIMIC 215 (326)
Q Consensus 189 ~~~a~~~~I~-v~I~n~~~~~----------~~GT~I~ 215 (326)
+..+.++|++ ++|.++..++ ..||.|.
T Consensus 246 a~~a~~~Gv~~v~I~~g~~~~~ll~el~~~~g~GT~i~ 283 (284)
T CHL00202 246 CIRALAQGVEAAHIIDGKEKHALLLEILTEKGIGSMLV 283 (284)
T ss_pred HHHHHHcCCCEEEEeCCCCCChHHHHHhcCCCCceEEe
Confidence 6777788987 7898876543 3578774
No 61
>PTZ00489 glutamate 5-kinase; Provisional
Probab=99.73 E-value=9.9e-17 Score=148.37 Aligned_cols=169 Identities=17% Similarity=0.209 Sum_probs=124.0
Q ss_pred HhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCC
Q 020431 36 TDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPD 115 (326)
Q Consensus 36 ~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~ 115 (326)
+....+.|.....+++...|.++|+++..+- +... .+. ....+....+.++++++ .+.|||+.|. .....
T Consensus 72 ~qa~aaiGq~~L~~~y~~~f~~~~~~~aqiL-----lt~~-d~~-~~~~~~n~~~~l~~lL~--~g~VPIinen-d~~~~ 141 (264)
T PTZ00489 72 KQALASMGQPLLMHMYYTELQKHGILCAQML-----LAAY-DLD-SRKRTINAHNTIEVLIS--HKVIPIINEN-DATAL 141 (264)
T ss_pred HHHHHHhCHHHHHHHHHHHHHhCCCeEEEee-----eecc-ccc-cchhhHHHHHHHHHHHH--CCCEEEECCC-CCccc
Confidence 3445567776777889999999999874332 2221 111 11234556788999998 8999999883 11111
Q ss_pred CCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeE---EeeecHHHHHHHh----hcCCcccchh-
Q 020431 116 NIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVI---LRTLSYQEAWEMS----YFGANVLHPR- 187 (326)
Q Consensus 116 g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~---i~~ls~~e~~~l~----~~g~~v~~~~- 187 (326)
.++. .|++|.+|+++|..++|+.++++|||||||++||+.+|+|++ +++++.++..... ..+.++|.++
T Consensus 142 ~e~~---~gdnD~lAa~lA~~l~Ad~LiilTDVdGVy~~dP~~~~~A~~~~~i~~i~~~~~~~~~~~~~~~~tGGM~~Kl 218 (264)
T PTZ00489 142 HELV---FGDNDRLSALVAHHFKADLLVILSDIDGYYTENPRTSTDAKIRSVVHELSPDDLVAEATPNNRFATGGIVTKL 218 (264)
T ss_pred ceeE---eCChHHHHHHHHHHhCCCEEEEeeccCeeEcCCCCCCCccceeeeeccCCHHHHHHhcCcCCCcccCChHHHH
Confidence 2332 256899999999999999999999999999999999999998 7788887664432 2457888885
Q ss_pred -hHHHHHhCCCCEEEEeccCCC-----------CCceEEeCC
Q 020431 188 -TIIPVMRYDIPIVIRNIFNLS-----------VPGIMICRP 217 (326)
Q Consensus 188 -a~~~a~~~~I~v~I~n~~~~~-----------~~GT~I~~~ 217 (326)
++..+.++|++++|.++.+++ ..||+|.+.
T Consensus 219 ~aa~~a~~~Gi~v~I~~g~~~~~i~~~l~g~~~~~GT~~~~~ 260 (264)
T PTZ00489 219 QAAQFLLERGGKMYLSSGFHLEKARDFLIGGSHEIGTLFYPR 260 (264)
T ss_pred HHHHHHHHCCCCEEEEeCCCchHHHHHHcCCCCCCceEEeec
Confidence 889999999999999986432 258888653
No 62
>cd04256 AAK_P5CS_ProBA AAK_P5CS_ProBA: Glutamate-5-kinase (G5K) domain of the bifunctional delta 1-pyrroline-5-carboxylate synthetase (P5CS), composed of an N-terminal G5K (ProB) and a C-terminal glutamyl 5- phosphate reductase (G5PR, ProA), the first and second enzyme catalyzing proline (and, in mammals, ornithine) biosynthesis. G5K transfers the terminal phosphoryl group of ATP to the gamma-carboxyl group of glutamate, and is subject to feedback allosteric inhibition by proline or ornithine. In plants, proline plays an important role as an osmoprotectant and, in mammals, ornithine biosynthesis is crucial for proper ammonia detoxification, since a G5K mutation has been shown to cause human hyperammonaemia.
Probab=99.73 E-value=5.8e-17 Score=151.58 Aligned_cols=168 Identities=18% Similarity=0.219 Sum_probs=125.5
Q ss_pred HhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecC-ccccCC
Q 020431 36 TDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATG-FIASTP 114 (326)
Q Consensus 36 ~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~G-fi~~~~ 114 (326)
+-.+.|.|+.-...++.+.|.++|+++ .++++ +.+.+.+.. .+....+.++.+++ .|.|||++| +...+.
T Consensus 94 ~qa~aa~gq~~L~~~y~~~f~~~~~~~-----~q~ll-t~~d~~~~~-~~~~~~~~l~~lL~--~g~iPVi~~nD~v~~~ 164 (284)
T cd04256 94 GRACAAVGQSGLMALYEAMFTQYGITV-----AQVLV-TKPDFYDEQ-TRRNLNGTLEELLR--LNIIPIINTNDAVSPP 164 (284)
T ss_pred HHHHHHcccHHHHHHHHHHHHHcCCcH-----HHeee-eccccccHH-HHHHHHHHHHHHHH--CCCEEEEeCCCccccc
Confidence 455778999999999999999999854 56644 433343211 12344577888888 899999986 332221
Q ss_pred -----CCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhh-----cCCccc
Q 020431 115 -----DNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY-----FGANVL 184 (326)
Q Consensus 115 -----~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~-----~g~~v~ 184 (326)
+|+..+ .-+++|++|+++|..++|+.++++|||||||++||+ .|+++++++++..|..++.. .|.++|
T Consensus 165 ~~~~~~~~~~~-~i~d~D~lAa~lA~~l~Ad~Li~lTDVdGVy~~dP~-~~~a~~I~~i~~~~~~~~~~~~~s~~gtGGM 242 (284)
T cd04256 165 PEPDEDLQGVI-SIKDNDSLAARLAVELKADLLILLSDVDGLYDGPPG-SDDAKLIHTFYPGDQQSITFGTKSRVGTGGM 242 (284)
T ss_pred ccccccccccc-cccChHHHHHHHHHHcCCCEEEEEeCCCeeecCCCC-CCCCeEcccccHhHHHHhhcccccCcccCCc
Confidence 122211 124689999999999999999999999999999997 58999999999877766632 357899
Q ss_pred chh--hHHHHHhCCCCEEEEeccCCC---------CCceEE
Q 020431 185 HPR--TIIPVMRYDIPIVIRNIFNLS---------VPGIMI 214 (326)
Q Consensus 185 ~~~--a~~~a~~~~I~v~I~n~~~~~---------~~GT~I 214 (326)
.|+ ++..+.++|++++|.|+..|+ ..||+|
T Consensus 243 ~~Kl~Aa~~a~~~Gi~v~I~~G~~~~~i~~~l~G~~~GT~~ 283 (284)
T cd04256 243 EAKVKAALWALQGGTSVVITNGMAGDVITKILEGKKVGTFF 283 (284)
T ss_pred HHHHHHHHHHHHCCCeEEEEcCCCccHHHHHHcCCCCCEEe
Confidence 985 888899999999999986543 457776
No 63
>PLN02418 delta-1-pyrroline-5-carboxylate synthase
Probab=99.73 E-value=4.5e-17 Score=169.58 Aligned_cols=170 Identities=15% Similarity=0.222 Sum_probs=126.0
Q ss_pred HHh--HhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCc-cc
Q 020431 35 FTD--FVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGF-IA 111 (326)
Q Consensus 35 ~~d--~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gf-i~ 111 (326)
..| .++|+||.++.+++..+|+++|+ +++++++ +++.++... .+....+.++.+++ .|.|||++|. ..
T Consensus 90 ~~~~qa~aa~Gq~~l~~~~~~~f~~~g~-----~~~qill-T~~~~~~~~-~~~~~~~~l~~ll~--~g~iPVv~~nd~v 160 (718)
T PLN02418 90 ELDGKACAAVGQSELMALYDTLFSQLDV-----TASQLLV-TDSDFRDPD-FRKQLSETVESLLD--LRVIPIFNENDAV 160 (718)
T ss_pred hHHHHHHHHhhHHHHHHHHHHHHHHcCC-----eEEEEEe-cHhHhcchh-HhHhHHHHHHHHHH--CCCEEEEcCCCCc
Confidence 456 78999999999999999999999 4455533 444443211 12345688888888 8899999773 11
Q ss_pred cCCCCC----cccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHH-Hhh-----cCC
Q 020431 112 STPDNI----PTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWE-MSY-----FGA 181 (326)
Q Consensus 112 ~~~~g~----~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~-l~~-----~g~ 181 (326)
.+..+. ...+ +++|++|+++|..++|+.++|||||||||++||+ .++++++++++..+... +.. .+.
T Consensus 161 ~~~~~~~~~~~~~~--~d~D~~A~~lA~~l~Ad~li~~TdVdGvy~~~p~-~~~a~~i~~i~~~~~~~~i~~~~~s~~~t 237 (718)
T PLN02418 161 STRRAPYEDSSGIF--WDNDSLAALLALELKADLLILLSDVEGLYTGPPS-DPSSKLIHTYIKEKHQDEITFGEKSRVGR 237 (718)
T ss_pred cccccccccccCee--cCcHHHHHHHHHHcCCCEEEEeecCCeeecCCCC-CCCceEcceecccchhhhhhcccccccCC
Confidence 111110 0011 3689999999999999999999999999999998 58999999997654332 221 357
Q ss_pred cccch--hhHHHHHhCCCCEEEEeccCCC---------CCceEEeC
Q 020431 182 NVLHP--RTIIPVMRYDIPIVIRNIFNLS---------VPGIMICR 216 (326)
Q Consensus 182 ~v~~~--~a~~~a~~~~I~v~I~n~~~~~---------~~GT~I~~ 216 (326)
++|.+ .++..+.++|++++|.|+..++ ..||.|.+
T Consensus 238 GGM~~Kl~Aa~~a~~~Gi~v~I~~g~~~~~l~~~l~g~~~GT~i~~ 283 (718)
T PLN02418 238 GGMTAKVKAAVNAASAGIPVVITSGYALDNIRKVLRGERVGTLFHQ 283 (718)
T ss_pred CCcHHHHHHHHHHHHCCCcEEEeCCCCcchHHHHhcCCCCceEecc
Confidence 89999 4888999999999999976542 46999975
No 64
>COG1608 Predicted archaeal kinase [General function prediction only]
Probab=99.68 E-value=2.6e-16 Score=140.44 Aligned_cols=153 Identities=18% Similarity=0.200 Sum_probs=117.8
Q ss_pred HHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhh-HHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcc
Q 020431 48 AQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSES-EKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (326)
Q Consensus 48 ~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~-~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggs 126 (326)
+..+++.|.+.|+++++..|..+. +.+++. .+ + -+.+.++++ .+.|||++|++..+.++.+.+++ +
T Consensus 83 ~~~V~~~l~~~Gv~av~~~P~s~~-~~~gr~-----~~--~~l~~i~~~l~--~gfvPvl~GDVv~d~~~g~~IiS---G 149 (252)
T COG1608 83 NSIVVDALLDAGVRAVSVVPISFS-TFNGRI-----LY--TYLEAIKDALE--KGFVPVLYGDVVPDDDNGYEIIS---G 149 (252)
T ss_pred HHHHHHHHHhcCCccccccCccee-ecCCce-----ee--chHHHHHHHHH--cCCEeeeecceEEcCCCceEEEe---c
Confidence 456788999999999999998886 333332 22 2 278888998 89999999999999875555554 3
Q ss_pred hHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcC----Ccccch--hhHHHHHhCCCCEE
Q 020431 127 DFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG----ANVLHP--RTIIPVMRYDIPIV 200 (326)
Q Consensus 127 D~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g----~~v~~~--~a~~~a~~~~I~v~ 200 (326)
|.++.+||+.|+|++++|+|||||||+.||.++|+++.++++...++ +...+ +++|-- +++..+.+++.+++
T Consensus 150 DdIv~~LA~~l~pd~v~f~tdVdGVy~~~p~~~p~~~~l~~i~~~~~--~~gs~~~DVTGGi~~Kl~~~~~~~~~~~~vy 227 (252)
T COG1608 150 DDIVLHLAKELKPDRVIFLTDVDGVYDRDPGKVPDARLLSEIEGRVA--LGGSGGTDVTGGIAKKLEALLEIARYGKEVY 227 (252)
T ss_pred cHHHHHHHHHhCCCEEEEEecCCceecCCCCcCccccchhhhhhhhh--hcCcCcccchhhHHHHHHHHHHHHhcCceEE
Confidence 99999999999999999999999999999999999999887754422 32212 345544 35666667788899
Q ss_pred EEeccCC---------CCCceEEe
Q 020431 201 IRNIFNL---------SVPGIMIC 215 (326)
Q Consensus 201 I~n~~~~---------~~~GT~I~ 215 (326)
++|+..| +..||.|.
T Consensus 228 i~ng~~~~ni~~~l~G~~vGT~I~ 251 (252)
T COG1608 228 IFNGNKPENIYRALRGENVGTRID 251 (252)
T ss_pred EECCCCHHHHHHHhcCCCCceEec
Confidence 9998644 45688874
No 65
>COG0548 ArgB Acetylglutamate kinase [Amino acid transport and metabolism]
Probab=99.63 E-value=5.5e-15 Score=135.42 Aligned_cols=151 Identities=17% Similarity=0.195 Sum_probs=125.5
Q ss_pred ccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCC--------CC---C-CCCCchhhHHHHHHHhhcCCCcEEEecC
Q 020431 41 GHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTS--------SN---Q-VDPDFSESEKRLEKWFSQSPSNTIIATG 108 (326)
Q Consensus 41 ~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~--------~g---~-~~~~~~~~~~~i~~~l~~~~~~ipVv~G 108 (326)
..|+. .+-+++.|+++|.+|+.+++.|..+++..+ +| + ..+|. +.++.+++ .+.|||+++
T Consensus 79 l~G~v--Nk~iva~l~~~g~~avGlsg~Dg~li~A~~~~~~~~id~g~vG~i~~Vn~----~~i~~ll~--~~~IpViap 150 (265)
T COG0548 79 LGGTV--NKEIVARLSKHGGQAVGLSGVDGNLVTAKKLDVDDGVDLGYVGEIRKVNP----ELIERLLD--NGAIPVIAP 150 (265)
T ss_pred HHHHH--HHHHHHHHHHhCCcceeeeecCCCEEEEEEcccccccccceeeeEEEECH----HHHHHHHh--CCCceEEec
Confidence 34677 888999999999999999998865553221 22 1 23454 78899998 899999999
Q ss_pred ccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcC--Ccccch
Q 020431 109 FIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHP 186 (326)
Q Consensus 109 fi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g--~~v~~~ 186 (326)
. +.+.+|++.++. +|+.|+.+|.+|+|++++++|||+||++..|. + +++++++.+|+.++...| ..+|.|
T Consensus 151 i-a~~~~G~~~Nvn---aD~~A~~iA~aLkAekLi~ltdv~Gvl~~~~~--~--s~i~~~~~~~~~~li~~~~i~~GMi~ 222 (265)
T COG0548 151 I-AVDEDGETLNVN---ADTAAGALAAALKAEKLILLTDVPGVLDDKGD--P--SLISELDAEEAEELIEQGIITGGMIP 222 (265)
T ss_pred c-eECCCCcEEeeC---HHHHHHHHHHHcCCCeEEEEeCCcccccCCCC--c--eeeccCCHHHHHHHHhcCCccCccHH
Confidence 5 889999999985 89999999999999999999999999998754 2 799999999999999877 578999
Q ss_pred h--hHHHHHhCCCC-EEEEeccCC
Q 020431 187 R--TIIPVMRYDIP-IVIRNIFNL 207 (326)
Q Consensus 187 ~--a~~~a~~~~I~-v~I~n~~~~ 207 (326)
+ ++..|.+.|++ +.|.|+..+
T Consensus 223 Kv~~a~~A~~~Gv~~v~ii~g~~~ 246 (265)
T COG0548 223 KVEAALEALESGVRRVHIISGRVP 246 (265)
T ss_pred HHHHHHHHHHhCCCeEEEecCCCc
Confidence 5 78888899995 999887543
No 66
>TIGR01092 P5CS delta l-pyrroline-5-carboxylate synthetase. This protein contains a glutamate 5-kinase (ProB, EC 2.7.2.11) region followed by a gamma-glutamyl phosphate reductase (ProA, EC 1.2.1.41) region.
Probab=99.59 E-value=1.6e-14 Score=150.68 Aligned_cols=162 Identities=12% Similarity=0.203 Sum_probs=116.4
Q ss_pred hhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCc
Q 020431 39 VVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIP 118 (326)
Q Consensus 39 i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~ 118 (326)
+.+.|+..-..++...|.++++. +.++++ +++.+... -.+...++.++.+++ .|.|||+.| ++.+
T Consensus 88 ~aa~gq~~L~~~y~~~f~~~~i~-----~aQ~Ll-t~~d~~~~-~~~~~~~~~l~~lL~--~g~iPVin~------nD~V 152 (715)
T TIGR01092 88 CAAVGQSGLMALYETMFTQLDIT-----AAQILV-TDLDFRDE-QFRRQLNETVHELLR--MNVVPVVNE------NDAV 152 (715)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCe-----eEEEEe-chhhcccH-HHHHHHHHHHHHHHH--CCCEEEEcC------CCcc
Confidence 44566665566666777776764 456644 43333211 112335678888888 889999975 2333
Q ss_pred ccccCC---------cchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHH-HHhh-----cCCcc
Q 020431 119 TTLKRD---------GSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAW-EMSY-----FGANV 183 (326)
Q Consensus 119 ~~lgrg---------gsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~-~l~~-----~g~~v 183 (326)
++.+++ ++|++|+++|.+++|+.++++|||||||++||+ .|+++++++++..+.. ++.. .++++
T Consensus 153 ~~~~~~~~~~~g~~~d~D~lAa~lA~~l~Ad~LiilTDVdGVy~~dP~-~~~a~~I~~i~~~~~~~~i~~~~~~~~~tGG 231 (715)
T TIGR01092 153 STRAAPYSDSQGIFWDNDSLAALLALELKADLLILLSDVEGLYDGPPS-DDDSKLIDTFYKEKHQGEITFGTKSRLGRGG 231 (715)
T ss_pred cccccccccccceecchHHHHHHHHHHcCCCEEEEEeCCCeeeCCCCC-CCCCeEeeeecccchhhhhccCcccccCCCC
Confidence 334333 479999999999999999999999999999997 5899999999865444 3322 34678
Q ss_pred cch--hhHHHHHhCCCCEEEEeccCC---------CCCceEEeC
Q 020431 184 LHP--RTIIPVMRYDIPIVIRNIFNL---------SVPGIMICR 216 (326)
Q Consensus 184 ~~~--~a~~~a~~~~I~v~I~n~~~~---------~~~GT~I~~ 216 (326)
|.+ .++..+.++|++++|.|+..+ +..||.|.+
T Consensus 232 M~~Kl~aa~~a~~~gi~v~I~~g~~~~~l~~~l~g~~~GT~~~~ 275 (715)
T TIGR01092 232 MTAKVKAAVWAAYGGTPVIIASGTAPKNITKVVEGKKVGTLFHE 275 (715)
T ss_pred chHHHHHHHHHHHCCCeEEEeCCCCcchHHHHhcCCCCceEecc
Confidence 988 588899999999999998654 246999965
No 67
>cd04236 AAK_NAGS-Urea AAK_NAGS-Urea: N-acetylglutamate (NAG) kinase-like domain of the NAG Synthase (NAGS) of the urea cycle found in animals. Ureogenic NAGS is a mitochondrial enzyme catalyzing the formation of NAG from acetylcoenzyme A and L-glutamate; NAG is an essential allosteric activator of carbamylphosphate synthase I, the first and rate limiting enzyme of the urea cycle. Ureogenic NAGS activity is dependent on the concentration of glutamate (substrate) and arginine (activator). Domain architecture of ureogenic NAGS consists of an N-terminal NAG kinase-like (ArgB) domain (this CD) and a C-terminal DUF619 domain. Members of this CD belong to the protein superfamily, the Amino Acid Kinase Family (AAKF).
Probab=99.51 E-value=1.4e-13 Score=127.60 Aligned_cols=140 Identities=14% Similarity=0.133 Sum_probs=114.1
Q ss_pred HHHHHHHHHHcCCceEEEcccceeec-----cCCCCCC-CCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccc
Q 020431 48 AQMLAAVVRKNGIDCKWMDTREVLIV-----NPTSSNQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTL 121 (326)
Q Consensus 48 ~~~~~~~L~~~Gi~a~~l~~~~~~~~-----~~~~~g~-~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~l 121 (326)
...++..|+++|++|+++.+...++. +.+..|+ .++|. +.|+.+++ .|.|||+++ ++.+.+|++.++
T Consensus 100 n~~Lv~~L~~~G~~A~gl~g~~~~i~a~~~~d~g~vG~V~~Vd~----~~I~~lL~--~g~IPVisp-lg~~~~G~~~Ni 172 (271)
T cd04236 100 CKTLVEALQANSAAAHPLFSGESVLQAEEPEPGASKGPSVSVDT----ELLQWCLG--SGHIPLVCP-IGETSSGRSVSL 172 (271)
T ss_pred HHHHHHHHHhCCCCeeeecCccceEEEEEcccCCccceEEEECH----HHHHHHHh--CCCeEEECC-ceECCCCCEEEE
Confidence 56788999999999999998753332 1112233 24666 88999998 899999999 589999999998
Q ss_pred cCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecH-HHHHHHhhcC--Cccc---chh--hHHHHH
Q 020431 122 KRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY-QEAWEMSYFG--ANVL---HPR--TIIPVM 193 (326)
Q Consensus 122 grggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~-~e~~~l~~~g--~~v~---~~~--a~~~a~ 193 (326)
+ +|..|+.+|.+|+|++++|+||++|||+. +.+++++++. +|+.+|...| .++| -|+ ++..+.
T Consensus 173 N---aD~~A~~lA~aL~A~KLIfltd~~GV~~~------~g~lI~~l~~~~e~~~li~~g~i~gGm~~ki~ki~~~l~~l 243 (271)
T cd04236 173 D---SSEVTTAIAKALQPIKVIFLNRSGGLRDQ------KHKVLPQVHLPADLPSLSDAEWLSETEQNRIQDIATLLNAL 243 (271)
T ss_pred C---HHHHHHHHHHHcCCCEEEEEeCCcceECC------CCCCccccCcHHHHHHHHhCCEEcCCeeechHHHHHHHHhc
Confidence 5 89999999999999999999999999973 3579999995 9999998876 4677 553 666777
Q ss_pred hCCCCEEEEe
Q 020431 194 RYDIPIVIRN 203 (326)
Q Consensus 194 ~~~I~v~I~n 203 (326)
..|+++.|.+
T Consensus 244 ~~g~sv~I~~ 253 (271)
T cd04236 244 PSMSSAVITS 253 (271)
T ss_pred ccCCeEEEeC
Confidence 8899988887
No 68
>cd04252 AAK_NAGK-fArgBP AAK_NAGK-fArgBP: N-Acetyl-L-glutamate kinase (NAGK) of the fungal arginine-biosynthetic pathway (fArgBP). The nuclear-encoded, mitochondrial polyprotein precursor with an N-terminal NAGK (ArgB) domain (this CD), a central DUF619 domain, and a C-terminal reductase domain (ArgC, N-Acetylglutamate Phosphate Reductase, NAGPR). The precursor is cleaved in the mitochondria into two distinct enzymes (NAGK-DUF619 and NAGPR). Native molecular weights of these proteins indicate that the kinase is an octamer whereas the reductase is a dimer. This CD also includes some gamma-proteobacteria (Xanthomonas and Xylella) NAG kinases with an N-terminal NAGK (ArgB) domain (this CD) and a C-terminal DUF619 domain. The DUF619 domain is described as a putative distant homolog of the acetyltransferase, ArgA, predicted to function in NAG synthase association in fungi. Eukaryotic sequences have an N-terminal mitochondrial transit peptide. Members of this NAG kinase domain CD belong to th
Probab=99.49 E-value=4.7e-13 Score=123.07 Aligned_cols=144 Identities=12% Similarity=0.126 Sum_probs=107.8
Q ss_pred ccchHHHHHHHHHHHHHcCCceEEEcccceeecc---CCCC---CC-CCCCchhhHHHHHHHhhcCCCcEEEecCccccC
Q 020431 41 GHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVN---PTSS---NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (326)
Q Consensus 41 ~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~---~~~~---g~-~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~ 113 (326)
+.++. ...+++.|.++|++++++.+..+ ... ...+ |. .++|. +.++++++ .+.|||++|. +.+
T Consensus 72 al~~v--n~~iv~~l~~~g~~a~~l~~~~~-~a~~~~~~d~g~~G~v~~i~~----~~i~~~L~--~g~IPVi~p~-~~~ 141 (248)
T cd04252 72 VFLEE--NLKLVEALERNGARARPITSGVF-EAEYLDKDKYGLVGKITGVNK----APIEAAIR--AGYLPILTSL-AET 141 (248)
T ss_pred HHHHH--HHHHHHHHHhCCCCcccccCceE-EEEECcCccCCccCceeeECH----HHHHHHHH--CCCeEEECCc-eEC
Confidence 34544 55667889999999999998633 221 1112 22 24566 88999998 8999999996 778
Q ss_pred CCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecH-HHHHHHhhcC--Ccccchh--h
Q 020431 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY-QEAWEMSYFG--ANVLHPR--T 188 (326)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~-~e~~~l~~~g--~~v~~~~--a 188 (326)
..|++.+++ +|..|+.+|.+|+|++++|+|||+|||+. +.+++++++. +++.++...| .++|.|+ +
T Consensus 142 ~~g~~~nvn---aD~~A~~lA~aL~a~kli~ltdv~GV~~~------~g~~i~~i~~~~~~~~l~~~~~vtgGM~~Kl~~ 212 (248)
T cd04252 142 PSGQLLNVN---ADVAAGELARVLEPLKIVFLNETGGLLDG------TGKKISAINLDEEYDDLMKQPWVKYGTKLKIKE 212 (248)
T ss_pred CCCCEEEEC---HHHHHHHHHHHcCCCeEEEEECCcccCCC------CCCcccccCHHHHHHHHHHcCCcCCchHHHHHH
Confidence 889888885 79999999999999999999999999964 3679999986 5777777654 4678885 4
Q ss_pred HHHHHhC--CC-CEEEEe
Q 020431 189 IIPVMRY--DI-PIVIRN 203 (326)
Q Consensus 189 ~~~a~~~--~I-~v~I~n 203 (326)
+..+.+. ++ .+.|.+
T Consensus 213 ~~~~~~~~~~~~~v~i~~ 230 (248)
T cd04252 213 IKELLDTLPRSSSVSITS 230 (248)
T ss_pred HHHHHHhCCCceEEEEEC
Confidence 5555555 43 466665
No 69
>cd04915 ACT_AK-Ectoine_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinas
Probab=99.49 E-value=1.4e-13 Score=100.96 Aligned_cols=65 Identities=25% Similarity=0.376 Sum_probs=62.4
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
+++|+++|.+|. .+|+.+++|++|++.||++.|++|++|+.+|||+|++++.+++++.||+.|++
T Consensus 2 ~a~VsvVG~gm~-~~gv~~ki~~~L~~~~I~v~~i~~~~s~~~is~~V~~~~~~~av~~Lh~~f~~ 66 (66)
T cd04915 2 VAIVSVIGRDLS-TPGVLARGLAALAEAGIEPIAAHQSMRNVDVQFVVDRDDYDNAIKALHAALVE 66 (66)
T ss_pred EEEEEEECCCCC-cchHHHHHHHHHHHCCCCEEEEEecCCeeEEEEEEEHHHHHHHHHHHHHHHhC
Confidence 689999999995 89999999999999999999999999999999999999999999999999873
No 70
>PRK12353 putative amino acid kinase; Reviewed
Probab=99.49 E-value=5e-13 Score=126.77 Aligned_cols=121 Identities=21% Similarity=0.228 Sum_probs=92.0
Q ss_pred HHHHHHhhcCCCcEEEecCc--cc-cCCCCCccccc-CCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEE
Q 020431 90 KRLEKWFSQSPSNTIIATGF--IA-STPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gf--i~-~~~~g~~~~lg-rggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i 165 (326)
+.++.+++ .|.|||++|. ++ .++++.+.+.. -+++|.+|+++|..++|++++++|||||||+++|+ |+++++
T Consensus 176 ~~i~~lL~--~g~IpV~~g~gg~Pi~~~~~~~~~~~~~~d~D~lAa~lA~~l~Ad~Li~lTdvdGVy~~~~~--~~a~~i 251 (314)
T PRK12353 176 EAIKTLVD--AGQVVIAAGGGGIPVIREGGGLKGVEAVIDKDFASAKLAELVDADLLIILTAVDKVYINFGK--PNQKKL 251 (314)
T ss_pred HHHHHHHH--CCCEEEEcCCCCCCEEEeCCceeeeeEecCHHHHHHHHHHHhCCCEEEEEeCCccccCCCCC--CCCeEC
Confidence 78888888 8999999987 11 12333332200 24579999999999999999999999999997663 889999
Q ss_pred eeecHHHHHHHhh---cCCcccchh--hH-HHH-HhCCCCEEEEecc------CCCCCceEEe
Q 020431 166 RTLSYQEAWEMSY---FGANVLHPR--TI-IPV-MRYDIPIVIRNIF------NLSVPGIMIC 215 (326)
Q Consensus 166 ~~ls~~e~~~l~~---~g~~v~~~~--a~-~~a-~~~~I~v~I~n~~------~~~~~GT~I~ 215 (326)
++++++|+.++.. .+.++|.|+ ++ +.+ .+.|++++|.+.. +.+ .||.|.
T Consensus 252 ~~i~~~e~~~~~~~~~~~tGGM~~Kl~aA~~a~~~~~g~~v~I~~~~~i~~~l~g~-~GT~i~ 313 (314)
T PRK12353 252 DEVTVSEAEKYIEEGQFAPGSMLPKVEAAISFVESRPGRKAIITSLEKAKEALEGK-AGTVIV 313 (314)
T ss_pred cCcCHHHHHHHHhcCCcCCCCcHHHHHHHHHHHHHcCCCEEEECCchHHHHHhCCC-CCeEec
Confidence 9999999988864 456789885 44 445 4778999998743 223 688874
No 71
>cd04235 AAK_CK AAK_CK: Carbamate kinase (CK) catalyzes both the ATP-phosphorylation of carbamate and carbamoyl phosphate (CP) utilization with the production of ATP from ADP and CP. Both CK (this CD) and nonhomologous CP synthetase synthesize carbamoyl phosphate, an essential precursor of arginine and pyrimidine bases, in the presence of ATP, bicarbonate, and ammonia. CK is a homodimer of 33 kDa subunits and is a member of the Amino Acid Kinase Superfamily (AAK).
Probab=99.49 E-value=6.8e-13 Score=124.80 Aligned_cols=119 Identities=18% Similarity=0.210 Sum_probs=90.9
Q ss_pred HHHHHHhhcCCCcEEEecCc----cccCCCCCccccc-CCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeE
Q 020431 90 KRLEKWFSQSPSNTIIATGF----IASTPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVI 164 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gf----i~~~~~g~~~~lg-rggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~ 164 (326)
+.++.+++ .|.|||++|. +.. .+|...+.. -.+.|++|++||..++|+.++++|||||||+.+| .|++++
T Consensus 172 ~~I~~Ll~--~g~IpI~~GggGiPv~~-~~~~~~gveaVid~D~~AallA~~l~Ad~LiilTdVdGVy~~~~--~pda~~ 246 (308)
T cd04235 172 EAIKTLVD--NGVIVIAAGGGGIPVVR-EGGGLKGVEAVIDKDLASALLAEEINADLLVILTDVDNVYINFG--KPNQKA 246 (308)
T ss_pred HHHHHHHH--CCCEEEEECCCccCEEE-cCCceeeeeeccCccHHHHHHHHHcCCCEEEEEecCCeEECCCC--CCCCeE
Confidence 56777888 8999999986 222 223322211 2346999999999999999999999999999654 378999
Q ss_pred EeeecHHHHHHHhh---cCCcccchh---hHHHHHhCCCCEEEEecc------CCCCCceEE
Q 020431 165 LRTLSYQEAWEMSY---FGANVLHPR---TIIPVMRYDIPIVIRNIF------NLSVPGIMI 214 (326)
Q Consensus 165 i~~ls~~e~~~l~~---~g~~v~~~~---a~~~a~~~~I~v~I~n~~------~~~~~GT~I 214 (326)
+++++++|+.++.. +++++|.|| |++.+.+.+.+++|.+.. +.+ .||.|
T Consensus 247 i~~Is~~e~~~l~~~g~~~tGGM~pKv~aA~~~a~~gg~~v~I~~~~~i~~aL~G~-~GT~I 307 (308)
T cd04235 247 LEQVTVEELEKYIEEGQFAPGSMGPKVEAAIRFVESGGKKAIITSLENAEAALEGK-AGTVI 307 (308)
T ss_pred cCCcCHHHHHHHHhcCccccCCcHHHHHHHHHHHHhCCCeEEECCHHHHHHHHCCC-CCeEE
Confidence 99999999999875 557899997 667777777888887743 222 58876
No 72
>cd04918 ACT_AK1-AT_2 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the second of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine (SAM). This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. In its inactive state, Arabidopsis AK1 binds the effectors lysine and SAM (two molecules each) at the interface of two ACT1 domain subunits. The second ACT domain (ACT2), this CD, does not interact with an effector. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.47 E-value=2.4e-13 Score=99.33 Aligned_cols=63 Identities=24% Similarity=0.360 Sum_probs=60.6
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
++|+++|. +...+++++++|++|+++||++.|++|++|+.++||+|++++.+++++.||++|+
T Consensus 2 a~VsvVG~-~~~~~~~~~~i~~aL~~~~I~v~~i~~g~s~~sis~~v~~~~~~~av~~Lh~~f~ 64 (65)
T cd04918 2 SIISLIGN-VQRSSLILERAFHVLYTKGVNVQMISQGASKVNISLIVNDSEAEGCVQALHKSFF 64 (65)
T ss_pred cEEEEECC-CCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHHh
Confidence 68999999 7778999999999999999999999999999999999999999999999999985
No 73
>cd04919 ACT_AK-Hom3_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.45 E-value=4.6e-13 Score=97.52 Aligned_cols=66 Identities=27% Similarity=0.424 Sum_probs=63.3
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
+++|+++|.++.+.+++.+++|+.|+++||+++|++|++|+.+++|++++++..++++.||++|+.
T Consensus 1 ~~~isvvg~~~~~~~~~~~~if~~L~~~~I~v~~i~q~~s~~~isf~v~~~~~~~a~~~lh~~~~~ 66 (66)
T cd04919 1 LAILSLVGKHMKNMIGIAGRMFTTLADHRINIEMISQGASEINISCVIDEKDAVKALNIIHTNLLE 66 (66)
T ss_pred CeEEEEECCCCCCCcCHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHHhC
Confidence 579999999999999999999999999999999999999999999999999999999999999863
No 74
>cd04922 ACT_AKi-HSDH-ThrA_2 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the second of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathwa
Probab=99.42 E-value=1e-12 Score=95.50 Aligned_cols=66 Identities=30% Similarity=0.533 Sum_probs=63.1
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
+++|+++|.++.+.+++.+++|+.|+++||+++|++|++|+.+++|++++++.+++++.||++|+.
T Consensus 1 ~~~isvvg~~~~~~~~~~~~i~~~l~~~~I~v~~i~~~~s~~~is~~v~~~~~~~~~~~lh~~~~~ 66 (66)
T cd04922 1 LSILALVGDGMAGTPGVAATFFSALAKANVNIRAIAQGSSERNISAVIDEDDATKALRAVHERFFL 66 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHHHHHHHHHHHHHhC
Confidence 478999999999999999999999999999999999988999999999999999999999999863
No 75
>cd04237 AAK_NAGS-ABP AAK_NAGS-ABP: N-acetylglutamate (NAG) kinase-like domain of the NAG Synthase (NAGS) of the arginine-biosynthesis pathway (ABP) found in gamma- and beta-proteobacteria and higher plant chloroplasts. Domain architecture of these NAGS consisted of an N-terminal NAG kinase-like (ArgB) domain (this CD) and a C-terminal NAG synthase, acetyltransferase (ArgA) domain. Both bacterial and plant sequences in this CD have a conserved N-terminal extension; a similar sequence in the NAG kinases of the cyclic arginine-biosynthesis pathway has been implicated in feedback inhibition sensing. Plant sequences also have an N-terminal chloroplast transit peptide and an insert (approx. 70 residues) in the C-terminal region of ArgB. Members of this CD belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.41 E-value=1.6e-12 Score=121.59 Aligned_cols=147 Identities=16% Similarity=0.187 Sum_probs=111.1
Q ss_pred cchHHHHHHHHHHHHHcCCceEEEcccceeec-----cC--------CCC---CC-CCCCchhhHHHHHHHhhcCCCcEE
Q 020431 42 HGELWSAQMLAAVVRKNGIDCKWMDTREVLIV-----NP--------TSS---NQ-VDPDFSESEKRLEKWFSQSPSNTI 104 (326)
Q Consensus 42 ~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~-----~~--------~~~---g~-~~~~~~~~~~~i~~~l~~~~~~ip 104 (326)
.|+. ...+.+.|++ |++++++++..+... .. -.+ |. ..++. +.++.+++ .|.+|
T Consensus 94 ~g~v--~~~l~~~l~~-~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~g~~G~v~~v~~----~~i~~lL~--~g~ip 164 (280)
T cd04237 94 AGAV--RLEIEALLSM-GLPNSPMAGARIRVVSGNFVTARPLGVVDGVDFGHTGEVRRIDA----DAIRRQLD--QGSIV 164 (280)
T ss_pred HHHH--HHHHHHHHHh-hccccCcCCCceEEecCeEEEEEECCcccCceEeeeccEEEEcH----HHHHHHHH--CCCEE
Confidence 4666 6667788855 998876654322111 10 011 21 12444 88999998 88999
Q ss_pred EecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcC---C
Q 020431 105 IATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG---A 181 (326)
Q Consensus 105 Vv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g---~ 181 (326)
|+++- +.+.+|+..+++ +|..|+.||.+|+|++++|+|||||||+. +++++++++.+|+.++...| .
T Consensus 165 v~~~~-g~~~~g~~lnvn---aD~~A~~LA~~L~a~klv~ltdv~GV~~~------~~~~i~~i~~~e~~~l~~~~~~~~ 234 (280)
T cd04237 165 LLSPL-GYSPTGEVFNLS---MEDVATAVAIALKADKLIFLTDGPGLLDD------DGELIRELTAQEAEALLETGALLT 234 (280)
T ss_pred EECCc-eECCCCCEEeeC---HHHHHHHHHHHcCCCEEEEEeCCCcccCC------CCCccccCCHHHHHHHHHcCCCCC
Confidence 99884 888889998875 79999999999999999999999999973 46899999999999998755 4
Q ss_pred cccchh--hHHHHHhCCC-CEEEEeccCC
Q 020431 182 NVLHPR--TIIPVMRYDI-PIVIRNIFNL 207 (326)
Q Consensus 182 ~v~~~~--a~~~a~~~~I-~v~I~n~~~~ 207 (326)
.+|.|| ++..+.+.|+ +++|.++..+
T Consensus 235 ggM~~Kv~~a~~a~~~Gv~~v~I~~~~~~ 263 (280)
T cd04237 235 NDTARLLQAAIEACRGGVPRVHLISYAED 263 (280)
T ss_pred CCHHHHHHHHHHHHHcCCCEEEEeCCCCC
Confidence 789996 6666777899 5999987654
No 76
>TIGR00746 arcC carbamate kinase. The seed alignment for this model includes experimentally confirmed examples from a set of phylogenetically distinct species. In a neighbor-joining tree constructed from an alignment of candidate carbamate kinases and several acetylglutamate kinases, the latter group forms a clear outgroup which roots the tree of carbamate kinase-like proteins. This analysis suggests that in E. coli, the ArcC paralog YqeA may be a second isozyme, while the paralog YahI branches as an outlier and is less likely to be an authentic carbamate kinase. The homolog from Mycoplasma pneumoniae likewise branches outside the set containing known carbamate kinases and also scores below the trusted cutoff.
Probab=99.40 E-value=5.7e-12 Score=119.01 Aligned_cols=200 Identities=15% Similarity=0.167 Sum_probs=128.8
Q ss_pred hhHHHHHHHHHHHHhhhcC---------------------CC----ChhH-HhHhhccchHHHHHHHHHHHH----HcCC
Q 020431 11 LSYEFIRSTYNFLSNVDSG---------------------HA----TESF-TDFVVGHGELWSAQMLAAVVR----KNGI 60 (326)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~~---------------------~~----~~~~-~d~i~~~GE~~s~~~~~~~L~----~~Gi 60 (326)
.+.+.++....+|..+... +. .+.. .|...|.|+-+-+.++...|+ ++|+
T Consensus 23 ~~~~~i~~~a~~ia~l~~~g~~vviv~gngpqvG~~~l~~~~~~~~~~~~p~~~~~A~~qg~lg~~~~~~l~~~l~~~g~ 102 (310)
T TIGR00746 23 AQRDNVRQTAPQIAKLIKRGYELVITHGNGPQVGNLLLQNQAADSEVPAMPLDVLGAMSQGMIGYMLQQALNNELPKRGM 102 (310)
T ss_pred hhHHHHHHHHHHHHHHHHCCCEEEEEECChHHHHHHHhccccccccCCCCcchHHHHhhHHHHHHHHHHHHHHHHHhcCC
Confidence 4466778888888877741 01 1112 578888888888888888887 8886
Q ss_pred ceEEEcc-cceeeccCC----------------------------------CCCC----CCCCchh--hHHHHHHHhhcC
Q 020431 61 DCKWMDT-REVLIVNPT----------------------------------SSNQ----VDPDFSE--SEKRLEKWFSQS 99 (326)
Q Consensus 61 ~a~~l~~-~~~~~~~~~----------------------------------~~g~----~~~~~~~--~~~~i~~~l~~~ 99 (326)
+...... .+..+..++ .+|+ +++.+.. -.+.|+.+++
T Consensus 103 ~~~v~~~vtqv~v~~~D~af~~p~k~ig~~y~~~~a~~~~~~~~~~~~~d~~~~~rrvv~sp~p~~iv~~~~I~~LL~-- 180 (310)
T TIGR00746 103 EKPVATVLTQTIVDPKDPAFQNPTKPIGPFYTEEEAKRLAAEKGWIVKEDAGRGWRRVVPSPRPKDIVEAETIKTLVE-- 180 (310)
T ss_pred CccceEEEEEEEECCCcccccCCCCcCCCCcCHHHHHHHHHHcCCeEeecCCCcceEeecCCCchhhccHHHHHHHHH--
Confidence 4422211 111111111 1111 1111111 1267888888
Q ss_pred CCcEEEecCc--ccc-CCCCCcccc-cCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHH
Q 020431 100 PSNTIIATGF--IAS-TPDNIPTTL-KRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWE 175 (326)
Q Consensus 100 ~~~ipVv~Gf--i~~-~~~g~~~~l-grggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~ 175 (326)
.|.++|.+|- ++. +++|.+... -.+++|.+|+.+|..++|+.++++|||||||+++ ..|+++++++++++|+.+
T Consensus 181 ~G~iVI~~ggggiPvi~e~~~~~g~e~~id~D~lAa~lA~~l~AD~LIiLTDVdGVy~~~--~~p~a~~i~~it~~e~~~ 258 (310)
T TIGR00746 181 NGVIVISSGGGGVPVVLEGAELKGVEAVIDKDLASEKLAEEVNADILVILTDVDAVYINY--GKPDEKALREVTVEELED 258 (310)
T ss_pred CCCEEEeCCCCCcCEEecCCeEEeeEecCCHHHHHHHHHHHhCCCEEEEEeCCCceeCCC--CCCCCcCCcCcCHHHHHH
Confidence 7776666653 111 334433210 0246799999999999999999999999999974 347899999999999999
Q ss_pred Hhh---cCCcccchh---hHHHHHhCCCCEEEEecc------CCCCCceEEe
Q 020431 176 MSY---FGANVLHPR---TIIPVMRYDIPIVIRNIF------NLSVPGIMIC 215 (326)
Q Consensus 176 l~~---~g~~v~~~~---a~~~a~~~~I~v~I~n~~------~~~~~GT~I~ 215 (326)
+.. +++++|.|+ |++.+.+.+.+++|.+.. +.+ .||+|.
T Consensus 259 ~~~~g~~~tGgM~~Kl~AA~~~~~~g~~~v~I~~~~~i~~~l~G~-~GT~I~ 309 (310)
T TIGR00746 259 YYKAGHFAAGSMGPKVEAAIEFVESGGKRAIITSLENAVEALEGK-AGTRVT 309 (310)
T ss_pred HHhcCCcCCCCcHHHHHHHHHHHHhCCCeEEEechHHHHHHHCCC-CCcEEe
Confidence 874 456888884 446666667889998743 233 688874
No 77
>PRK05279 N-acetylglutamate synthase; Validated
Probab=99.40 E-value=2.2e-12 Score=128.00 Aligned_cols=157 Identities=17% Similarity=0.182 Sum_probs=117.9
Q ss_pred cchHHHHHHHHHHHHHcCCceEEEcccceeeccCC-------------CCCC----CCCCchhhHHHHHHHhhcCCCcEE
Q 020431 42 HGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPT-------------SSNQ----VDPDFSESEKRLEKWFSQSPSNTI 104 (326)
Q Consensus 42 ~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~-------------~~g~----~~~~~~~~~~~i~~~l~~~~~~ip 104 (326)
.|+. ...+.+.|+ .|++++++.+..+...+.. .+|. ..++. +.++.+++ .|.||
T Consensus 101 ~g~v--~~~l~~~l~-~g~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~G~v~~v~~----~~i~~ll~--~g~ip 171 (441)
T PRK05279 101 AGEL--RLDIEARLS-MGLPNTPMAGAHIRVVSGNFVTARPLGVDDGVDYQHTGEVRRIDA----EAIRRQLD--SGAIV 171 (441)
T ss_pred HHHH--HHHHHHHHh-ccCCCCcccCCcceEeeccEEEEEECCCCCCccccceeeEEEEeH----HHHHHHHH--CCCeE
Confidence 3544 566677774 5999988776654433311 1121 12344 88999998 88999
Q ss_pred EecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhh---cC-
Q 020431 105 IATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY---FG- 180 (326)
Q Consensus 105 Vv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~---~g- 180 (326)
|+++ ++.+.+|++.+++ +|.+|+.||..|+|++++|+|||||||+. +++++++++.+|+.++.. .|
T Consensus 172 V~~~-i~~~~~g~~~ni~---~D~~a~~lA~~l~a~~lv~ltdv~GV~~~------~~~~i~~i~~~~~~~~~~~~~~~~ 241 (441)
T PRK05279 172 LLSP-LGYSPTGESFNLT---MEEVATQVAIALKADKLIFFTESQGVLDE------DGELIRELSPNEAQALLEALEDGD 241 (441)
T ss_pred EECC-ceECCCCCEEEEC---HHHHHHHHHHHcCCCEEEEEECCCCccCC------CCchhhhCCHHHHHHHHhhhhcCC
Confidence 9955 6888889988875 79999999999999999999999999953 478999999999988875 33
Q ss_pred -Ccccchh--hHHHHHhCCC-CEEEEeccCC----------CCCceEEeCC
Q 020431 181 -ANVLHPR--TIIPVMRYDI-PIVIRNIFNL----------SVPGIMICRP 217 (326)
Q Consensus 181 -~~v~~~~--a~~~a~~~~I-~v~I~n~~~~----------~~~GT~I~~~ 217 (326)
.++|.|+ ++..+.+.|+ +++|.++..| +..||.|...
T Consensus 242 ~~ggM~~Kv~~a~~~~~~gv~~v~i~~~~~~~~l~~~l~~~~g~GT~i~~~ 292 (441)
T PRK05279 242 YNSGTARFLRAAVKACRGGVRRSHLISYAEDGALLQELFTRDGIGTMIVME 292 (441)
T ss_pred CCccHHHHHHHHHHHHHcCCCEEEEecCCCCcHHHHHHhcCCCCceEEecC
Confidence 4788886 5556667899 5999887543 2469999875
No 78
>cd04921 ACT_AKi-HSDH-ThrA-like_1 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the first of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pat
Probab=99.40 E-value=2.8e-12 Score=97.06 Aligned_cols=80 Identities=49% Similarity=0.743 Sum_probs=76.7
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEc
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSF 320 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~ 320 (326)
+++|+++|.++.+.+++.+++|+.|++++|+++|++|++++.++||+++.++..++++.||+.|+.++++.++.++.++.
T Consensus 1 ~~~I~vvg~~~~~~~~~~~~i~~~L~~~~I~v~~i~~~~~~~~isf~v~~~d~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 80 (80)
T cd04921 1 VALINIEGTGMVGVPGIAARIFSALARAGINVILISQASSEHSISFVVDESDADKALEALEEEFALEIKAGLIKPIEVEK 80 (80)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCcceEEEEEeHHHHHHHHHHHHHHHHhhhhhCcccceEeeC
Confidence 57999999999999999999999999999999999999899999999999999999999999999999999999998863
No 79
>cd04937 ACT_AKi-DapG-BS_2 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive AK isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The BS AKI is tetrameric consisting of two alpha and two beta subunits; th
Probab=99.36 E-value=3e-12 Score=93.12 Aligned_cols=63 Identities=30% Similarity=0.521 Sum_probs=59.9
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
+++|+++|.+|...||+++|+|++|+++||++.+++ +|+.+|||+|++++..++++.||++|+
T Consensus 1 ~~~isvvG~~~~~~~gi~~~if~aL~~~~I~v~~~~--~Se~~is~~v~~~~~~~av~~Lh~~f~ 63 (64)
T cd04937 1 CAKVTIIGSRIRGVPGVMAKIVGALSKEGIEILQTA--DSHTTISCLVSEDDVKEAVNALHEAFE 63 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHHCCCCEEEEE--cCccEEEEEEcHHHHHHHHHHHHHHhc
Confidence 478999999999999999999999999999999988 489999999999999999999999984
No 80
>PRK12686 carbamate kinase; Reviewed
Probab=99.35 E-value=6.1e-12 Score=118.48 Aligned_cols=122 Identities=18% Similarity=0.214 Sum_probs=91.1
Q ss_pred HHHHHHhhcCCCcEEEecCccc---cCCCCCccccc-CCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEE
Q 020431 90 KRLEKWFSQSPSNTIIATGFIA---STPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gfi~---~~~~g~~~~lg-rggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i 165 (326)
+.|+.+++ .|.|||.+|.-| .++++.+.... -+++|.+|+.||..++|++++|+|||||||+. |+ .|+++++
T Consensus 174 ~~I~~Ll~--~G~IpI~~GgggIPVv~~~~~~~gv~avid~D~~Aa~LA~~L~Ad~LIiLTDVdGVy~~-~~-~p~ak~I 249 (312)
T PRK12686 174 DTIRTLVD--GGNIVIACGGGGIPVIRDDNTLKGVEAVIDKDFASEKLAEQIDADLLIILTGVENVFIN-FN-KPNQQKL 249 (312)
T ss_pred HHHHHHHH--CCCEEEEeCCCCCCeEecCCcEEeeecccCccHHHHHHHHHcCCCEEEEEeCchhhccC-CC-CCCCeEC
Confidence 77888998 899999987622 23445433321 34679999999999999999999999999994 65 3789999
Q ss_pred eeecHHHHHHHhh---cCCcccchh--hHHHHHh--CCCCEEEEeccCC-----CCCceEEe
Q 020431 166 RTLSYQEAWEMSY---FGANVLHPR--TIIPVMR--YDIPIVIRNIFNL-----SVPGIMIC 215 (326)
Q Consensus 166 ~~ls~~e~~~l~~---~g~~v~~~~--a~~~a~~--~~I~v~I~n~~~~-----~~~GT~I~ 215 (326)
++++.+|+.++.. +++++|.|| ++..+.+ .|.+++|.+..+. ...||.|.
T Consensus 250 ~~I~~~e~~~li~~g~~~tGGM~pKveAA~~av~~g~g~~viI~~~~~i~~aL~G~~GT~I~ 311 (312)
T PRK12686 250 DDITVAEAKQYIAEGQFAPGSMLPKVEAAIDFVESGEGKKAIITSLEQAKEALAGNAGTHIT 311 (312)
T ss_pred CccCHHHHHHHhhCCCccCCCcHHHHHHHHHHHHhCCCCEEEEeCchHHHHHhCCCCCeEEe
Confidence 9999999999874 446889996 5555553 3578888875321 12688874
No 81
>cd04916 ACT_AKiii-YclM-BS_2 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. B. subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from B. subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.35 E-value=4.9e-12 Score=91.85 Aligned_cols=66 Identities=32% Similarity=0.450 Sum_probs=63.1
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
+++|+++|.++...+++.+++|+.|+++||+++|++|+.++.+++|++++++..++++.||++|+.
T Consensus 1 ~~lisivg~~~~~~~~~~~~i~~~L~~~~i~v~~i~~~~s~~~isf~v~~~d~~~~~~~lh~~~~~ 66 (66)
T cd04916 1 LALIMVVGEGMKNTVGVSARATAALAKAGINIRMINQGSSEISIMIGVHNEDADKAVKAIYEEFFN 66 (66)
T ss_pred CeEEEEEcCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHHHHHHHHHHHHHhC
Confidence 578999999999999999999999999999999999988999999999999999999999999863
No 82
>cd04917 ACT_AKiii-LysC-EC_2 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The second ACT domain (ACT2), this CD, is not involved in the binding of heterotrophic effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.34 E-value=5e-12 Score=91.85 Aligned_cols=63 Identities=37% Similarity=0.604 Sum_probs=60.2
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
+++|+++|.+|.+.+++.+++|++|++ +++.+++|++|+.+++|+|++++.+++++.||++|+
T Consensus 1 ~alIsvvG~~~~~~~~v~~~i~~~L~~--i~i~~i~~~~s~~~is~~V~~~~~~~a~~~Lh~~f~ 63 (64)
T cd04917 1 LALVALIGNDISETAGVEKRIFDALED--INVRMICYGASNHNLCFLVKEEDKDEVVQRLHSRLF 63 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHh--CCeEEEEEecCccEEEEEEeHHHHHHHHHHHHHHHh
Confidence 589999999999999999999999975 799999999999999999999999999999999987
No 83
>cd04920 ACT_AKiii-DAPDC_2 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC). This CD includes the second of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.34 E-value=3.9e-12 Score=92.36 Aligned_cols=63 Identities=21% Similarity=0.318 Sum_probs=58.3
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
++|+++|.+|...+|+.+++|++|++. ++.+++|++|+.+|||+|+++|.+++++.||++||.
T Consensus 1 a~VsvVG~g~~~~~gv~~~~~~~L~~~--~i~~i~~~~s~~~is~vv~~~d~~~av~~LH~~f~~ 63 (63)
T cd04920 1 AAVSLVGRGIRSLLHKLGPALEVFGKK--PVHLVSQAANDLNLTFVVDEDQADGLCARLHFQLIE 63 (63)
T ss_pred CEEEEECCCcccCccHHHHHHHHHhcC--CceEEEEeCCCCeEEEEEeHHHHHHHHHHHHHHHhC
Confidence 589999999999999999999999886 566788889999999999999999999999999973
No 84
>TIGR01890 N-Ac-Glu-synth amino-acid N-acetyltransferase. This model represents a clade of amino-acid N-acetyltransferases acting mainly on glutamate in the first step of the "acetylated" ornithine biosynthesis pathway. For this reason it is also called N-acetylglutamate synthase. The enzyme may also act on aspartate.
Probab=99.33 E-value=1.4e-11 Score=121.94 Aligned_cols=157 Identities=13% Similarity=0.096 Sum_probs=114.8
Q ss_pred cchHHHHHHHHHHHHHcCCceEE-----Ecccceeecc-----------CCCCCC-CCCCchhhHHHHHHHhhcCCCcEE
Q 020431 42 HGELWSAQMLAAVVRKNGIDCKW-----MDTREVLIVN-----------PTSSNQ-VDPDFSESEKRLEKWFSQSPSNTI 104 (326)
Q Consensus 42 ~GE~~s~~~~~~~L~~~Gi~a~~-----l~~~~~~~~~-----------~~~~g~-~~~~~~~~~~~i~~~l~~~~~~ip 104 (326)
.|+. .+.+++.|.+. +++.. +.+.+..++. .+..|+ ..++. +.++.+++ .|.||
T Consensus 93 ~g~v--n~~l~~~l~~~-~~~~~~~~~~l~~~dg~~~~a~~~~~~~~~~~g~~G~v~~v~~----~~l~~ll~--~g~ip 163 (429)
T TIGR01890 93 AGTL--RLAIEARLSMS-LSNTPMAGSRLPVVSGNFVTARPIGVIEGVDYEHTGVIRKIDT----EGIRRQLD--AGSIV 163 (429)
T ss_pred hChH--HHHHHHHHHhc-CCcccccccCceEccceEEEEEECCCCcCccccccceEEEEcH----HHHHHHHH--CCCeE
Confidence 5666 67778888777 54443 3333322221 011222 23555 88999998 88999
Q ss_pred EecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcc-
Q 020431 105 IATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANV- 183 (326)
Q Consensus 105 Vv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v- 183 (326)
|++.. +.+.+|++.+++ +|..|+.||.+|+|++++|+|||+|||+. +.+++++|+.+|+.++.......
T Consensus 164 vi~pi-~~~~~g~~~nvn---aD~~A~~lA~al~a~kli~ltdv~Gv~~~------~g~~i~~i~~~~~~~l~~~~~~~~ 233 (429)
T TIGR01890 164 LLSPL-GHSPTGETFNLD---MEDVATSVAISLKADKLIYFTLSPGISDP------DGTLAAELSPQEVESLAERLGSET 233 (429)
T ss_pred EECCc-ccCCCCCEEEeC---HHHHHHHHHHHcCCCEEEEEeCCCcccCC------CCCCcccCCHHHHHHHHHhccCCC
Confidence 99885 888899999986 89999999999999999999999999963 36799999999998887533333
Q ss_pred cchh--hHHHHHhCCC-CEEEEeccCC----------CCCceEEeCC
Q 020431 184 LHPR--TIIPVMRYDI-PIVIRNIFNL----------SVPGIMICRP 217 (326)
Q Consensus 184 ~~~~--a~~~a~~~~I-~v~I~n~~~~----------~~~GT~I~~~ 217 (326)
|.|+ ++..|.+.|+ ++.|.++..+ +..||.|...
T Consensus 234 ~~~kl~~a~~a~~~gv~~v~i~~g~~~~~l~~el~~~~g~GT~i~~d 280 (429)
T TIGR01890 234 TRRLLSAAVKACRGGVHRSHIVSYAEDGSLLQELFTRDGIGTSISKE 280 (429)
T ss_pred cHHHHHHHHHHHHcCCCeEEEECCCCCcHHHHHHhcCCCCcceEecc
Confidence 4675 6667778897 5899997533 3479999764
No 85
>KOG1154 consensus Gamma-glutamyl kinase [Amino acid transport and metabolism]
Probab=99.31 E-value=8.8e-12 Score=110.85 Aligned_cols=157 Identities=16% Similarity=0.230 Sum_probs=109.7
Q ss_pred hhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCc
Q 020431 39 VVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIP 118 (326)
Q Consensus 39 i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~ 118 (326)
..+.|.-=...++-..|.++|+.+ .++.+++. .+-+ .-.+......|.++|. -+.|||+ |+|..+
T Consensus 92 ~AAvGQ~~Lmalye~lF~Qy~~~i-----AQvLvT~~-Di~d-~~~r~Nl~~Ti~eLL~--m~viPIv------NeNDav 156 (285)
T KOG1154|consen 92 CAAVGQSGLMALYETLFTQYGITI-----AQVLVTRN-DILD-EQQRKNLQNTISELLS--MNVIPIV------NENDAV 156 (285)
T ss_pred HHHhCcchHHHHHHHHHHHhccch-----heeeecCc-chhh-HHHHHHHHHHHHHHHh--CCceeee------cCCCcc
Confidence 445555444567788999999964 34444332 2211 0012233466778887 8999998 334333
Q ss_pred cc--ccCCc---chHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHH-H-----HhhcCCcccchh
Q 020431 119 TT--LKRDG---SDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAW-E-----MSYFGANVLHPR 187 (326)
Q Consensus 119 ~~--lgrgg---sD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~-~-----l~~~g~~v~~~~ 187 (326)
.. +.+|+ +|..|+++|..++||.++++|||||+||..|... .+++++.++..+.. + -+..|.++|..+
T Consensus 157 s~~~~~~~D~~dNDsLsA~laaei~ADlLilLsDVdglYt~PPd~~-~~~li~~~~~~~~~v~~tfG~~SkvGtGGM~tK 235 (285)
T KOG1154|consen 157 SPREIPFGDSSDNDSLAAILAAEIKADLLILLSDVDGLYTGPPDAD-PSKLIHTFSPGDPQVSTTFGSKSKVGTGGMETK 235 (285)
T ss_pred CCcccccCCCCcccHHHHHHHHHhccCEEEEEecccccccCCCCCC-cceeeeeeccCCCCCccccCccCccCcCcchhh
Confidence 22 33455 7999999999999999999999999999766543 46888888765443 2 234678899885
Q ss_pred --hHHHHHhCCCCEEEEeccCCCCCc
Q 020431 188 --TIIPVMRYDIPIVIRNIFNLSVPG 211 (326)
Q Consensus 188 --a~~~a~~~~I~v~I~n~~~~~~~G 211 (326)
|+..|...|+++.|.|+..|+..+
T Consensus 236 v~AA~~A~~~Gv~viI~~g~~p~~I~ 261 (285)
T KOG1154|consen 236 VKAAVNALNAGVSVIITNGDAPENIT 261 (285)
T ss_pred HHHHHHHhcCCceEEEeCCCChHHHH
Confidence 889999999999999998877443
No 86
>PLN02551 aspartokinase
Probab=99.31 E-value=1.6e-11 Score=123.71 Aligned_cols=123 Identities=16% Similarity=0.185 Sum_probs=94.2
Q ss_pred cccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCc------chh---hccCCeeeEEeecCeEEEEEecCCCC
Q 020431 182 NVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENE------DEQ---IIDSPVKGFATIDNLALVNVEGTGMA 252 (326)
Q Consensus 182 ~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~------~~~---~~~~~v~~I~~~~~ia~IsivG~~~~ 252 (326)
.++..+.+..+.++||++.+.++.. ....+.-+..+... ..+ .+-..+..+.+.+++++|+++|. |.
T Consensus 380 ~g~~arvf~~l~~~~I~Vd~IssSe---~sIs~~v~~~~~~~~~~i~~~l~~l~~el~~~~~V~v~~~vAiISvVG~-~~ 455 (521)
T PLN02551 380 YGFLAKVFSTFEDLGISVDVVATSE---VSISLTLDPSKLWSRELIQQELDHLVEELEKIAVVNLLQGRSIISLIGN-VQ 455 (521)
T ss_pred ccHHHHHHHHHHHcCCcEEEEeccC---CEEEEEEehhHhhhhhhHHHHHHHHHHHhhcCCeEEEeCCEEEEEEEcc-CC
Confidence 3455567888899999988886542 22222211111100 010 01123567889999999999998 78
Q ss_pred CcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHh
Q 020431 253 GVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREAL 308 (326)
Q Consensus 253 ~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~ 308 (326)
..+|+++++|++|+++||||.||+|++|+.+|||+|+++|.+++++.||++|+...
T Consensus 456 ~~~gvaariF~aLa~~gInV~mIsqgaSeinIS~vV~~~d~~~Av~aLH~~Ff~~~ 511 (521)
T PLN02551 456 RSSLILEKVFRVLRTNGVNVQMISQGASKVNISLIVNDDEAEQCVRALHSAFFEGD 511 (521)
T ss_pred CCccHHHHHHHHHHHCCCCeEEEEecCCCcEEEEEEeHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999999999999999999999999999999999999998643
No 87
>cd04924 ACT_AK-Arch_2 ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). Included in this CD is the second of two ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). The first or N-terminal ACT domain of these proteins cluster with the ThrA-like ACT 1 domains (ACT_AKi-HSDH-ThrA-like_1) which includes the threonine-sensitive archaeal Methanococcus jannaschii aspartokinase ACT 1 domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.31 E-value=1.2e-11 Score=89.61 Aligned_cols=64 Identities=47% Similarity=0.734 Sum_probs=61.8
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKF 304 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f 304 (326)
+++|+++|.++.+.+++.+++|+.|+++||+++|++|+.++.+++|++++++.+++.+.||++|
T Consensus 1 ~~~isivg~~~~~~~~~~~~i~~~L~~~~I~v~~i~q~~s~~~isf~i~~~~~~~~~~~Lh~~~ 64 (66)
T cd04924 1 VAVVAVVGSGMRGTPGVAGRVFGALGKAGINVIMISQGSSEYNISFVVAEDDGWAAVKAVHDEF 64 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHh
Confidence 4799999999999999999999999999999999999889999999999999999999999987
No 88
>PRK12454 carbamate kinase-like carbamoyl phosphate synthetase; Reviewed
Probab=99.30 E-value=2e-11 Score=114.93 Aligned_cols=121 Identities=19% Similarity=0.162 Sum_probs=90.9
Q ss_pred HHHHHHhhcCCCcEEEecCcc---ccCCCCCccccc-CCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEE
Q 020431 90 KRLEKWFSQSPSNTIIATGFI---ASTPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gfi---~~~~~g~~~~lg-rggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i 165 (326)
+.|+.+++ .|.|||++|.- ..+.+|.+.++. -.+.|.+|+.||..++|++++|+|||||||+. |+ .|+++++
T Consensus 176 ~aI~~LLe--~G~IvI~~GgGGiPV~~~~g~~~gveaViD~D~aAa~LA~~L~AD~LIiLTdVdGVy~~-~~-~p~~~~i 251 (313)
T PRK12454 176 EVIKALVE--NGFIVIASGGGGIPVIEEDGELKGVEAVIDKDLASELLAEELNADIFIILTDVEKVYLN-YG-KPDQKPL 251 (313)
T ss_pred HHHHHHHH--CCCEEEEeCCCccceEcCCCcEEeeeeecCccHHHHHHHHHcCCCEEEEEeCCceeeCC-CC-CCCCeEc
Confidence 67888888 89999999872 144556544322 13469999999999999999999999999986 43 4789999
Q ss_pred eeecHHHHHHHhh---cCCcccchh--hH-HHHHhCCCCEEEEecc------CCCCCceEEe
Q 020431 166 RTLSYQEAWEMSY---FGANVLHPR--TI-IPVMRYDIPIVIRNIF------NLSVPGIMIC 215 (326)
Q Consensus 166 ~~ls~~e~~~l~~---~g~~v~~~~--a~-~~a~~~~I~v~I~n~~------~~~~~GT~I~ 215 (326)
++++++|+.++.. ++.+.|.|| ++ +.+.+.+.+++|.+.. +.+ .||.|.
T Consensus 252 ~~It~~e~~~~i~~g~~~~GgM~pKv~AA~~~v~~gg~~a~I~~~~~i~~aL~G~-~GT~I~ 312 (313)
T PRK12454 252 DKVTVEEAKKYYEEGHFKAGSMGPKILAAIRFVENGGKRAIIASLEKAVEALEGK-TGTRII 312 (313)
T ss_pred cccCHHHHHHHHhcCCcCCCChHHHHHHHHHHHHcCCCeEEECchHHHHHHHCCC-CCeEeC
Confidence 9999999988764 345779884 44 5555556778887643 222 689885
No 89
>cd04240 AAK_UC AAK_UC: Uncharacterized (UC) amino acid kinase-like proteins found mainly in archaea and a few bacteria. Sequences in this CD are members of the Amino Acid Kinase (AAK) superfamily.
Probab=99.29 E-value=1.1e-11 Score=110.83 Aligned_cols=102 Identities=23% Similarity=0.249 Sum_probs=81.0
Q ss_pred HHHHHHHhhcCCCcEEEecCcccc----CCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeE
Q 020431 89 EKRLEKWFSQSPSNTIIATGFIAS----TPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVI 164 (326)
Q Consensus 89 ~~~i~~~l~~~~~~ipVv~Gfi~~----~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~ 164 (326)
.+.+...+. .+.+||+.++ +. ++.++..++ .+|..|+.+|..++|++++++|||||||++| +++
T Consensus 81 ~~~~~~~~~--~g~ipV~~P~-~~~~~~~~~~~~~~~---ttD~lAa~lA~~l~A~~Li~ltdVdGVy~~d------a~~ 148 (203)
T cd04240 81 LAELTDVLE--RGKIAILLPY-RLLLDTDPLPHSWEV---TSDSIAAWLAKKLGAKRLVIVTDVDGIYEKD------GKL 148 (203)
T ss_pred HHHHHHHHH--CCCcEEEeCc-hhhcccCCCCccccc---CHHHHHHHHHHHcCCCEEEEEeCCccccCCC------CcC
Confidence 367777777 7899999776 22 223333333 2799999999999999999999999999864 899
Q ss_pred EeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccCC
Q 020431 165 LRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNL 207 (326)
Q Consensus 165 i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~~ 207 (326)
++++++.|+. +..++++-+.+.+.++|++++|.|+..|
T Consensus 149 i~~i~~~e~~-----~~~~id~~~~~~~~~~gi~v~I~~g~~~ 186 (203)
T cd04240 149 VNEIAAAELL-----GETSVDPAFPRLLTKYGIRCYVVNGDDP 186 (203)
T ss_pred ccccCHHHhC-----CCCeehhhHHHHHHhCCCeEEEECCCCc
Confidence 9999988764 2567777677888999999999998755
No 90
>PRK06291 aspartate kinase; Provisional
Probab=99.25 E-value=1.8e-11 Score=122.19 Aligned_cols=123 Identities=25% Similarity=0.359 Sum_probs=94.4
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchh-----hccCCeeeEEeecCeEEEEEecCCCCCcccH
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQ-----IIDSPVKGFATIDNLALVNVEGTGMAGVPGT 257 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~-----~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i 257 (326)
++-.+.+..+.++||++...+....+ ..-.+.-...+.....+ .....++.+++.+++++|+++|.+|++.+|+
T Consensus 336 g~~arvf~~L~~~gI~V~mIsq~sse-~sIsf~V~~~d~~~av~~L~~~~~~~~~~~i~~~~~~a~IsvvG~gm~~~~gv 414 (465)
T PRK06291 336 GTAARIFSALAEEGVNVIMISQGSSE-SNISLVVDEADLEKALKALRREFGEGLVRDVTFDKDVCVVAVVGAGMAGTPGV 414 (465)
T ss_pred cHHHHHHHHHHHCCCcEEEEEecCCC-ceEEEEEeHHHHHHHHHHHHHHHHHhcCcceEEeCCEEEEEEEcCCccCCcCh
Confidence 44556788889999999888754322 21122211111000000 1112457799999999999999999999999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 258 ANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 258 ~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
.+|+|++|++.||+|.||+|++|+.+|||+|++++.+++++.||++|+.
T Consensus 415 ~~rif~aL~~~~I~v~~isqgsSe~~Is~vV~~~d~~~av~~Lh~~f~~ 463 (465)
T PRK06291 415 AGRIFSALGESGINIKMISQGSSEVNISFVVDEEDGERAVKVLHDEFIL 463 (465)
T ss_pred HHHHHHHHHHCCCCEEEEEeccccCeEEEEEeHHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999999999999999999999853
No 91
>PRK12354 carbamate kinase; Reviewed
Probab=99.23 E-value=1.8e-10 Score=108.17 Aligned_cols=122 Identities=20% Similarity=0.150 Sum_probs=88.3
Q ss_pred HHHHHHhhcCCCcEEEecCcccc----CCCCCccccc-CCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeE
Q 020431 90 KRLEKWFSQSPSNTIIATGFIAS----TPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVI 164 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gfi~~----~~~g~~~~lg-rggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~ 164 (326)
+.|+.+++ .+.|||..|-=|. +.++...... -.++|.+|+.||..++|+.++|+|||||||++++ .|++++
T Consensus 166 ~~I~~Ll~--~g~ivIa~GGGGIPV~~~~~~~~~gv~aViD~D~~Aa~LA~~l~Ad~LiiLTdVdGVy~~~~--~p~~k~ 241 (307)
T PRK12354 166 RPIRWLLE--KGHLVICAGGGGIPVVYDADGKLHGVEAVIDKDLAAALLAEQLDADLLLILTDVDAVYLDWG--KPTQRA 241 (307)
T ss_pred HHHHHHHH--CCCEEEEeCCCccCeEecCCCceeeeeecCCccHHHHHHHHHcCCCEEEEEeCCcceecCCC--CCCCeE
Confidence 78899998 8887776542111 1123222211 2357999999999999999999999999999753 378999
Q ss_pred EeeecHHHHHHHhhcCCcccchh---hHHHHHhCCCCEEEEecc------CCCCCceEEeCC
Q 020431 165 LRTLSYQEAWEMSYFGANVLHPR---TIIPVMRYDIPIVIRNIF------NLSVPGIMICRP 217 (326)
Q Consensus 165 i~~ls~~e~~~l~~~g~~v~~~~---a~~~a~~~~I~v~I~n~~------~~~~~GT~I~~~ 217 (326)
+++++.+|+.++ .+.++.|.|| |++.+.+.+.+++|.+.. +. ..||.|.+.
T Consensus 242 i~~it~~e~~~~-~f~~GgM~pKV~AA~~~~~~gg~~viI~~~~~l~~al~G-~~GT~I~~~ 301 (307)
T PRK12354 242 IAQATPDELREL-GFAAGSMGPKVEAACEFVRATGKIAGIGSLEDIQAILAG-EAGTRISPE 301 (307)
T ss_pred CCCCCHHHHHhh-CCCcCChHHHHHHHHHHHHhCCCEEEECCHHHHHHHHCC-CCceEEecC
Confidence 999999999888 6678899996 445555556678776532 12 269999763
No 92
>COG0527 LysC Aspartokinases [Amino acid transport and metabolism]
Probab=99.22 E-value=6e-11 Score=117.31 Aligned_cols=120 Identities=27% Similarity=0.267 Sum_probs=90.4
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCCCceEEe-CCCCCCCcc---hhhc-cCCeeeEEeecCeEEEEEecCCCCCcccH
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC-RPPVDENED---EQII-DSPVKGFATIDNLALVNVEGTGMAGVPGT 257 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~-~~~~~~~~~---~~~~-~~~v~~I~~~~~ia~IsivG~~~~~~~~i 257 (326)
++..+-+..+.++|+++..+.+...+ .+-.+. +..+ .+.. ++.. ......+...+++++|+++|.+|.++||+
T Consensus 322 g~~a~vf~~l~~~~i~v~~I~q~~~~-~~i~~~v~~~~-~~~a~~~l~~~~~~~~~~v~~~~~~a~vsiVG~gm~~~~gv 399 (447)
T COG0527 322 GFAARVFGILAEAGINVDLITQSISE-VSISFTVPESD-APRALRALLEEKLELLAEVEVEEGLALVSIVGAGMRSNPGV 399 (447)
T ss_pred cHHHHHHHHHHHcCCcEEEEEeccCC-CeEEEEEchhh-HHHHHHHHHHHHhhhcceEEeeCCeeEEEEEccccccCcCH
Confidence 44556788888999998666544322 232222 2211 1100 1111 11122688899999999999999999999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 258 ANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 258 ~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
++++|++|++++||+.||+ +|+.+|||+|++++.+++++.||+.|+.
T Consensus 400 aa~~f~aL~~~~ini~~is--sSe~~Is~vV~~~~~~~av~~LH~~~~~ 446 (447)
T COG0527 400 AARIFQALAEENINIIMIS--SSEISISFVVDEKDAEKAVRALHEAFFL 446 (447)
T ss_pred HHHHHHHHHhCCCcEEEEE--cCCceEEEEEccHHHHHHHHHHHHHHhc
Confidence 9999999999999999999 8999999999999999999999999874
No 93
>PRK09181 aspartate kinase; Validated
Probab=99.22 E-value=4.3e-11 Score=119.37 Aligned_cols=125 Identities=18% Similarity=0.256 Sum_probs=91.7
Q ss_pred cccchhhHHHHHhCCCCEEEEeccCCCCCceEEe-CCCCCC-CcchhhccC--CeeeEEeecCeEEEEEecCCCCCcccH
Q 020431 182 NVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC-RPPVDE-NEDEQIIDS--PVKGFATIDNLALVNVEGTGMAGVPGT 257 (326)
Q Consensus 182 ~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~-~~~~~~-~~~~~~~~~--~v~~I~~~~~ia~IsivG~~~~~~~~i 257 (326)
.++..+.+..+.+++|++....... ....+. ....+. ....+.... ....+.. +++++|++||.+|. .||+
T Consensus 343 ~g~~~~if~~l~~~~i~v~~i~ss~---~sis~~v~~~~~~~~~~~~~L~~~~~~~~i~~-~~~a~VsvVG~gm~-~~gv 417 (475)
T PRK09181 343 DGYDLEILEILTRHKVSYISKATNA---NTITHYLWGSLKTLKRVIAELEKRYPNAEVTV-RKVAIVSAIGSNIA-VPGV 417 (475)
T ss_pred chHHHHHHHHHHHcCCeEEEEEecC---cEEEEEEcCChHHHHHHHHHHHHhcCCceEEE-CCceEEEEeCCCCC-cccH
Confidence 3444567888899999988765442 222222 211010 000111111 1235664 89999999999995 8999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCC
Q 020431 258 ANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAG 311 (326)
Q Consensus 258 ~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~ 311 (326)
.+++|++|++.|||+.||+|++|+.+|||+|+++|.+++++.||++|+....++
T Consensus 418 ~ak~f~aL~~~~Ini~~i~qg~se~~Is~vV~~~d~~~Av~~lH~~f~~~~~~~ 471 (475)
T PRK09181 418 LAKAVQALAEAGINVLALHQSMRQVNMQFVVDEDDYEKAICALHEALVENHNHG 471 (475)
T ss_pred HHHHHHHHHHCCCCeEEEEecCCcceEEEEEeHHHHHHHHHHHHHHHhcCCCcc
Confidence 999999999999999999999999999999999999999999999998655443
No 94
>PRK09436 thrA bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional
Probab=99.21 E-value=7.5e-11 Score=124.95 Aligned_cols=125 Identities=23% Similarity=0.361 Sum_probs=96.8
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcc---------hhhccCCeeeEEeecCeEEEEEecCCCCC
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENED---------EQIIDSPVKGFATIDNLALVNVEGTGMAG 253 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~---------~~~~~~~v~~I~~~~~ia~IsivG~~~~~ 253 (326)
++-.+.+..+.++||++...+....+ ..-.+.-+..+.... .+.....++.|++.+++++|+++|.+|..
T Consensus 330 G~~arIf~~La~~gI~V~mIsqssSe-~sIsf~V~~~d~~~av~~L~~~f~~el~~~~~~~i~~~~~valIsvvG~gm~~ 408 (819)
T PRK09436 330 GMASRVFAALSRAGISVVLITQSSSE-YSISFCVPQSDAAKAKRALEEEFALELKEGLLEPLEVEENLAIISVVGDGMRT 408 (819)
T ss_pred CHHHHHHHHHHHCCCcEEEEEcCCCC-ceEEEEEeHHHHHHHHHHHHHHHHHHhccCCcceEEEeCCEEEEEEEccCccc
Confidence 34456788889999999888754322 221222111110000 01112357789999999999999999999
Q ss_pred cccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHh
Q 020431 254 VPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREAL 308 (326)
Q Consensus 254 ~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~ 308 (326)
.+|+.+|+|++|++.||||.||+|++|+.+|||+|++++.+++++.||++|+.+.
T Consensus 409 ~~gv~arif~aL~~~~InI~~IsqgsSe~~Is~vV~~~d~~~al~~LH~~f~~~~ 463 (819)
T PRK09436 409 HPGIAAKFFSALGRANINIVAIAQGSSERSISVVIDNDDATKALRACHQSFFLSD 463 (819)
T ss_pred CcCHHHHHHHHHHHCCCCEEEEEeccccceEEEEEcHHHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999999999999999999999997653
No 95
>PF13840 ACT_7: ACT domain ; PDB: 3S1T_A 1ZHV_A 3AB4_K 3AB2_O 2DTJ_A 3AAW_A 2RE1_B 3MAH_A 1ZVP_D.
Probab=99.18 E-value=8.5e-11 Score=85.91 Aligned_cols=63 Identities=38% Similarity=0.588 Sum_probs=58.6
Q ss_pred eecCeEEEEEecCCCCC-cccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHH
Q 020431 237 TIDNLALVNVEGTGMAG-VPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 237 ~~~~ia~IsivG~~~~~-~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~ 302 (326)
..++++.|+++|.+|.. .||+++++|++|+++||++.+++ |+.+++++|+++++++|++.||+
T Consensus 2 ~~~~~~~i~v~g~g~~~~~~Gv~a~i~~~La~~~I~i~~is---S~~~~~ilV~~~~~~~A~~~L~~ 65 (65)
T PF13840_consen 2 IEEDWAKISVVGPGLRFDVPGVAAKIFSALAEAGINIFMIS---SEISISILVKEEDLEKAVEALHE 65 (65)
T ss_dssp EESEEEEEEEEEECGTTTSHHHHHHHHHHHHHTTS-ECEEE---ESSEEEEEEEGGGHHHHHHHHHH
T ss_pred ccCCEEEEEEEccccCCCcccHHHHHHHHHHHCCCCEEEEE---EeeeEEEEEeHHHHHHHHHHhcC
Confidence 46789999999999976 99999999999999999999998 79999999999999999999985
No 96
>PRK09034 aspartate kinase; Reviewed
Probab=99.15 E-value=1.3e-10 Score=115.74 Aligned_cols=121 Identities=21% Similarity=0.192 Sum_probs=92.6
Q ss_pred cchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCc-----chh-hc-cCCeeeEEeecCeEEEEEecCCCCCccc
Q 020431 184 LHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENE-----DEQ-II-DSPVKGFATIDNLALVNVEGTGMAGVPG 256 (326)
Q Consensus 184 ~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~-----~~~-~~-~~~v~~I~~~~~ia~IsivG~~~~~~~~ 256 (326)
+-.+.+..+.++|+++.+.+... ..-.+.-+..+... ... .. .-...++++.+|+++|+++|.+|.+.++
T Consensus 324 ~~a~if~~la~~~I~Vd~i~ss~---~sis~~v~~~~~~~a~~~~l~~el~~~~~~~~I~~~~~va~VsivG~g~~~~~g 400 (454)
T PRK09034 324 FGRKVLQILEDHGISYEHMPSGI---DDLSIIIRERQLTPKKEDEILAEIKQELNPDELEIEHDLAIIMVVGEGMRQTVG 400 (454)
T ss_pred HHHHHHHHHHHcCCeEEEEcCCC---cEEEEEEeHHHhhHHHHHHHHHHHHHhhCCceEEEeCCEEEEEEECCCCCCCcc
Confidence 33467788889999988874221 22222211111100 000 01 1235789999999999999999999999
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHH
Q 020431 257 TANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREA 307 (326)
Q Consensus 257 i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~ 307 (326)
+.+++|++|+++||||+||+|++|+.+|||+|++++..++++.||++|+.+
T Consensus 401 v~arif~aL~~~~InV~mIsq~~Se~~Is~vV~~~d~~~av~~LH~~f~~~ 451 (454)
T PRK09034 401 VAAKITKALAEANINIQMINQGSSEISIMFGVKNEDAEKAVKAIYNAFFKE 451 (454)
T ss_pred HHHHHHHHHHHCCCCEEEEEecCCcceEEEEEcHHHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999999999999754
No 97
>PRK07431 aspartate kinase; Provisional
Probab=99.15 E-value=1.6e-10 Score=118.74 Aligned_cols=132 Identities=17% Similarity=0.219 Sum_probs=100.2
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCC--CceEEeCCCCCCCcch---hhccCCe--eeEEeecCeEEEEEecCCCCCcc
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSV--PGIMICRPPVDENEDE---QIIDSPV--KGFATIDNLALVNVEGTGMAGVP 255 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~--~GT~I~~~~~~~~~~~---~~~~~~v--~~I~~~~~ia~IsivG~~~~~~~ 255 (326)
++-.+-+..+.++|+++...++.-++. ..-.+.-...+..... ......+ ..+++.+++++|+++|.+|++.+
T Consensus 283 g~~a~if~~l~~~~I~v~~i~qs~~~~~~~~isf~i~~~d~~~~~~~l~~l~~~~~~~~i~~~~~~a~IsvvG~gm~~~~ 362 (587)
T PRK07431 283 GIAAQLFEELAAQGVNVDLIIQSIHEGNSNDIAFTVAENELKKAEAVAEAIAPALGGAEVLVETNVAKLSISGAGMMGRP 362 (587)
T ss_pred cHHHHHHHHHHHcCCcEEEEEeccCCCCCccEEEEEeHHHHHHHHHHHHHHHHHcCCCcEEEeCCeEEEEEECCCcccCc
Confidence 444567888899999988886543221 1222222111100000 0011111 46889999999999999999999
Q ss_pred cHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcce
Q 020431 256 GTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQV 316 (326)
Q Consensus 256 ~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v 316 (326)
|+.+++|++|++++|+|.||+ +|+.+|||+|++++.+++++.||++|+.+..+.++.++
T Consensus 363 gi~~ki~~aL~~~~I~i~~i~--sSe~~Is~vv~~~d~~~av~~Lh~~f~~~~~~~~~~~~ 421 (587)
T PRK07431 363 GIAAKMFDTLAEAGINIRMIS--TSEVKVSCVIDAEDGDKALRAVCEAFELEDSQIEINPT 421 (587)
T ss_pred cHHHHHHHHHHHCCCcEEEEE--cCCCEEEEEEcHHHHHHHHHHHHHHhccCCcccccCcc
Confidence 999999999999999999999 89999999999999999999999999988888888877
No 98
>PRK09411 carbamate kinase; Reviewed
Probab=99.14 E-value=7.6e-10 Score=103.28 Aligned_cols=118 Identities=18% Similarity=0.248 Sum_probs=87.6
Q ss_pred HHHHHHhhcCCCcEEEecCc--cc--cCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEE
Q 020431 90 KRLEKWFSQSPSNTIIATGF--IA--STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gf--i~--~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i 165 (326)
+.|+.+++ .|.|||.+|- ++ .+.+|...++ +.|.+|+.||..|+|++++|+|||||||..++ .|+++++
T Consensus 167 ~~I~~Ll~--~G~IVI~~gGGGIPV~~~~~G~e~vI---DkD~~Aa~LA~~L~Ad~LIiLTDVdGV~~n~~--~p~~~~I 239 (297)
T PRK09411 167 EAIELLLK--EGHVVICSGGGGVPVTEDGAGSEAVI---DKDLAAALLAEQINADGLVILTDADAVYENWG--TPQQRAI 239 (297)
T ss_pred HHHHHHHH--CCCEEEecCCCCCCeEEcCCCeEEec---CHHHHHHHHHHHhCCCEEEEEeCchhhccCCC--CCCCcCC
Confidence 78999998 8888887643 11 2223444433 47999999999999999999999999998643 4788999
Q ss_pred eeecHHHHHHHhhcCCcccchh---hHHHHHhCCCCEEEEeccCC-----CCCceEEe
Q 020431 166 RTLSYQEAWEMSYFGANVLHPR---TIIPVMRYDIPIVIRNIFNL-----SVPGIMIC 215 (326)
Q Consensus 166 ~~ls~~e~~~l~~~g~~v~~~~---a~~~a~~~~I~v~I~n~~~~-----~~~GT~I~ 215 (326)
++++.+|+.++.. ..+.|.|| |++.+...+.+++|.+..+. ...||.|.
T Consensus 240 ~~it~~e~~~~~~-~~GgM~pKVeAA~~~v~~~g~~a~I~~l~~~~~~l~G~~GT~I~ 296 (297)
T PRK09411 240 RHATPDELAPFAK-ADGAMGPKVTAVSGYVRSRGKPAWIGALSRIEETLAGEAGTCIS 296 (297)
T ss_pred CCcCHHHHHHhcc-CCCCcHHHHHHHHHHHHhCCCeEEECChhHHHHHHCCCCCeEEe
Confidence 9999999977764 45678886 45666667788888764320 12688874
No 99
>PRK09084 aspartate kinase III; Validated
Probab=99.10 E-value=7e-10 Score=110.31 Aligned_cols=119 Identities=22% Similarity=0.298 Sum_probs=90.4
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCC------c--chhhccCCeeeEEeecCeEEEEEecCCCCCc
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDEN------E--DEQIIDSPVKGFATIDNLALVNVEGTGMAGV 254 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~------~--~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~ 254 (326)
++-.+.+..+.++||++.+.++.. ..-.+.-+..+.. . ....+-..+..+.+.+|+++|+++|.+|.+.
T Consensus 321 g~~a~if~~l~~~~I~Vd~I~sse---~sIs~~i~~~~~~~~~~~~~~~~l~~el~~~~~i~~~~~va~IsvvG~gm~~~ 397 (448)
T PRK09084 321 GFLAEVFGILARHKISVDLITTSE---VSVSLTLDTTGSTSTGDTLLTQALLTELSQLCRVEVEEGLALVALIGNNLSKA 397 (448)
T ss_pred cHHHHHHHHHHHcCCeEEEEeccC---cEEEEEEechhhhhhhhHHHHHHHHHHHhcCCeEEEECCeEEEEEECCCcccC
Confidence 444567888999999988887542 2212221111100 0 0000112356788999999999999999999
Q ss_pred ccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 255 PGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 255 ~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
||+++|+|++|++ +||.||+|++|+.+|||+|++++..++++.||++|+.
T Consensus 398 ~gv~arif~aL~~--~nI~~I~qgsSe~sIS~vV~~~d~~~al~~LH~~f~~ 447 (448)
T PRK09084 398 CGVAKRVFGVLEP--FNIRMICYGASSHNLCFLVPESDAEQVVQALHQNLFE 447 (448)
T ss_pred cChHHHHHHHHHh--CCeEEEEEcCCCCcEEEEEcHHHHHHHHHHHHHHHhc
Confidence 9999999999986 6899999999999999999999999999999999974
No 100
>PRK12352 putative carbamate kinase; Reviewed
Probab=99.10 E-value=5.1e-10 Score=106.01 Aligned_cols=120 Identities=13% Similarity=0.124 Sum_probs=85.8
Q ss_pred HHHHHHhhcCCCcEEEec-----CccccCCCCCcccccC-CcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCe
Q 020431 90 KRLEKWFSQSPSNTIIAT-----GFIASTPDNIPTTLKR-DGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAV 163 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~-----Gfi~~~~~g~~~~lgr-ggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~ 163 (326)
+.|+.+++ .+.|+|.+ .. +.+..|+..++.- =+.|..|+.+|.+|+|++++|+|||+|||.++|+ ++++
T Consensus 177 ~~I~~ll~--~g~iVi~~ggggiPv-~~~~~g~~~n~~~nInaD~aAa~iA~aL~AdkLI~LTDV~GV~~d~~~--~~~~ 251 (316)
T PRK12352 177 PAIKALIQ--QGFVVIGAGGGGIPV-VRTDAGDYQSVDAVIDKDLSTALLAREIHADILVITTGVEKVCIHFGK--PQQQ 251 (316)
T ss_pred HHHHHHHH--CCCEEEecCCCCCCE-EeCCCCCccCceeeecHHHHHHHHHHHhCCCEEEEEeCchhhccCCCC--CCcc
Confidence 78888998 88885543 21 2233333322110 0279999999999999999999999999988654 6788
Q ss_pred EEeeecHHHHHHHhhcC---Ccccchh--hHHHHHhCCC-CEEEEecc------CCCCCceEEe
Q 020431 164 ILRTLSYQEAWEMSYFG---ANVLHPR--TIIPVMRYDI-PIVIRNIF------NLSVPGIMIC 215 (326)
Q Consensus 164 ~i~~ls~~e~~~l~~~g---~~v~~~~--a~~~a~~~~I-~v~I~n~~------~~~~~GT~I~ 215 (326)
++++++.+|+.++...| .+.|.|+ ++..+.+.|+ +++|.+.. +.+ .||+|.
T Consensus 252 li~~lt~~e~~~li~~g~i~~GgM~pKl~aA~~al~~Gv~~v~I~~~~~i~~al~g~-~GT~I~ 314 (316)
T PRK12352 252 ALDRVDIATMTRYMQEGHFPPGSMLPKIIASLTFLEQGGKEVIITTPECLPAALRGE-TGTHII 314 (316)
T ss_pred cccccCHHHHHHHHhcCCcCCCCCHHHHHHHHHHHHhCCCeEEEcchHHHHHHHcCC-CCeEEE
Confidence 99999999999998644 4688885 4544455555 68888743 222 688885
No 101
>cd04892 ACT_AK-like_2 ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the second of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). The exception in this group, is the inclusion of the first ACT domain of the bifunctional aspartokinase - homoserine dehydrogenase-like enzyme group (ACT_AKi-HSDH-ThrA-like_1) which includes the monofunctional, threonine-sensitive, aspartokinase found in Methanococcus jannaschii and other related archaeal species. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. AK is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of AK with different repressors an
Probab=99.05 E-value=9.9e-10 Score=78.37 Aligned_cols=64 Identities=47% Similarity=0.733 Sum_probs=60.5
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
++|+++|.++...+++.+++|+.|++++|++.+++|+.++.+++|++++++..++++.||++|+
T Consensus 1 ~~i~i~g~~~~~~~~~~~~i~~~l~~~~i~v~~i~~~~~~~~i~~~v~~~~~~~~~~~l~~~~~ 64 (65)
T cd04892 1 ALVSVVGAGMRGTPGVAARIFSALAEAGINIIMISQGSSEVNISFVVDEDDADKAVKALHEEFF 64 (65)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEcCCCceeEEEEEeHHHHHHHHHHHHHHHh
Confidence 5799999999999999999999999999999999997778999999999999999999999875
No 102
>cd04936 ACT_AKii-LysC-BS-like_2 ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis strain 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive AK isoenzymes. The B. subtilis strain 168 AKII is induced by methionine and repressed and inhibited by lysine. Although C. glutamicum is known to contain a single AK, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regu
Probab=99.04 E-value=1e-09 Score=78.47 Aligned_cols=62 Identities=34% Similarity=0.554 Sum_probs=58.1
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
++|+++|.++.+.+++.+++|+.|+++||+++|+++ ++.+++|+|++++.+++++.||++|+
T Consensus 1 ~~i~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~--s~~~is~~v~~~d~~~~~~~l~~~~~ 62 (63)
T cd04936 1 AKVSIVGAGMRSHPGVAAKMFEALAEAGINIEMIST--SEIKISCLIDEDDAEKAVRALHEAFE 62 (63)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEc--cCceEEEEEeHHHHHHHHHHHHHHhc
Confidence 478999999999999999999999999999999994 58999999999999999999999884
No 103
>cd04923 ACT_AK-LysC-DapG-like_2 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the second and fourth, of four, ACT domains present in cyanobacteria AK. Also included are the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (B. subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.02 E-value=1.4e-09 Score=77.81 Aligned_cols=62 Identities=35% Similarity=0.562 Sum_probs=58.2
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
++|+++|.++...+++.+++|+.|++++|++++++ +++.+++|++++++..++++.||++|+
T Consensus 1 ~~v~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~--~s~~~is~~v~~~~~~~~~~~l~~~l~ 62 (63)
T cd04923 1 AKVSIVGAGMRSHPGVAAKMFKALAEAGINIEMIS--TSEIKISCLVDEDDAEKAVRALHEAFE 62 (63)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEE--ccCCeEEEEEeHHHHHHHHHHHHHHhc
Confidence 47899999999999999999999999999999999 468999999999999999999999884
No 104
>TIGR00656 asp_kin_monofn aspartate kinase, monofunctional class. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. The protein slr0657 from Synechocystis PCC6803 is extended by a duplication of the C-terminal region corresponding to the beta chain. Incorporation of a second copy of the C-terminal domain may be quite common in this subgroup of aspartokinases.
Probab=99.01 E-value=1.4e-09 Score=106.78 Aligned_cols=121 Identities=26% Similarity=0.402 Sum_probs=91.2
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhc-----cCCeeeEEeecCeEEEEEecCCCCCcccH
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQII-----DSPVKGFATIDNLALVNVEGTGMAGVPGT 257 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~-----~~~v~~I~~~~~ia~IsivG~~~~~~~~i 257 (326)
++-.+.+..+.+++|++...+....+ ..-.+.-...+.....+.. ...+..+...+|+++|+++|.+|++.||+
T Consensus 275 g~~~~if~~L~~~~I~i~~i~~~~s~-~~Is~~V~~~d~~~a~~~L~~~~~~~~~~~i~~~~~~a~IsvVG~~~~~~~g~ 353 (401)
T TIGR00656 275 GFLARIFGALAERNINVDLISQTPSE-TSISLTVDETDADEAVRALKDQSGAAGLDRVEVEEGLAKVSIVGAGMVGAPGV 353 (401)
T ss_pred cHHHHHHHHHHHcCCcEEEEEcCCCC-ceEEEEEeHHHHHHHHHHHHHHHHhcCCceEEEeCCeEEEEEECCCcccCccH
Confidence 34446778888999999888765322 2222221111111011100 11246788999999999999999999999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 258 ANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 258 ~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
++++|+.|+++|||+.+++ +|+.+++|+|+++|.+++++.||++|+.
T Consensus 354 ~a~i~~~L~~~gIni~~i~--~s~~~is~vv~~~d~~~av~~Lh~~f~~ 400 (401)
T TIGR00656 354 ASEIFSALEEKNINILMIG--SSETNISFLVDEKDAEKAVRKLHEVFEE 400 (401)
T ss_pred HHHHHHHHHHCCCcEEEEE--cCCCEEEEEEeHHHHHHHHHHHHHHHcc
Confidence 9999999999999999987 8999999999999999999999999864
No 105
>PRK04531 acetylglutamate kinase; Provisional
Probab=99.00 E-value=5.7e-09 Score=102.02 Aligned_cols=113 Identities=12% Similarity=0.151 Sum_probs=82.4
Q ss_pred HHHHhhcCCCcEEEecCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecH-
Q 020431 92 LEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY- 170 (326)
Q Consensus 92 i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~- 170 (326)
++.+++ .|.|||++++ |.+..|++.+++ +|..|+.||.+|+|++++|+|||+|||+. +.+++++++.
T Consensus 122 I~~~L~--~g~IPVlspl-g~~~~G~~~Nvn---aD~vA~~LA~aL~a~KLIfltdv~GV~d~------~g~~i~~i~~~ 189 (398)
T PRK04531 122 VESSLR--AGSIPVIASL-GETPSGQILNIN---ADVAANELVSALQPYKIIFLTGTGGLLDA------DGKLISSINLS 189 (398)
T ss_pred HHHHHH--CCCEEEEeCc-EECCCCcEEEEC---HHHHHHHHHHHcCCCEEEEEECCCCccCC------CCCCcccCCHH
Confidence 666776 8999999986 777889988875 79999999999999999999999999974 3678999986
Q ss_pred HHHHHHhhcC--Ccccchh--hHHHHHhCCCCEEEEecc----------CCCCCceEEeC
Q 020431 171 QEAWEMSYFG--ANVLHPR--TIIPVMRYDIPIVIRNIF----------NLSVPGIMICR 216 (326)
Q Consensus 171 ~e~~~l~~~g--~~v~~~~--a~~~a~~~~I~v~I~n~~----------~~~~~GT~I~~ 216 (326)
+|...+...+ .++|.|+ ++..|.+..-.+.++... ..++.||.|..
T Consensus 190 ~e~~~l~~~~~vtgGM~~KL~~a~~al~~~~~~~~V~i~~~~~Ll~eLft~~G~GT~I~~ 249 (398)
T PRK04531 190 TEYDHLMQQPWINGGMKLKLEQIKELLDRLPLESSVSITSPSDLAKELFTHKGSGTLVRR 249 (398)
T ss_pred HHHHHHHhcCCCCccHHHHHHHHHHHHhCCCcEEEEEecCCCHHHHHHccCCCCCeEEec
Confidence 5777775433 4678775 444444331123333322 22347999975
No 106
>TIGR00657 asp_kinases aspartate kinase. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. This may be a feature of a number of closely related forms, including a paralog from B. subtilis.
Probab=98.95 E-value=3.8e-09 Score=104.96 Aligned_cols=120 Identities=25% Similarity=0.317 Sum_probs=91.2
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchh-----hccCCeeeEEeecCeEEEEEecCCCCCcccH
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQ-----IIDSPVKGFATIDNLALVNVEGTGMAGVPGT 257 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~-----~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i 257 (326)
++-.+.+..+.++||++...++...+ ..-.+.-+..+...... .....++.|++.+|+++|+++|.+|.+.||+
T Consensus 316 g~la~if~~L~~~~I~I~~i~q~~se-~sIs~~I~~~~~~~a~~~L~~~~~~~~~~~I~~~~~~a~VsvvG~~~~~~~g~ 394 (441)
T TIGR00657 316 GFLARVFGALAEAGINVDLITQSSSE-TSISFTVDKEDADQAKTLLKSELNLSALSSVEVEKGLAKVSLVGAGMKSAPGV 394 (441)
T ss_pred cHHHHHHHHHHHcCCeEEEEEecCCC-ceEEEEEEHHHHHHHHHHHHHHHHhcCcceEEEcCCeEEEEEEcCCCCCCCch
Confidence 33446778889999998877643322 22222211111000100 1134678899999999999999999999999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 258 ANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 258 ~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
.+++|+.|+++||||.||+ +|+.+|+|+|+++|.+++++.||++|+
T Consensus 395 ~a~if~~La~~~Inv~~i~--~se~~Is~vV~~~d~~~a~~~Lh~~f~ 440 (441)
T TIGR00657 395 ASKIFEALAQNGINIEMIS--SSEINISFVVDEKDAEKAVRLLHNALF 440 (441)
T ss_pred HHHHHHHHHHCCCCEEEEE--ecCCcEEEEEeHHHHHHHHHHHHHHhh
Confidence 9999999999999999999 578999999999999999999999986
No 107
>cd04912 ACT_AKiii-LysC-EC-like_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC) and plants, (Zea mays Ask1, Ask2, and Arabidopsis thaliana AK1). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Like the A. thaliana AK1 (AK1-AT), the E. coli AKIII (LysC) has two bound feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The lysine-sensitive plant isoenzyme is synergistically inhibited by S-adenosylmethionine. A homolog of this group appears to be the Saccharomyces cerevisiae AK (Hom3) which clusters with this group as well. Members of this CD
Probab=98.93 E-value=9.3e-09 Score=77.13 Aligned_cols=71 Identities=24% Similarity=0.386 Sum_probs=60.4
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccH---HHHHHHHHHHHHHHhcCCCCcceE
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEV---KAVAEALESKFREALNAGRLSQVC 317 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~---~~av~~Lh~~f~~~~~~~~~~~v~ 317 (326)
+++|+++|.++.+.+|+.+++|++|+++||++++++ +|+.++||++++++. ...++.|-+++.. +.+++
T Consensus 1 ~~~Vsi~g~~l~~~~g~~~~if~~L~~~~I~v~~i~--~s~~~is~~v~~~~~~~~~~~~~~~~~~l~~------~~~~~ 72 (75)
T cd04912 1 ITLLNIKSNRMLGAHGFLAKVFEIFAKHGLSVDLIS--TSEVSVSLTLDPTKNLSDQLLLDALVKDLSQ------IGDVE 72 (75)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHcCCeEEEEE--cCCcEEEEEEEchhhccchHHHHHHHHHHHh------CCEEE
Confidence 478999999999999999999999999999999998 578999999999886 5567677676644 66666
Q ss_pred EE
Q 020431 318 LS 319 (326)
Q Consensus 318 ~~ 319 (326)
++
T Consensus 73 ~~ 74 (75)
T cd04912 73 VE 74 (75)
T ss_pred Ee
Confidence 54
No 108
>PLN02825 amino-acid N-acetyltransferase
Probab=98.91 E-value=6.2e-09 Score=104.53 Aligned_cols=109 Identities=9% Similarity=0.107 Sum_probs=85.0
Q ss_pred HHHHHcCCce----EEEcccceeeccCC--------CCC---C-CCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCC
Q 020431 53 AVVRKNGIDC----KWMDTREVLIVNPT--------SSN---Q-VDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDN 116 (326)
Q Consensus 53 ~~L~~~Gi~a----~~l~~~~~~~~~~~--------~~g---~-~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g 116 (326)
..|+++|+++ ..+++.+...++.. .+| + .++|. +.|+.+++ .|.|||++.. |.+.+|
T Consensus 111 ~~l~~~G~~a~~~~~gl~~~~Gn~v~a~~~gv~dgvD~g~vG~V~~Vd~----~~i~~~L~--~g~Ipvispl-g~s~~G 183 (515)
T PLN02825 111 PNLRRHGDNSRWHEVGVSVASGNFLAAKRRGVVNGVDFGATGEVKKIDV----SRIKERLD--SNCIVLLSNL-GYSSSG 183 (515)
T ss_pred hHHHhcCCCCccccCceEeccCcEEEEEECCCCcCccccceeeEEEEcH----HHHHHHHh--CCCeEEECCc-eECCCC
Confidence 3469999998 66665553222211 222 2 24566 88999998 8999999995 999999
Q ss_pred CcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhh
Q 020431 117 IPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY 178 (326)
Q Consensus 117 ~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~ 178 (326)
++.|++ +|..|+.+|.+|+|++++|+||++ +++. +.+++++++.+|+.++..
T Consensus 184 e~~Nin---aD~vA~avA~aL~A~KLI~ltd~~-~~~~------~g~li~~l~~~e~~~li~ 235 (515)
T PLN02825 184 EVLNCN---TYEVATACALAIGADKLICIVDGP-ILDE------NGRLIRFMTLEEADMLIR 235 (515)
T ss_pred CEEeeC---HHHHHHHHHHHcCCCeEEEEeCcc-eecC------CCCCcCcCCHHHHHHHHH
Confidence 999985 899999999999999999999977 5542 357999999999998864
No 109
>PRK08961 bifunctional aspartate kinase/diaminopimelate decarboxylase protein; Provisional
Probab=98.91 E-value=3.9e-09 Score=112.82 Aligned_cols=121 Identities=15% Similarity=0.179 Sum_probs=91.5
Q ss_pred cccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCC---Ccchh---hccCCeeeEEeecCeEEEEEecCCCCCcc
Q 020431 182 NVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDE---NEDEQ---IIDSPVKGFATIDNLALVNVEGTGMAGVP 255 (326)
Q Consensus 182 ~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~---~~~~~---~~~~~v~~I~~~~~ia~IsivG~~~~~~~ 255 (326)
.++..+.+..+.+++|++.+++... ..-.+.-...+. +...+ ..-..+..+.+.+++++|++||.+|.+.+
T Consensus 336 ~g~~a~if~~la~~~I~Vd~I~sse---~sis~~i~~~~~~~~~~~~~~l~~~l~~~~~i~~~~~va~ISvVG~gm~~~~ 412 (861)
T PRK08961 336 VGFLADVFTLFKKHGLSVDLISSSE---TNVTVSLDPSENLVNTDVLAALSADLSQICRVKIIVPCAAVSLVGRGMRSLL 412 (861)
T ss_pred ccHHHHHHHHHHHcCCeEEEEEcCC---CEEEEEEccccccchHHHHHHHHHHHhhcCcEEEeCCeEEEEEeCCCcccCc
Confidence 3555677888999999988886442 222222111111 01111 11123456888899999999999999999
Q ss_pred cHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHH
Q 020431 256 GTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREA 307 (326)
Q Consensus 256 ~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~ 307 (326)
|+++++|++|++. +|.|++|++|+.+|||+|+++|.+++++.||++|+..
T Consensus 413 gv~arif~aL~~~--~I~~i~~gsSe~~Is~vV~~~d~~~av~~LH~~f~~~ 462 (861)
T PRK08961 413 HKLGPAWATFGAE--RVHLISQASNDLNLTFVIDESDADGLLPRLHAELIES 462 (861)
T ss_pred ChHHHHHHHHhhc--CeEEEECCCccccEEEEEeHHHHHHHHHHHHHHHhcC
Confidence 9999999999986 5788999999999999999999999999999999765
No 110
>cd04932 ACT_AKiii-LysC-EC_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.89 E-value=1.5e-08 Score=76.10 Aligned_cols=71 Identities=21% Similarity=0.316 Sum_probs=56.2
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHH--HHHH-HHHHHHHHHhcCCCCcceE
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVK--AVAE-ALESKFREALNAGRLSQVC 317 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~--~av~-~Lh~~f~~~~~~~~~~~v~ 317 (326)
+++|++.|.++.+.+|+.+++|+.|+++||+|+||+| |+.++||+++.++.. ++++ .|-++|.. ++.|+
T Consensus 1 ~~~ItI~~~~~~~~~g~~~~IF~~La~~~I~VDmI~~--s~~~iSftv~~~d~~~~~~~~~~l~~~l~~------~~~v~ 72 (75)
T cd04932 1 QTLVTLKSPNMLHAQGFLAKVFGILAKHNISVDLITT--SEISVALTLDNTGSTSDQLLTQALLKELSQ------ICDVK 72 (75)
T ss_pred CEEEEEecCCCCCCcCHHHHHHHHHHHcCCcEEEEee--cCCEEEEEEeccccchhHHHHHHHHHHHHh------ccEEE
Confidence 4789998889999999999999999999999999996 579999999998743 2443 44444422 56666
Q ss_pred EE
Q 020431 318 LS 319 (326)
Q Consensus 318 ~~ 319 (326)
++
T Consensus 73 ~~ 74 (75)
T cd04932 73 VE 74 (75)
T ss_pred ee
Confidence 54
No 111
>PRK05925 aspartate kinase; Provisional
Probab=98.88 E-value=7.2e-09 Score=102.67 Aligned_cols=117 Identities=17% Similarity=0.098 Sum_probs=87.4
Q ss_pred hhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCC-Ccch---hhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHH
Q 020431 186 PRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDE-NEDE---QIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAI 261 (326)
Q Consensus 186 ~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~-~~~~---~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~i 261 (326)
.+.+..+.++||++.+.+... .+-.+.-...+. .... ....+.+..+.+.+++++|+++|.+|++ +++.+++
T Consensus 316 ~~if~~l~~~~I~vd~i~s~~---~sis~~i~~~~~~~~~~~~l~~~l~~~~~i~~~~~~a~VsvVG~gm~~-~~v~~~~ 391 (440)
T PRK05925 316 EDVLGILRSLGIVPGLVMAQN---LGVYFTIDDDDISEEYPQHLTDALSAFGTVSCEGPLALITMIGAKLAS-WKVVRTF 391 (440)
T ss_pred HHHHHHHHHcCCcEEEEeccC---CEEEEEEechhccHHHHHHHHHHhcCCceEEEECCEEEEEEeCCCccc-ccHHHHH
Confidence 367788899999986654331 222222111111 1011 1112345678999999999999999998 7899999
Q ss_pred HHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHh
Q 020431 262 FGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREAL 308 (326)
Q Consensus 262 f~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~ 308 (326)
|++|++.|||+.+++| |+.+|||+|+++|..++++.||++|+...
T Consensus 392 ~~aL~~~~Ini~~i~~--s~~~is~vV~~~d~~~av~~LH~~f~~~~ 436 (440)
T PRK05925 392 TEKLRGYQTPVFCWCQ--SDMALNLVVNEELAVAVTELLHNDYVKQK 436 (440)
T ss_pred HHHHhhCCCCEEEEEC--CCceEEEEEehHHHHHHHHHHHHHHhccc
Confidence 9999999999999986 57799999999999999999999998654
No 112
>PRK09466 metL bifunctional aspartate kinase II/homoserine dehydrogenase II; Provisional
Probab=98.88 E-value=8.7e-09 Score=108.92 Aligned_cols=123 Identities=12% Similarity=0.128 Sum_probs=89.7
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhc--cCCeeeEEeecCeEEEEEecCCCCCcccHHHH
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQII--DSPVKGFATIDNLALVNVEGTGMAGVPGTANA 260 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~--~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~ 260 (326)
.+..+.+..+.+++|++.+.++...+ ....+.-...+........ ......+.+.+++++|++||.+|++.+|+.++
T Consensus 332 g~~~~if~~l~~~~I~v~~i~~~~s~-~sis~~i~~~~~~~~~~~l~~~~~~~~i~v~~~~a~VsvVG~gm~~~~gv~~~ 410 (810)
T PRK09466 332 LAQKELDQLLKRAQLRPLAVGVHPDR-QLLQLAYTSEVADSALKLLDDAALPGELKLREGLALVALVGAGVTRNPLHCHR 410 (810)
T ss_pred hHHHHHHHHHHHCCCeEEEEEecCCC-cEEEEEEeHHHHHHHHHHHHhhcCCCcEEEeCCeEEEEEeCCCcccCccHHHH
Confidence 33456788889999998888654322 2223322111111100000 01236788899999999999999999999999
Q ss_pred HHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHh
Q 020431 261 IFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREAL 308 (326)
Q Consensus 261 if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~ 308 (326)
+|++|++.+|++ ++|++|+.+|||+|+++|.+++++.||++|+...
T Consensus 411 ~f~aL~~~~I~i--i~~~~s~~sis~vV~~~d~~~av~~LH~~f~~~~ 456 (810)
T PRK09466 411 FYQQLKDQPVEF--IWQSEDGLSLVAVLRQGPTESLIQGLHQSLFRAE 456 (810)
T ss_pred HHHHHHhCCCcE--EEEeCCCcEEEEEEehHHHHHHHHHHHHHHhCcC
Confidence 999999997765 5556889999999999999999999999997643
No 113
>PRK06635 aspartate kinase; Reviewed
Probab=98.87 E-value=1e-08 Score=100.77 Aligned_cols=121 Identities=23% Similarity=0.266 Sum_probs=91.2
Q ss_pred ccchhhHHHHHhCCCCEEEEeccCCCC--CceEEeCCCCCCCcchh---h--ccCCeeeEEeecCeEEEEEecCCCCCcc
Q 020431 183 VLHPRTIIPVMRYDIPIVIRNIFNLSV--PGIMICRPPVDENEDEQ---I--IDSPVKGFATIDNLALVNVEGTGMAGVP 255 (326)
Q Consensus 183 v~~~~a~~~a~~~~I~v~I~n~~~~~~--~GT~I~~~~~~~~~~~~---~--~~~~v~~I~~~~~ia~IsivG~~~~~~~ 255 (326)
+.-.+.+..+.++||++...++...+. ..-.+.-...+.....+ . ..-.++.+++.+|+++|+++|.+|.+.|
T Consensus 275 g~l~~i~~~L~~~~I~i~~is~s~~~~~~~~is~~v~~~~~~~a~~~L~~~~~~~~~~~i~~~~~ia~isvvG~~~~~~~ 354 (404)
T PRK06635 275 GIAAQIFGALAEANINVDMIVQNVSEDGKTDITFTVPRDDLEKALELLEEVKDEIGAESVTYDDDIAKVSVVGVGMRSHP 354 (404)
T ss_pred cHHHHHHHHHHHcCCeEEEEEecCCCCCceeEEEEEcHHHHHHHHHHHHHHHHHcCcceEEEcCCeEEEEEECCCCCCCc
Confidence 333467888899999998887764331 12222211111111111 0 0113677999999999999999999999
Q ss_pred cHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 256 GTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 256 ~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
|+++++|++|+++||||.+++ +|+.+++|+++++|.+++++.||++|.
T Consensus 355 g~~a~i~~~La~~~Ini~~i~--ss~~~is~vv~~~d~~~a~~~Lh~~f~ 402 (404)
T PRK06635 355 GVAAKMFEALAEEGINIQMIS--TSEIKISVLIDEKYLELAVRALHEAFG 402 (404)
T ss_pred hHHHHHHHHHHHCCCCEEEEE--ecCCeEEEEEcHHHHHHHHHHHHHHHC
Confidence 999999999999999999998 579999999999999999999999984
No 114
>cd04868 ACT_AK-like ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes each of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). Typically, AK consists of two ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Aspartokinase is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind am
Probab=98.86 E-value=9.2e-09 Score=71.85 Aligned_cols=60 Identities=43% Similarity=0.680 Sum_probs=55.9
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALE 301 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh 301 (326)
++|+++|.++...+++.+++|+.|++++|++++++|+.++.+++|++++++.+++++.||
T Consensus 1 ~~i~v~g~~~~~~~~~~~~i~~~l~~~~i~i~~i~~~~~~~~~s~~v~~~~~~~~~~~lh 60 (60)
T cd04868 1 AKVSIVGVGMRGTPGVAAKIFSALAEAGINVDMISQSESEVNISFTVDESDLEKAVKALH 60 (60)
T ss_pred CEEEEECCCCCCCCCHHHHHHHHHHHCCCcEEEEEcCCCcEEEEEEEeHHHHHHHHHHhC
Confidence 478999999989999999999999999999999998877799999999999999998886
No 115
>cd04934 ACT_AK-Hom3_1 CT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydro
Probab=98.85 E-value=2.1e-08 Score=74.93 Aligned_cols=64 Identities=19% Similarity=0.239 Sum_probs=55.7
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHH-HHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKA-VAEALESKFRE 306 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~-av~~Lh~~f~~ 306 (326)
++.|++.+.+|...+|+.+++|+.|+++||+++||+| ++.++||++++++... .++.|.+++..
T Consensus 1 ~~~I~i~~~~m~~~~g~~~~If~~la~~~I~vd~I~~--s~~~isftv~~~~~~~~~l~~l~~el~~ 65 (73)
T cd04934 1 ILVINIHSNKKSLSHGFLARIFAILDKYRLSVDLIST--SEVHVSMALHMENAEDTNLDAAVKDLQK 65 (73)
T ss_pred CEEEEEEcccCccccCHHHHHHHHHHHcCCcEEEEEe--CCCEEEEEEehhhcChHHHHHHHHHHHH
Confidence 4789999999999999999999999999999999996 5799999999987654 67777666544
No 116
>PRK08210 aspartate kinase I; Reviewed
Probab=98.85 E-value=1.2e-08 Score=100.33 Aligned_cols=138 Identities=20% Similarity=0.298 Sum_probs=96.3
Q ss_pred eEEeeecHHHHHHHhh-cC---CcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeEEee
Q 020431 163 VILRTLSYQEAWEMSY-FG---ANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATI 238 (326)
Q Consensus 163 ~~i~~ls~~e~~~l~~-~g---~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I~~~ 238 (326)
+.++-+++.+-..+.. .+ ..+...+.+..+.++||++...+... + ..+..... .+-+.........-..+.+.
T Consensus 260 ~~v~~It~~~~i~~isv~~~~~~~g~la~If~~L~~~~I~i~~i~~~~-~-~is~~v~~-~~~~~a~~~l~~~~~~v~~~ 336 (403)
T PRK08210 260 RLITGIAHVSNVTQIKVKAKENAYDLQQEVFKALAEAGISVDFINIFP-T-EVVFTVSD-EDSEKAKEILENLGLKPSVR 336 (403)
T ss_pred CceEEEEEcCCcEEEEEecCCCcchHHHHHHHHHHHcCCeEEEEEecC-c-eEEEEEcH-HHHHHHHHHHHHhCCcEEEe
Confidence 3566666543322221 11 13455567888899999988877663 2 23322221 11000000000011157888
Q ss_pred cCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHH
Q 020431 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 239 ~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~ 305 (326)
+|+++|+++|.+|++.||+++++|++|+++||++.+++ +|+.+++|+|++++.+++++.||++|+
T Consensus 337 ~~~a~isvvG~~~~~~~g~~~~i~~aL~~~~I~i~~~~--~s~~~is~vv~~~~~~~a~~~Lh~~f~ 401 (403)
T PRK08210 337 ENCAKVSIVGAGMAGVPGVMAKIVTALSEEGIEILQSA--DSHTTIWVLVKEEDMEKAVNALHDAFE 401 (403)
T ss_pred CCcEEEEEEcCCcCCCccHHHHHHHHHHhCCCCEEEEe--cCCCEEEEEEcHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999876 589999999999999999999999984
No 117
>cd04933 ACT_AK1-AT_1 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the first of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine. This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. Like the Escherichia coli AKIII (LysC), Arabidopsis AK1 binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. A loop in common is involved in the binding of both Lys and S-adenosylmethionine providing an explanation for the synergistic inhibition by these effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.82 E-value=2.7e-08 Score=75.24 Aligned_cols=63 Identities=16% Similarity=0.324 Sum_probs=54.3
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHH------HHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVK------AVAEALESKFR 305 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~------~av~~Lh~~f~ 305 (326)
+++|++.+.++.+.||+.+++|+.|+++||+++||+| ++.++||++++++.. ..++.|-++|.
T Consensus 1 ~~~i~i~~~~~~~~~g~~a~IF~~La~~~InVDmI~q--s~~sISftV~~sd~~~~~~~~~~l~~~~~~~~ 69 (78)
T cd04933 1 VTMLDITSTRMLGQYGFLAKVFSIFETLGISVDVVAT--SEVSISLTLDPSKLWSRELIQQELDHVVEELE 69 (78)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEe--cCCEEEEEEEhhhhhhhhhHHHHHHHHHHHHH
Confidence 4789999999999999999999999999999999996 679999999999873 45556655553
No 118
>cd04935 ACT_AKiii-DAPDC_1 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. This CD includes the first of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.78 E-value=5.6e-08 Score=73.01 Aligned_cols=64 Identities=27% Similarity=0.387 Sum_probs=54.5
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEcccc--HHH-HHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKE--VKA-VAEALESKFRE 306 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d--~~~-av~~Lh~~f~~ 306 (326)
+++|++.+.++.+.+|+.+++|+.|+++||+++||+| ++.++||++++.+ ... .++.|-+++..
T Consensus 1 ~~~i~i~~~~~~~~~g~~~~IF~~La~~~I~vDmI~~--s~~~isftv~~~~~~~~~~~~~~l~~el~~ 67 (75)
T cd04935 1 IRLVSMETLGMWQQVGFLADVFAPFKKHGVSVDLVST--SETNVTVSLDPDPNGLDPDVLDALLDDLNQ 67 (75)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEe--CCCEEEEEEeCcccccchHHHHHHHHHHHh
Confidence 4689999999999999999999999999999999996 5799999999987 343 66666665533
No 119
>COG2054 Uncharacterized archaeal kinase related to aspartokinases, uridylate kinases [General function prediction only]
Probab=98.77 E-value=8.8e-09 Score=88.58 Aligned_cols=83 Identities=25% Similarity=0.350 Sum_probs=70.6
Q ss_pred chHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEecc
Q 020431 126 SDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIF 205 (326)
Q Consensus 126 sD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~ 205 (326)
||.+++++|+.+++.++++.|||||||+.+|+ ++++++|+..|... |-..++|-+-+++.++++.++++|+.
T Consensus 118 SDsis~~Ia~~~~~~~vv~aTDVdGI~~~~~~----~kLv~eI~A~dl~~----~~t~vD~~~P~Ll~k~~m~~~Vvng~ 189 (212)
T COG2054 118 SDSISVWIAAKAGATEVVKATDVDGIYEEDPK----GKLVREIRASDLKT----GETSVDPYLPKLLVKYKMNCRVVNGK 189 (212)
T ss_pred ccHHHHHHHHHcCCcEEEEEecCCcccccCCc----chhhhhhhHhhccc----CcccccchhhHHHHHcCCceEEECCC
Confidence 69999999999999999999999999998864 58999887776532 66788998889999999999999998
Q ss_pred CCC----------CCceEEeC
Q 020431 206 NLS----------VPGIMICR 216 (326)
Q Consensus 206 ~~~----------~~GT~I~~ 216 (326)
.|+ ..||.|.+
T Consensus 190 ~pervi~~lrGk~~v~T~Ivg 210 (212)
T COG2054 190 EPERVILALRGKEVVGTLIVG 210 (212)
T ss_pred CHHHHHHHHhccccceEEEeC
Confidence 664 35777754
No 120
>cd04890 ACT_AK-like_1 ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the first of two ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids, lysine, threonine, methionine, and isoleucine. This CD, includes the first ACT domain of the Escherichia coli (EC) isoenzyme, AKIII (LysC) and the Arabidopsis isoenzyme, asparate kinase 1, both enzymes monofunctional and involved in lysine synthesis, as well as the the first ACT domain of Bacillus subtilis (BS) isoenzyme, AKIII (YclM), and of the Saccharomyces cerevisiae AK (Hom3). Also included are the first ACT domains of the Methylomicrobium alcaliphilum AK, the first enzyme of the ectoine biosynthetic pathway. Members of this CD bel
Probab=98.64 E-value=1.5e-07 Score=67.56 Aligned_cols=60 Identities=22% Similarity=0.274 Sum_probs=54.2
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHH
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKF 304 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f 304 (326)
.|++.+.+|.+.+|+.+++|+.|++++|+++||+| ++.++||+++..+.++.++.|-+++
T Consensus 2 ~i~i~~~~m~~~~~~~~~if~~l~~~~i~v~~i~t--~~~~is~~v~~~~~~~~~~~l~~~l 61 (62)
T cd04890 2 AIEIFDQLMNGEVGFLRKIFEILEKHGISVDLIPT--SENSVTLYLDDSLLPKKLKRLLAEL 61 (62)
T ss_pred EEEEeccccCcccCHHHHHHHHHHHcCCeEEEEec--CCCEEEEEEehhhhhHHHHHHHHhh
Confidence 57899999999999999999999999999999984 6799999999998888888776653
No 121
>COG0549 ArcC Carbamate kinase [Amino acid transport and metabolism]
Probab=98.55 E-value=6.6e-07 Score=82.33 Aligned_cols=116 Identities=22% Similarity=0.311 Sum_probs=88.0
Q ss_pred HHHHHHhhcCCCcEEEecCccccCCCCCcccccCC----------cchHHHHHHHHhhccceEEEeeccCcccccCCCCC
Q 020431 90 KRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRD----------GSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKV 159 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrg----------gsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~ 159 (326)
+.|+.+++ .|.++|..|= |.+.++..+ +-|.+++.||..++||.++|+||||+||-.=-+
T Consensus 175 ~~Ik~L~~--~g~vVI~~GG------GGIPVv~~~~~~~GVeAVIDKDlasalLA~~i~AD~liILTdVd~Vy~n~gk-- 244 (312)
T COG0549 175 EAIKALLE--SGHVVIAAGG------GGIPVVEEGAGLQGVEAVIDKDLASALLAEQIDADLLIILTDVDAVYVNFGK-- 244 (312)
T ss_pred HHHHHHHh--CCCEEEEeCC------CCcceEecCCCcceeeEEEccHHHHHHHHHHhcCCEEEEEeccchheecCCC--
Confidence 67888887 7888887662 223222222 259999999999999999999999999986433
Q ss_pred CCCeEEeeecHHHHHHHhh---cCCcccchh---hHHHHHhCCCCEEEEeccCC-----CCCceEEe
Q 020431 160 SEAVILRTLSYQEAWEMSY---FGANVLHPR---TIIPVMRYDIPIVIRNIFNL-----SVPGIMIC 215 (326)
Q Consensus 160 ~~a~~i~~ls~~e~~~l~~---~g~~v~~~~---a~~~a~~~~I~v~I~n~~~~-----~~~GT~I~ 215 (326)
|+.+.++.++.+|+++... |..+-|-|| |+......|-+..|.+..+. ...||.|.
T Consensus 245 p~q~~L~~v~~~e~~~yl~eg~Fa~GSM~PKVeAai~Fv~~~gk~A~ItsLe~~~~~l~g~~GT~I~ 311 (312)
T COG0549 245 PNQQALDRVTVDEMEKYLAEGQFAAGSMGPKVEAAISFVENTGKPAIITSLENAEAALEGKAGTVIV 311 (312)
T ss_pred ccchhhcccCHHHHHHHHhcCCCCCCCccHHHHHHHHHHHcCCCceEECcHHHHHHHhccCCCcEec
Confidence 6788999999999988775 445788886 67777777888888876532 24688885
No 122
>cd04891 ACT_AK-LysC-DapG-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the first and third, of four, ACT domains present in cyanobacteria AK. Also included are the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (Bacillus subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.54 E-value=3.7e-07 Score=64.16 Aligned_cols=57 Identities=35% Similarity=0.599 Sum_probs=50.5
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCc---cEEEEEEccccHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE---HSVCFAVPEKEVKAVAEAL 300 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se---~sIs~~V~~~d~~~av~~L 300 (326)
++|+++| +.+.+|+.+++|+.|+++||++++++|+.++ .+++|++++++..++++.|
T Consensus 1 ~~v~v~~--~~~~~~~~~~i~~~L~~~~i~i~~i~~~~~~~~~~~is~~v~~~~~~~~~~~l 60 (61)
T cd04891 1 AQVTIKG--VPDKPGVAAKIFSALAEAGINVDMIVQSVSRGGTTDISFTVPKSDLEKALAIL 60 (61)
T ss_pred CEEEEec--CCCCCcHHHHHHHHHHHcCCcEEEEEEcCCCCCcEEEEEEEeHHHHHHHHHHh
Confidence 4678877 6788999999999999999999999998765 8899999999999887765
No 123
>cd04913 ACT_AKii-LysC-BS-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is fee
Probab=98.52 E-value=4.5e-07 Score=66.58 Aligned_cols=61 Identities=34% Similarity=0.550 Sum_probs=54.3
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEccccHHHHHHHHHHH
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEKEVKAVAEALESK 303 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~~d~~~av~~Lh~~ 303 (326)
+++|+++| +.+.+|+.+++|+.|+++||++++++|+.+ +.+++|++++++.+++++.||+.
T Consensus 1 ~~~v~v~~--~~~~~g~~~~i~~~L~~~~I~i~~i~~~~~~~~~~~is~~v~~~d~~~~~~~l~~~ 64 (75)
T cd04913 1 QAKITLRG--VPDKPGVAAKIFGALAEANINVDMIVQNVSRDGTTDISFTVPKSDLKKALAVLEKL 64 (75)
T ss_pred CeEEEECC--CCCCCcHHHHHHHHHHHcCCeEEEEEeCCCCCCcEEEEEEecHHHHHHHHHHHHHH
Confidence 46889977 678899999999999999999999999765 35799999999999999999984
No 124
>cd04914 ACT_AKi-DapG-BS_1 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria, bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and
Probab=98.34 E-value=3e-06 Score=62.12 Aligned_cols=57 Identities=21% Similarity=0.337 Sum_probs=48.1
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~ 302 (326)
+.|++.| ..+.+++.+++|+.|+++||+++||+|. ++ ++||+++..+.+++.+.|.+
T Consensus 2 ~~vtv~~--~~~~~~~~a~if~~La~~~InvDmI~~~-~~-~isFtv~~~d~~~~~~il~~ 58 (67)
T cd04914 2 TQIKVKA--KDNENDLQQRVFKALANAGISVDLINVS-PE-EVIFTVDGEVAEKAVDILEK 58 (67)
T ss_pred eEEEEec--CCCCccHHHHHHHHHHHcCCcEEEEEec-CC-CEEEEEchhhHHHHHHHHHH
Confidence 5788887 4466999999999999999999999876 34 79999999999998666544
No 125
>cd04910 ACT_AK-Ectoine_1 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase
Probab=97.77 E-value=0.00011 Score=54.53 Aligned_cols=65 Identities=20% Similarity=0.254 Sum_probs=57.1
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
..|.+.+++|.+.+|+.++||+.|+++++++.+..+++.+.++++..+.+.+++++..|.+.|..
T Consensus 2 ~alevfdqdMvG~~g~d~~i~~~l~~~~v~ii~K~~nANtit~yl~~~~k~~~r~~~~Le~~~p~ 66 (71)
T cd04910 2 FALEVFDQDMVGEVGYDLEILELLQRFKVSIIAKDTNANTITHYLAGSLKTIKRLTEDLENRFPN 66 (71)
T ss_pred eEEEEeCCCccCChhHHHHHHHHHHHcCCeEEEEecCCCeEEEEEEcCHHHHHHHHHHHHHhCcc
Confidence 45788999999999999999999999999999998777777777777788999999999987753
No 126
>cd04911 ACT_AKiii-YclM-BS_1 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Bacillus subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from Bacillus subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.53 E-value=0.00041 Score=52.06 Aligned_cols=73 Identities=10% Similarity=0.209 Sum_probs=55.4
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHH-HHHHHHHHHHHHhcCCCCcceEEE
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKA-VAEALESKFREALNAGRLSQVCLS 319 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~-av~~Lh~~f~~~~~~~~~~~v~~~ 319 (326)
+.|++.-..|....||..|++++|.++||+++++. ++..++|++++++++.. .++.+-+++..++.-+ .++++
T Consensus 2 ~~I~i~K~~Mn~evGF~rk~L~I~E~~~is~Eh~P--SGID~~Siii~~~~~~~~~~~~i~~~i~~~~~pD---~i~v~ 75 (76)
T cd04911 2 CSIYISKYLMNREVGFGRKLLSILEDNGISYEHMP--SGIDDISIIIRDNQLTDEKEQKILAEIKEELHPD---EIEII 75 (76)
T ss_pred ceEehhHhhccchhcHHHHHHHHHHHcCCCEeeec--CCCccEEEEEEccccchhhHHHHHHHHHHhcCCC---EEEEe
Confidence 45677778889999999999999999999999997 78999999999996655 4444444444444333 35554
No 127
>PRK08841 aspartate kinase; Validated
Probab=97.38 E-value=0.00078 Score=66.13 Aligned_cols=76 Identities=16% Similarity=0.131 Sum_probs=61.4
Q ss_pred CCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhc
Q 020431 230 SPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALN 309 (326)
Q Consensus 230 ~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~ 309 (326)
..+++|+..+|+++|++.|. .++++|+.|+++||++++++| ++.+++|++++.++.++. ..
T Consensus 247 ~~i~~i~~~~~~~~i~v~~~-------~~~~i~~~l~~~~i~v~~i~~--~~~~~~~~v~~~~~~~~~----~~------ 307 (392)
T PRK08841 247 QAVCGIALQRDLALIEVESE-------SLPSLTKQCQMLGIEVWNVIE--EADRAQIVIKQDACAKLK----LV------ 307 (392)
T ss_pred CcEEEEEEeCCeEEEEeccc-------hHHHHHHHHHHcCCCEEEEEe--cCCcEEEEECHHHHHHHH----Hh------
Confidence 46999999999999999763 368999999999999999985 578899999987765541 11
Q ss_pred CCCCcceEEEcCeeecC
Q 020431 310 AGRLSQVCLSFWLCDYT 326 (326)
Q Consensus 310 ~~~~~~v~~~~~~~~~~ 326 (326)
..+++.+++++++|+
T Consensus 308 --~~~~i~~~~~~a~vs 322 (392)
T PRK08841 308 --FDDKIRNSESVSLLT 322 (392)
T ss_pred --CcccEEEeCCEEEEE
Confidence 134688999999874
No 128
>PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C ....
Probab=97.04 E-value=0.0012 Score=46.94 Aligned_cols=53 Identities=26% Similarity=0.391 Sum_probs=43.4
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCCcc-----EEEEEEccccHHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASSEH-----SVCFAVPEKEVKAVAEALESK 303 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~-----sIs~~V~~~d~~~av~~Lh~~ 303 (326)
+.++||+++++++.|+++|+||..+.|.++.. .+.+..++.+..++++.|++.
T Consensus 7 ~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 64 (66)
T PF01842_consen 7 VPDRPGILADVTEILADHGINIDSISQSSDKDGVGIVFIVIVVDEEDLEKLLEELEAL 64 (66)
T ss_dssp EETSTTHHHHHHHHHHHTTEEEEEEEEEEESSTTEEEEEEEEEEGHGHHHHHHHHHHH
T ss_pred cCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCCceEEEEEEECCCCCHHHHHHHHHcc
Confidence 56899999999999999999999999887643 333445566899999998874
No 129
>COG3830 ACT domain-containing protein [Signal transduction mechanisms]
Probab=96.97 E-value=0.0028 Score=48.80 Aligned_cols=76 Identities=18% Similarity=0.142 Sum_probs=56.9
Q ss_pred CeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC--ccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceE
Q 020431 240 NLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVC 317 (326)
Q Consensus 240 ~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s--e~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~ 317 (326)
..++|++.|. ++||+.+.+++.|+++|+||.=|||..- -.++-++|+-.....-..++.+++..+.+... -.|.
T Consensus 2 ~~avITV~Gk---Dr~GIva~is~vLAe~~vNIldisQtvm~~~ftm~~lV~~~~~~~d~~~lr~~l~~~~~~lg-v~V~ 77 (90)
T COG3830 2 MRAVITVIGK---DRVGIVAAVSRVLAEHGVNILDISQTVMDGFFTMIMLVDISKEVVDFAALRDELAAEGKKLG-VDVR 77 (90)
T ss_pred ceEEEEEEcC---CCCchhHHHHHHHHHcCCcEEEHHHHHHhhhceeeeEEcCChHhccHHHHHHHHHHHHHhcC-cEEE
Confidence 4689999985 6899999999999999999999999764 45666667766666667777777766555444 2344
Q ss_pred EE
Q 020431 318 LS 319 (326)
Q Consensus 318 ~~ 319 (326)
+|
T Consensus 78 vq 79 (90)
T COG3830 78 VQ 79 (90)
T ss_pred Ee
Confidence 44
No 130
>cd04888 ACT_PheB-BS C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and related domains. This CD includes the C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and other related ACT domains. In B. subtilis, the upstream gene of pheB, pheA encodes prephenate dehydratase (PDT). The presumed product of the pheB gene is chorismate mutase (CM). The deduced product of the B. subtilis pheB gene, however, has no significant homology to the CM portion of the bifunctional CM-PDT of Escherichia coli. The presence of an ACT domain lends support to the prediction that these proteins function as a phenylalanine-binding regulatory protein. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=96.34 E-value=0.02 Score=42.04 Aligned_cols=53 Identities=17% Similarity=0.330 Sum_probs=41.3
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEccccHHHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEKEVKAVAEALESKF 304 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~~d~~~av~~Lh~~f 304 (326)
.+.||.++++++.|+++|+++.+++|... ...++|.++..+.+..++.|.+.+
T Consensus 8 ~d~~g~l~~I~~~la~~~inI~~i~~~~~~~~~~~i~~~v~v~~~~~~l~~l~~~L 63 (76)
T cd04888 8 EHRPGVLSKVLNTIAQVRGNVLTINQNIPIHGRANVTISIDTSTMNGDIDELLEEL 63 (76)
T ss_pred cCCCchHHHHHHHHHHcCCCEEEEEeCCCCCCeEEEEEEEEcCchHHHHHHHHHHH
Confidence 45799999999999999999999998432 356889998887775555555543
No 131
>COG3603 Uncharacterized conserved protein [Function unknown]
Probab=96.12 E-value=0.036 Score=44.77 Aligned_cols=71 Identities=17% Similarity=0.213 Sum_probs=60.2
Q ss_pred CCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHH
Q 020431 230 SPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESK 303 (326)
Q Consensus 230 ~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~ 303 (326)
+....|....+-..+.+.|.--.+.+|+++.+.+.|++.||.|..+|.- .. =-++|.++|++++++.|.+.
T Consensus 52 ~vp~~V~~~~GW~~lk~~gpf~FgltGilasV~~pLsd~gigIFavSty--dt-DhiLVr~~dLekAv~~L~ea 122 (128)
T COG3603 52 RVPDVVQIEKGWSCLKFEGPFDFGLTGILASVSQPLSDNGIGIFAVSTY--DT-DHILVREEDLEKAVKALEEA 122 (128)
T ss_pred cCCcceEecCCeEEEEEeccccCCcchhhhhhhhhHhhCCccEEEEEec--cC-ceEEEehhhHHHHHHHHHHc
Confidence 4455678888999999999988899999999999999999999999832 22 23678999999999999873
No 132
>KOG2436 consensus Acetylglutamate kinase/acetylglutamate synthase [Amino acid transport and metabolism]
Probab=96.04 E-value=0.011 Score=58.83 Aligned_cols=118 Identities=13% Similarity=0.072 Sum_probs=83.1
Q ss_pred ccchHHHHHHHHHHHHHcCCceEEEccccee--eccC--------CCCC---C-CCCCchhhHHHHHHHhhcCCCcEEEe
Q 020431 41 GHGELWSAQMLAAVVRKNGIDCKWMDTREVL--IVNP--------TSSN---Q-VDPDFSESEKRLEKWFSQSPSNTIIA 106 (326)
Q Consensus 41 ~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~--~~~~--------~~~g---~-~~~~~~~~~~~i~~~l~~~~~~ipVv 106 (326)
-+||.-- -+...|+++|-.+++.+..... .+.. ..|| + .+++. ++++.+++ .|.+|++
T Consensus 170 ~~~E~n~--~lv~nL~~~g~~ar~~s~g~~v~~~f~a~~~~v~d~~~y~~~gei~~vd~----d~i~~l~~--~G~mp~L 241 (520)
T KOG2436|consen 170 VSLEANL--NLVINLSQLGTRARPSSSGVRVGNFFPADRNGVLDGEDYGLVGEIKKVDV----DRIRHLLD--AGSMPLL 241 (520)
T ss_pred chhhhhh--HHHHHHHHhhceeccccccccccceeecccccccccceeeeecccceech----hhhhhhhh--CCCchhe
Confidence 4577733 3788899999998888765322 1111 1122 1 23444 88888887 8999998
Q ss_pred cCccccCCCCCcccccCCcchHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHH
Q 020431 107 TGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEM 176 (326)
Q Consensus 107 ~Gfi~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l 176 (326)
... +.+..|+++|+. +|..|..+|..|+|++++..+|+ |-.-. .+.+.+..++..|...+
T Consensus 242 ~sl-a~TaSGqvlnvN---a~~~a~elA~~L~~~kli~l~d~-g~~l~-----e~ge~~S~l~l~~e~~~ 301 (520)
T KOG2436|consen 242 RSL-AATASGQVLNVN---ADEVAGELALALGPDKLILLMDK-GRILK-----ENGEDISSLILQEEDAG 301 (520)
T ss_pred hhh-cccCccceEEee---HHHHhhHHHhccCcceeEEeccc-ccccc-----cCcccccccccchhHhh
Confidence 885 889999999885 89999999999999999999998 55433 23445555555444433
No 133
>KOG0456 consensus Aspartate kinase [Amino acid transport and metabolism]
Probab=95.96 E-value=0.0079 Score=58.00 Aligned_cols=93 Identities=16% Similarity=0.255 Sum_probs=73.8
Q ss_pred ccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHH--HHH-HHHHHHH
Q 020431 228 IDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVK--AVA-EALESKF 304 (326)
Q Consensus 228 ~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~--~av-~~Lh~~f 304 (326)
.+..+..|+.++|+.++.|....|....||++++|.+|.+.|+.|+.|+ +||.+||+.++..+.. .++ +.||+.+
T Consensus 380 ~k~~~TsI~lK~nv~mldI~Str~l~q~GFLAkvFti~ek~~isVDvva--TSEV~iSltL~~~~~~sreliq~~l~~a~ 457 (559)
T KOG0456|consen 380 SKAGLTSIVLKRNVTMLDIASTRMLGQHGFLAKVFTIFEKLGISVDVVA--TSEVSISLTLDPSKLDSRELIQGELDQAV 457 (559)
T ss_pred hhccceEEEEeccEEEEEecccchhhhhhHHHHHHHHHHHhCcEEEEEE--eeeEEEEEecChhhhhhHHHHHhhHHHHH
Confidence 3467889999999999999999999999999999999999999999999 8999999999987543 333 6666644
Q ss_pred HHHhcCCCCcceEEEcCeeec
Q 020431 305 REALNAGRLSQVCLSFWLCDY 325 (326)
Q Consensus 305 ~~~~~~~~~~~v~~~~~~~~~ 325 (326)
. ++ +.+..|..-.+++|+
T Consensus 458 e-eL--~ki~~vdll~~~sIi 475 (559)
T KOG0456|consen 458 E-EL--EKIAVVDLLKGRSII 475 (559)
T ss_pred H-HH--HHhhhhhhhccchHH
Confidence 2 22 335556665666554
No 134
>cd02116 ACT ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-p
Probab=95.26 E-value=0.081 Score=34.64 Aligned_cols=48 Identities=25% Similarity=0.450 Sum_probs=37.9
Q ss_pred CcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccc-cHHHHHHHH
Q 020431 253 GVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEK-EVKAVAEAL 300 (326)
Q Consensus 253 ~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~-d~~~av~~L 300 (326)
+.+|.++++++.|+++++++..+.+... ...+++.++.. +...+++.|
T Consensus 7 ~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 59 (60)
T cd02116 7 DRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGDGDLEKLLEAL 59 (60)
T ss_pred CCCchHHHHHHHHHHCCCcEEEEEeEEcCCCCeEEEEEEEechHHHHHHHHHh
Confidence 4689999999999999999999987543 36677888877 566666554
No 135
>PF13740 ACT_6: ACT domain; PDB: 1ZPV_A 3P96_A 1U8S_A.
Probab=95.05 E-value=0.11 Score=38.54 Aligned_cols=59 Identities=25% Similarity=0.314 Sum_probs=39.4
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEE--EEEEccccHHHHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSV--CFAVPEKEVKAVAEALESKFR 305 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sI--s~~V~~~d~~~av~~Lh~~f~ 305 (326)
.+|++.|. ++||+.+++++.|+++|.||.-+.|..-+... .+.++-. +.....|.+.+.
T Consensus 3 ~vItv~G~---DrpGiv~~v~~~l~~~g~ni~d~~~~~~~~~f~~~~~v~~~--~~~~~~l~~~L~ 63 (76)
T PF13740_consen 3 LVITVVGP---DRPGIVAAVTGVLAEHGCNIEDSRQAVLGGRFTLIMLVSIP--EDSLERLESALE 63 (76)
T ss_dssp EEEEEEEE-----TTHHHHHHHHHHCTT-EEEEEEEEEETTEEEEEEEEEES--HHHHHHHHHHHH
T ss_pred EEEEEEec---CCCcHHHHHHHHHHHCCCcEEEEEEEEEcCeEEEEEEEEeC--cccHHHHHHHHH
Confidence 57899985 68999999999999999999999987754444 4444333 223444444443
No 136
>cd04908 ACT_Bt0572_1 N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains. Included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains as seen in the uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related ACT domains. These tandem ACT domain proteins belong to the superfamily of ACT regulatory domains.
Probab=94.98 E-value=0.15 Score=36.68 Aligned_cols=52 Identities=19% Similarity=0.270 Sum_probs=38.8
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~ 302 (326)
+.+.||.++++.+.|+++|+||..+.-...+....+-+.-++.+++.+.|.+
T Consensus 8 v~d~pG~La~v~~~l~~~~inI~~i~~~~~~~~~~~rl~~~~~~~~~~~L~~ 59 (66)
T cd04908 8 LENKPGRLAAVTEILSEAGINIRALSIADTSEFGILRLIVSDPDKAKEALKE 59 (66)
T ss_pred EcCCCChHHHHHHHHHHCCCCEEEEEEEecCCCCEEEEEECCHHHHHHHHHH
Confidence 6789999999999999999999766533333345555555666788888765
No 137
>PRK04435 hypothetical protein; Provisional
Probab=94.82 E-value=0.21 Score=42.32 Aligned_cols=62 Identities=15% Similarity=0.321 Sum_probs=45.5
Q ss_pred cCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCc---cEEEEEEccccHHHHHHHHHHH
Q 020431 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE---HSVCFAVPEKEVKAVAEALESK 303 (326)
Q Consensus 239 ~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se---~sIs~~V~~~d~~~av~~Lh~~ 303 (326)
...+.+++. +.+.||+++++++.++++|+||..|+|.... .+++|.++..+....++.|-+.
T Consensus 67 ~r~vtL~i~---l~Dr~GlLs~Il~~IA~~~aNIltI~q~i~~~g~a~vs~tVevs~~~~~L~~Li~~ 131 (147)
T PRK04435 67 GKIITLSLL---LEDRSGTLSKVLNVIAEAGGNILTINQSIPLQGRANVTISIDTSSMEGDIDELLEK 131 (147)
T ss_pred CcEEEEEEE---EecCCCHHHHHHHHHHHcCCCeEEEEEEcCCCCEEEEEEEEEeCChHHHHHHHHHH
Confidence 445666666 4567999999999999999999999986532 5678888777665444444443
No 138
>PRK13562 acetolactate synthase 1 regulatory subunit; Provisional
Probab=94.53 E-value=0.16 Score=38.84 Aligned_cols=52 Identities=19% Similarity=0.208 Sum_probs=40.4
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCCcc----EEEEEEc-cc--cHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASSEH----SVCFAVP-EK--EVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~----sIs~~V~-~~--d~~~av~~Lh~ 302 (326)
..+.||+++|+...|++.|.||+.++-+.++. .++++++ .+ .++++.+.|++
T Consensus 9 VeN~~GVL~Rit~lFsRRg~NI~SLtvg~Te~~~iSRmtivv~~~d~~~ieqI~kQL~K 67 (84)
T PRK13562 9 VADQVSTLNRITSAFVRLQYNIDTLHVTHSEQPGISNMEIQVDIQDDTSLHILIKKLKQ 67 (84)
T ss_pred EECCCCHHHHHHHHHhccCcCeeeEEecccCCCCceEEEEEEeCCCHHHHHHHHHHHhC
Confidence 45789999999999999999999999776643 6778885 33 34566666665
No 139
>CHL00100 ilvH acetohydroxyacid synthase small subunit
Probab=94.41 E-value=0.26 Score=42.95 Aligned_cols=57 Identities=16% Similarity=0.228 Sum_probs=44.2
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC----CccEEEEEEccc--cHHHHHHHHHH
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS----SEHSVCFAVPEK--EVKAVAEALES 302 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~----se~sIs~~V~~~--d~~~av~~Lh~ 302 (326)
.+++.+ .++||+++|+...|+++|+||+.++-+. ....++++++.. .++++.+.|++
T Consensus 4 ~isvlv---~n~PGVL~RIt~lFsrRg~NIesLsv~~t~~~~~sr~TIvv~~~~~~ieqL~kQL~K 66 (174)
T CHL00100 4 TLSVLV---EDESGVLTRIAGLFARRGFNIESLAVGPAEQKGISRITMVVPGDDRTIEQLTKQLYK 66 (174)
T ss_pred EEEEEE---eCcCCHHHHHHHHHHhCCCCeeEEEeeEcCCCCccEEEEEEECCHHHHHHHHHHHHH
Confidence 356664 4689999999999999999999998554 245688888875 36677777766
No 140
>cd04870 ACT_PSP_1 CT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_1 CD includes the first of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=93.68 E-value=0.28 Score=36.24 Aligned_cols=57 Identities=23% Similarity=0.345 Sum_probs=39.1
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC--ccEEEEEEc--cc-cHHHHHHHHHH
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVP--EK-EVKAVAEALES 302 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s--e~sIs~~V~--~~-d~~~av~~Lh~ 302 (326)
+|++.|. ++||+.+++.+.|+++|+||.-++|..- ...+.+.+. +. +...+.+.|..
T Consensus 1 ~vtv~G~---DrpGiv~~vt~~la~~~~nI~dl~~~~~~~~f~~~~~v~~p~~~~~~~l~~~l~~ 62 (75)
T cd04870 1 LITVTGP---DRPGLTSALTEVLAAHGVRILDVGQAVIHGRLSLGILVQIPDSADSEALLKDLLF 62 (75)
T ss_pred CEEEEcC---CCCCHHHHHHHHHHHCCCCEEecccEEEcCeeEEEEEEEcCCCCCHHHHHHHHHH
Confidence 3678874 6899999999999999999999876553 334444444 33 34444444443
No 141
>cd04882 ACT_Bt0572_2 C-terminal ACT domain of a novel protein composed of just two ACT domains. Included in this CD is the C-terminal ACT domain of a novel protein composed of just two ACT domains, as seen in the yet uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related proteins. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=93.20 E-value=0.4 Score=33.64 Aligned_cols=52 Identities=13% Similarity=0.277 Sum_probs=36.0
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCCc--cEEEEEEccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE--HSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~se--~sIs~~V~~~d~~~av~~Lh~ 302 (326)
+.+.||.++++.+.|+++|+||..+.+.... ....+.+.-++.+++.+.|.+
T Consensus 6 ~~d~pG~L~~i~~~l~~~~~nI~~i~~~~~~~~~~~~v~~~ve~~~~~~~~L~~ 59 (65)
T cd04882 6 VPDKPGGLHEILQILSEEGINIEYMYAFVEKKGGKALLIFRTEDIEKAIEVLQE 59 (65)
T ss_pred eCCCCcHHHHHHHHHHHCCCChhheEEEccCCCCeEEEEEEeCCHHHHHHHHHH
Confidence 5688999999999999999999877643322 223333343446677776665
No 142
>PRK08178 acetolactate synthase 1 regulatory subunit; Reviewed
Probab=92.84 E-value=0.49 Score=37.10 Aligned_cols=58 Identities=14% Similarity=0.240 Sum_probs=41.1
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccc-cHHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEK-EVKAVAEALES 302 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~-d~~~av~~Lh~ 302 (326)
..|++. ..+.||+++|+...|++.|.||+.++-+.+ -..+++++.++ .++++.+.|++
T Consensus 9 ~tisvl---v~N~pGVL~RIaglFsRRgyNIeSLtvg~te~~~iSRmtivv~~~~~i~Qi~kQL~K 71 (96)
T PRK08178 9 VILELT---VRNHPGVMSHVCGLFARRAFNVEGILCLPIQDGDKSRIWLLVNDDQRLEQMISQIEK 71 (96)
T ss_pred EEEEEE---EECCcCHHHHHHHHHhcCCcCeeeEEEeecCCCCceEEEEEEcCchHHHHHHHHHhC
Confidence 345554 457899999999999999999999975554 24566677632 45555555555
No 143
>PRK11152 ilvM acetolactate synthase 2 regulatory subunit; Provisional
Probab=92.77 E-value=0.5 Score=35.46 Aligned_cols=52 Identities=12% Similarity=0.215 Sum_probs=39.8
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccc-cHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEK-EVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~-d~~~av~~Lh~ 302 (326)
..+.||+++|+...++..|.||+.++=+.. -..+.+++.++ .++.+.+.|++
T Consensus 10 v~n~pGVL~Ri~~lf~rRGfnI~sl~v~~t~~~~~sriti~v~~~~~i~ql~kQL~K 66 (76)
T PRK11152 10 ARFRPEVLERVLRVVRHRGFQVCSMNMTQNTDAQNINIELTVASERPIDLLSSQLNK 66 (76)
T ss_pred EECCccHHHHHHHHHhcCCeeeeeEEeeecCCCCEEEEEEEECCCchHHHHHHHHhc
Confidence 457899999999999999999999986552 34777888643 45566666655
No 144
>COG4747 ACT domain-containing protein [General function prediction only]
Probab=92.22 E-value=1.8 Score=35.27 Aligned_cols=109 Identities=21% Similarity=0.257 Sum_probs=69.0
Q ss_pred hhhHHHHHhCCCCEEEEeccCCCCCce--EEeCCCCCCCcchhhccCCeeeEEeecCeEEEEEecCCCCCcccHHHHHHH
Q 020431 186 PRTIIPVMRYDIPIVIRNIFNLSVPGI--MICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFG 263 (326)
Q Consensus 186 ~~a~~~a~~~~I~v~I~n~~~~~~~GT--~I~~~~~~~~~~~~~~~~~v~~I~~~~~ia~IsivG~~~~~~~~i~a~if~ 263 (326)
..++..++++||.++-.+..+...-|. .|.++++ ...+-.. =++++++ .-.+.+-.|.+.||-+++|..
T Consensus 18 ~~~~~~L~eagINiRA~tiAdt~dFGIiRmvV~~~d---~A~~~Le--e~gF~Vr----~~dVlaVEmeD~PG~l~~I~~ 88 (142)
T COG4747 18 ASVANKLKEAGINIRAFTIADTGDFGIIRMVVDRPD---EAHSVLE--EAGFTVR----ETDVLAVEMEDVPGGLSRIAE 88 (142)
T ss_pred HHHHHHHHHcCCceEEEEeccccCcceEEEEcCChH---HHHHHHH--HCCcEEE----eeeEEEEEecCCCCcHHHHHH
Confidence 356777888999988777665433442 2223221 0000000 0122222 112344458899999999999
Q ss_pred HHHhCCCcEEEEEecCC-ccEEEEEEccccHHHHHHHHHHH
Q 020431 264 AVKDVGANVIMISQASS-EHSVCFAVPEKEVKAVAEALESK 303 (326)
Q Consensus 264 ~L~~~~I~v~~Isq~~s-e~sIs~~V~~~d~~~av~~Lh~~ 303 (326)
.|.+++||++.|--..+ ...-.++++-+|.+++..+|.+.
T Consensus 89 vl~d~diNldYiYAFv~ek~KAlli~r~ed~d~~~~aLed~ 129 (142)
T COG4747 89 VLGDADINLDYIYAFVTEKQKALLIVRVEDIDRAIKALEDA 129 (142)
T ss_pred HHhhcCcCceeeeeeeecCceEEEEEEhhHHHHHHHHHHHc
Confidence 99999999998864444 34455667778999999999873
No 145
>PRK00194 hypothetical protein; Validated
Probab=92.09 E-value=0.39 Score=36.65 Aligned_cols=37 Identities=22% Similarity=0.315 Sum_probs=31.7
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS 280 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s 280 (326)
..++++.|. +.||+++++.+.|+++|+||.-++|...
T Consensus 3 ~~~ltv~g~---DrpGiva~vt~~la~~g~nI~~~~~~~~ 39 (90)
T PRK00194 3 KAIITVIGK---DKVGIIAGVSTVLAELNVNILDISQTIM 39 (90)
T ss_pred eEEEEEEcC---CCCCHHHHHHHHHHHcCCCEEehhhHhh
Confidence 357888875 5899999999999999999999987653
No 146
>PRK11895 ilvH acetolactate synthase 3 regulatory subunit; Reviewed
Probab=91.84 E-value=0.4 Score=41.25 Aligned_cols=53 Identities=13% Similarity=0.292 Sum_probs=41.4
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCCc----cEEEEEEcc--ccHHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVPE--KEVKAVAEALESK 303 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~se----~sIs~~V~~--~d~~~av~~Lh~~ 303 (326)
..+.||+++++...|+++|+||..++-+.++ ..+.+.++. ..++++.+.|++.
T Consensus 9 veN~pGvL~rI~~lf~rrg~NI~Sl~v~~te~~~~sriti~V~~~~~~i~qi~kQl~KL 67 (161)
T PRK11895 9 VENEPGVLSRVAGLFSRRGYNIESLTVGPTEDPGLSRMTIVTSGDEQVIEQITKQLNKL 67 (161)
T ss_pred EcCCCcHHHHHHHHHHhCCCcEEEEEeeecCCCCEEEEEEEEECCHHHHHHHHHHHhcc
Confidence 5688999999999999999999888765543 236677763 3578888888874
No 147
>PRK06737 acetolactate synthase 1 regulatory subunit; Validated
Probab=91.71 E-value=0.51 Score=35.42 Aligned_cols=52 Identities=12% Similarity=0.140 Sum_probs=38.2
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCCc----cEEEEEEcc--ccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVPE--KEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~se----~sIs~~V~~--~d~~~av~~Lh~ 302 (326)
..+.||+++|+...|++.|.||+.++-+.++ ..+.+++.. ..++++.+.|++
T Consensus 9 v~n~pGVL~Ri~~lf~rRgfNI~Sl~vg~te~~~~sriti~~~~~~~~i~qi~kQL~K 66 (76)
T PRK06737 9 IHNDPSVLLRISGIFARRGYYISSLNLNERDTSGVSEMKLTAVCTENEATLLVSQLKK 66 (76)
T ss_pred EecCCCHHHHHHHHHhccCcceEEEEecccCCCCeeEEEEEEECCHHHHHHHHHHHhC
Confidence 3578999999999999999999999966543 245566443 346666666655
No 148
>cd04883 ACT_AcuB C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. This CD includes the C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. AcuB is putatively involved in the anaerobic catabolism of acetoin, and related proteins. Studies report the induction of AcuB by nitrate respiration and also by fermentation. Since acetoin can be secreted and later serve as a source of carbon, it has been proposed that, during anaerobic growth when other carbon sources are exhausted, the induction of the AcuB protein results in acetoin catabolism. AcuB-like proteins have two N-terminal tandem CBS domains and a single C-terminal ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=91.59 E-value=1.6 Score=31.28 Aligned_cols=52 Identities=23% Similarity=0.364 Sum_probs=38.4
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~d~~~av~~Lh~ 302 (326)
+.+.||.++++.+.|+++|+|+..+..... ...+.|-++..+.+.+.+.|.+
T Consensus 8 ~~d~pG~l~~i~~~l~~~~inI~~i~~~~~~~~~~~~v~i~v~~~~~~~~~~~L~~ 63 (72)
T cd04883 8 VPDRPGQLADIAAIFKDRGVNIVSVLVYPSKEEDNKILVFRVQTMNPRPIIEDLRR 63 (72)
T ss_pred ECCCCCHHHHHHHHHHHcCCCEEEEEEeccCCCCeEEEEEEEecCCHHHHHHHHHH
Confidence 678899999999999999999987753322 2335666666666677777765
No 149
>cd04889 ACT_PDH-BS-like C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate. Included in this CD is the C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Also included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem A
Probab=91.14 E-value=0.92 Score=31.13 Aligned_cols=50 Identities=18% Similarity=0.228 Sum_probs=32.6
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCCc-cEEEEEEccccHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE-HSVCFAVPEKEVKAVAEAL 300 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~se-~sIs~~V~~~d~~~av~~L 300 (326)
+.+.||.++++.+.|+++|+|+..+.-...+ ..-.+.+.=++.+++.+.|
T Consensus 5 ~~d~~G~l~~i~~~l~~~~inI~~~~~~~~~~~~~~~~~~v~~~~~a~~~l 55 (56)
T cd04889 5 VENKPGRLAEVTEILAEAGINIKAISIAETRGEFGILRLIFSDPERAKEVL 55 (56)
T ss_pred eCCCCChHHHHHHHHHHcCCCEeeEEEEEccCCcEEEEEEECCHHHHHHHh
Confidence 5678999999999999999999766532322 1122222333466666554
No 150
>cd04893 ACT_GcvR_1 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR int
Probab=91.06 E-value=1.1 Score=33.27 Aligned_cols=34 Identities=29% Similarity=0.443 Sum_probs=30.1
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS 279 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~ 279 (326)
+|++.|+ ++||+.+++.+.|+++|.||.-++|..
T Consensus 3 iltv~g~---Dr~GiVa~vs~~la~~g~nI~d~~q~~ 36 (77)
T cd04893 3 VISALGT---DRPGILNELTRAVSESGCNILDSRMAI 36 (77)
T ss_pred EEEEEeC---CCChHHHHHHHHHHHcCCCEEEceeeE
Confidence 5788874 689999999999999999999998865
No 151
>cd04909 ACT_PDH-BS C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH). The C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback-inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=91.03 E-value=0.95 Score=32.38 Aligned_cols=52 Identities=13% Similarity=0.196 Sum_probs=37.2
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEcc-ccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPE-KEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~-~d~~~av~~Lh~ 302 (326)
+.+.||.++++.+.|+++|+++..+.+... ...+.+.++. .+.+++.+.|.+
T Consensus 8 ~~d~~G~L~~l~~~l~~~~i~i~~~~~~~~~~~~~~~~~i~v~~~~~~~~~~~~L~~ 64 (69)
T cd04909 8 VPDEPGVIAEVTQILGDAGISIKNIEILEIREGIGGILRISFKTQEDRERAKEILKE 64 (69)
T ss_pred cCCCCCHHHHHHHHHHHcCCCceeeEeEEeecCCcEEEEEEECCHHHHHHHHHHHHH
Confidence 668999999999999999999987654332 3345566652 356666666654
No 152
>cd04872 ACT_1ZPV ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein. This CD, ACT_1ZPV, includes those single ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein (pdb structure 1ZPV). Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=90.84 E-value=1.3 Score=33.58 Aligned_cols=36 Identities=22% Similarity=0.342 Sum_probs=31.3
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS 280 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s 280 (326)
.+|++.|+ +.||+++++.+.|+++|+||.-++|.+.
T Consensus 2 ~vl~i~g~---D~pGiva~vt~~la~~g~nI~~~~~~~~ 37 (88)
T cd04872 2 AVITVVGK---DRVGIVAGVSTKLAELNVNILDISQTIM 37 (88)
T ss_pred EEEEEEcC---CCCCHHHHHHHHHHHcCCCEEechhHhh
Confidence 46788875 5899999999999999999999998763
No 153
>cd04869 ACT_GcvR_2 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the second of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR in
Probab=90.63 E-value=1.7 Score=32.04 Aligned_cols=34 Identities=21% Similarity=0.288 Sum_probs=28.7
Q ss_pred EEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC
Q 020431 244 VNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS 280 (326)
Q Consensus 244 IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s 280 (326)
|++.|. +.||+++++.+.|+++|+||.-+++.+.
T Consensus 2 l~v~g~---D~~Giv~~it~~l~~~~~nI~~~~~~~~ 35 (81)
T cd04869 2 VEVVGN---DRPGIVHEVTQFLAQRNINIEDLSTETY 35 (81)
T ss_pred EEEEeC---CCCCHHHHHHHHHHHcCCCeEEeEeeee
Confidence 567764 5899999999999999999999987543
No 154
>TIGR00119 acolac_sm acetolactate synthase, small subunit. acetohydroxyacid synthase is a synonym.
Probab=90.24 E-value=0.79 Score=39.29 Aligned_cols=52 Identities=15% Similarity=0.303 Sum_probs=36.6
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCCc----cEEEEEEccc--cHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVPEK--EVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~se----~sIs~~V~~~--d~~~av~~Lh~ 302 (326)
..+.||+++++...|+++|+||..++-+.++ ..+++.++.. .++++.+.|++
T Consensus 8 ven~pGvL~rI~~lf~rrg~NI~Sl~v~~t~~~~~sriti~V~~d~~~i~qi~kQl~K 65 (157)
T TIGR00119 8 VENEPGVLSRVAGLFTRRGFNIESLTVGPTEDPDLSRMTIVVVGDDKVLEQITKQLNK 65 (157)
T ss_pred EcCCCcHHHHHHHHHHhCCceEEEEEEeecCCCCEEEEEEEEECCHHHHHHHHHHHhc
Confidence 5678999999999999999999888755543 2366667652 34444444444
No 155
>cd04875 ACT_F4HF-DF N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase). This CD includes the N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase) which catalyzes the hydrolysis of 10-formyltetrahydrofolate (formyl-FH4) to FH4 and formate. Formyl-FH4 hydrolase generates the formate that is used by purT-encoded 5'-phosphoribosylglycinamide transformylase for step three of de novo purine nucleotide synthesis. Formyl-FH4 hydrolase, a hexamer which is activated by methionine and inhibited by glycine, is proposed to regulate the balance FH4 and C1-FH4 in response to changing growth conditions. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=90.07 E-value=2.1 Score=31.19 Aligned_cols=33 Identities=21% Similarity=0.405 Sum_probs=28.9
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEec
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA 278 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~ 278 (326)
+|++.|. ++||+++++.+.|+++|+||.-++|.
T Consensus 1 ii~v~g~---D~~Giv~~it~~l~~~g~nI~~~~~~ 33 (74)
T cd04875 1 ILTLSCP---DRPGIVAAVSGFLAEHGGNIVESDQF 33 (74)
T ss_pred CEEEEcC---CCCCHHHHHHHHHHHcCCCEEeeeee
Confidence 3677764 68999999999999999999999876
No 156
>cd04903 ACT_LSD C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit. The C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit, found in various bacterial anaerobes such as Clostridium, Bacillis, and Treponema species. These enzymes catalyze the deamination of L-serine, producing pyruvate and ammonia. Unlike the eukaryotic L-serine dehydratase, which requires the pyridoxal-5'-phosphate (PLP) cofactor, the prokaryotic L-serine dehydratase contains an [4Fe-4S] cluster instead of a PLP active site. The LSD alpha and beta subunits of the 'clostridial' enzyme are encoded by the sdhA and sdhB genes. The single subunit bacterial homologs of L-serine dehydratase (LSD1, LSD2, TdcG) present in Escherichia coli, and other enterobacterials, lack the ACT domain described here. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=89.70 E-value=1.3 Score=31.18 Aligned_cols=52 Identities=13% Similarity=0.223 Sum_probs=38.8
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~d~~~av~~Lh~ 302 (326)
..+.||.++++.+.|+++|+++..+.+... ...+.+.++..+.+++++.|.+
T Consensus 6 ~~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~~~~~~i~i~v~~~~~~~~i~~l~~ 61 (71)
T cd04903 6 HKDKPGAIAKVTSVLADHEINIAFMRVSRKEKGDQALMVIEVDQPIDEEVIEEIKK 61 (71)
T ss_pred eCCCCChHHHHHHHHHHcCcCeeeeEEEeccCCCeEEEEEEeCCCCCHHHHHHHHc
Confidence 357899999999999999999988765431 2235666777677777777765
No 157
>cd04886 ACT_ThrD-II-like C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. This CD includes the C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. The Escherichia coli tdcB gene product, ThrD-II, anaerobically catalyzes the pyridoxal phosphate-dependent dehydration of L-threonine and L-serine to ammonia and to alpha-ketobutyrate and pyruvate, respectively. Tetrameric ThrD-II is subject to allosteric activation by AMP, inhibition by alpha-keto acids, and catabolite inactivation by several metabolites of glycolysis and the citric acid cycle. Also included in this CD are N-terminal ACT domains present in smaller (~170 a.a.) archaeal proteins of unknown function. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=89.31 E-value=1.9 Score=30.34 Aligned_cols=52 Identities=21% Similarity=0.463 Sum_probs=34.7
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC-------ccEEEEEEccc---cHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS-------EHSVCFAVPEK---EVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s-------e~sIs~~V~~~---d~~~av~~Lh~ 302 (326)
+.+.||.++++.+.++++|++|.-+.+... ...+.+.++-. +++.+++.|.+
T Consensus 5 ~~d~~G~L~~i~~~i~~~~~nI~~i~~~~~~~~~~~~~~~~~i~v~~~~~~~l~~l~~~l~~ 66 (73)
T cd04886 5 LPDRPGQLAKLLAVIAEAGANIIEVSHDRAFKTLPLGEVEVELTLETRGAEHIEEIIAALRE 66 (73)
T ss_pred eCCCCChHHHHHHHHHHcCCCEEEEEEEeccCCCCCceEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 457899999999999999999987765432 12344444433 44455555544
No 158
>cd04880 ACT_AAAH-PDT-like ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. Eukaryotic AAAHs have an N-terminal ACT (regulatory) domain, a middle catalytic domain and a C-terminal domain which is responsible for the oligomeric state of the enzyme forming a domain-swapped tetrameric coiled-coil. The PAH, TH, and TPH enzymes contain highly conserved catalytic domains but distinct N-terminal ACT domains and differ in their mech
Probab=87.50 E-value=1.9 Score=31.53 Aligned_cols=50 Identities=22% Similarity=0.305 Sum_probs=34.2
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEc------cccHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVP------EKEVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~------~~d~~~av~~Lh~ 302 (326)
.+.||.++++++.|+++|+|+..|. +.. .....|.++ +...+++++.|.+
T Consensus 7 ~d~pG~L~~vL~~f~~~~vni~~I~-Srp~~~~~~~~~f~id~~~~~~~~~~~~~l~~l~~ 66 (75)
T cd04880 7 KNKPGALAKALKVFAERGINLTKIE-SRPSRKGLWEYEFFVDFEGHIDDPDVKEALEELKR 66 (75)
T ss_pred CCcCCHHHHHHHHHHHCCCCEEEEE-eeecCCCCceEEEEEEEECCCCCHHHHHHHHHHHH
Confidence 4679999999999999999999994 332 223444433 2245566666654
No 159
>COG0440 IlvH Acetolactate synthase, small (regulatory) subunit [Amino acid transport and metabolism]
Probab=87.29 E-value=1.1 Score=38.56 Aligned_cols=54 Identities=13% Similarity=0.268 Sum_probs=43.4
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEcc--ccHHHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPE--KEVKAVAEALESKF 304 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~--~d~~~av~~Lh~~f 304 (326)
..+.||+++|+...|++.|.|+++++-+.. ...+.+++.. ..++++.+.||+..
T Consensus 11 v~ne~GvLsRv~glfsrRG~NIeSltv~~tE~~~~SRiTivv~g~~~~~EQi~kQL~kLi 70 (163)
T COG0440 11 VENEPGVLSRVTGLFSRRGYNIESLTVGPTETPGLSRITIVVSGDEQVLEQIIKQLNKLI 70 (163)
T ss_pred EECCCCeeehhhHHHHhcCcccceEEEEecCCCCceEEEEEEcCCcchHHHHHHHHHhhc
Confidence 347899999999999999999999986654 4567777776 34899999998843
No 160
>cd04874 ACT_Af1403 N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, and related domains. This CD includes the N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, from Archaeoglobus fulgidus and other related archeal ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=85.52 E-value=4.1 Score=28.59 Aligned_cols=51 Identities=16% Similarity=0.348 Sum_probs=34.9
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEccc-cHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEK-EVKAVAEALE 301 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~~-d~~~av~~Lh 301 (326)
+.+.+|.++++.+.|+++++++.-+.+... ...+.+.++.. ....+++.|.
T Consensus 7 ~~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~L~ 61 (72)
T cd04874 7 AEDKPGVLRDLTGVIAEHGGNITYTQQFIEREGKARIYMELEGVGDIEELVEELR 61 (72)
T ss_pred eCCCCChHHHHHHHHHhCCCCEEEEEEeccCCCeEEEEEEEeccccHHHHHHHHh
Confidence 457899999999999999999987765432 22355556554 3444444444
No 161
>cd04878 ACT_AHAS N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). ACT_AHAS: N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). AHAS catalyses the first common step in the biosynthesis of the three branched-chain amino acids. The first step involves the condensation of either pyruvate or 2-ketobutyrate with the two-carbon hydroxyethyl fragment derived from another pyruvate molecule, covalently bound to the coenzyme thiamine diphosphate. Bacterial AHASs generally consist of regulatory and catalytic subunits. The effector (valine) binding sites are proposed to be located in two symmetrically related positions in the interface between a pair of N-terminal ACT domains with the C-terminal domain of IlvH contacting the catalytic dimer. Plants Arabidopsis and Oryza have tandem IlvH subunits; both the first and second ACT domain sequences are present in this CD. Members of
Probab=84.49 E-value=3.8 Score=28.67 Aligned_cols=51 Identities=18% Similarity=0.309 Sum_probs=35.4
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccc--cHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEK--EVKAVAEALE 301 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~--d~~~av~~Lh 301 (326)
..+.+|.++++...|+++++++..+.+... ...+.+.+... ++..++..|.
T Consensus 7 ~~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 63 (72)
T cd04878 7 VENEPGVLNRISGLFARRGFNIESLTVGPTEDPGISRITIVVEGDDDVIEQIVKQLN 63 (72)
T ss_pred EcCCCcHHHHHHHHHHhCCCCEEEEEeeecCCCCeEEEEEEEECCHHHHHHHHHHHh
Confidence 357889999999999999999998886542 23466666653 3444444443
No 162
>cd04879 ACT_3PGDH-like ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). ACT_3PGDH-like: The ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with or without an extended C-terminal (xct) region found in various bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback controlled by the end product L-serine in an allosteric manner. In the Escherichia coli homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active
Probab=84.46 E-value=3.7 Score=28.54 Aligned_cols=52 Identities=17% Similarity=0.227 Sum_probs=35.6
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~d~~~av~~Lh~ 302 (326)
..+.+|.++++.+.|+++|+++..+..... ...+.+.++.....++++.|.+
T Consensus 6 ~~d~~g~l~~i~~~l~~~~~nI~~~~~~~~~~~~~~~~~~~v~~~~~~~l~~~l~~ 61 (71)
T cd04879 6 HKDVPGVIGKVGTILGEHGINIAAMQVGRKEKGGIAYMVLDVDSPVPEEVLEELKA 61 (71)
T ss_pred ecCCCCHHHHHHHHHHhcCCCeeeEEEeccCCCCEEEEEEEcCCCCCHHHHHHHHc
Confidence 457899999999999999999987754332 2224555655454555555544
No 163
>PF13291 ACT_4: ACT domain; PDB: 2KO1_B 3IBW_A.
Probab=84.28 E-value=5.5 Score=29.34 Aligned_cols=57 Identities=16% Similarity=0.338 Sum_probs=37.1
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccccHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALE 301 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~d~~~av~~Lh 301 (326)
+.|.+.+ .+++|++++|.+.+++.|+||..++.... ...+.|.+.-.+.+.+-+.+.
T Consensus 7 ~~l~i~~---~dr~GlL~dI~~~i~~~~~nI~~i~~~~~~~~~~~~~~l~v~V~d~~~L~~ii~ 67 (80)
T PF13291_consen 7 VRLRIEA---EDRPGLLADITSVISENGVNIRSINARTNKDDGTARITLTVEVKDLEHLNQIIR 67 (80)
T ss_dssp EEEEEEE---E--TTHHHHHHHHHHCSSSEEEEEEEEE--ETTEEEEEEEEEESSHHHHHHHHH
T ss_pred EEEEEEE---EcCCCHHHHHHHHHHHCCCCeEEEEeEEeccCCEEEEEEEEEECCHHHHHHHHH
Confidence 4455654 46899999999999999999999986653 124555555555544444443
No 164
>cd04877 ACT_TyrR N-terminal ACT domain of the TyrR protein. ACT_TyrR: N-terminal ACT domain of the TyrR protein. The TyrR protein of Escherichia coli controls the expression of a group of transcription units (TyrR regulon) whose gene products are involved in the biosynthesis or transport of the aromatic amino acids. Binding to specific DNA sequences known as TyrR boxes, the TyrR protein can either activate or repress transcription at different sigma70 promoters. Its regulatory activity occurs in response to intracellular levels of tyrosine, phenylalanine and tryptophan. The TyrR protein consists of an N-terminal region important for transcription activation with an ATP-independent aromatic amino acid binding site (contained within the ACT domain) and is involved in dimerization; a central region with an ATP binding site, an ATP-dependent aromatic amino acid binding site and is involved in hexamerization; and a helix turn helix DNA binding C-terminal region. In solution, in the absence
Probab=83.67 E-value=6 Score=28.83 Aligned_cols=45 Identities=9% Similarity=0.168 Sum_probs=33.4
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVA 297 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av 297 (326)
.+++|+++++.+.+++.|+|+..+.+.+. ..+.+.+.-.+...+-
T Consensus 8 ~dr~Gll~dI~~~i~~~~~nI~~~~~~~~-~~i~l~i~v~~~~~L~ 52 (74)
T cd04877 8 EDRLGITQEVLDLLVEHNIDLRGIEIDPK-GRIYLNFPTIEFEKLQ 52 (74)
T ss_pred EccchHHHHHHHHHHHCCCceEEEEEecC-CeEEEEeEecCHHHHH
Confidence 36799999999999999999999987553 3356555555555443
No 165
>PRK11589 gcvR glycine cleavage system transcriptional repressor; Provisional
Probab=83.35 E-value=4.3 Score=35.86 Aligned_cols=60 Identities=20% Similarity=0.245 Sum_probs=44.4
Q ss_pred CeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC--ccEEEEEEccccHHHHHHHHHHHH
Q 020431 240 NLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPEKEVKAVAEALESKF 304 (326)
Q Consensus 240 ~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s--e~sIs~~V~~~d~~~av~~Lh~~f 304 (326)
...+||++|. ++||+.+++.+.|+++|.||.=++|..- +....+++.... ..+..|...+
T Consensus 7 ~~lviTviG~---DrpGIVa~vs~~l~~~g~NI~ds~~t~lgg~Fa~i~lvs~~~--~~~~~le~~L 68 (190)
T PRK11589 7 HYLVITALGA---DRPGIVNTITRHVSSCGCNIEDSRLAMLGEEFTFIMLLSGSW--NAITLIESTL 68 (190)
T ss_pred cEEEEEEEcC---CCChHHHHHHHHHHHcCCCeeehhhHhhCCceEEEEEEeCCh--hHHHHHHHHH
Confidence 5678999995 6899999999999999999998887543 566666775442 2444444444
No 166
>TIGR00655 PurU formyltetrahydrofolate deformylase. This model describes formyltetrahydrofolate deformylases. The enzyme is a homohexamer. Sequences from a related enzyme formyl tetrahydrofolate-specific enzyme, phosphoribosylglycinamide formyltransferase, serve as an outgroup for phylogenetic analysis. Putative members of this family, scoring below the trusted cutoff, include a sequence from Rhodobacter capsulatus that lacks an otherwise conserved C-terminal region.
Probab=83.15 E-value=3.3 Score=38.86 Aligned_cols=34 Identities=26% Similarity=0.270 Sum_probs=30.7
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS 279 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~ 279 (326)
+|++.|. ++||+.+++.+.|+++|+||.-++|..
T Consensus 2 ~itv~g~---D~~GIVA~Vt~~La~~g~NI~d~sq~~ 35 (280)
T TIGR00655 2 ILLVSCP---DQKGLVAAISTFIAKHGANIISNDQHT 35 (280)
T ss_pred EEEEECC---CCCChHHHHHHHHHHCCCCEEeeeEEE
Confidence 5788874 689999999999999999999999876
No 167
>cd04881 ACT_HSDH-Hom ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) and related domains. The ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) encoded by the hom gene of Bacillus subtilis and other related sequences. HSDH reduces aspartate semi-aldehyde to the amino acid homoserine, one that is required for the biosynthesis of Met, Thr, and Ile from Asp. Neither the enzyme nor the aspartate pathway is found in the animal kingdom. This mostly bacterial HSDH group has a C-terminal ACT domain and is believed to be involved in enzyme regulation. A C-terminal deletion in the Corynebacterium glutamicum HSDH abolished allosteric inhibition by L-threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=82.99 E-value=7.6 Score=27.59 Aligned_cols=52 Identities=19% Similarity=0.323 Sum_probs=36.3
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccc---cHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEK---EVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~---d~~~av~~Lh~ 302 (326)
+.+.+|.++++...|+++|+++.-+.+... ...+.+.+... +++.+++.|++
T Consensus 7 ~~d~~g~l~~i~~~l~~~~i~I~~~~~~~~~~~~~~~~~i~~~~~~~~~l~~~i~~L~~ 65 (79)
T cd04881 7 VKDKPGVLAKITGILAEHGISIESVIQKEADGGETAPVVIVTHETSEAALNAALAEIEA 65 (79)
T ss_pred eCCCCcHHHHHHHHHHHcCCCeEEEEEcccCCCCceeEEEEEccCCHHHHHHHHHHHHc
Confidence 457889999999999999999998875432 23455655544 45555555554
No 168
>cd04901 ACT_3PGDH C-terminal ACT (regulatory) domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in fungi and bacteria. The C-terminal ACT (regulatory) domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in fungi and bacteria. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In Escherichia coli, the SerA 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. In the homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active site is postulated to involve the tethering of the regulatory domains together to create a rigid quaternary structure with a solvent-
Probab=81.87 E-value=1.3 Score=31.49 Aligned_cols=52 Identities=17% Similarity=0.193 Sum_probs=37.9
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecC--CccEEEEEEccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQAS--SEHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~--se~sIs~~V~~~d~~~av~~Lh~ 302 (326)
..+.||.++++.+.++++|+|+..+...+ ....+.+.++..+.+.+++.|.+
T Consensus 6 ~~d~~g~l~~i~~~l~~~~~nI~~~~~~~~~~~a~~~~~~~~~~l~~li~~l~~ 59 (69)
T cd04901 6 HKNVPGVLGQINTILAEHNINIAAQYLQTRGEIGYVVIDIDSEVSEELLEALRA 59 (69)
T ss_pred ecCCCcHHHHHHHHHHHcCCCHHHHhccCCCCEEEEEEEcCCCCCHHHHHHHHc
Confidence 45789999999999999999987665433 23334555666677777777765
No 169
>PF13710 ACT_5: ACT domain; PDB: 2FGC_A 2PC6_A 2F1F_B.
Probab=81.49 E-value=3 Score=29.82 Aligned_cols=50 Identities=24% Similarity=0.398 Sum_probs=36.3
Q ss_pred CcccHHHHHHHHHHhCCCcEEEEEecCC----ccEEEEEEccc--cHHHHHHHHHH
Q 020431 253 GVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEK--EVKAVAEALES 302 (326)
Q Consensus 253 ~~~~i~a~if~~L~~~~I~v~~Isq~~s----e~sIs~~V~~~--d~~~av~~Lh~ 302 (326)
+.||++.|+...+.+.|.|+..++=+.+ -..+.+++..+ .++.+.+.|++
T Consensus 1 n~~GvL~Ri~~vf~rRg~nI~sl~v~~~~~~~~~riti~v~~~~~~i~~l~~Ql~K 56 (63)
T PF13710_consen 1 NQPGVLNRITGVFRRRGFNIESLSVGPTEDPGISRITIVVSGDDREIEQLVKQLEK 56 (63)
T ss_dssp SSTTHHHHHHHHHHTTT-EECEEEEEE-SSTTEEEEEEEEES-CCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCeEEeeEEeeecCCCCEEEEEEEEeeCchhHHHHHHHHhc
Confidence 4689999999999999999999885542 35667777663 56666666665
No 170
>PRK06027 purU formyltetrahydrofolate deformylase; Reviewed
Probab=80.40 E-value=7.2 Score=36.66 Aligned_cols=36 Identities=17% Similarity=0.240 Sum_probs=32.0
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS 279 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~ 279 (326)
..+|+++|. ++||+.+++.+.|+++|+||.-++|..
T Consensus 6 ~~vitv~G~---DrpGIVa~Vt~~La~~g~NI~d~s~~~ 41 (286)
T PRK06027 6 RYVLTLSCP---DRPGIVAAVSNFLYEHGGNIVDADQFV 41 (286)
T ss_pred eEEEEEECC---CCCcHHHHHHHHHHHCCCCEEEceeEE
Confidence 467899985 689999999999999999999998765
No 171
>PRK13010 purU formyltetrahydrofolate deformylase; Reviewed
Probab=80.24 E-value=4.9 Score=37.93 Aligned_cols=35 Identities=17% Similarity=0.359 Sum_probs=31.6
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEec
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA 278 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~ 278 (326)
-.+|++.|. ++||+.+++.+.|+++|+||.-++|-
T Consensus 9 ~~iitv~G~---Dr~GIVA~Vs~~Lae~g~NI~disq~ 43 (289)
T PRK13010 9 SYVLTLACP---SAPGIVAAVSGFLAEKGCYIVELTQF 43 (289)
T ss_pred CEEEEEECC---CCCCcHHHHHHHHHHCCCCEEecccc
Confidence 468999985 68999999999999999999999984
No 172
>cd04887 ACT_MalLac-Enz ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI and related domains. The ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI, a malolactic enzyme (MalLac-Enz) which converts malate to lactate, and other related ACT domains. The yqkJ product is predicted to convert malate directly to lactate, as opposed to related malic enzymes that convert malate to pyruvate. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=79.79 E-value=10 Score=27.20 Aligned_cols=52 Identities=12% Similarity=0.173 Sum_probs=35.8
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~~d~~~av~~Lh~ 302 (326)
..++||.++++.+.+++.|+|+.-+..... ...+.|.+.-.+.+.+-+.+++
T Consensus 6 ~~d~~g~L~~i~~~i~~~~~nI~~v~~~~~~~~~~~~~~~vev~~~~~l~~i~~~ 60 (74)
T cd04887 6 LPNRPGMLGRVTTAIGEAGGDIGAIDLVEQGRDYTVRDITVDAPSEEHAETIVAA 60 (74)
T ss_pred eCCCCchHHHHHHHHHHcCCcEEEEEEEEecCCEEEEEEEEEcCCHHHHHHHHHH
Confidence 457899999999999999999987764332 3335556665555555444443
No 173
>cd04905 ACT_CM-PDT C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme. The C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme, found in plants, fungi, bacteria, and archaea. The P-protein of E. coli (CM-PDT, PheA) catalyzes the conversion of chorismate to prephenate and then the decarboxylation and dehydration to form phenylpyruvate. These are the first two steps in the biosynthesis of L-Phe and L-Tyr via the shikimate pathway in microorganisms and plants. The E. coli P-protein (CM-PDT) has three domains with an N-terminal domain with chorismate mutase activity, a middle domain with prephenate dehydratase activity, and an ACT regulatory C-terminal domain. The prephenate dehydratase enzyme has a PDT and ACT domain. The ACT domain is essential to bring about the negative allosteric regulation by L-Phe bindi
Probab=79.00 E-value=9.8 Score=28.09 Aligned_cols=52 Identities=21% Similarity=0.330 Sum_probs=34.5
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEcc------ccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPE------KEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~------~d~~~av~~Lh~ 302 (326)
+.+.||.++++.+.|+++|||+..+.--.. ...+.|.|+- .++.++++.|.+
T Consensus 8 ~~d~~G~L~~il~~f~~~~ini~~i~s~p~~~~~~~~~f~vd~~~~~~~~~~~~~l~~l~~ 68 (80)
T cd04905 8 LPNKPGALYDVLGVFAERGINLTKIESRPSKGGLWEYVFFIDFEGHIEDPNVAEALEELKR 68 (80)
T ss_pred ECCCCCHHHHHHHHHHHCCcCEEEEEEEEcCCCCceEEEEEEEECCCCCHHHHHHHHHHHH
Confidence 456799999999999999999976642222 3345555542 245556665554
No 174
>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=78.93 E-value=18 Score=26.38 Aligned_cols=44 Identities=20% Similarity=0.367 Sum_probs=32.2
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC--CccEEEEEEc
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS--SEHSVCFAVP 289 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~--se~sIs~~V~ 289 (326)
+|++.+. ++||+++++..+|+++|+||......+ ...--+|.|.
T Consensus 2 ~~~v~~~---Dr~gLl~~i~~~l~~~~lnI~~A~i~t~~~~~~d~f~V~ 47 (74)
T cd04925 2 AIELTGT---DRPGLLSEVFAVLADLHCNVVEARAWTHNGRLACVIYVR 47 (74)
T ss_pred EEEEEEC---CCCCHHHHHHHHHHHCCCcEEEEEEEEECCEEEEEEEEE
Confidence 5778775 689999999999999999998744322 2334455554
No 175
>cd04871 ACT_PSP_2 ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_2 CD includes the second of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains
Probab=78.79 E-value=2.2 Score=32.34 Aligned_cols=34 Identities=24% Similarity=0.304 Sum_probs=28.8
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEec
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA 278 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~ 278 (326)
+|++.|..+ ..++++++-+.|+++|+||+-|+|=
T Consensus 1 ivtvlg~~~--~a~~ia~Vs~~lA~~~~NI~~I~~l 34 (84)
T cd04871 1 IVTLLGRPL--TAEQLAAVTRVVADQGLNIDRIRRL 34 (84)
T ss_pred CEEEEcCcC--CHHHHHHHHHHHHHcCCCHHHHHHh
Confidence 478888653 5799999999999999999988874
No 176
>PRK08577 hypothetical protein; Provisional
Probab=78.78 E-value=13 Score=30.65 Aligned_cols=60 Identities=15% Similarity=0.284 Sum_probs=40.0
Q ss_pred CeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCc----cEEEEEEc--c--ccHHHHHHHHHH
Q 020431 240 NLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVP--E--KEVKAVAEALES 302 (326)
Q Consensus 240 ~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se----~sIs~~V~--~--~d~~~av~~Lh~ 302 (326)
+.+.+++.. .+.||+++++.+.|+++++++..+++.... ..+.+.++ . .++..+++.|.+
T Consensus 55 ~~~~I~V~~---~Dr~GvLa~I~~~l~~~~inI~~i~~~~~~~~~~~~i~l~vev~~~~~~l~~l~~~L~~ 122 (136)
T PRK08577 55 KLVEIELVV---EDRPGVLAKITGLLAEHGVDILATECEELKRGELAECVIIVDLSKSDIDLEELEEELKK 122 (136)
T ss_pred cEEEEEEEE---cCCCCHHHHHHHHHHHCCCCEEEEEEEEecCCCEEEEEEEEEeCCchhhHHHHHHHHHc
Confidence 467788874 578999999999999999999876543321 23444444 3 245555555554
No 177
>PRK13011 formyltetrahydrofolate deformylase; Reviewed
Probab=78.73 E-value=10 Score=35.67 Aligned_cols=35 Identities=11% Similarity=0.227 Sum_probs=31.5
Q ss_pred eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEec
Q 020431 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA 278 (326)
Q Consensus 241 ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~ 278 (326)
-..|+++|. ++||+.+++.+.|+++|+||.-++|.
T Consensus 7 ~~vitv~G~---DrpGIVa~VT~~La~~~vNI~dls~~ 41 (286)
T PRK13011 7 TFVLTLSCP---SAAGIVAAVTGFLAEHGCYITELHSF 41 (286)
T ss_pred eEEEEEEeC---CCCCHHHHHHHHHHhCCCCEEEeeee
Confidence 467899985 68999999999999999999999984
No 178
>cd04884 ACT_CBS C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This CD includes the C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This protein has two N-terminal tandem CBS domains and a single C-terminal ACT domain. The CBS domain is found in a wide range of proteins, often in tandem arrangements and together with a variety of other functional domains. It has been proposed that the CBS domain may play a regulatory role, although its exact function is unknown. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=78.17 E-value=7.9 Score=27.88 Aligned_cols=29 Identities=24% Similarity=0.453 Sum_probs=25.2
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecC
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQAS 279 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~ 279 (326)
+.+.||.++++.+.|+++|+||..+.+..
T Consensus 6 ~~d~pG~L~~l~~~i~~~g~nI~~i~~~~ 34 (72)
T cd04884 6 LEDKPGTLKPVVDTLREFNARIISILTAF 34 (72)
T ss_pred ecCCCccHHHHHHHHHHCCCeEEEEEecc
Confidence 67899999999999999999998775543
No 179
>cd04902 ACT_3PGDH-xct C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). The C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with an extended C-terminal (xct) region from bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. Some 3PGDH enzymes have an additional domain formed by an extended C-terminal region. This additional domain introduces significant asymmetry to the homotetramer. Adjacent ACT (regulatory) domains interact, creating two serine-binding sites, however, this asymmetric arrangement results in the formation of two different and distinct domain interfaces between iden
Probab=77.88 E-value=5 Score=28.56 Aligned_cols=52 Identities=19% Similarity=0.252 Sum_probs=33.0
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEE-ecC---CccEEEEEEccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMIS-QAS---SEHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Is-q~~---se~sIs~~V~~~d~~~av~~Lh~ 302 (326)
..+.||.++++.+.|+++|+|+..+. ... ....+.+-++......+++.|.+
T Consensus 6 ~~d~~G~l~~i~~~l~~~~inI~~~~~~~~~~~~~~~~~i~v~~~~~~~~~~~l~~ 61 (73)
T cd04902 6 NTDRPGVIGKVGTILGEAGINIAGMQVGRDEPGGEALMVLSVDEPVPDEVLEELRA 61 (73)
T ss_pred eCCCCCHHHHHHHHHHHcCcChhheEeeccCCCCEEEEEEEeCCCCCHHHHHHHHc
Confidence 45789999999999999999996543 111 12234444555433355555544
No 180
>cd04929 ACT_TPH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxytryptamine (serotonin) and the first reaction in the synthesis of melatonin. Very little is known about the role of the ACT domain in TPH, which appears to be regulated by phosphorylation but not by its substrate or cofactor. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=77.11 E-value=11 Score=27.96 Aligned_cols=51 Identities=16% Similarity=0.226 Sum_probs=34.3
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEcc----ccHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPE----KEVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~----~d~~~av~~Lh~ 302 (326)
.+.||-++++++.|+++|||+..|-.-++ .-...|.|+= ..+.++++.|++
T Consensus 8 ~~~~g~L~~iL~~f~~~~inl~~IeSRP~~~~~~~y~F~id~e~~~~~i~~~l~~l~~ 65 (74)
T cd04929 8 KNEVGGLAKALKLFQELGINVVHIESRKSKRRSSEFEIFVDCECDQRRLDELVQLLKR 65 (74)
T ss_pred CCCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEEEEcCHHHHHHHHHHHHH
Confidence 46799999999999999999999863333 2234555552 244455555544
No 181
>PF11760 CbiG_N: Cobalamin synthesis G N-terminal; InterPro: IPR021744 Members of this family are involved in cobalamin synthesis. The gene encoded by P72862 from SWISSPROT has been designated cbiH but in fact represents a fusion between cbiH and cbiG. As other multi-functional proteins involved in cobalamin biosynthesis catalyse adjacent steps in the pathway, including CysG, CobL (CbiET), CobIJ and CobA-HemD, it is therefore possible that CbiG catalyses a reaction step adjacent to CbiH. In the anaerobic pathway such a step could be the formation of a gamma lactone, which is thought to help to mediate the anaerobic ring contraction process []. Within the cobalamin synthesis pathway CbiG catalyses the both the opening of the lactone ring and the extrusion of the two-carbon fragment of cobalt-precorrin-5A from C-20 and its associated methyl group (deacylation) to give cobalt-precorrin-5B. The N-terminal of the enzyme is conserved in this family, and the C-terminal and the mid-sections are conserved independently in other families, CbiG_C and CbiG_mid, although the distinct function of each region is unclear. ; PDB: 3EEQ_B.
Probab=77.10 E-value=3.8 Score=31.31 Aligned_cols=49 Identities=18% Similarity=0.256 Sum_probs=25.8
Q ss_pred HHHHHHhhcCCCcEEEecCccccCCCCCccc--cc--CCcchHHHHHHHHhhccceE
Q 020431 90 KRLEKWFSQSPSNTIIATGFIASTPDNIPTT--LK--RDGSDFSAAIMGALLRAHQV 142 (326)
Q Consensus 90 ~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~--lg--rggsD~~A~~lA~~l~a~~~ 142 (326)
+.+..++..+...=+|+ +.+++|...+ +| +||++..|-.+|..+++..+
T Consensus 26 R~iap~l~dK~~DPaVv----vvde~g~~vIplL~GH~GGan~lA~~iA~~lga~~V 78 (84)
T PF11760_consen 26 RAIAPLLKDKDTDPAVV----VVDEDGRFVIPLLGGHRGGANELARQIAELLGAQPV 78 (84)
T ss_dssp HHHHHH---TTT--EEE----EE-TT--EEEEEE-TTTT-HHHHHHHHHHHTT-EE-
T ss_pred HHhChhhcccCCCCCEE----EEeCCCCEEEEeccCCcchHHHHHHHHHHHhCCEEE
Confidence 44555555333344443 6677787544 44 78899999999999999654
No 182
>cd04904 ACT_AAAH ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe; TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines; and TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxy
Probab=76.95 E-value=10 Score=27.75 Aligned_cols=51 Identities=16% Similarity=0.218 Sum_probs=34.0
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEc----cccHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVP----EKEVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~----~~d~~~av~~Lh~ 302 (326)
.+.||-++++++.|+++|||+.-|-.-++ .-...|.|+ ..++.++++.|.+
T Consensus 8 ~~~pG~L~~vL~~f~~~~iNlt~IeSRP~~~~~~~y~Ffvd~~~~~~~~~~~l~~L~~ 65 (74)
T cd04904 8 KEEVGALARALKLFEEFGVNLTHIESRPSRRNGSEYEFFVDCEVDRGDLDQLISSLRR 65 (74)
T ss_pred CCCCcHHHHHHHHHHHCCCcEEEEECCCCCCCCceEEEEEEEEcChHHHHHHHHHHHH
Confidence 45799999999999999999999862222 223455554 2244555555544
No 183
>cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD. This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t
Probab=76.81 E-value=18 Score=25.21 Aligned_cols=45 Identities=22% Similarity=0.294 Sum_probs=31.5
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC--ccEEEEEEcc
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPE 290 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s--e~sIs~~V~~ 290 (326)
.|.+.+ .+.||+++++...|+++|++|..+...+. .....|.+..
T Consensus 2 ~l~i~~---~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~~~~~~~~v~~ 48 (70)
T cd04873 2 VVEVYA---PDRPGLLADITRVLADLGLNIHDARISTTGERALDVFYVTD 48 (70)
T ss_pred EEEEEe---CCCCCHHHHHHHHHHHCCCeEEEEEEeecCCEEEEEEEEEC
Confidence 345553 47899999999999999999977664443 3334454543
No 184
>cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=76.68 E-value=19 Score=26.50 Aligned_cols=66 Identities=11% Similarity=0.138 Sum_probs=40.6
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC--cc-EEEEEEcccc----HHHHHHHHHHHHHHHhcCC
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EH-SVCFAVPEKE----VKAVAEALESKFREALNAG 311 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s--e~-sIs~~V~~~d----~~~av~~Lh~~f~~~~~~~ 311 (326)
++.|.. +++||+++++..+|+++|++|...--.++ +. -=+|.|.+.+ -+...+.+.+.+...+++.
T Consensus 2 ~~ei~~---~Dr~gLfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~~~~~~~~~~~~l~~~L~~~L~~~ 74 (76)
T cd04927 2 LLKLFC---SDRKGLLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDARELLHTKKRREETYDYLRAVLGDS 74 (76)
T ss_pred EEEEEE---CCCCCHHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCCCCCCCHHHHHHHHHHHHHHHchh
Confidence 456664 47999999999999999999987433221 21 1244454432 2244555666665555443
No 185
>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=75.11 E-value=22 Score=25.73 Aligned_cols=31 Identities=26% Similarity=0.342 Sum_probs=25.8
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEE
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMIS 276 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Is 276 (326)
.|.|.+ +++||+++++..+|+.+|++|....
T Consensus 3 ~i~v~~---~Dr~gLl~~i~~~l~~~~l~I~~A~ 33 (73)
T cd04900 3 EVFIYT---PDRPGLFARIAGALDQLGLNILDAR 33 (73)
T ss_pred EEEEEe---cCCCCHHHHHHHHHHHCCCCeEEeE
Confidence 456664 4799999999999999999998743
No 186
>cd04931 ACT_PAH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe. In PAH, an autoregulatory sequence, N-terminal of the ACT domain, extends across the catalytic domain active site and regulates the enzyme by intrasteric regulation. It appears that the activation by L-Phe induces a conformational change that converts the enzyme to a high-affinity and high-activity state. Modulation of activity is achieved through inhibition by BH4 and activation by phosphorylation of serine residues of the autoregulatory region. The molecular basis for the cooperative activation process is not fully understood yet. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=73.75 E-value=19 Score=27.72 Aligned_cols=51 Identities=12% Similarity=0.208 Sum_probs=34.7
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEc-----cccHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVP-----EKEVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~-----~~d~~~av~~Lh~ 302 (326)
.+.||-+.++++.|+++|||+..|-.-++ .-...|.|+ +..+.++++.|++
T Consensus 22 ~~~pGsL~~vL~~Fa~~~INLt~IeSRP~~~~~~~Y~FfVDieg~~~~~~~~~l~~L~~ 80 (90)
T cd04931 22 KEEVGALAKVLRLFEEKDINLTHIESRPSRLNKDEYEFFINLDKKSAPALDPIIKSLRN 80 (90)
T ss_pred CCCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEEEEcCCCHHHHHHHHHHHH
Confidence 45799999999999999999999863332 223456555 2234556666555
No 187
>COG0462 PrsA Phosphoribosylpyrophosphate synthetase [Nucleotide transport and metabolism / Amino acid transport and metabolism]
Probab=73.11 E-value=30 Score=32.99 Aligned_cols=95 Identities=16% Similarity=0.087 Sum_probs=55.1
Q ss_pred HhHhhccchHHHHHHHHHHHHHcCCc-eEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcC--CCcEEEecCcccc
Q 020431 36 TDFVVGHGELWSAQMLAAVVRKNGID-CKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQS--PSNTIIATGFIAS 112 (326)
Q Consensus 36 ~d~i~~~GE~~s~~~~~~~L~~~Gi~-a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~--~~~ipVv~Gfi~~ 112 (326)
+|.....||.+||++++..|...|.+ ...+|..+-.+ .+ |-..-+|.......+.+++... .....|+.++.|
T Consensus 98 QDk~~~~repIsaklvA~lL~~aG~drv~TvDlH~~qi--qg-fFdipvdnl~a~p~l~~~~~~~~~~~d~vVVSPD~G- 173 (314)
T COG0462 98 QDKAFKPREPISAKLVANLLETAGADRVLTVDLHAPQI--QG-FFDIPVDNLYAAPLLAEYIREKYDLDDPVVVSPDKG- 173 (314)
T ss_pred cCcccCCCCCEeHHHHHHHHHHcCCCeEEEEcCCchhh--cc-cCCCccccccchHHHHHHHHHhcCCCCcEEECCCcc-
Confidence 44555789999999999999999995 33444443211 11 1122233333445555555432 123455554422
Q ss_pred CCCCCcccccCCcchHHHHHHHHhhccceEEEeec
Q 020431 113 TPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTD 147 (326)
Q Consensus 113 ~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~tD 147 (326)
| =.-|-.+|..|+++.-+|-+.
T Consensus 174 ---g----------v~RAr~~A~~L~~~~a~i~K~ 195 (314)
T COG0462 174 ---G----------VKRARALADRLGAPLAIIDKR 195 (314)
T ss_pred ---H----------HHHHHHHHHHhCCCEEEEEEe
Confidence 2 233889999999875555554
No 188
>COG1058 CinA Predicted nucleotide-utilizing enzyme related to molybdopterin-biosynthesis enzyme MoeA [General function prediction only]
Probab=72.61 E-value=20 Score=33.17 Aligned_cols=68 Identities=24% Similarity=0.289 Sum_probs=49.1
Q ss_pred HHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcc
Q 020431 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (326)
Q Consensus 47 s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggs 126 (326)
++.-++..|.++|++...... +-| +.....+.++.+.+ .-.+.|++|=+|.+.+
T Consensus 22 Na~~la~~L~~~G~~v~~~~~-----VgD--------~~~~I~~~l~~a~~--r~D~vI~tGGLGPT~D----------- 75 (255)
T COG1058 22 NAAFLADELTELGVDLARITT-----VGD--------NPDRIVEALREASE--RADVVITTGGLGPTHD----------- 75 (255)
T ss_pred hHHHHHHHHHhcCceEEEEEe-----cCC--------CHHHHHHHHHHHHh--CCCEEEECCCcCCCcc-----------
Confidence 456789999999998776532 222 34445577777776 3567777776787766
Q ss_pred hHHHHHHHHhhccc
Q 020431 127 DFSAAIMGALLRAH 140 (326)
Q Consensus 127 D~~A~~lA~~l~a~ 140 (326)
|.|+-.+|++||-+
T Consensus 76 DiT~e~vAka~g~~ 89 (255)
T COG1058 76 DLTAEAVAKALGRP 89 (255)
T ss_pred HhHHHHHHHHhCCC
Confidence 99999999999954
No 189
>cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=72.23 E-value=38 Score=25.22 Aligned_cols=33 Identities=15% Similarity=0.177 Sum_probs=26.5
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEec
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA 278 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~ 278 (326)
++.|. -.++||.++++.++|+++|++|...--+
T Consensus 2 vlev~---a~DRpGLL~~i~~~l~~~~l~i~~AkI~ 34 (75)
T cd04896 2 LLQIR---CVDQKGLLYDILRTSKDCNIQISYGRFS 34 (75)
T ss_pred EEEEE---eCCcccHHHHHHHHHHHCCeEEEEEEEe
Confidence 34555 3579999999999999999998876544
No 190
>PRK08198 threonine dehydratase; Provisional
Probab=71.91 E-value=21 Score=35.08 Aligned_cols=61 Identities=20% Similarity=0.399 Sum_probs=44.3
Q ss_pred ecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC-------CccEEEEEEcccc---HHHHHHHHH
Q 020431 238 IDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS-------SEHSVCFAVPEKE---VKAVAEALE 301 (326)
Q Consensus 238 ~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~-------se~sIs~~V~~~d---~~~av~~Lh 301 (326)
......+++. +.+.||.++++++.++++|+||.-|.|.- ....+++.++-.+ .+++++.|.
T Consensus 324 ~gr~~~l~v~---l~D~PG~L~~ll~~i~~~g~NI~~i~~~~~~~~~~~~~~~v~v~ie~~~~~~~~~l~~~L~ 394 (404)
T PRK08198 324 AGRYLKLRVR---LPDRPGQLAKLLSIIAELGANVIDVDHDRFSPDLRLGEVEVELTLETRGPEHIEEILDALR 394 (404)
T ss_pred cCCEEEEEEE---eCCCCCHHHHHHHHHhhCCCceEEEEEEEccCCCCCceEEEEEEEEeCCHHHHHHHHHHHH
Confidence 3455667775 78999999999999999999999888862 2466667666544 444444443
No 191
>cd04876 ACT_RelA-SpoT ACT domain found C-terminal of the RelA/SpoT domains. ACT_RelA-SpoT: the ACT domain found C-terminal of the RelA/SpoT domains. Enzymes of the Rel/Spo family enable bacteria to survive prolonged periods of nutrient limitation by controlling guanosine-3'-diphosphate-5'-(tri)diphosphate ((p)ppGpp) production and subsequent rRNA repression (stringent response). Both the synthesis of (p)ppGpp from ATP and GDP(GTP), and its hydrolysis to GDP(GTP) and pyrophosphate, are catalyzed by Rel/Spo proteins. In Escherichia coli and its close relatives, the metabolism of (p)ppGpp is governed by two homologous proteins, RelA and SpoT. The RelA protein catalyzes (p)ppGpp synthesis in a reaction requiring its binding to ribosomes bearing codon-specified uncharged tRNA. The major role of the SpoT protein is the breakdown of (p)ppGpp by a manganese-dependent (p)ppGpp pyrophosphohydrolase activity. Although the stringent response appears to be tightly regulated by these two enzymes i
Probab=71.33 E-value=21 Score=23.76 Aligned_cols=50 Identities=10% Similarity=0.278 Sum_probs=32.7
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCCc---cEEEEEEccc---cHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASSE---HSVCFAVPEK---EVKAVAEALE 301 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~se---~sIs~~V~~~---d~~~av~~Lh 301 (326)
.+.||.++++...|+++++++.-+.+..+. ..+.+.+... ++..+++.|.
T Consensus 6 ~~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 61 (71)
T cd04876 6 IDRPGLLADITTVIAEEKINILSVNTRTDDDGLATIRLTLEVRDLEHLARIMRKLR 61 (71)
T ss_pred eccCcHHHHHHHHHHhCCCCEEEEEeEECCCCEEEEEEEEEECCHHHHHHHHHHHh
Confidence 467899999999999999999887654433 2344444432 3444444443
No 192
>PRK11589 gcvR glycine cleavage system transcriptional repressor; Provisional
Probab=69.59 E-value=18 Score=31.89 Aligned_cols=32 Identities=16% Similarity=0.130 Sum_probs=28.2
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEE
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMIS 276 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Is 276 (326)
..++++|. ++||+..++.+.|+++||||.-.+
T Consensus 96 ~~v~v~G~---DrPGIV~~vT~~la~~~iNI~~L~ 127 (190)
T PRK11589 96 VWVQVEVA---DSPHLIERFTALFDSHHMNIAELV 127 (190)
T ss_pred EEEEEEEC---CCCCHHHHHHHHHHHcCCChhheE
Confidence 67889985 689999999999999999987665
No 193
>COG2150 Predicted regulator of amino acid metabolism, contains ACT domain [General function prediction only]
Probab=69.13 E-value=26 Score=30.06 Aligned_cols=63 Identities=13% Similarity=0.179 Sum_probs=46.2
Q ss_pred cCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC----CccEEEEEEccccHHHHHHHHHH
Q 020431 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS----SEHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 239 ~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~----se~sIs~~V~~~d~~~av~~Lh~ 302 (326)
-+..+|++.-. -.+.||+++.+++.++++||+|.-+--.- .+..+.++.++.--.+++..|.+
T Consensus 91 lG~gViei~~~-~~~~pgi~A~V~~~iak~gi~Irqi~~~dpe~~~e~~l~IVte~~iP~~li~el~~ 157 (167)
T COG2150 91 LGLGVIEIYPE-DARYPGILAGVASLIAKRGISIRQIISEDPELQEEPKLTIVTERPIPGDLIDELKK 157 (167)
T ss_pred cCCeEEEEEec-cCCCccHHHHHHHHHHHcCceEEEEecCCcccCCCceEEEEEeccCCHHHHHHHhc
Confidence 35566666642 45689999999999999999998775111 15678888888766777777765
No 194
>cd04899 ACT_ACR-UUR-like_2 C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=67.62 E-value=24 Score=24.81 Aligned_cols=34 Identities=15% Similarity=0.302 Sum_probs=26.9
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS 279 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~ 279 (326)
+|.+.+ .+.||+++++...|++++++|..+...+
T Consensus 2 ~l~v~~---~d~~gll~~i~~~l~~~~~~I~~~~~~~ 35 (70)
T cd04899 2 VLELTA---LDRPGLLADVTRVLAELGLNIHSAKIAT 35 (70)
T ss_pred EEEEEE---cCCccHHHHHHHHHHHCCCeEEEEEEEe
Confidence 456664 4689999999999999999997665433
No 195
>cd04906 ACT_ThrD-I_1 First of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase). This CD includes the first of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase) which catalyzes the committed step in branched chain amino acid biosynthesis in plants and microorganisms, the pyridoxal 5'-phosphate (PLP)-dependent dehydration/deamination of L-threonine (or L-serine) to 2-ketobutyrate (or pyruvate). ThrD-I is a cooperative, feedback-regulated (isoleucine and valine) allosteric enzyme that forms a tetramer and contains four pyridoxal phosphate moieties. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=66.17 E-value=28 Score=26.16 Aligned_cols=51 Identities=12% Similarity=0.171 Sum_probs=36.4
Q ss_pred CCCCcccHHHHHHHHHHhCCCcEEEEEecC---CccEEEEEEcccc----HHHHHHHHHH
Q 020431 250 GMAGVPGTANAIFGAVKDVGANVIMISQAS---SEHSVCFAVPEKE----VKAVAEALES 302 (326)
Q Consensus 250 ~~~~~~~i~a~if~~L~~~~I~v~~Isq~~---se~sIs~~V~~~d----~~~av~~Lh~ 302 (326)
.+++.||-+.++.+.|+..+|+ .+.|.. ....+.+.++-.+ .+++++.|.+
T Consensus 7 ~ipD~PG~L~~ll~~l~~anI~--~~~y~~~~~~~~~v~i~ie~~~~~~~~~~i~~~L~~ 64 (85)
T cd04906 7 TIPERPGSFKKFCELIGPRNIT--EFNYRYADEKDAHIFVGVSVANGAEELAELLEDLKS 64 (85)
T ss_pred ecCCCCcHHHHHHHHhCCCcee--EEEEEccCCCeeEEEEEEEeCCcHHHHHHHHHHHHH
Confidence 3789999999999999966555 444433 3566777777444 7777777766
No 196
>COG4747 ACT domain-containing protein [General function prediction only]
Probab=66.00 E-value=34 Score=27.97 Aligned_cols=56 Identities=18% Similarity=0.340 Sum_probs=39.7
Q ss_pred EEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC-CccE-EEEEEccccHHHHHHHHHHH
Q 020431 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS-SEHS-VCFAVPEKEVKAVAEALESK 303 (326)
Q Consensus 243 ~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~-se~s-Is~~V~~~d~~~av~~Lh~~ 303 (326)
.||+. ..++||-++.+...|+++|||+...|-.. ++.- |..+|++.| .+-..||+.
T Consensus 5 QISvF---lENk~GRL~~~~~~L~eagINiRA~tiAdt~dFGIiRmvV~~~d--~A~~~Lee~ 62 (142)
T COG4747 5 QISVF---LENKPGRLASVANKLKEAGINIRAFTIADTGDFGIIRMVVDRPD--EAHSVLEEA 62 (142)
T ss_pred EEEEE---ecCCcchHHHHHHHHHHcCCceEEEEeccccCcceEEEEcCChH--HHHHHHHHC
Confidence 34554 55789999999999999999999988543 3333 566777764 345556664
No 197
>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=65.16 E-value=33 Score=24.81 Aligned_cols=40 Identities=13% Similarity=0.135 Sum_probs=28.0
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC--ccEEEEEEcc
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPE 290 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s--e~sIs~~V~~ 290 (326)
+.++||.++++..+|+++|+||....-.+. ..-.+|.|.+
T Consensus 8 ~~D~~Gll~~i~~~l~~~~lnI~sa~i~t~~~~~~d~f~v~~ 49 (72)
T cd04926 8 TEDRVGLLSDVTRVFRENGLTVTRAEISTQGDMAVNVFYVTD 49 (72)
T ss_pred ECCccCHHHHHHHHHHHCCcEEEEEEEecCCCeEEEEEEEEC
Confidence 457999999999999999999965432233 2335555543
No 198
>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=63.05 E-value=14 Score=27.26 Aligned_cols=59 Identities=19% Similarity=0.198 Sum_probs=38.4
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC--ccEEEEEEccccH-----HHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPEKEV-----KAVAEALESK 303 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s--e~sIs~~V~~~d~-----~~av~~Lh~~ 303 (326)
++|.|.. .++||.++++.++|+++|++|..-.-++. ..-=.|.|.+.+- +...+.|.+.
T Consensus 2 Tviev~a---~DRpGLL~~i~~~l~~~gl~I~~AkIsT~Gerv~DvFyV~d~~g~kl~d~~~~~~l~~~ 67 (72)
T cd04895 2 TLVKVDS---ARKPGILLEAVQVLTDLDLCITKAYISSDGGWFMDVFHVTDQLGNKLTDDSLIAYIEKS 67 (72)
T ss_pred EEEEEEE---CCcCCHHHHHHHHHHHCCcEEEEEEEeecCCeEEEEEEEECCCCCCCCCHHHHHHHHHH
Confidence 3556664 57999999999999999999987654443 2222466654432 3444455543
No 199
>cd04885 ACT_ThrD-I Tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase). This CD includes each of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase) which catalyzes the committed step in branched chain amino acid biosynthesis in plants and microorganisms, the pyridoxal 5'-phosphate (PLP)-dependent dehydration/deamination of L-threonine (or L-serine) to 2-ketobutyrate (or pyruvate). ThrD-I is a cooperative, feedback-regulated (isoleucine and valine) allosteric enzyme that forms a tetramer and contains four pyridoxal phosphate moieties. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=62.34 E-value=42 Score=23.86 Aligned_cols=51 Identities=16% Similarity=0.253 Sum_probs=36.7
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEccc---cHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEK---EVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~~---d~~~av~~Lh~ 302 (326)
+.++||-+.++.+.+++ +.||..+.|.-+ ...+.+.++-. +.+++++.|.+
T Consensus 5 ipdkPG~l~~~~~~i~~-~~nI~~~~~~~~~~~~~~v~v~ie~~~~~~~~~i~~~L~~ 61 (68)
T cd04885 5 FPERPGALKKFLELLGP-PRNITEFHYRNQGGDEARVLVGIQVPDREDLAELKERLEA 61 (68)
T ss_pred CCCCCCHHHHHHHHhCC-CCcEEEEEEEcCCCCceEEEEEEEeCCHHHHHHHHHHHHH
Confidence 67899999999999999 999999888642 44455555543 45555555544
No 200
>COG4492 PheB ACT domain-containing protein [General function prediction only]
Probab=59.63 E-value=31 Score=28.76 Aligned_cols=52 Identities=21% Similarity=0.358 Sum_probs=39.0
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEc----cccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVP----EKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~----~~d~~~av~~Lh~ 302 (326)
+.++.|.++++++.+++.++||.-|.|+.. ..++.+.++ +.+++++++.|.+
T Consensus 79 ledr~G~LS~vLd~iA~~~~nvLTI~Q~ipl~g~Anvtlsi~~ssm~~~V~~ii~kl~k 137 (150)
T COG4492 79 LEDRVGILSDVLDVIAREEINVLTIHQTIPLQGRANVTLSIDTSSMEKDVDKIIEKLRK 137 (150)
T ss_pred EhhhhhhHHHHHHHHHHhCCcEEEEecccccCceeeEEEEEEchhhhhhHHHHHHHHhc
Confidence 567889999999999999999999999764 334444444 3466777766655
No 201
>cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=58.08 E-value=75 Score=23.61 Aligned_cols=65 Identities=11% Similarity=0.127 Sum_probs=41.0
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCc--cEEEEEEccccH-----HHHHHHHHHHHHHHhc
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE--HSVCFAVPEKEV-----KAVAEALESKFREALN 309 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se--~sIs~~V~~~d~-----~~av~~Lh~~f~~~~~ 309 (326)
++|.|.+ .++||.+.++..+|.+.|++|..-.-++.. .-=.|.|...+- +...+.|.+.+...++
T Consensus 2 TvveV~~---~DRpGLL~~i~~~l~~~~l~I~~A~I~T~gera~D~FyV~d~~g~kl~~~~~~~~l~~~L~~al~ 73 (75)
T cd04897 2 SVVTVQC---RDRPKLLFDVVCTLTDMDYVVFHATIDTDGDDAHQEYYIRHKDGRTLSTEGERQRVIKCLEAAIE 73 (75)
T ss_pred EEEEEEe---CCcCcHHHHHHHHHHhCCeEEEEEEEeecCceEEEEEEEEcCCCCccCCHHHHHHHHHHHHHHHh
Confidence 4566664 579999999999999999999876654432 222455544332 2234455555444443
No 202
>cd00885 cinA Competence-damaged protein. CinA is the first gene in the competence- inducible (cin) operon and is thought to be specifically required at some stage in the process of transformation. This domain is closely related to a domain, found in a variety of proteins involved in biosynthesis of molybdopterin cofactor, where the domain is presumed to bind molybdopterin.
Probab=57.40 E-value=68 Score=27.59 Aligned_cols=69 Identities=19% Similarity=0.234 Sum_probs=44.8
Q ss_pred HHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCc
Q 020431 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (326)
Q Consensus 46 ~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrgg 125 (326)
-++..+++.|++.|+++.... ++.| +.....+.++++++ ...+.|++|=.+.+ .
T Consensus 19 ~n~~~l~~~L~~~G~~v~~~~-----~v~D--------d~~~I~~~l~~~~~--~~dlVIttGG~G~t-----------~ 72 (170)
T cd00885 19 TNAAFLAKELAELGIEVYRVT-----VVGD--------DEDRIAEALRRASE--RADLVITTGGLGPT-----------H 72 (170)
T ss_pred hHHHHHHHHHHHCCCEEEEEE-----EeCC--------CHHHHHHHHHHHHh--CCCEEEECCCCCCC-----------C
Confidence 356688999999999764432 2233 23334466666665 45677777743433 3
Q ss_pred chHHHHHHHHhhccc
Q 020431 126 SDFSAAIMGALLRAH 140 (326)
Q Consensus 126 sD~~A~~lA~~l~a~ 140 (326)
-|.+.-.++.+++-+
T Consensus 73 ~D~t~ea~~~~~~~~ 87 (170)
T cd00885 73 DDLTREAVAKAFGRP 87 (170)
T ss_pred CChHHHHHHHHhCCC
Confidence 499999999999853
No 203
>PF02254 TrkA_N: TrkA-N domain; InterPro: IPR003148 The regulator of K+ conductance (RCK) domain is found in many ligand-gated K+ channels, most often attached to the intracellular carboxy terminus. The domain is prevalent among prokaryotic K+ channels, and also found in eukaryotic, high-conductance Ca2+-activated K+ channels (BK channels) [, , ]. Largely involved in redox-linked regulation of potassium channels, the N-terminal part of the RCK domain is predicted to be an active dehydrogenase at least in some cases []. Some have a conserved sequence motif (G-x-G-x-x-G-x(n)-[DE]) for NAD+ binding [], but others do not, reflecting the diversity of ligands for RCK domains. The C-terminal part is less conserved, being absent in some channels, such as the kefC antiporter from Escherichia coli. It is predicted to bind unidentified ligands and to regulate sulphate, sodium and other transporters. The X-ray structure of several RCK domains has been solved [, , ]. It reveals an alpha-beta fold similar to dehydrogenase enzymes. The domain forms a homodimer, producing a cleft between two lobes. It has a composite structure, with an N-terminal (RCK-N), and a C-terminal (RCK-C) subdomain. The RCK-N subdomain forms a Rossmann fold with two alpha helices on one side of a six stranded parallel beta sheet and three alpha helices on the other side. The RCK-C subdomain is an all-beta-strand fold. It forms an extention of the dimer interface and further stabilises the RCK homodimer [, , ]. Ca2+ is a ligand that opens the channel in a concentration-dependent manner. Two Ca2+ ions are located at the base of a cleft between two RCK domains, coordinated by the carboxylate groups of two glutamate residues, and by an aspartate residue [, , ]. RCK domains occur in at least five different contexts: As a single domain on the C terminus of some K+ channels (for example, many prokaryotic K+ channels). As two tandem RCK domains on the C terminus of some transporters that form gating rings (for example, eukaryotic BK channels). The gating ring has an arrangement of eight identical RCK domains, one from each of the four pore-forming subunits and four from the intracellular solution. As two domains, one at the N terminus and another at the C terminus of transporter (for example, the prokaryotic trk system potassium uptake protein A). As a soluble protein (not part of a K+ channel) consisting of two tandem RCK domains. As a soluble protein consisting of a single RCK domain. This entry represents the N-terminal subdomain of RCK.; GO: 0006813 potassium ion transport; PDB: 3L4B_E 1LSS_C 3LLV_A 2FY8_D 2AEF_A 1LNQ_E 3RBX_C 3KXD_A 2AEJ_A 3RBZ_A ....
Probab=57.09 E-value=39 Score=26.26 Aligned_cols=69 Identities=25% Similarity=0.355 Sum_probs=42.0
Q ss_pred hhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCc
Q 020431 39 VVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIP 118 (326)
Q Consensus 39 i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~ 118 (326)
++++|+. ++.++..|.+.+.+.+.++. |. +.++++.+ .+ ++++.|+..
T Consensus 3 I~G~g~~--~~~i~~~L~~~~~~vvvid~----------------d~----~~~~~~~~--~~-~~~i~gd~~------- 50 (116)
T PF02254_consen 3 IIGYGRI--GREIAEQLKEGGIDVVVIDR----------------DP----ERVEELRE--EG-VEVIYGDAT------- 50 (116)
T ss_dssp EES-SHH--HHHHHHHHHHTTSEEEEEES----------------SH----HHHHHHHH--TT-SEEEES-TT-------
T ss_pred EEcCCHH--HHHHHHHHHhCCCEEEEEEC----------------Cc----HHHHHHHh--cc-cccccccch-------
Confidence 5688887 99999999998766665542 23 44555554 34 667766521
Q ss_pred ccccCCcchHHHHHHHHhhccceEEEeec
Q 020431 119 TTLKRDGSDFSAAIMGALLRAHQVTIWTD 147 (326)
Q Consensus 119 ~~lgrggsD~~A~~lA~~l~a~~~~~~tD 147 (326)
|.-...-|..-+|+.++++++
T Consensus 51 --------~~~~l~~a~i~~a~~vv~~~~ 71 (116)
T PF02254_consen 51 --------DPEVLERAGIEKADAVVILTD 71 (116)
T ss_dssp --------SHHHHHHTTGGCESEEEEESS
T ss_pred --------hhhHHhhcCccccCEEEEccC
Confidence 443444455556777777765
No 204
>cd04930 ACT_TH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tyrosine hydroxylases (TH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tyrosine hydroxylases (TH). TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines (dopamine, noradrenaline and adrenaline), functioning as hormones and neurotransmitters. The enzyme is not regulated by its amino acid substrate, but instead by phosphorylation at several serine residues located N-terminal of the ACT domain, and by feedback inhibition by catecholamines at the active site. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=56.68 E-value=44 Score=26.94 Aligned_cols=38 Identities=11% Similarity=0.044 Sum_probs=28.0
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEc
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVP 289 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~ 289 (326)
.+.||.++++++.|+++|||+..|-.-++ .-...|.|+
T Consensus 49 ~~~pGsL~~iL~~Fa~~gINLt~IESRP~~~~~~eY~FfId 89 (115)
T cd04930 49 KEGFSSLSRILKVFETFEAKIHHLESRPSRKEGGDLEVLVR 89 (115)
T ss_pred CCCCcHHHHHHHHHHHCCCCEEEEECCcCCCCCceEEEEEE
Confidence 45799999999999999999999963222 122455555
No 205
>PRK03673 hypothetical protein; Provisional
Probab=55.81 E-value=62 Score=31.97 Aligned_cols=69 Identities=19% Similarity=0.187 Sum_probs=46.5
Q ss_pred HHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCc
Q 020431 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (326)
Q Consensus 46 ~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrgg 125 (326)
-++..+++.|.+.|++..... ++.| |.+...+.+++.++ ...+.|++|=.|.+.+
T Consensus 21 tN~~~la~~L~~~G~~v~~~~-----~v~D--------~~~~i~~~l~~a~~--~~DlVI~tGGlGpt~d---------- 75 (396)
T PRK03673 21 TNAAWLADFFFHQGLPLSRRN-----TVGD--------NLDALVAILRERSQ--HADVLIVNGGLGPTSD---------- 75 (396)
T ss_pred hHHHHHHHHHHHCCCEEEEEE-----EcCC--------CHHHHHHHHHHHhc--cCCEEEEcCCCCCCCc----------
Confidence 357788999999999765542 2233 34445566666665 4567777775554433
Q ss_pred chHHHHHHHHhhccc
Q 020431 126 SDFSAAIMGALLRAH 140 (326)
Q Consensus 126 sD~~A~~lA~~l~a~ 140 (326)
|.+.-.+|.++|-.
T Consensus 76 -D~t~~avA~a~g~~ 89 (396)
T PRK03673 76 -DLSALAAATAAGEG 89 (396)
T ss_pred -ccHHHHHHHHcCCC
Confidence 99999999999953
No 206
>PRK06349 homoserine dehydrogenase; Provisional
Probab=55.58 E-value=25 Score=34.88 Aligned_cols=52 Identities=21% Similarity=0.314 Sum_probs=38.1
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEccc---cHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEK---EVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~~---d~~~av~~Lh~ 302 (326)
+.+.||+++++-..|++++|++..+.|... ...+.+++... ++.+++..|.+
T Consensus 355 v~d~pGvLa~I~~~f~~~~vsI~si~q~~~~~~~~~ivivT~~~~e~~l~~~i~~L~~ 412 (426)
T PRK06349 355 VADKPGVLAKIAAIFAENGISIESILQKGAGGEGAEIVIVTHETSEAALRAALAAIEA 412 (426)
T ss_pred ecCCcchHHHHHHHHhhcCccEEEEEeccCCCCceeEEEEEEeCCHHHHHHHHHHHhc
Confidence 567899999999999999999999998753 24677776644 34444444443
No 207
>PRK03670 competence damage-inducible protein A; Provisional
Probab=54.49 E-value=66 Score=29.70 Aligned_cols=70 Identities=16% Similarity=0.225 Sum_probs=45.3
Q ss_pred HHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCc
Q 020431 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (326)
Q Consensus 46 ~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrgg 125 (326)
-++..++..|.+.|++.... .++.| |.....+.+++++. ....+.|++|=+|.+.+
T Consensus 20 tN~~~la~~L~~~G~~v~~~-----~iV~D--------d~~~I~~~l~~a~~-~~~DlVIttGGlGpt~d---------- 75 (252)
T PRK03670 20 SNSAFIAQKLTEKGYWVRRI-----TTVGD--------DVEEIKSVVLEILS-RKPEVLVISGGLGPTHD---------- 75 (252)
T ss_pred hhHHHHHHHHHHCCCEEEEE-----EEcCC--------CHHHHHHHHHHHhh-CCCCEEEECCCccCCCC----------
Confidence 35668899999999975443 23333 33334466666554 13467777775555444
Q ss_pred chHHHHHHHHhhccc
Q 020431 126 SDFSAAIMGALLRAH 140 (326)
Q Consensus 126 sD~~A~~lA~~l~a~ 140 (326)
|.+.-.+|.+++-+
T Consensus 76 -D~T~eava~a~g~~ 89 (252)
T PRK03670 76 -DVTMLAVAEALGRE 89 (252)
T ss_pred -CchHHHHHHHhCCC
Confidence 99999999999843
No 208
>PTZ00145 phosphoribosylpyrophosphate synthetase; Provisional
Probab=54.48 E-value=85 Score=31.47 Aligned_cols=36 Identities=19% Similarity=0.150 Sum_probs=27.0
Q ss_pred hHHhHhhccchHHHHHHHHHHHHHcCCc-eEEEcccc
Q 020431 34 SFTDFVVGHGELWSAQMLAAVVRKNGID-CKWMDTRE 69 (326)
Q Consensus 34 ~~~d~i~~~GE~~s~~~~~~~L~~~Gi~-a~~l~~~~ 69 (326)
.-.|.....||.+++++++..|...|++ .+.+|+..
T Consensus 211 aRQDR~~~~gepIsak~vA~lL~~~G~d~VitvDlHs 247 (439)
T PTZ00145 211 ARQDRKLSSRVPISAADVARMIEAMGVDRVVAIDLHS 247 (439)
T ss_pred hheecccCCCCChhHHHHHHHHHHcCCCeEEEEecCh
Confidence 3345556689999999999999999985 34455543
No 209
>PTZ00445 p36-lilke protein; Provisional
Probab=52.66 E-value=67 Score=29.02 Aligned_cols=27 Identities=22% Similarity=0.241 Sum_probs=22.3
Q ss_pred HHHHHHHHHHHcCCceEEEcccceeec
Q 020431 47 SAQMLAAVVRKNGIDCKWMDTREVLIV 73 (326)
Q Consensus 47 s~~~~~~~L~~~Gi~a~~l~~~~~~~~ 73 (326)
+++.++..|++.||+++..|-..-++.
T Consensus 30 ~~~~~v~~L~~~GIk~Va~D~DnTlI~ 56 (219)
T PTZ00445 30 SADKFVDLLNECGIKVIASDFDLTMIT 56 (219)
T ss_pred HHHHHHHHHHHcCCeEEEecchhhhhh
Confidence 388899999999999999987665443
No 210
>TIGR01127 ilvA_1Cterm threonine dehydratase, medium form. A form of threonine dehydratase with two copies of the C-terminal domain Pfam:PF00585 is described by TIGR01124. This model describes a phylogenetically distinct form with a single copy of pfam00585. This form branches with the catabolic threonine dehydratase of E. coli; many members are designated as catabolic for this reason. However, the catabolic form lacks any pfam00585 domain. Many members of this model are found in species with other Ile biosynthetic enzymes.
Probab=50.36 E-value=72 Score=30.91 Aligned_cols=61 Identities=11% Similarity=0.261 Sum_probs=41.5
Q ss_pred cCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEec-------CCccEEEEEEccc---cHHHHHHHHHH
Q 020431 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA-------SSEHSVCFAVPEK---EVKAVAEALES 302 (326)
Q Consensus 239 ~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~-------~se~sIs~~V~~~---d~~~av~~Lh~ 302 (326)
.....+++. +.+.||.++++.+.+++++.||.-|.+. .....+.+.++-. +.+++++.|.+
T Consensus 303 gr~~~l~v~---l~D~pG~L~~v~~~i~~~~~NI~~i~~~r~~~~~~~~~~~v~v~vet~~~~~~~~i~~~L~~ 373 (380)
T TIGR01127 303 GRKVRIETV---LPDRPGALYHLLESIAEARANIVKIDHDRLSKEIPPGFAMVEITLETRGKEHLDEILKILRD 373 (380)
T ss_pred CCEEEEEEE---eCCCCCHHHHHHHHHhcCCCcEEEEEeeccccCCCCceEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 344556664 7889999999999999999999877543 1244566666653 34444544433
No 211
>cd05014 SIS_Kpsf KpsF-like protein. KpsF is an arabinose-5-phosphate isomerase which contains SIS (Sugar ISomerase) domains. SIS domains are found in many phosphosugar isomerases and phosphosugar binding proteins. KpsF catalyzes the reversible reaction of ribulose 5-phosphate to arabinose 5-phosphate. This is the second step in the CMP-Kdo biosynthesis pathway.
Probab=49.10 E-value=70 Score=25.27 Aligned_cols=79 Identities=11% Similarity=0.019 Sum_probs=41.1
Q ss_pred CCcccccCCcchHHHHHHHHhhcc--ceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHH
Q 020431 116 NIPTTLKRDGSDFSAAIMGALLRA--HQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVM 193 (326)
Q Consensus 116 g~~~~lgrggsD~~A~~lA~~l~a--~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~ 193 (326)
|.+..+|+|+|...|.+++..|.. ..+.++.+...++..-....++. ++=-+| ..|..---.++++.|+
T Consensus 1 ~~I~i~G~G~S~~~a~~~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~d-~vi~iS--------~sG~t~~~~~~~~~a~ 71 (128)
T cd05014 1 GKVVVTGVGKSGHIARKIAATLSSTGTPAFFLHPTEALHGDLGMVTPGD-VVIAIS--------NSGETDELLNLLPHLK 71 (128)
T ss_pred CeEEEEeCcHhHHHHHHHHHHhhcCCCceEEcccchhhccccCcCCCCC-EEEEEe--------CCCCCHHHHHHHHHHH
Confidence 346678889999999999988752 23444444332222111111111 111111 1222211235688899
Q ss_pred hCCCCEEEEe
Q 020431 194 RYDIPIVIRN 203 (326)
Q Consensus 194 ~~~I~v~I~n 203 (326)
+.|+++....
T Consensus 72 ~~g~~vi~iT 81 (128)
T cd05014 72 RRGAPIIAIT 81 (128)
T ss_pred HCCCeEEEEe
Confidence 9999966554
No 212
>PF00994 MoCF_biosynth: Probable molybdopterin binding domain; InterPro: IPR001453 Eukaryotic and prokaryotic molybdoenzymes require a molybdopterin cofactor (MoCF) for their activity. The biosynthesis of this cofactor involves a complex multistep enzymatic pathway. One of the eukaryotic proteins involved in this pathway is the Drosophila protein cinnamon [] which is highly similar to gephyrin, a rat microtubule-associated protein which was thought to anchor the glycine receptor to subsynaptic microtubules. Cinnamon and gephyrin are evolutionary related, in their N-terminal half, to the Escherichia coli MoCF biosynthesis proteins mog/chlG and moaB/chlA2 and, in their C-terminal half, to E. coli moeA/chlE.; GO: 0006777 Mo-molybdopterin cofactor biosynthetic process; PDB: 3TCR_B 1O8O_B 1O8Q_G 1EAV_D 1O8N_C 1UUX_A 1UUY_A 2G2C_A 2G4R_C 3K6A_F ....
Probab=48.10 E-value=1e+02 Score=25.29 Aligned_cols=68 Identities=19% Similarity=0.233 Sum_probs=44.5
Q ss_pred HHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCc
Q 020431 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (326)
Q Consensus 46 ~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrgg 125 (326)
-++..+.+.|++.|+...... ++.| |.....+.++..++ ...+.|++|=.+. |-
T Consensus 17 ~n~~~l~~~l~~~G~~v~~~~-----~v~D--------d~~~i~~~l~~~~~--~~D~VittGG~g~-----------~~ 70 (144)
T PF00994_consen 17 SNGPFLAALLEELGIEVIRYG-----IVPD--------DPDAIKEALRRALD--RADLVITTGGTGP-----------GP 70 (144)
T ss_dssp HHHHHHHHHHHHTTEEEEEEE-----EEES--------SHHHHHHHHHHHHH--TTSEEEEESSSSS-----------ST
T ss_pred hHHHHHHHHHHHcCCeeeEEE-----EECC--------CHHHHHHHHHhhhc--cCCEEEEcCCcCc-----------cc
Confidence 467788999999999665542 2333 34445566777766 5577777773332 22
Q ss_pred chHHHHHHHHhhcc
Q 020431 126 SDFSAAIMGALLRA 139 (326)
Q Consensus 126 sD~~A~~lA~~l~a 139 (326)
.|++.-.++.+.+.
T Consensus 71 ~D~t~~a~~~~~~~ 84 (144)
T PF00994_consen 71 DDVTPEALAEAGGR 84 (144)
T ss_dssp TCHHHHHHHHHSSE
T ss_pred CCcccHHHHHhcCc
Confidence 48888888877763
No 213
>PRK01215 competence damage-inducible protein A; Provisional
Probab=47.11 E-value=96 Score=28.77 Aligned_cols=69 Identities=16% Similarity=0.182 Sum_probs=46.1
Q ss_pred HHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCc
Q 020431 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (326)
Q Consensus 46 ~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrgg 125 (326)
-++..++..|.+.|++..... ++.| |.+...+.++++++ ...+.|++|=.+.+.
T Consensus 23 tn~~~l~~~L~~~G~~v~~~~-----~v~D--------d~~~I~~~l~~a~~--~~DlVIttGG~g~t~----------- 76 (264)
T PRK01215 23 TNASWIARRLTYLGYTVRRIT-----VVMD--------DIEEIVSAFREAID--RADVVVSTGGLGPTY----------- 76 (264)
T ss_pred hhHHHHHHHHHHCCCeEEEEE-----EeCC--------CHHHHHHHHHHHhc--CCCEEEEeCCCcCCh-----------
Confidence 456788999999999865542 2233 33334566666665 447777777444333
Q ss_pred chHHHHHHHHhhccc
Q 020431 126 SDFSAAIMGALLRAH 140 (326)
Q Consensus 126 sD~~A~~lA~~l~a~ 140 (326)
-|.+.-.+|.+++-+
T Consensus 77 dD~t~eaia~~~g~~ 91 (264)
T PRK01215 77 DDKTNEGFAKALGVE 91 (264)
T ss_pred hhhHHHHHHHHhCCC
Confidence 399999999999853
No 214
>COG0499 SAM1 S-adenosylhomocysteine hydrolase [Coenzyme metabolism]
Probab=46.68 E-value=54 Score=32.09 Aligned_cols=77 Identities=13% Similarity=0.128 Sum_probs=45.5
Q ss_pred HHHHHcCC---ceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhc-CCCcEEEecCccccCCCCCcccccCCcchH
Q 020431 53 AVVRKNGI---DCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQ-SPSNTIIATGFIASTPDNIPTTLKRDGSDF 128 (326)
Q Consensus 53 ~~L~~~Gi---~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~-~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~ 128 (326)
..+.+.|. |+..++-+-.--..|++||.-. ..-+-|.+..+. ..|+..||.|| |. .|||
T Consensus 161 ~am~~~G~L~fPai~VNDs~tK~~FDNrYGtgq----S~~DgI~RaTn~liaGK~vVV~GY------G~---vGrG---- 223 (420)
T COG0499 161 RAMEKDGVLKFPAINVNDSVTKSLFDNRYGTGQ----SLLDGILRATNVLLAGKNVVVAGY------GW---VGRG---- 223 (420)
T ss_pred HHHHhcCCcccceEeecchhhhcccccccccch----hHHHHHHhhhceeecCceEEEecc------cc---cchH----
Confidence 34455554 7777765544333456666311 111333332221 37899999987 33 5688
Q ss_pred HHHHHHHhhccceEEEeeccC
Q 020431 129 SAAIMGALLRAHQVTIWTDVD 149 (326)
Q Consensus 129 ~A~~lA~~l~a~~~~~~tDV~ 149 (326)
.+..++.+||+ ++.|+||
T Consensus 224 -~A~~~rg~GA~--ViVtEvD 241 (420)
T COG0499 224 -IAMRLRGMGAR--VIVTEVD 241 (420)
T ss_pred -HHHHhhcCCCe--EEEEecC
Confidence 78889999996 6677876
No 215
>PRK03659 glutathione-regulated potassium-efflux system protein KefB; Provisional
Probab=46.18 E-value=1e+02 Score=32.13 Aligned_cols=116 Identities=14% Similarity=0.137 Sum_probs=62.9
Q ss_pred HhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCC
Q 020431 38 FVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNI 117 (326)
Q Consensus 38 ~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~ 117 (326)
.++++|.. ++.++..|.++|++.+.+|. |+ ++++.+.+ . ..++++|+..
T Consensus 404 II~G~Gr~--G~~va~~L~~~g~~vvvID~----------------d~----~~v~~~~~--~-g~~v~~GDat------ 452 (601)
T PRK03659 404 IIVGFGRF--GQVIGRLLMANKMRITVLER----------------DI----SAVNLMRK--Y-GYKVYYGDAT------ 452 (601)
T ss_pred EEecCchH--HHHHHHHHHhCCCCEEEEEC----------------CH----HHHHHHHh--C-CCeEEEeeCC------
Confidence 36788888 99999999999998777653 23 44444432 2 3567777622
Q ss_pred cccccCCcchHHHHHHHHhhccceEEEeeccCccc--cc--CCCCCCCCeEEeee-cHHHHHHHhhcCCcccchhhHHHH
Q 020431 118 PTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVY--SA--DPRKVSEAVILRTL-SYQEAWEMSYFGANVLHPRTIIPV 192 (326)
Q Consensus 118 ~~~lgrggsD~~A~~lA~~l~a~~~~~~tDV~Gv~--~~--dP~~~~~a~~i~~l-s~~e~~~l~~~g~~v~~~~a~~~a 192 (326)
|.-.-.-|..-+|+.++..+|-|-.= .. ==+..|+.+.+-+. +.+++.+|...|+..+-|.+++.+
T Consensus 453 ---------~~~~L~~agi~~A~~vv~~~~d~~~n~~i~~~~r~~~p~~~IiaRa~~~~~~~~L~~~Ga~~vv~e~~es~ 523 (601)
T PRK03659 453 ---------QLELLRAAGAEKAEAIVITCNEPEDTMKIVELCQQHFPHLHILARARGRVEAHELLQAGVTQFSRETFSSA 523 (601)
T ss_pred ---------CHHHHHhcCCccCCEEEEEeCCHHHHHHHHHHHHHHCCCCeEEEEeCCHHHHHHHHhCCCCEEEccHHHHH
Confidence 22222233334555555555432100 00 00012444555443 456677777778776656544433
Q ss_pred H
Q 020431 193 M 193 (326)
Q Consensus 193 ~ 193 (326)
.
T Consensus 524 l 524 (601)
T PRK03659 524 L 524 (601)
T ss_pred H
Confidence 3
No 216
>COG0011 Uncharacterized conserved protein [Function unknown]
Probab=45.01 E-value=1.5e+02 Score=23.36 Aligned_cols=71 Identities=10% Similarity=0.023 Sum_probs=43.7
Q ss_pred EEEecCC--CCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 020431 244 VNVEGTG--MAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLS 319 (326)
Q Consensus 244 IsivG~~--~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~ 319 (326)
++++-.+ ..+...+.+++.+.|.+.|++-.. ++.++.|-- +-+++-.+++.+|+..+.....+-...+++.
T Consensus 7 ~sviP~gt~~~svs~yVa~~i~~lk~~glky~~---~pm~T~iEg--~~del~~~ik~~~Ea~~~~g~~Rv~t~ikId 79 (100)
T COG0011 7 LSVIPLGTGGPSVSKYVAEAIEILKESGLKYQL---GPMGTVIEG--ELDELMEAVKEAHEAVFEKGAPRVSTVIKID 79 (100)
T ss_pred EEEEecCCCCCCHHHHHHHHHHHHHHcCCceee---cCcceEEEe--cHHHHHHHHHHHHHHHHhcCCceEEEEEEee
Confidence 4444433 445678999999999999998766 244444433 5556666777777765554333333444443
No 217
>PRK06382 threonine dehydratase; Provisional
Probab=44.66 E-value=1.1e+02 Score=30.22 Aligned_cols=62 Identities=21% Similarity=0.344 Sum_probs=43.2
Q ss_pred ecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEec----C---CccEEEEEEccc---cHHHHHHHHHH
Q 020431 238 IDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA----S---SEHSVCFAVPEK---EVKAVAEALES 302 (326)
Q Consensus 238 ~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~----~---se~sIs~~V~~~---d~~~av~~Lh~ 302 (326)
......+.+. +.+.||.++++.+.++++|+||.-+.+. . ....+.|-++.. +..++++.|.+
T Consensus 327 ~~~~~rl~v~---v~D~pG~L~~l~~ii~~~~~nI~~v~~~~~~~~~~~~~~~v~i~vet~~~~~~~~v~~~L~~ 398 (406)
T PRK06382 327 LGQLVRIECN---IPDRPGNLYRIANAIASNGGNIYHAEVDNLRKETPPGFQSVTFTVNVRGQDHLDRILNALRE 398 (406)
T ss_pred cCCEEEEEEE---cCCCCCHHHHHHHHHhcCCCcEEEEEEeeccccCCCCcEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 3455666674 7899999999999999999999766653 1 244577777764 33355555544
No 218
>TIGR00719 sda_beta L-serine dehydratase, iron-sulfur-dependent, beta subunit. This family of enzymes is not homologous to the pyridoxal phosphate-dependent threonine deaminases and eukaryotic serine deaminases.
Probab=44.63 E-value=49 Score=29.48 Aligned_cols=47 Identities=9% Similarity=0.092 Sum_probs=32.9
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecC---CccEEEEE-EccccHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQAS---SEHSVCFA-VPEKEVKAVAE 298 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~---se~sIs~~-V~~~d~~~av~ 298 (326)
.++||+++++-+.|.+++|||-..+-+- .+..+.++ +++.--+.+++
T Consensus 156 ~D~PG~Ig~vg~~Lg~~~iNIa~m~v~r~~~g~~Ai~vl~vD~~v~~~vl~ 206 (208)
T TIGR00719 156 NDKFGTIAGVANLLAGFEINIEHLETAKKDIGNIALLTIEIDKNIDDHIKD 206 (208)
T ss_pred CCCCChHHHHHHHHHhCCccEEEEEEEecCCCCEEEEEEEeCCCCCHHHHh
Confidence 6899999999999999999997665332 24555555 44444444443
No 219
>PRK03092 ribose-phosphate pyrophosphokinase; Provisional
Probab=44.25 E-value=2.5e+02 Score=26.52 Aligned_cols=34 Identities=24% Similarity=0.208 Sum_probs=25.7
Q ss_pred HhHhhccchHHHHHHHHHHHHHcCCc-eEEEcccc
Q 020431 36 TDFVVGHGELWSAQMLAAVVRKNGID-CKWMDTRE 69 (326)
Q Consensus 36 ~d~i~~~GE~~s~~~~~~~L~~~Gi~-a~~l~~~~ 69 (326)
.|+....||.++++.++..|...|++ .+.+|+..
T Consensus 83 QDr~~~~~e~isak~va~lL~~~g~d~vitvD~H~ 117 (304)
T PRK03092 83 QDKKHRGREPISARLVADLFKTAGADRIMTVDLHT 117 (304)
T ss_pred cccccCCCCCccHHHHHHHHHhcCCCeEEEEecCh
Confidence 45555579999999999999999984 34445543
No 220
>TIGR00177 molyb_syn molybdenum cofactor synthesis domain. The Drosophila protein cinnamon, the Arabidopsis protein cnx1, and rat protein gephyrin each have one domain like MoeA and one like MoaB and Mog. These domains are, however, distantly related to each other, as captured by this model. Gephyrin is unusual in that it seems to be a tubulin-binding neuroprotein involved in the clustering of both blycine receptors and GABA receptors, rather than a protein of molybdenum cofactor biosynthesis.
Probab=43.73 E-value=1.7e+02 Score=24.08 Aligned_cols=65 Identities=22% Similarity=0.300 Sum_probs=40.7
Q ss_pred HHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcc
Q 020431 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (326)
Q Consensus 47 s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggs 126 (326)
++.++.+.|++.|+++.... ++.| |.+...+.++++++ ...+.|++|=.+ .|..
T Consensus 28 n~~~l~~~l~~~G~~v~~~~-----~v~D--------d~~~i~~~l~~~~~--~~DliIttGG~g-----------~g~~ 81 (144)
T TIGR00177 28 NGPLLAALLEEAGFNVSRLG-----IVPD--------DPEEIREILRKAVD--EADVVLTTGGTG-----------VGPR 81 (144)
T ss_pred cHHHHHHHHHHCCCeEEEEe-----ecCC--------CHHHHHHHHHHHHh--CCCEEEECCCCC-----------CCCC
Confidence 46688899999998755542 2232 23334456666655 456777776322 2334
Q ss_pred hHHHHHHHHhh
Q 020431 127 DFSAAIMGALL 137 (326)
Q Consensus 127 D~~A~~lA~~l 137 (326)
|++...++...
T Consensus 82 D~t~~ai~~~g 92 (144)
T TIGR00177 82 DVTPEALEELG 92 (144)
T ss_pred ccHHHHHHHhC
Confidence 88888888776
No 221
>PRK02269 ribose-phosphate pyrophosphokinase; Provisional
Probab=43.13 E-value=3e+02 Score=26.21 Aligned_cols=93 Identities=14% Similarity=0.173 Sum_probs=51.9
Q ss_pred HHhHhhccchHHHHHHHHHHHHHcCCc-eEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcC---CCcEEEecCcc
Q 020431 35 FTDFVVGHGELWSAQMLAAVVRKNGID-CKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQS---PSNTIIATGFI 110 (326)
Q Consensus 35 ~~d~i~~~GE~~s~~~~~~~L~~~Gi~-a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~---~~~ipVv~Gfi 110 (326)
-.|+....||.+++++++..|...|++ .+.+|+..-.+ . +-| +..++.......+.+++... .....|++.+
T Consensus 98 RQDr~~~~~e~isak~~a~ll~~~g~d~vit~D~H~~~~-~-~~f-~~p~~~l~~~p~l~~~i~~~~~~~~~~vvVsPd- 173 (320)
T PRK02269 98 RQDRKARSREPITSKLVANMLEVAGVDRLLTVDLHAAQI-Q-GFF-DIPVDHLMGAPLIADYFDRRGLVGDDVVVVSPD- 173 (320)
T ss_pred hhhcccCCCCCchHHHHHHHHhhcCCCEEEEECCChHHH-h-ccc-cCCchhhhhHHHHHHHHHHhCCCCCCcEEEEEC-
Confidence 356666689999999999999999984 44555543211 1 112 11223223334444444311 1233344332
Q ss_pred ccCCCCCcccccCCcchHHHHHHHHhhccceEEE
Q 020431 111 ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTI 144 (326)
Q Consensus 111 ~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~ 144 (326)
. |+=..|..+|..|+....++
T Consensus 174 ---~----------G~~~~A~~lA~~lg~~~~~~ 194 (320)
T PRK02269 174 ---H----------GGVTRARKLAQFLKTPIAII 194 (320)
T ss_pred ---c----------cHHHHHHHHHHHhCCCEEEE
Confidence 1 24556899999999765443
No 222
>PF09413 DUF2007: Domain of unknown function (DUF2007); InterPro: IPR018551 This is a family of proteins with unknown function. ; PDB: 2HFV_A.
Probab=43.12 E-value=67 Score=22.62 Aligned_cols=46 Identities=26% Similarity=0.315 Sum_probs=29.4
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCCcc--------EEEEEEccccHHHHHHHHHH
Q 020431 257 TANAIFGAVKDVGANVIMISQASSEH--------SVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 257 i~a~if~~L~~~~I~v~~Isq~~se~--------sIs~~V~~~d~~~av~~Lh~ 302 (326)
-+.-+-..|.+.||....-....+.. -+.+.|+++|.++|.+.|++
T Consensus 11 ea~~i~~~L~~~gI~~~v~~~~~~~~~g~~g~~~~~~v~V~~~d~~~A~~il~~ 64 (67)
T PF09413_consen 11 EAELIKGLLEENGIPAFVKNEHMSGYAGEPGTGGQVEVYVPEEDYERAREILEE 64 (67)
T ss_dssp HHHHHHHHHHHTT--EE--S----SS---S--SSSEEEEEEGGGHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCcEEEECCccchhhcccCccCceEEEECHHHHHHHHHHHHH
Confidence 35566778889999866543322221 18899999999999999976
No 223
>COG1778 Low specificity phosphatase (HAD superfamily) [General function prediction only]
Probab=42.72 E-value=23 Score=30.43 Aligned_cols=52 Identities=21% Similarity=0.199 Sum_probs=32.0
Q ss_pred EEeeccCcccccCCCCCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEeccC
Q 020431 143 TIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFN 206 (326)
Q Consensus 143 ~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~~ 206 (326)
.+.+|||||+|+ .+++-.-.-+|. . ...+.+--.++.++++|+.+-|..+-+
T Consensus 10 Lli~DVDGvLTD-------G~ly~~~~Gee~---K--aFnv~DG~Gik~l~~~Gi~vAIITGr~ 61 (170)
T COG1778 10 LLILDVDGVLTD-------GKLYYDENGEEI---K--AFNVRDGHGIKLLLKSGIKVAIITGRD 61 (170)
T ss_pred EEEEeccceeec-------CeEEEcCCCcee---e--eeeccCcHHHHHHHHcCCeEEEEeCCC
Confidence 356899999985 344432212221 1 123444457888889999988887654
No 224
>PRK05788 cobalamin biosynthesis protein CbiG; Validated
Probab=42.32 E-value=26 Score=33.48 Aligned_cols=45 Identities=24% Similarity=0.214 Sum_probs=33.6
Q ss_pred ccCCCCCccc--cc--CCcchHHHHHHHHhhccceEE-EeeccCcccccC
Q 020431 111 ASTPDNIPTT--LK--RDGSDFSAAIMGALLRAHQVT-IWTDVDGVYSAD 155 (326)
Q Consensus 111 ~~~~~g~~~~--lg--rggsD~~A~~lA~~l~a~~~~-~~tDV~Gv~~~d 155 (326)
+.|+.|+..+ +| .||+...|-.+|..+||..++ =.||+.|.+.-|
T Consensus 83 vvDe~G~~vIsLLsGH~GGAN~LA~~iA~~lga~pVITTAtd~~g~~avD 132 (315)
T PRK05788 83 VVDEKGKFVISLLSGHHGGANELARDLAKILGAVPVITTATDVNGKAAVD 132 (315)
T ss_pred EEeCCCCEEEEcccCCcccHHHHHHHHHHHhCCEEEEeCCccccCCccHH
Confidence 5577787644 44 588999999999999997654 466887776543
No 225
>COG3602 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=42.05 E-value=37 Score=27.50 Aligned_cols=65 Identities=15% Similarity=0.203 Sum_probs=49.5
Q ss_pred EEeecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHH
Q 020431 235 FATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 235 I~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~ 302 (326)
+.+.--+.+|++.-..-....|+.+.+-..|+++||...+++ .--+. -+.|+.++.++++..|..
T Consensus 64 l~~~~~~~lITL~VhSsLeaVGltAA~ataLa~aGis~Nvva--ayyHD-HlFVp~e~a~~A~~~L~~ 128 (134)
T COG3602 64 LSYSAVCRLITLNVHSSLEAVGLTAAFATALAEAGISCNVVA--AYYHD-HLFVPAERAKEALVVLQG 128 (134)
T ss_pred CCccceeeeEEeehhhhhhhhhHHHHHHHHHHHcCcccchhh--hhhcc-eeeeeHHHHHHHHHHHHH
Confidence 344455778888766666678999999999999999999886 32333 356788888999888865
No 226
>COG0303 MoeA Molybdopterin biosynthesis enzyme [Coenzyme metabolism]
Probab=41.51 E-value=99 Score=30.64 Aligned_cols=71 Identities=25% Similarity=0.300 Sum_probs=47.7
Q ss_pred HHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcch
Q 020431 48 AQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSD 127 (326)
Q Consensus 48 ~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD 127 (326)
..++.+.|++.|.....+ +++.| |++..++.+++.++ ...+.|++|=.. -|..|
T Consensus 205 ~~~l~a~l~~~G~e~~~~-----giv~D--------d~~~l~~~i~~a~~--~~DviItsGG~S-----------vG~~D 258 (404)
T COG0303 205 SYMLAALLERAGGEVVDL-----GIVPD--------DPEALREAIEKALS--EADVIITSGGVS-----------VGDAD 258 (404)
T ss_pred HHHHHHHHHHcCCceeec-----cccCC--------CHHHHHHHHHHhhh--cCCEEEEeCCcc-----------CcchH
Confidence 457888999999854443 33333 55566677777776 567888877211 14459
Q ss_pred HHHHHHHHhhccceEEEee
Q 020431 128 FSAAIMGALLRAHQVTIWT 146 (326)
Q Consensus 128 ~~A~~lA~~l~a~~~~~~t 146 (326)
++-..+...+| .+.||.
T Consensus 259 ~v~~~l~~~lG--~v~~~g 275 (404)
T COG0303 259 YVKAALERELG--EVLFHG 275 (404)
T ss_pred hHHHHHHhcCC--cEEEEe
Confidence 98888887788 677763
No 227
>PRK07334 threonine dehydratase; Provisional
Probab=41.01 E-value=1.3e+02 Score=29.55 Aligned_cols=58 Identities=21% Similarity=0.412 Sum_probs=40.0
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC-------CccEEEEEEcccc---HHHHHHHHHH
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS-------SEHSVCFAVPEKE---VKAVAEALES 302 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~-------se~sIs~~V~~~d---~~~av~~Lh~ 302 (326)
+.|.|. ..+++|.+++|.+.+++.++||..++..+ ....+.|.+.-.+ +.++++.|.+
T Consensus 327 v~l~I~---~~dr~GlL~dI~~~is~~~~nI~~v~~~~~~~~~~~~~~~i~l~i~V~d~~~L~~vi~~Lr~ 394 (403)
T PRK07334 327 ARLRVD---IRDRPGALARVTALIGEAGANIIEVSHQRLFTDLPAKGAELELVIETRDAAHLQEVIAALRA 394 (403)
T ss_pred EEEEEE---eCCCCCHHHHHHHHHhhCCCceEEEEEEecccCCCCCeEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 666676 45789999999999999999999887432 1333555555444 4455555554
No 228
>smart00852 MoCF_biosynth Probable molybdopterin binding domain. This domain is found a variety of proteins involved in biosynthesis of molybdopterin cofactor. The domain is presumed to bind molybdopterin. The structure of this domain is known, and it forms an alpha/beta structure. In the known structure of Gephyrin this domain mediates trimerisation.
Probab=40.97 E-value=1.2e+02 Score=24.53 Aligned_cols=69 Identities=19% Similarity=0.209 Sum_probs=42.8
Q ss_pred HHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCC
Q 020431 45 LWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRD 124 (326)
Q Consensus 45 ~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrg 124 (326)
-.++..+.+.|++.|....... ++.| |.+...+.++++++ ...+.|++|=.+. |
T Consensus 17 d~~~~~l~~~l~~~G~~~~~~~-----~v~D--------d~~~I~~~l~~~~~--~~dliittGG~g~-----------g 70 (135)
T smart00852 17 DSNGPALAELLTELGIEVTRYV-----IVPD--------DKEAIKEALREALE--RADLVITTGGTGP-----------G 70 (135)
T ss_pred cCcHHHHHHHHHHCCCeEEEEE-----EeCC--------CHHHHHHHHHHHHh--CCCEEEEcCCCCC-----------C
Confidence 4466788999999998755432 2222 33344566666665 3466777663222 2
Q ss_pred cchHHHHHHHHhhcc
Q 020431 125 GSDFSAAIMGALLRA 139 (326)
Q Consensus 125 gsD~~A~~lA~~l~a 139 (326)
-.|++-..++..++.
T Consensus 71 ~~D~t~~~l~~~~~~ 85 (135)
T smart00852 71 PDDVTPEAVAEALGK 85 (135)
T ss_pred CCcCcHHHHHHHhCC
Confidence 348888888888764
No 229
>PRK00549 competence damage-inducible protein A; Provisional
Probab=39.39 E-value=1.4e+02 Score=29.70 Aligned_cols=69 Identities=25% Similarity=0.247 Sum_probs=44.8
Q ss_pred HHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCc
Q 020431 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (326)
Q Consensus 46 ~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrgg 125 (326)
-++..++..|.+.|++..... ++.| |.+...+.+++.++ ...+.|++|=++.+.
T Consensus 20 tN~~~L~~~L~~~G~~v~~~~-----~v~D--------d~~~I~~~l~~a~~--~~DlVItTGGlGpt~----------- 73 (414)
T PRK00549 20 TNAQFLSEKLAELGIDVYHQT-----VVGD--------NPERLLSALEIAEE--RSDLIITTGGLGPTK----------- 73 (414)
T ss_pred hhHHHHHHHHHHCCCeEEEEE-----EeCC--------CHHHHHHHHHHhcc--CCCEEEECCCCCCCC-----------
Confidence 456688999999999765432 2333 23334455555543 456778777445443
Q ss_pred chHHHHHHHHhhccc
Q 020431 126 SDFSAAIMGALLRAH 140 (326)
Q Consensus 126 sD~~A~~lA~~l~a~ 140 (326)
-|.+.-.+|.+++.+
T Consensus 74 dD~t~ea~a~~~g~~ 88 (414)
T PRK00549 74 DDLTKETVAKFLGRE 88 (414)
T ss_pred CccHHHHHHHHhCCC
Confidence 399999999999854
No 230
>cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=38.41 E-value=74 Score=23.19 Aligned_cols=29 Identities=14% Similarity=0.265 Sum_probs=24.1
Q ss_pred EEEecCCCCCcccHHHHHHHHHHhCCCcEEEE
Q 020431 244 VNVEGTGMAGVPGTANAIFGAVKDVGANVIMI 275 (326)
Q Consensus 244 IsivG~~~~~~~~i~a~if~~L~~~~I~v~~I 275 (326)
|.|.. +++||+++++..+|+.+|+||.-.
T Consensus 4 I~V~~---~Dr~gLFa~iag~L~~~~LnI~~A 32 (68)
T cd04928 4 ITFAA---GDKPKLLSQLSSLLGDLGLNIAEA 32 (68)
T ss_pred EEEEE---CCCcchHHHHHHHHHHCCCceEEE
Confidence 45553 479999999999999999998763
No 231
>cd04817 PA_VapT_like PA_VapT_like: Protease-associated domain containing proteins like VapT from Vibrio metschnikovii strain RH530. This group contains various PA domain-containing proteins similar to V. metschnikovii VapT, including the serine alkaline protease SapSh from the psychotroph Shewanella strain Ac10 and the Apa1 protease from the psychrotroph Pseudoalteromonas Sp. As-11. VapT is a sodium dodecyl sulfate (SDS) resistant extracellular alkaline serine protease showing high activity over a broad pH range and temperature. SapSh has a high level of protease activity at low temperatures. Apa1 is also cold-adapted. The significance of the PA domain to these proteins has not been ascertained. It may be a protein-protein interaction domain. At peptidase active sites, the PA domain may participate in substrate binding and/or promoting conformational changes, which influence the stability and accessibility of the site to substrate.
Probab=37.84 E-value=1.6e+02 Score=24.55 Aligned_cols=65 Identities=9% Similarity=0.125 Sum_probs=42.2
Q ss_pred ccCCCCCcccccCCc-c-----hHHHHHHHHhhccceEEEeecc--CcccccCCCCCC--CCeEEe--eecHHHHHHHh
Q 020431 111 ASTPDNIPTTLKRDG-S-----DFSAAIMGALLRAHQVTIWTDV--DGVYSADPRKVS--EAVILR--TLSYQEAWEMS 177 (326)
Q Consensus 111 ~~~~~g~~~~lgrgg-s-----D~~A~~lA~~l~a~~~~~~tDV--~Gv~~~dP~~~~--~a~~i~--~ls~~e~~~l~ 177 (326)
+.+..|++..+-||+ + -.--+..|..-||.-++++.|. +|.+.. .... +...|+ .+++++..+|.
T Consensus 52 ~~d~~GkIaLI~RG~c~~~~~~f~~Kv~~A~~aGA~avIIyNn~~~~g~~~~--~lg~~~~~~~IP~v~is~~dG~~L~ 128 (139)
T cd04817 52 CGGMAGKICLIERGGNSKSVYPEIDKVKACQNAGAIAAIVYSNAALAGLQNP--FLVDTNNDTTIPSVSVDRADGQALL 128 (139)
T ss_pred CCCcCccEEEEECCCCCCCcccHHHHHHHHHHCCCeEEEEEeCCCCCCcccc--cccCCCCCceEeEEEeeHHHHHHHH
Confidence 445568888888885 2 3344777889999999999999 885421 1111 123455 45667666664
No 232
>COG0077 PheA Prephenate dehydratase [Amino acid transport and metabolism]
Probab=37.47 E-value=1.9e+02 Score=27.13 Aligned_cols=126 Identities=18% Similarity=0.130 Sum_probs=68.4
Q ss_pred CCeEEeeecHHHHHHHhhcC-----CcccchhhHHHHHhCCCCEEEEeccCCCCCceEEeCCCCCCCcchhhccCCeeeE
Q 020431 161 EAVILRTLSYQEAWEMSYFG-----ANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGF 235 (326)
Q Consensus 161 ~a~~i~~ls~~e~~~l~~~g-----~~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~~~~~~~~~~~~~~~~~v~~I 235 (326)
.++.+..=|-.+|.++...+ +-+-.+.| |..+|..+...|..+....-|++.--.- . .......
T Consensus 122 ~~~~~~~~STa~Aak~v~~~~~~~~AAIas~~a---A~~YgL~il~~~I~D~~~N~TRF~vl~r-~------~~~~~~~- 190 (279)
T COG0077 122 GVEIEYTSSTAEAAKLVAEGPDETVAAIASELA---AELYGLDILAENIEDEPNNRTRFLVLSR-R------KPPSVSD- 190 (279)
T ss_pred CceEEEcCCHHHHHHHHHhCCCcCeeEEcCHHH---HHHcCcHhHhhcccCCCCCeEEEEEEec-c------CCCCcCC-
Confidence 45666665667777776532 22333333 3457777766665554444565532100 0 0001111
Q ss_pred EeecCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEc------cccHHHHHHHHHH
Q 020431 236 ATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVP------EKEVKAVAEALES 302 (326)
Q Consensus 236 ~~~~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~------~~d~~~av~~Lh~ 302 (326)
. ...+.+-+. +.+.||-+.+++..|+.+|||...|--=.+ --.-.|.|+ +..+.++++.|++
T Consensus 191 -~-~~kTsl~f~---~~n~PGaL~~~L~~Fa~~gINlTkIESRP~k~~~~~Y~F~iD~eg~~~~~~v~~AL~el~~ 261 (279)
T COG0077 191 -G-PEKTSLIFS---VPNKPGALYKALGVFAKRGINLTKIESRPLKTGLGEYLFFIDIEGHIDDPLVKEALEELKE 261 (279)
T ss_pred -C-CceEEEEEE---cCCCCchHHHHHHHHHHcCcceeeEeecccCCCCeeEEEEEEEecCcCcHhHHHHHHHHHh
Confidence 0 012222222 348899999999999999999988851111 233455554 3346778888876
No 233
>PRK11092 bifunctional (p)ppGpp synthetase II/ guanosine-3',5'-bis pyrophosphate 3'-pyrophosphohydrolase; Provisional
Probab=37.33 E-value=2.5e+02 Score=29.98 Aligned_cols=69 Identities=12% Similarity=0.211 Sum_probs=44.1
Q ss_pred CCeeeEEeecC-----eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCc---cEEEEEEcccc---HHHHHH
Q 020431 230 SPVKGFATIDN-----LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE---HSVCFAVPEKE---VKAVAE 298 (326)
Q Consensus 230 ~~v~~I~~~~~-----ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se---~sIs~~V~~~d---~~~av~ 298 (326)
..+-.+.+..+ .+.|.|.+ .+++|+++.|...+++.++||..++..+.. ..+.|.+.-.+ +..++.
T Consensus 610 er~i~v~W~~~~~~~~~v~i~I~~---~dr~GlL~dI~~~i~~~~~nI~~v~~~~~~~~~~~~~~~ieV~~~~~L~~i~~ 686 (702)
T PRK11092 610 EKFMAVEWDKETEQEFIAEIKVEM---FNHQGALANLTAAINTTGSNIQSLNTEEKDGRVYSAFIRLTARDRVHLANIMR 686 (702)
T ss_pred ceeEEeEECCCCCceeEEEEEEEE---eCCCCHHHHHHHHHHHCCCCeEEEEEEEcCCCEEEEEEEEEECCHHHHHHHHH
Confidence 34556677543 24555553 578999999999999999999999843332 13444454444 444454
Q ss_pred HHH
Q 020431 299 ALE 301 (326)
Q Consensus 299 ~Lh 301 (326)
.|.
T Consensus 687 ~Lr 689 (702)
T PRK11092 687 KIR 689 (702)
T ss_pred HHh
Confidence 444
No 234
>PRK11790 D-3-phosphoglycerate dehydrogenase; Provisional
Probab=37.09 E-value=58 Score=32.22 Aligned_cols=52 Identities=21% Similarity=0.232 Sum_probs=33.2
Q ss_pred CCCcccHHHHHHHHHHhCCCcEEEEE-ecCCccEEEEE-EccccHHHHHHHHHH
Q 020431 251 MAGVPGTANAIFGAVKDVGANVIMIS-QASSEHSVCFA-VPEKEVKAVAEALES 302 (326)
Q Consensus 251 ~~~~~~i~a~if~~L~~~~I~v~~Is-q~~se~sIs~~-V~~~d~~~av~~Lh~ 302 (326)
..+.||+++++.+.|+++||||.... ....+..++++ +++..-+.+++.|.+
T Consensus 345 h~d~pG~ia~it~~l~~~~iNI~~m~~~~~~~~A~~iie~D~~~~~~~~~~i~~ 398 (409)
T PRK11790 345 HENRPGVLAAINQIFAEQGINIAAQYLQTDGEIGYVVIDVDADYAEEALDALKA 398 (409)
T ss_pred eCCCCCHHHHHHHHHHhcCCCHHHheeccCCCEEEEEEEeCCCCcHHHHHHHHc
Confidence 46789999999999999999994432 11223333332 444345556666654
No 235
>PRK13581 D-3-phosphoglycerate dehydrogenase; Provisional
Probab=36.16 E-value=2e+02 Score=29.44 Aligned_cols=51 Identities=16% Similarity=0.253 Sum_probs=36.9
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecC---CccEEE-EEEccccHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQAS---SEHSVC-FAVPEKEVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~---se~sIs-~~V~~~d~~~av~~Lh~ 302 (326)
.+.||+++++-+.|++++|||-....+- ....+. +-+++.--+.+++.|++
T Consensus 460 ~D~pG~I~~v~~~L~~~~iNIa~m~~~r~~~g~~al~~i~~D~~v~~~~l~~i~~ 514 (526)
T PRK13581 460 RDRPGVIGKVGTLLGEAGINIAGMQLGRREAGGEALMVLSVDDPVPEEVLEELRA 514 (526)
T ss_pred CCcCChhHHHHHHHhhcCCCchhcEeccCCCCCeEEEEEECCCCCCHHHHHHHhc
Confidence 6889999999999999999997665321 234444 44566556777777765
No 236
>PF12122 DUF3582: Protein of unknown function (DUF3582); InterPro: IPR022732 In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold: Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, N-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins. Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; N, asparagine; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule. In the case of the asparagine endopeptidases, the nucleophile is asparagine and all are self-processing endopeptidases. In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding. Proteolytic enzymes that exploit serine in their catalytic activity are ubiquitous, being found in viruses, bacteria and eukaryotes []. They include a wide range of peptidase activity, including exopeptidase, endopeptidase, oligopeptidase and omega-peptidase activity. Over 20 families (denoted S1 - S66) of serine protease have been identified, these being grouped into clans on the basis of structural similarity and other functional evidence []. Structures are known for members of the clans and the structures indicate that some appear to be totally unrelated, suggesting different evolutionary origins for the serine peptidases []. Not withstanding their different evolutionary origins, there are similarities in the reaction mechanisms of several peptidases. Chymotrypsin, subtilisin and carboxypeptidase C have a catalytic triad of serine, aspartate and histidine in common: serine acts as a nucleophile, aspartate as an electrophile, and histidine as a base []. The geometric orientations of the catalytic residues are similar between families, despite different protein folds []. The linear arrangements of the catalytic residues commonly reflect clan relationships. For example the catalytic triad in the chymotrypsin clan (PA) is ordered HDS, but is ordered DHS in the subtilisin clan (SB) and SDH in the carboxypeptidase clan (SC) [, ]. This entry represents the N-terminal domain of membrane-bound serine endopeptidases belonging to MEROPS peptidase family S54 (rhomboid-1, clan ST). This domain contains a conserved ASW sequence motif and a single completely conserved residue F that may be functionally important. The tertiary structure of the GlpG protein from Escherichia coli has been determined []. The GlpG protein has six transmembrane domains (other members of the family are predicted to have seven), with the N- and C-terminal ends anchored in the cytoplasm. One transmembrane domain is shorter than the rest, creating an internal, aqueous cavity just below the membrane surface and it is here were proteolysis occurs. There is also a membrane-embedded loop between the first and second transmembrane domains which is postulated to act as a gate controlling substrate access to the active site. No other family of serine peptidases is known to have active site residues within transmembrane domains (although transmembrane active sites are known for aspartic peptidase and metallopeptidases), and the GlpG protein has the type structure for clan ST.; GO: 0004252 serine-type endopeptidase activity, 0016021 integral to membrane; PDB: 3UBB_A 3B45_A 3B44_A 2NRF_A 3TXT_A 2O7L_A 2XTU_A 2IRV_A 2XOW_A 2XTV_A ....
Probab=35.97 E-value=1.1e+02 Score=24.03 Aligned_cols=59 Identities=17% Similarity=0.279 Sum_probs=36.0
Q ss_pred CcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEE-ccccHHHHHHHHHHHHHHHhcCCCCc
Q 020431 253 GVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAV-PEKEVKAVAEALESKFREALNAGRLS 314 (326)
Q Consensus 253 ~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V-~~~d~~~av~~Lh~~f~~~~~~~~~~ 314 (326)
++|..+..+.+-|+..||.+.+-.++ +..+.+.+ ++++.+++-.++.. |.....+..+.
T Consensus 8 ~n~r~AqaF~DYl~sqgI~~~i~~~~--~~~~~lwl~de~~~~~a~~el~~-Fl~nP~~~rYq 67 (101)
T PF12122_consen 8 NNPRAAQAFIDYLASQGIELQIEPEG--QGQFALWLHDEEHLEQAEQELEE-FLQNPNDPRYQ 67 (101)
T ss_dssp SSHHHHHHHHHHHHHTT--EEEE-SS--SE--EEEES-GGGHHHHHHHHHH-HHHS-SS----
T ss_pred CCHHHHHHHHHHHHHCCCeEEEEECC--CCceEEEEeCHHHHHHHHHHHHH-HHHCCCCHHHH
Confidence 56888999999999999999887632 33355555 56688888888866 76555544443
No 237
>PRK11898 prephenate dehydratase; Provisional
Probab=34.91 E-value=3e+02 Score=25.67 Aligned_cols=126 Identities=14% Similarity=0.114 Sum_probs=69.4
Q ss_pred CCCeEEeeecHHHHHHHhhcCC----cccchhhHHHHHhCCCCEEEEeccCCCCCceEEe---CCCCCCCcchhhccCCe
Q 020431 160 SEAVILRTLSYQEAWEMSYFGA----NVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC---RPPVDENEDEQIIDSPV 232 (326)
Q Consensus 160 ~~a~~i~~ls~~e~~~l~~~g~----~v~~~~a~~~a~~~~I~v~I~n~~~~~~~GT~I~---~~~~~~~~~~~~~~~~v 232 (326)
|+.+++..-+..+|.++...+. ..+-+ -..|..+|.++.-.|..+....-|++. .+.. . ...
T Consensus 122 p~~~~~~~~sTa~Aa~~v~~~~~~~~aAI~s--~~aa~~ygL~il~~~I~d~~~N~TRF~vi~~~~~-~--------~~~ 190 (283)
T PRK11898 122 PGAELEPANSTAAAAQYVAEHPDEPIAAIAS--ELAAELYGLEILAEDIQDYPNNRTRFWLLGRKKP-P--------PPL 190 (283)
T ss_pred CCCEEEEcCchHHHHHHHhcCCCCCeEEECC--HHHHHHcCCcEehhcCCCCCccceEEEEEEcCcc-c--------CCC
Confidence 5677777777788877765331 12223 334456788887776655333445553 1110 0 000
Q ss_pred eeEEeecCeEEEEEecCCCC-CcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEc----cc--cHHHHHHHHHH
Q 020431 233 KGFATIDNLALVNVEGTGMA-GVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVP----EK--EVKAVAEALES 302 (326)
Q Consensus 233 ~~I~~~~~ia~IsivG~~~~-~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~----~~--d~~~av~~Lh~ 302 (326)
....+ +.+++= .+. +.||.+.++++.|+++|||+..|---++ .-...|.|+ .. .+.+++..|.+
T Consensus 191 ---~~~~~--ktslif-~l~~~~pGsL~~~L~~F~~~~INLt~IeSRP~~~~~~~y~F~vd~eg~~~~~~~~~al~~L~~ 264 (283)
T PRK11898 191 ---RTGGD--KTSLVL-TLPNNLPGALYKALSEFAWRGINLTRIESRPTKTGLGTYFFFIDVEGHIDDVLVAEALKELEA 264 (283)
T ss_pred ---CCCCC--eEEEEE-EeCCCCccHHHHHHHHHHHCCCCeeeEecccCCCCCccEEEEEEEEccCCCHHHHHHHHHHHH
Confidence 00112 222221 122 3499999999999999999998851111 223556655 22 36667777765
No 238
>PRK03562 glutathione-regulated potassium-efflux system protein KefC; Provisional
Probab=34.14 E-value=2e+02 Score=30.09 Aligned_cols=28 Identities=18% Similarity=0.488 Sum_probs=23.5
Q ss_pred hHhhccchHHHHHHHHHHHHHcCCceEEEc
Q 020431 37 DFVVGHGELWSAQMLAAVVRKNGIDCKWMD 66 (326)
Q Consensus 37 d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~ 66 (326)
-.++++|.. ++.++..|.++|++.+.+|
T Consensus 403 vII~G~Gr~--G~~va~~L~~~g~~vvvID 430 (621)
T PRK03562 403 VIIAGFGRF--GQIVGRLLLSSGVKMTVLD 430 (621)
T ss_pred EEEEecChH--HHHHHHHHHhCCCCEEEEE
Confidence 347888888 9999999999999877765
No 239
>PRK06545 prephenate dehydrogenase; Validated
Probab=33.48 E-value=91 Score=30.06 Aligned_cols=60 Identities=10% Similarity=0.165 Sum_probs=39.8
Q ss_pred CeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC----CccEEEEEEcc-ccHHHHHHHHHH
Q 020431 240 NLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS----SEHSVCFAVPE-KEVKAVAEALES 302 (326)
Q Consensus 240 ~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~----se~sIs~~V~~-~d~~~av~~Lh~ 302 (326)
...-+.+. +.+.||.+++++..|++.|||+.-|.-.- ..--+.+.+.. ++.+++...|.+
T Consensus 289 ~~~~~~v~---v~d~pg~~~~~~~~~~~~~i~i~~~~i~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 353 (359)
T PRK06545 289 SFYDLYVD---VPDEPGVIARVTAILGEEGISIENLRILEAREDIHGVLQISFKNEEDRERAKALLEE 353 (359)
T ss_pred cceEEEEe---CCCCCCHHHHHHHHHHHcCCCeecceeeeccCCcCceEEEEeCCHHHHHHHHHHHHh
Confidence 44455554 67899999999999999999987654211 11224444455 466777766655
No 240
>TIGR00200 cinA_nterm competence/damage-inducible protein CinA N-terminal domain. cinA is a DNA damage- or competence-inducible protein that is polycistronic with recA in a number of species
Probab=33.45 E-value=2.2e+02 Score=28.27 Aligned_cols=68 Identities=16% Similarity=0.174 Sum_probs=44.5
Q ss_pred HHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcc
Q 020431 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (326)
Q Consensus 47 s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggs 126 (326)
++..++..|++.|++..... ++.| |.+...+.++++++ ...+.|++|=.+.+. -
T Consensus 21 N~~~l~~~L~~~G~~v~~~~-----~v~D--------d~~~i~~~l~~a~~--~~DlVIttGGlgpt~-----------d 74 (413)
T TIGR00200 21 NAQWLADFLAHQGLPLSRRT-----TVGD--------NPERLKTIIRIASE--RADVLIFNGGLGPTS-----------D 74 (413)
T ss_pred hHHHHHHHHHHCCCeEEEEE-----EeCC--------CHHHHHHHHHHHhc--CCCEEEEcCCCCCCC-----------c
Confidence 46678899999999765532 2232 33334466666664 456777777444433 3
Q ss_pred hHHHHHHHHhhccc
Q 020431 127 DFSAAIMGALLRAH 140 (326)
Q Consensus 127 D~~A~~lA~~l~a~ 140 (326)
|.+.-.+|.+++-+
T Consensus 75 D~t~eava~~~g~~ 88 (413)
T TIGR00200 75 DLTAETIATAKGEP 88 (413)
T ss_pred ccHHHHHHHHhCCC
Confidence 99999999999853
No 241
>PF06153 DUF970: Protein of unknown function (DUF970); InterPro: IPR010375 This is a family of uncharacterised bacterial proteins.; PDB: 3M05_A.
Probab=33.27 E-value=1.7e+02 Score=23.46 Aligned_cols=50 Identities=18% Similarity=0.344 Sum_probs=37.7
Q ss_pred HHHHHHHHHHhCCCcEEEEEecC-----CccEEEEEEccccHHHHHHHHHHHHHH
Q 020431 257 TANAIFGAVKDVGANVIMISQAS-----SEHSVCFAVPEKEVKAVAEALESKFRE 306 (326)
Q Consensus 257 i~a~if~~L~~~~I~v~~Isq~~-----se~sIs~~V~~~d~~~av~~Lh~~f~~ 306 (326)
-..++.++|.++|+.+--++-.- .+..+.+-++++.++++++.+++....
T Consensus 12 Da~~l~~~L~~~g~~~TkLsstGGFLr~GNtTlliGvede~v~~vl~iIk~~c~~ 66 (109)
T PF06153_consen 12 DADDLSDALNENGFRVTKLSSTGGFLREGNTTLLIGVEDEKVDEVLEIIKENCKK 66 (109)
T ss_dssp HHHHHHHHHHHTT--EEEEEEEETTTTEEEEEEEEEEEGGGHHHHHHHHHHHH--
T ss_pred hHHHHHHHHHHCCceEEEEecccceeccCCEEEEEEecHHHHHHHHHHHHHhhcC
Confidence 36789999999999998887211 167788889999999999999997654
No 242
>TIGR02667 moaB_proteo molybdenum cofactor biosynthesis protein B, proteobacterial. This model represents the MoaB protein molybdopterin biosynthesis regions in Proteobacteria. This crystallized but incompletely characterized protein is thought to be involved in, though not required for, early steps in molybdopterin biosynthesis. It may bind a molybdopterin precursor. A distinctive conserved motif PCN near the C-terminus helps distinguish this clade from other homologs, including sets of proteins designated MogA.
Probab=32.73 E-value=2.3e+02 Score=24.08 Aligned_cols=71 Identities=20% Similarity=0.270 Sum_probs=42.8
Q ss_pred hHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccC
Q 020431 44 ELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKR 123 (326)
Q Consensus 44 E~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgr 123 (326)
+--++..+++.|++.|+++..+ .++.| |.+...+.++++++.....+.|++|=.+.
T Consensus 20 ~d~n~~~l~~~L~~~G~~v~~~-----~iv~D--------d~~~i~~~l~~~~~~~~~DlVIttGGtg~----------- 75 (163)
T TIGR02667 20 DDTSGQYLVERLTEAGHRLADR-----AIVKD--------DIYQIRAQVSAWIADPDVQVILITGGTGF----------- 75 (163)
T ss_pred CCCcHHHHHHHHHHCCCeEEEE-----EEcCC--------CHHHHHHHHHHHHhcCCCCEEEECCCcCC-----------
Confidence 3445668888999999865443 23333 33444566666653224577777773332
Q ss_pred CcchHHHHHHHHhhc
Q 020431 124 DGSDFSAAIMGALLR 138 (326)
Q Consensus 124 ggsD~~A~~lA~~l~ 138 (326)
|--|++.-.++..++
T Consensus 76 g~~D~t~eal~~l~~ 90 (163)
T TIGR02667 76 TGRDVTPEALEPLFD 90 (163)
T ss_pred CCCCCcHHHHHHHHC
Confidence 234888888877765
No 243
>PHA01735 hypothetical protein
Probab=32.65 E-value=1.2e+02 Score=22.24 Aligned_cols=49 Identities=16% Similarity=0.199 Sum_probs=34.7
Q ss_pred HHHHHHHhhhcCCCChhHHhHhhccchHHHHHHHH--HHHHHcCCceEEEccccee
Q 020431 18 STYNFLSNVDSGHATESFTDFVVGHGELWSAQMLA--AVVRKNGIDCKWMDTREVL 71 (326)
Q Consensus 18 ~~~~~l~~~~~~~~~~~~~d~i~~~GE~~s~~~~~--~~L~~~Gi~a~~l~~~~~~ 71 (326)
..|.+|+.++. .....+|.+ ||--++-+=+ ..|++++|.++..+++.+-
T Consensus 8 e~fs~LH~~lt----~El~~Riks-geATtaDL~AA~d~Lk~NdItgv~~~gspl~ 58 (76)
T PHA01735 8 EQFDELHQLLT----NELLSRIKS-GEATTADLRAACDWLKSNDITGVAVDGSPLA 58 (76)
T ss_pred HHHHHHHHHHH----HHHHHHHhc-CcccHHHHHHHHHHHHHCCCceeeCCCCHHH
Confidence 34777888774 444555554 7777776554 5899999999999887653
No 244
>TIGR01327 PGDH D-3-phosphoglycerate dehydrogenase. This model represents a long form of D-3-phosphoglycerate dehydrogenase, the serA gene of one pathway of serine biosynthesis. Shorter forms, scoring between trusted and noise cutoff, include SerA from E. coli.
Probab=31.38 E-value=2.1e+02 Score=29.27 Aligned_cols=51 Identities=12% Similarity=0.225 Sum_probs=35.3
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEec---CCccEEEE-EEccccHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQA---SSEHSVCF-AVPEKEVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~---~se~sIs~-~V~~~d~~~av~~Lh~ 302 (326)
.+.||+++++-+.|++++|||-...-+ ..+..+++ -+++.--+.+++.|.+
T Consensus 459 ~D~pG~I~~v~~~L~~~~iNIa~m~~~R~~~g~~al~~i~~D~~v~~~~l~~i~~ 513 (525)
T TIGR01327 459 LDKPGVIGKVGTLLGTAGINIASMQLGRKEKGGEALMLLSLDQPVPDEVLEEIKA 513 (525)
T ss_pred cCcCCcchHHHhHHhhcCCChHHcEeecCCCCCeEEEEEEcCCCCCHHHHHHHhc
Confidence 578999999999999999999654421 12344543 3555555667777665
No 245
>PF00289 CPSase_L_chain: Carbamoyl-phosphate synthase L chain, N-terminal domain; InterPro: IPR005481 Carbamoyl phosphate synthase (CPSase) is a heterodimeric enzyme composed of a small and a large subunit (with the exception of CPSase III, see below). CPSase catalyses the synthesis of carbamoyl phosphate from biocarbonate, ATP and glutamine (6.3.5.5 from EC) or ammonia (6.3.4.16 from EC), and represents the first committed step in pyrimidine and arginine biosynthesis in prokaryotes and eukaryotes, and in the urea cycle in most terrestrial vertebrates [, ]. CPSase has three active sites, one in the small subunit and two in the large subunit. The small subunit contains the glutamine binding site and catalyses the hydrolysis of glutamine to glutamate and ammonia. The large subunit has two homologous carboxy phosphate domains, both of which have ATP-binding sites; however, the N-terminal carboxy phosphate domain catalyses the phosphorylation of biocarbonate, while the C-terminal domain catalyses the phosphorylation of the carbamate intermediate []. The carboxy phosphate domain found duplicated in the large subunit of CPSase is also present as a single copy in the biotin-dependent enzymes acetyl-CoA carboxylase (6.4.1.2 from EC) (ACC), propionyl-CoA carboxylase (6.4.1.3 from EC) (PCCase), pyruvate carboxylase (6.4.1.1 from EC) (PC) and urea carboxylase (6.3.4.6 from EC). Most prokaryotes carry one form of CPSase that participates in both arginine and pyrimidine biosynthesis, however certain bacteria can have separate forms. The large subunit in bacterial CPSase has four structural domains: the carboxy phosphate domain 1, the oligomerisation domain, the carbamoyl phosphate domain 2 and the allosteric domain []. CPSase heterodimers from Escherichia coli contain two molecular tunnels: an ammonia tunnel and a carbamate tunnel. These inter-domain tunnels connect the three distinct active sites, and function as conduits for the transport of unstable reaction intermediates (ammonia and carbamate) between successive active sites []. The catalytic mechanism of CPSase involves the diffusion of carbamate through the interior of the enzyme from the site of synthesis within the N-terminal domain of the large subunit to the site of phosphorylation within the C-terminal domain. Eukaryotes have two distinct forms of CPSase: a mitochondrial enzyme (CPSase I) that participates in both arginine biosynthesis and the urea cycle; and a cytosolic enzyme (CPSase II) involved in pyrimidine biosynthesis. CPSase II occurs as part of a multi-enzyme complex along with aspartate transcarbamoylase and dihydroorotase; this complex is referred to as the CAD protein []. The hepatic expression of CPSase is transcriptionally regulated by glucocorticoids and/or cAMP []. There is a third form of the enzyme, CPSase III, found in fish, which uses glutamine as a nitrogen source instead of ammonia []. CPSase III is closely related to CPSase I, and is composed of a single polypeptide that may have arisen from gene fusion of the glutaminase and synthetase domains []. This entry represents the N-terminal domain of the large subunit of carbamoyl phosphate synthase. This domain can also be found in certain other related proteins. ; GO: 0003824 catalytic activity, 0008152 metabolic process; PDB: 3VA7_A 3OUU_A 3OUZ_B 1W96_B 1W93_A 1ULZ_A 3HB9_C 3HO8_A 3BG5_C 3HBL_A ....
Probab=31.22 E-value=18 Score=28.96 Aligned_cols=29 Identities=21% Similarity=0.434 Sum_probs=24.0
Q ss_pred HhhccchHHHHHHHHHHHHHcCCceEEEccc
Q 020431 38 FVVGHGELWSAQMLAAVVRKNGIDCKWMDTR 68 (326)
Q Consensus 38 ~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~ 68 (326)
.|+..||+ |..+...+++.|++++.++..
T Consensus 6 LIanrGei--a~r~~ra~r~~Gi~tv~v~s~ 34 (110)
T PF00289_consen 6 LIANRGEI--AVRIIRALRELGIETVAVNSN 34 (110)
T ss_dssp EESS-HHH--HHHHHHHHHHTTSEEEEEEEG
T ss_pred EEECCCHH--HHHHHHHHHHhCCcceeccCc
Confidence 36778999 888899999999999999764
No 246
>PRK02458 ribose-phosphate pyrophosphokinase; Provisional
Probab=31.10 E-value=4.8e+02 Score=24.94 Aligned_cols=36 Identities=22% Similarity=0.288 Sum_probs=27.2
Q ss_pred hHHhHhhccchHHHHHHHHHHHHHcCCc-eEEEcccc
Q 020431 34 SFTDFVVGHGELWSAQMLAAVVRKNGID-CKWMDTRE 69 (326)
Q Consensus 34 ~~~d~i~~~GE~~s~~~~~~~L~~~Gi~-a~~l~~~~ 69 (326)
.-.|+....||.+|++.++..|...|.+ .+.+|+..
T Consensus 101 aRQDr~~~~ge~isak~~a~lL~~~g~d~vitvD~H~ 137 (323)
T PRK02458 101 ARQDRIAKPREPITAKLVANMLVKAGVDRVLTLDLHA 137 (323)
T ss_pred chhhcccCCCCCchHHHHHHHHhhcCCCeEEEEecCc
Confidence 3355666689999999999999999984 44556553
No 247
>cd04819 PA_2 PA_2: Protease-associated (PA) domain subgroup 2. A subgroup of PA-domain containing proteins. The PA domain is an insert domain in a diverse fraction of proteases. The significance of the PA domain to many of the proteins in which it is inserted is undetermined. It may be a protein-protein interaction domain. At peptidase active sites, the PA domain may participate in substrate binding and/or promoting conformational changes, which influence the stability and accessibility of the site to substrate. Proteins in this group contain a C-terminal RING-finger domain. Proteins into which the PA domain is inserted include the following: i) various signal peptide peptidases: such as hSPPL2a and 2b, ii) various E3 ubiquitin ligases similar to human GRAIL (gene related to anergy in lymphocytes) protein, iii) various proteins containing a RING finger motif such as Arabidopsis ReMembR-H2 protein, iv) EDEM3 (ER-degradation-enhancing mannosidase-like 3 protein), v) various plant vacuola
Probab=30.72 E-value=1.4e+02 Score=24.07 Aligned_cols=41 Identities=17% Similarity=0.113 Sum_probs=28.2
Q ss_pred CCCCCcccccCCcc-h--HHHHHHHHhhccceEEEeeccCcccc
Q 020431 113 TPDNIPTTLKRDGS-D--FSAAIMGALLRAHQVTIWTDVDGVYS 153 (326)
Q Consensus 113 ~~~g~~~~lgrggs-D--~~A~~lA~~l~a~~~~~~tDV~Gv~~ 153 (326)
+-.|++..+.||+. + .--+..|...||.-++++.+.+|.+.
T Consensus 42 ~v~GkIvlv~~g~~~~~~~~k~~~A~~~GA~avi~~~~~~g~~~ 85 (127)
T cd04819 42 DLEGKIAVVKRDDPDVDRKEKYAKAVAAGAAAFVVVNTVPGVLP 85 (127)
T ss_pred CCCCeEEEEEcCCCchhHHHHHHHHHHCCCEEEEEEeCCCCcCc
Confidence 34455555555543 1 23577888999999999999988653
No 248
>PF08544 GHMP_kinases_C: GHMP kinases C terminal ; InterPro: IPR013750 This domain is found in homoserine kinases (2.7.1.39 from EC), galactokinases (2.7.1.6 from EC) and mevalonate kinases (2.7.1.36 from EC). These kinases make up the GHMP kinase superfamily of ATP-dependent enzymes []. These enzymes are involved in the biosynthesis of isoprenes and amino acids as well as in carbohydrate metabolism. The C-terminal domain of homoserine kinase has a central alpha-beta plait fold and an insertion of four helices, which, together with the N-terminal fold, create a novel nucleotide binding fold [].; PDB: 2R3V_C 4EMD_A 4DXL_A 4ED4_A 2GS8_A 1K47_E 3GON_A 3K17_B 1PIE_A 2AJ4_A ....
Probab=29.86 E-value=1.9e+02 Score=20.82 Aligned_cols=50 Identities=22% Similarity=0.262 Sum_probs=37.0
Q ss_pred cHHHHHHHHHHhCCCcEEEEEecCCccEEEEEE-ccccHHHHHHHHHHHHH
Q 020431 256 GTANAIFGAVKDVGANVIMISQASSEHSVCFAV-PEKEVKAVAEALESKFR 305 (326)
Q Consensus 256 ~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V-~~~d~~~av~~Lh~~f~ 305 (326)
.-+.++.+.+.+.|+-.-.+|.+...-++-.+. ++.+.+++.+.+.+.|.
T Consensus 34 ~~i~~~~~~~~~~Ga~~~~~sGsG~G~~v~~l~~~~~~~~~v~~~l~~~~~ 84 (85)
T PF08544_consen 34 PEIDELKEAAEENGALGAKMSGSGGGPTVFALCKDEDDAERVAEALREHYK 84 (85)
T ss_dssp HHHHHHHHHHHHTTESEEEEETTSSSSEEEEEESSHHHHHHHHHHHHHHTH
T ss_pred HHHHHHHHHHHHCCCCceecCCCCCCCeEEEEECCHHHHHHHHHHHHHhCC
Confidence 346778889999996667777322277888888 56688999999987653
No 249
>TIGR02726 phenyl_P_delta phenylphosphate carboxylase, delta subunit. Members of this protein family are the alpha subunit of phenylphosphate carboxylase. Phenol (methyl-benzene) is converted to phenylphosphate, then para-carboxylated by this four-subunit enzyme, with the release of phosphate, to 4-hydroxybenzoate. The enzyme contains neither biotin nor thiamin pyrophosphate. This delta subunit belongs to HAD family hydrolases.
Probab=29.76 E-value=45 Score=28.72 Aligned_cols=50 Identities=20% Similarity=0.213 Sum_probs=27.1
Q ss_pred EEeeccCcccccCCC-CCCCCeEEeeecHHHHHHHhhcCCcccchhhHHHHHhCCCCEEEEecc
Q 020431 143 TIWTDVDGVYSADPR-KVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIF 205 (326)
Q Consensus 143 ~~~tDV~Gv~~~dP~-~~~~a~~i~~ls~~e~~~l~~~g~~v~~~~a~~~a~~~~I~v~I~n~~ 205 (326)
.+.+|||||+|..-- ..++......++... --++..+.+.|+++.|.+..
T Consensus 9 ~~v~d~dGv~tdg~~~~~~~g~~~~~~~~~D-------------~~~~~~L~~~Gi~laIiT~k 59 (169)
T TIGR02726 9 LVILDVDGVMTDGRIVINDEGIESRNFDIKD-------------GMGVIVLQLCGIDVAIITSK 59 (169)
T ss_pred EEEEeCceeeECCeEEEcCCCcEEEEEecch-------------HHHHHHHHHCCCEEEEEECC
Confidence 367899999996311 112233333333221 22456666777777766544
No 250
>TIGR00106 uncharacterized protein, MTH1187 family. This protein has been crystallized in both Methanobacterium thermoautotrophicum and yeast, but its function remains unknown. Both crystal structures showed sulfate ions bound at the interface of two dimers to form a tetramer.
Probab=29.56 E-value=2.7e+02 Score=21.63 Aligned_cols=63 Identities=11% Similarity=0.051 Sum_probs=41.2
Q ss_pred CcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEEc
Q 020431 253 GVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLSF 320 (326)
Q Consensus 253 ~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~~ 320 (326)
+...+.+++.+.|.+.|++..+- +.++.|- -+-+++-.+++.+|+..+...-.+-+..+++.+
T Consensus 16 s~s~yVa~~i~~l~~sGl~y~~~---pm~T~IE--Ge~dev~~~i~~~~e~~~~~G~~Rv~t~ikid~ 78 (97)
T TIGR00106 16 SVSSYVAAAIEVLKESGLKYELH---PMGTLIE--GDLDELFEAIKAIHEAVLEKGSDRVYTSIKIDT 78 (97)
T ss_pred cHHHHHHHHHHHHHHcCCCeEec---CCccEEe--cCHHHHHHHHHHHHHHHHHcCCCeEEEEEEEEe
Confidence 45678999999999999998873 3344443 234566677777887776654444444444443
No 251
>cd00886 MogA_MoaB MogA_MoaB family. Members of this family are involved in biosynthesis of the molybdenum cofactor (MoCF) an essential cofactor of a diverse group of redox enzymes. MoCF biosynthesis is an evolutionarily conserved pathway present in eubacteria, archaea, and eukaryotes. MoCF contains a tricyclic pyranopterin, termed molybdopterin (MPT). MogA, together with MoeA, is responsible for the metal incorporation into MPT, the third step in MoCF biosynthesis. The plant homolog Cnx1 is a MoeA-MogA fusion protein. The mammalian homolog gephyrin is a MogA-MoeA fusion protein, that plays a critical role in postsynaptic anchoring of inhibitory glycine receptors and major GABAa receptor subtypes. In contrast, MoaB shows high similarity to MogA, but little is known about its physiological role. All well studied members of this family form highly stable trimers.
Probab=29.37 E-value=3.2e+02 Score=22.71 Aligned_cols=68 Identities=22% Similarity=0.274 Sum_probs=40.1
Q ss_pred HHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcc
Q 020431 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (326)
Q Consensus 47 s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggs 126 (326)
++.++.+.|++.|.+.... .++.| |.+...+.+++.++.....+.|++|=.+.+ .-
T Consensus 21 n~~~l~~~l~~~G~~v~~~-----~~v~D--------d~~~i~~~l~~~~~~~~~DlVittGG~s~g-----------~~ 76 (152)
T cd00886 21 SGPALVELLEEAGHEVVAY-----EIVPD--------DKDEIREALIEWADEDGVDLILTTGGTGLA-----------PR 76 (152)
T ss_pred hHHHHHHHHHHcCCeeeeE-----EEcCC--------CHHHHHHHHHHHHhcCCCCEEEECCCcCCC-----------CC
Confidence 4667889999999864443 23333 333344556655541134677777733322 33
Q ss_pred hHHHHHHHHhhc
Q 020431 127 DFSAAIMGALLR 138 (326)
Q Consensus 127 D~~A~~lA~~l~ 138 (326)
|++...++..++
T Consensus 77 D~t~~al~~~~~ 88 (152)
T cd00886 77 DVTPEATRPLLD 88 (152)
T ss_pred cCcHHHHHHHhC
Confidence 787777777764
No 252
>TIGR01251 ribP_PPkin ribose-phosphate pyrophosphokinase. In some systems, close homologs lacking enzymatic activity exist and perform regulatory functions. The model is designated subfamily rather than equivalog for this reason.
Probab=29.36 E-value=1.3e+02 Score=28.46 Aligned_cols=94 Identities=18% Similarity=0.130 Sum_probs=50.8
Q ss_pred HhHhhccchHHHHHHHHHHHHHcCCce-EEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcC-CCcEEEecCccccC
Q 020431 36 TDFVVGHGELWSAQMLAAVVRKNGIDC-KWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQS-PSNTIIATGFIAST 113 (326)
Q Consensus 36 ~d~i~~~GE~~s~~~~~~~L~~~Gi~a-~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~-~~~ipVv~Gfi~~~ 113 (326)
.|+..-.||.++++.++..|.+.|.+. ..+++..-.+ .+-| +..++.......+-+++... .....|+ +.+
T Consensus 95 qDr~~~~ge~is~~~~a~ll~~~g~d~vit~DlHs~~~--~~~f-~ip~~~l~a~~~l~~~i~~~~~~~~viv----~pd 167 (308)
T TIGR01251 95 QDKKFKSREPISAKLVANLLETAGADRVLTVDLHSPQI--QGFF-DVPVDNLYASPVLAEYLKKKILDNPVVV----SPD 167 (308)
T ss_pred hccccCCCCCchHHHHHHHHHHcCCCEEEEecCChHHh--cCcC-CCceecccCHHHHHHHHHhhCCCCCEEE----EEC
Confidence 455556799999999999999999854 3445543211 1111 11222222223334444321 1222222 222
Q ss_pred CCCCcccccCCcchHHHHHHHHhhccceEEEee
Q 020431 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWT 146 (326)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~t 146 (326)
. |+-..|..+|..|+.....+.+
T Consensus 168 ~----------g~~~~A~~lA~~Lg~~~~~i~k 190 (308)
T TIGR01251 168 A----------GGVERAKKVADALGCPLAIIDK 190 (308)
T ss_pred C----------chHHHHHHHHHHhCCCEEEEEE
Confidence 1 2455689999999976555544
No 253
>smart00460 TGc Transglutaminase/protease-like homologues. Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events.
Probab=29.20 E-value=68 Score=22.22 Aligned_cols=24 Identities=29% Similarity=0.519 Sum_probs=20.5
Q ss_pred cchHHHHHHHHHHHHHcCCceEEEcc
Q 020431 42 HGELWSAQMLAAVVRKNGIDCKWMDT 67 (326)
Q Consensus 42 ~GE~~s~~~~~~~L~~~Gi~a~~l~~ 67 (326)
+.+. |.+++..|+..||++..+.+
T Consensus 9 C~~~--a~l~~~llr~~GIpar~v~g 32 (68)
T smart00460 9 CGEF--AALFVALLRSLGIPARVVSG 32 (68)
T ss_pred eHHH--HHHHHHHHHHCCCCeEEEee
Confidence 4566 88999999999999999865
No 254
>PRK01259 ribose-phosphate pyrophosphokinase; Provisional
Probab=28.15 E-value=1.4e+02 Score=28.32 Aligned_cols=93 Identities=17% Similarity=0.083 Sum_probs=51.6
Q ss_pred hHHhHhhccchHHHHHHHHHHHHHcCCce-EEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcC-CCcEEEecCccc
Q 020431 34 SFTDFVVGHGELWSAQMLAAVVRKNGIDC-KWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQS-PSNTIIATGFIA 111 (326)
Q Consensus 34 ~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a-~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~-~~~ipVv~Gfi~ 111 (326)
.-+|+....||.++++.++..|...|.+. +.+|+..-.+ .+-| +..++.......+.+++... .....|+ +
T Consensus 92 sRQDr~~~~ge~isak~~a~lL~~~g~d~vitvD~H~~~~--~~~f-~~p~~~l~~~~~l~~~i~~~~~~~~vvv----~ 164 (309)
T PRK01259 92 ARQDRKARSRVPITAKLVANLLETAGADRVLTMDLHADQI--QGFF-DIPVDNLYGSPILLEDIKQKNLENLVVV----S 164 (309)
T ss_pred chhhhhhccCCCchHHHHHHHHhhcCCCEEEEEcCChHHH--cCcC-CCCceeeeecHHHHHHHHhcCCCCcEEE----E
Confidence 34566666799999999999999999854 3456554311 1111 11222222223344444311 1222333 2
Q ss_pred cCCCCCcccccCCcchHHHHHHHHhhccceEE
Q 020431 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVT 143 (326)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~ 143 (326)
.+. |+-..|..+|..|+.....
T Consensus 165 pd~----------Gg~~~A~~la~~Lg~~~~~ 186 (309)
T PRK01259 165 PDV----------GGVVRARALAKRLDADLAI 186 (309)
T ss_pred ECC----------CcHHHHHHHHHHhCCCEEE
Confidence 221 3466799999999976554
No 255
>PRK11899 prephenate dehydratase; Provisional
Probab=27.82 E-value=1.9e+02 Score=27.09 Aligned_cols=51 Identities=16% Similarity=0.189 Sum_probs=36.4
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEcc------ccHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPE------KEVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~------~d~~~av~~Lh~ 302 (326)
.+.||.+.++++.|+++|||...|---+. .-...|.++= ..+.++++.|.+
T Consensus 202 ~~~pGaL~~vL~~Fa~~gINLtkIeSRP~~~~~~~Y~F~id~eg~~~d~~v~~aL~~l~~ 261 (279)
T PRK11899 202 RNIPAALYKALGGFATNGVNMTKLESYMVGGSFTATQFYADIEGHPEDRNVALALEELRF 261 (279)
T ss_pred CCCCChHHHHHHHHHHcCCCeeeEEeeecCCCCceEEEEEEEECCCCCHHHHHHHHHHHH
Confidence 47899999999999999999988852211 3456777662 235566766655
No 256
>PF11823 DUF3343: Protein of unknown function (DUF3343); InterPro: IPR021778 This family of proteins are functionally uncharacterised. This protein is found in bacteria and archaea. Proteins in this family are typically between 78 to 102 amino acids in length.
Probab=27.60 E-value=1.8e+02 Score=20.97 Aligned_cols=48 Identities=17% Similarity=0.210 Sum_probs=38.6
Q ss_pred ccHHHHHHHHHHhCCCcEEEEEecC---CccEEEEEEccccHHHHHHHHHH
Q 020431 255 PGTANAIFGAVKDVGANVIMISQAS---SEHSVCFAVPEKEVKAVAEALES 302 (326)
Q Consensus 255 ~~i~a~if~~L~~~~I~v~~Isq~~---se~sIs~~V~~~d~~~av~~Lh~ 302 (326)
..-+-+.-+.|.++|++..++.-+. +...+++-++.+|.+.+.+.|.+
T Consensus 11 t~~a~~~ek~lk~~gi~~~liP~P~~i~~~CG~al~~~~~d~~~i~~~l~~ 61 (73)
T PF11823_consen 11 THDAMKAEKLLKKNGIPVRLIPTPREISAGCGLALRFEPEDLEKIKEILEE 61 (73)
T ss_pred HHHHHHHHHHHHHCCCcEEEeCCChhccCCCCEEEEEChhhHHHHHHHHHH
Confidence 3446677789999999999986332 37789999999999999999887
No 257
>PF09413 DUF2007: Domain of unknown function (DUF2007); InterPro: IPR018551 This is a family of proteins with unknown function. ; PDB: 2HFV_A.
Probab=27.04 E-value=62 Score=22.80 Aligned_cols=33 Identities=15% Similarity=0.218 Sum_probs=19.4
Q ss_pred hhccchHHHHHHHHHHHHHcCCceEEEccccee
Q 020431 39 VVGHGELWSAQMLAAVVRKNGIDCKWMDTREVL 71 (326)
Q Consensus 39 i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~ 71 (326)
+..++..+-|.++...|++.||++...+.....
T Consensus 3 l~~~~~~~ea~~i~~~L~~~gI~~~v~~~~~~~ 35 (67)
T PF09413_consen 3 LYTAGDPIEAELIKGLLEENGIPAFVKNEHMSG 35 (67)
T ss_dssp EEEE--HHHHHHHHHHHHHTT--EE--S----S
T ss_pred EEEcCCHHHHHHHHHHHHhCCCcEEEECCccch
Confidence 345677889999999999999999988765443
No 258
>cd02129 PA_hSPPL_like PA_hSPPL_like: Protease-associated domain containing human signal peptide peptidase-like (hSPPL)-like. This group contains various PA domain-containing proteins similar to hSPPL2a and 2b. These SPPLs are GxGD aspartic proteases. SPPL2a is sorted to the late endosomes, SPPL2b to the plasma membrane. In activated dendritic cells, hSPPL2a and 2b catalyze the intramembrane proteolysis of tumor necrosis factor alpha triggering IL-12 production. hSPPL2a and 2b may have a broad substrate spectrum. The significance of the PA domain to these SPPLs has not been ascertained. It may be a protein-protein interaction domain. At peptidase active sites, the PA domain may participate in substrate binding and/or promoting conformational changes, which influence the stability and accessibility of the site to substrate.
Probab=26.80 E-value=2.9e+02 Score=22.43 Aligned_cols=63 Identities=17% Similarity=0.189 Sum_probs=36.5
Q ss_pred CCCcccccCCcc-hHHHHHHHHhhccceEEEeeccCcccccCCCCCCCCe--EEeeecHHHHHHHh
Q 020431 115 DNIPTTLKRDGS-DFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAV--ILRTLSYQEAWEMS 177 (326)
Q Consensus 115 ~g~~~~lgrggs-D~~A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~--~i~~ls~~e~~~l~ 177 (326)
.|.+..+-||+- =..=+..|...||..++++.|.++..-.+.......- +.-.|++++...|.
T Consensus 44 ~gkIaLV~RG~CsF~~K~~~Aq~aGA~aVII~nn~~~~~~~~~~~~~~~v~IP~v~Is~~dG~~i~ 109 (120)
T cd02129 44 KGKAVVVMRGNCTFYEKARLAQSLGAEGLLIVSRERLVPPSGNRSEYEKIDIPVALLSYKDMLDIQ 109 (120)
T ss_pred CCeEEEEECCCcCHHHHHHHHHHCCCCEEEEEECCCCCCCCCCCCCCcCCcccEEEEeHHHHHHHH
Confidence 366666677752 2223677999999999999998753211100001111 33356777776664
No 259
>cd00758 MoCF_BD MoCF_BD: molybdenum cofactor (MoCF) binding domain (BD). This domain is found a variety of proteins involved in biosynthesis of molybdopterin cofactor, like MoaB, MogA, and MoeA. The domain is presumed to bind molybdopterin.
Probab=26.71 E-value=3.4e+02 Score=21.87 Aligned_cols=66 Identities=15% Similarity=0.153 Sum_probs=40.5
Q ss_pred HHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCc
Q 020431 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (326)
Q Consensus 46 ~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrgg 125 (326)
-++.++.+.|++.|.+.... .++.| |.....+.++++++ ...+.|++|=.+. |-
T Consensus 19 ~n~~~l~~~l~~~G~~v~~~-----~~v~D--------d~~~i~~~i~~~~~--~~DlvittGG~g~-----------g~ 72 (133)
T cd00758 19 TNGPALEALLEDLGCEVIYA-----GVVPD--------DADSIRAALIEASR--EADLVLTTGGTGV-----------GR 72 (133)
T ss_pred chHHHHHHHHHHCCCEEEEe-----eecCC--------CHHHHHHHHHHHHh--cCCEEEECCCCCC-----------CC
Confidence 35678889999999765433 12232 33344566666665 3567777763332 23
Q ss_pred chHHHHHHHHhh
Q 020431 126 SDFSAAIMGALL 137 (326)
Q Consensus 126 sD~~A~~lA~~l 137 (326)
.|.+...++...
T Consensus 73 ~D~t~~ai~~~g 84 (133)
T cd00758 73 RDVTPEALAELG 84 (133)
T ss_pred CcchHHHHHHhc
Confidence 488888887765
No 260
>PRK04923 ribose-phosphate pyrophosphokinase; Provisional
Probab=25.83 E-value=5.6e+02 Score=24.44 Aligned_cols=34 Identities=18% Similarity=0.144 Sum_probs=24.7
Q ss_pred HhHhh-ccchHHHHHHHHHHHHHcCCc-eEEEcccc
Q 020431 36 TDFVV-GHGELWSAQMLAAVVRKNGID-CKWMDTRE 69 (326)
Q Consensus 36 ~d~i~-~~GE~~s~~~~~~~L~~~Gi~-a~~l~~~~ 69 (326)
.|+.. ..||.++++.++..|.+.|.+ .+.+|+..
T Consensus 100 QDr~~~~~~~~isak~va~ll~~~g~d~vitvD~H~ 135 (319)
T PRK04923 100 QDRRMRSSRVPITAKVAAKMISAMGADRVLTVDLHA 135 (319)
T ss_pred ccccccCCCCCccHHHHHHHHHhcCCCEEEEEeCCh
Confidence 44444 457799999999999999984 44556553
No 261
>COG0329 DapA Dihydrodipicolinate synthase/N-acetylneuraminate lyase [Amino acid transport and metabolism / Cell envelope biogenesis, outer membrane]
Probab=25.71 E-value=3.2e+02 Score=25.73 Aligned_cols=54 Identities=15% Similarity=0.100 Sum_probs=32.7
Q ss_pred HHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCc
Q 020431 48 AQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGF 109 (326)
Q Consensus 48 ~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gf 109 (326)
-+.+++.+.+.|++...+.+... +. .....+.-.+.++...+...+++||+.|-
T Consensus 27 ~~~lv~~li~~Gv~gi~~~GttG-----E~---~~Ls~eEr~~v~~~~v~~~~grvpviaG~ 80 (299)
T COG0329 27 LRRLVEFLIAAGVDGLVVLGTTG-----ES---PTLTLEERKEVLEAVVEAVGGRVPVIAGV 80 (299)
T ss_pred HHHHHHHHHHcCCCEEEECCCCc-----cc---hhcCHHHHHHHHHHHHHHHCCCCcEEEec
Confidence 35567889999999888876422 10 11122222244555555457899999884
No 262
>cd00952 CHBPH_aldolase Trans-o-hydroxybenzylidenepyruvate hydratase-aldolase (HBPHA) and trans-2'-carboxybenzalpyruvate hydratase-aldolase (CBPHA). HBPHA catalyzes HBP to salicyaldehyde and pyruvate. This reaction is part of the degradative pathways for naphthalene and naphthalenesulfonates by bacteria. CBPHA is homologous to HBPHA and catalyzes the cleavage of CBP to 2-carboxylbenzaldehyde and pyruvate during the degradation of phenanthrene. They are member of the DHDPS family of Schiff-base-dependent class I aldolases.
Probab=25.02 E-value=1.6e+02 Score=27.89 Aligned_cols=79 Identities=11% Similarity=-0.021 Sum_probs=44.6
Q ss_pred HHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccCCCCCcccccCCcchH
Q 020431 49 QMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDF 128 (326)
Q Consensus 49 ~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~~~g~~~~lgrggsD~ 128 (326)
+.++..+.+.|++...+.++.. .+ .....+.-.+.++...+...+++||+.|- + ...|- |.
T Consensus 32 ~~lv~~li~~Gv~Gi~v~GstG------E~--~~Lt~eEr~~v~~~~~~~~~grvpvi~Gv-~-----~~~t~-----~a 92 (309)
T cd00952 32 ARLVERLIAAGVDGILTMGTFG------EC--ATLTWEEKQAFVATVVETVAGRVPVFVGA-T-----TLNTR-----DT 92 (309)
T ss_pred HHHHHHHHHcCCCEEEECcccc------cc--hhCCHHHHHHHHHHHHHHhCCCCCEEEEe-c-----cCCHH-----HH
Confidence 4557788889999888866422 01 11122222244555555457889999773 2 11110 21
Q ss_pred -HHHHHHHhhccceEEEee
Q 020431 129 -SAAIMGALLRAHQVTIWT 146 (326)
Q Consensus 129 -~A~~lA~~l~a~~~~~~t 146 (326)
-.+..|..+||+.+.+..
T Consensus 93 i~~a~~A~~~Gad~vlv~~ 111 (309)
T cd00952 93 IARTRALLDLGADGTMLGR 111 (309)
T ss_pred HHHHHHHHHhCCCEEEECC
Confidence 245667778888776654
No 263
>PF11713 Peptidase_C80: Peptidase C80 family; InterPro: IPR020974 In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold: Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, N-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins. Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; N, asparagine; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule. In the case of the asparagine endopeptidases, the nucleophile is asparagine and all are self-processing endopeptidases. In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding. Cysteine peptidases have characteristic molecular topologies, which can be seen not only in their three-dimensional structures, but commonly also in the two-dimensional structures. These are peptidases in which the nucleophile is the sulphydryl group of a cysteine residue. Cysteine proteases are divided into clans (proteins which are evolutionary related), and further sub-divided into families, on the basis of the architecture of their catalytic dyad or triad []. This entry identifies a domain that functions as a cysteine peptidase that belongs to MEROPS peptidase family C80 (RTX self-cleaving toxin, clan CD). This domain is found in bacterial toxins that self-process by a cysteine peptidase mechanism. These include Vibrio cholerae RTX toxin [], and Clostridium difficile toxins A and B []. Some pathogenic bacteria produce unrelated toxins that also require activation and processing, the processing often being autolytic as it is in anthrax lethal factor, tentoxilysin (the tetanus neurotoxin) and bontoxilysin (the botulinum neurotoxin), all of which are metallopeptidases.; PDB: 3GCD_C 3EEB_B 3FZY_A 3PEE_A 3PA8_B 3HO6_A.
Probab=24.54 E-value=1.2e+02 Score=25.90 Aligned_cols=35 Identities=20% Similarity=0.188 Sum_probs=29.0
Q ss_pred EEEEecCCCCCc---ccHHHHHHHHHHhCCCcEEEEEe
Q 020431 243 LVNVEGTGMAGV---PGTANAIFGAVKDVGANVIMISQ 277 (326)
Q Consensus 243 ~IsivG~~~~~~---~~i~a~if~~L~~~~I~v~~Isq 277 (326)
.|+++|..+.+. .+|..++...|.+.||+.....+
T Consensus 105 ~IsLvGC~l~~~~~~~~fa~~f~~~L~~~gi~~~V~A~ 142 (157)
T PF11713_consen 105 KISLVGCSLADNNKQESFALQFAQALKKQGINASVSAY 142 (157)
T ss_dssp EEEEESSS-S-TTGGGSHHHHHHHHHHHHHHCEEEEEE
T ss_pred EEEEEEecccCCcccccHHHHHHHHHHhcCCcceEEEE
Confidence 778899888765 78999999999999999888775
No 264
>PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i.e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B ....
Probab=24.54 E-value=64 Score=24.75 Aligned_cols=28 Identities=18% Similarity=0.259 Sum_probs=21.0
Q ss_pred ccchHHHHHHHHHHHHHcCCceEEEcccce
Q 020431 41 GHGELWSAQMLAAVVRKNGIDCKWMDTREV 70 (326)
Q Consensus 41 ~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~ 70 (326)
.+.+. |.++++.|+..||+|..+.+...
T Consensus 53 ~C~~~--a~l~~allr~~Gipar~v~g~~~ 80 (113)
T PF01841_consen 53 DCEDY--ASLFVALLRALGIPARVVSGYVK 80 (113)
T ss_dssp SHHHH--HHHHHHHHHHHT--EEEEEEEEE
T ss_pred ccHHH--HHHHHHHHhhCCCceEEEEEEcC
Confidence 46677 89999999999999999876433
No 265
>TIGR00691 spoT_relA (p)ppGpp synthetase, RelA/SpoT family. (p)ppGpp is a regulatory metabolite of the stringent response, but appears also to be involved in antibiotic biosynthesis in some species.
Probab=24.45 E-value=2.9e+02 Score=29.43 Aligned_cols=67 Identities=15% Similarity=0.190 Sum_probs=43.0
Q ss_pred CeeeEEeecC-----eEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCc---cEEEEEEccccHHHHHHHH
Q 020431 231 PVKGFATIDN-----LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE---HSVCFAVPEKEVKAVAEAL 300 (326)
Q Consensus 231 ~v~~I~~~~~-----ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se---~sIs~~V~~~d~~~av~~L 300 (326)
.+-.+.+..+ .+.|.|. ..+++|+++.|...+++.++||..++..+.. ..+.|.+.-.+...+-..+
T Consensus 595 r~I~v~W~~~~~~~f~v~I~I~---~~dr~GlLadI~~~ia~~~~nI~~v~~~~~~~~~~~~~~~ieV~~~~~L~~ii 669 (683)
T TIGR00691 595 KIIEVEWNASKPRRFIVDINIE---AVDRKGVLSDLTTAISENDSNIVSISTKTYGKREAILNITVEIKNYKHLLKIM 669 (683)
T ss_pred cEEEEEecCCCCceeEEEEEEE---EecCCCHHHHHHHHHHHCCCCeEEEEeEEcCCCEEEEEEEEEECCHHHHHHHH
Confidence 4445666543 2455555 4578999999999999999999988854332 2344555544444443333
No 266
>PF13721 SecD-TM1: SecD export protein N-terminal TM region
Probab=23.71 E-value=3.3e+02 Score=21.30 Aligned_cols=44 Identities=18% Similarity=0.174 Sum_probs=33.9
Q ss_pred HHHHHHHHhCCCcEEEEEecCCccEEEEEEccc-cHHHHHHHHHHHH
Q 020431 259 NAIFGAVKDVGANVIMISQASSEHSVCFAVPEK-EVKAVAEALESKF 304 (326)
Q Consensus 259 a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~-d~~~av~~Lh~~f 304 (326)
.++-+.|.++||.+..|.+. +.++-+.+++. +--+|-+.|.+.+
T Consensus 49 ~~v~~~L~~~~I~~k~i~~~--~~~llirf~~~~~Ql~Ak~~L~~~L 93 (101)
T PF13721_consen 49 FQVEQALKAAGIAVKSIEQE--GDSLLIRFDSTDQQLKAKDVLSKAL 93 (101)
T ss_pred HHHHHHHHHCCCCcceEEee--CCEEEEEECCHHHHHHHHHHHHHHc
Confidence 59999999999999999854 67777777776 4555666666644
No 267
>PRK10872 relA (p)ppGpp synthetase I/GTP pyrophosphokinase; Provisional
Probab=23.36 E-value=3.3e+02 Score=29.36 Aligned_cols=68 Identities=13% Similarity=0.099 Sum_probs=43.8
Q ss_pred CeeeEEeecC---e--EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecCCc----cEEEEEEcccc---HHHHHH
Q 020431 231 PVKGFATIDN---L--ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVPEKE---VKAVAE 298 (326)
Q Consensus 231 ~v~~I~~~~~---i--a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~se----~sIs~~V~~~d---~~~av~ 298 (326)
.+-.+.+..+ . +.|.|. ..+++|+++.|.+.+++.++||..++..+.. ..+.|.+.-.+ +.+++.
T Consensus 651 R~I~V~W~~~~~~~~~v~I~I~---~~Dr~GlL~dIt~~is~~~~nI~~v~~~~~~~~~~~~~~~~ieV~~~~~L~~l~~ 727 (743)
T PRK10872 651 RIVDAVWGESYSSGYSLVVRVT---ANDRSGLLRDITTILANEKVNVLGVASRSDTKQQLATIDMTIEIYNLQVLGRVLG 727 (743)
T ss_pred eEEEeEecCCCCceeEEEEEEE---EcCCCCHHHHHHHHHHHCCCCeEEEEeEEcCCCCEEEEEEEEEECCHHHHHHHHH
Confidence 4556777532 1 345555 4578999999999999999999988743322 33555555444 444454
Q ss_pred HHH
Q 020431 299 ALE 301 (326)
Q Consensus 299 ~Lh 301 (326)
.|.
T Consensus 728 ~L~ 730 (743)
T PRK10872 728 KLN 730 (743)
T ss_pred HHh
Confidence 444
No 268
>PF01910 DUF77: Domain of unknown function DUF77; InterPro: IPR002767 This entry contains several hypothetical proteins of unknown function found in archaebacteria, eukaryotes and eubacteria. The structures of YBL001c from Saccharomyces cerevisiae and its homologue MTH1187 from the archaea Methanobacterium thermoautotrophicum have been determined []. These proteins have a ferredoxin-like alpha/beta sandwich structure with anti-parallel beta-sheets. Generally, they have two domains that form a single beta-sheet dimer, where two dimers pack sheet-to-sheet into a tetramer, some proteins having an extra C-terminal helix. ; PDB: 1LXJ_A 1YQH_A 2EKY_G 2EPI_A 1VK8_D 2IBO_C 1LXN_B.
Probab=22.77 E-value=2.5e+02 Score=21.56 Aligned_cols=63 Identities=13% Similarity=0.068 Sum_probs=39.2
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEccccHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQVCLS 319 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d~~~av~~Lh~~f~~~~~~~~~~~v~~~ 319 (326)
.+...+.+++.+.|++.|++..+- +.++.|-- +-+++-.+++.+|+..+...-.+-+..+++.
T Consensus 13 ~s~~~~V~~~i~~i~~sgl~y~v~---pm~T~iEG--e~dev~~~i~~~~e~~~~~G~~Rv~t~ikId 75 (92)
T PF01910_consen 13 ESVSAYVAEAIEVIKESGLKYEVG---PMGTTIEG--ELDEVMALIKEAHEALFEAGAKRVVTVIKID 75 (92)
T ss_dssp SHHHHHHHHHHHHHHTSSSEEEEE---TTEEEEEE--EHHHHHHHHHHHHHHHHCTTSSEEEEEEEEE
T ss_pred CCHHHHHHHHHHHHHHcCCceEEc---CCccEEEe--cHHHHHHHHHHHHHHHHHcCCCeEEEEEEEE
Confidence 345678899999999999997763 44444432 3445666666777765554333444444443
No 269
>PRK00934 ribose-phosphate pyrophosphokinase; Provisional
Probab=22.68 E-value=2.7e+02 Score=26.03 Aligned_cols=92 Identities=13% Similarity=0.035 Sum_probs=52.2
Q ss_pred hHHhHhhccchHHHHHHHHHHHHHcCCceEEEcccceeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCccccC
Q 020431 34 SFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (326)
Q Consensus 34 ~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi~~~ 113 (326)
.-.|...--||.++++.++..|...|=....+|+..-.+ . +-| +..++.....+.+.+++........|+ +.+
T Consensus 90 aRqDr~~~~ge~isak~~a~ll~~~~d~vitvD~H~~~~-~-~~f-~~~~~~l~a~~~la~~i~~~~~~~vvv----~pd 162 (285)
T PRK00934 90 ARQDKRFKPGEPISARAIAKIISAYYDRIITINIHEPSI-L-EFF-PIPFINLDAAPLIAEYIGDKLDDPLVL----APD 162 (285)
T ss_pred cccccccCCCCCccHHHHHHHHHHhcCEEEEEcCChHHH-c-CcC-CCcEeEeecHHHHHHHHHhcCCCCEEE----EeC
Confidence 335666667999999999999999986677777765422 1 112 111221122234444443111121232 211
Q ss_pred CCCCcccccCCcchHHHHHHHHhhccceE
Q 020431 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQV 142 (326)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~a~~~ 142 (326)
.|+-..|..+|..++....
T Consensus 163 ----------~Ga~~~a~~lA~~l~~~~~ 181 (285)
T PRK00934 163 ----------KGALELAKEAAEILGCEYD 181 (285)
T ss_pred ----------CchHHHHHHHHHHhCCCEE
Confidence 1356668999999997643
No 270
>PRK14324 glmM phosphoglucosamine mutase; Provisional
Probab=22.53 E-value=5.8e+02 Score=25.31 Aligned_cols=53 Identities=13% Similarity=0.026 Sum_probs=33.7
Q ss_pred HHHHHHHHHHhhhcCCCChhHHhHhhccchHHHHHHHHHHHHHcCCceEEEcc
Q 020431 15 FIRSTYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDT 67 (326)
Q Consensus 15 ~i~~~~~~l~~~~~~~~~~~~~d~i~~~GE~~s~~~~~~~L~~~Gi~a~~l~~ 67 (326)
.++.|.+.|.+.++.+....-...++-++--..+.++...|++.|+++..++.
T Consensus 155 ~~~~Y~~~l~~~i~~~~~~~~lkVvvD~~nGa~~~~~~~ll~~lG~~v~~i~~ 207 (446)
T PRK14324 155 VIGRYIVHIKNSFPKDLTLKGLRIVLDTANGAAYKVAPTVFSELGADVIVIND 207 (446)
T ss_pred HHHHHHHHHHHhcCCccCCCCCEEEEECCCchHHHHHHHHHHHcCCeEEEECC
Confidence 45667777776664222212223355555555678888899999999888764
No 271
>COG1707 ACT domain-containing protein [General function prediction only]
Probab=22.15 E-value=2.7e+02 Score=24.31 Aligned_cols=51 Identities=18% Similarity=0.333 Sum_probs=38.8
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCCcc----EEEEEEccc-cHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASSEH----SVCFAVPEK-EVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~se~----sIs~~V~~~-d~~~av~~Lh~ 302 (326)
.+.||++.++...++++|.|+-...|..-.. .|.+=++.- |.+++++.|+.
T Consensus 10 enk~GvL~~ltgiiae~ggNIt~~q~~~~~~g~~~~iYmEiEgi~d~e~l~~~lks 65 (218)
T COG1707 10 ENKPGVLRDLTGIIAEEGGNITYAQQFLEKDGEKALIYMEIEGIDDFEKLLERLKS 65 (218)
T ss_pred ecCccHHHHHHHHHHhcCCceEeeehhhhccCceEEEEEEeeCCCCHHHHHHHhhc
Confidence 4679999999999999999999998865422 244445543 78888887765
No 272
>PRK08526 threonine dehydratase; Provisional
Probab=21.97 E-value=2.4e+02 Score=27.84 Aligned_cols=61 Identities=15% Similarity=0.279 Sum_probs=42.9
Q ss_pred cCeEEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEEEecC-------CccEEEEEEccc---cHHHHHHHHHH
Q 020431 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS-------SEHSVCFAVPEK---EVKAVAEALES 302 (326)
Q Consensus 239 ~~ia~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~Isq~~-------se~sIs~~V~~~---d~~~av~~Lh~ 302 (326)
.-...+.+. +.++||-++++.+.+++.+.||.-+.+.- .+..+.+.++-. +.+++++.|.+
T Consensus 324 ~r~~~~~~~---~~d~pg~l~~~~~~~~~~~~~i~~~~~~r~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~l~~ 394 (403)
T PRK08526 324 YRKMKLHVT---LVDKPGALMGLTDILKEANANIVKIDYDRFSTKLDYGDAMISITLETKGKEHQEEIRKILTE 394 (403)
T ss_pred CCEEEEEEE---cCCCCCHHHHHHHHHccCCCcEEEEEEEeccCCCCCccEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 344555554 78999999999999999999999888733 345666666644 44555555533
No 273
>PLN02317 arogenate dehydratase
Probab=21.30 E-value=2.7e+02 Score=27.42 Aligned_cols=51 Identities=14% Similarity=0.101 Sum_probs=36.1
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCCc-----------------cEEEEEEcc------ccHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASSE-----------------HSVCFAVPE------KEVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~se-----------------~sIs~~V~~------~d~~~av~~Lh~ 302 (326)
.+.||.+.++++.|+.+|||+..|---.+. ....|+|+= ..+.++++.|++
T Consensus 291 ~~~pG~L~k~L~~Fa~~~INLtkIESRP~~~~~~~~~~~~~~~~~~~~eY~FyVD~eg~~~d~~~~~aL~~L~~ 364 (382)
T PLN02317 291 EEGPGVLFKALAVFALRDINLTKIESRPQRKRPLRVVDDSNSGTAKYFDYLFYVDFEASMADPRAQNALAHLQE 364 (382)
T ss_pred CCCCchHHHHHHHHHHCCCCEEEEEeeecCCCCccccccccccccccccEEEEEEEEcCcCCHHHHHHHHHHHH
Confidence 457999999999999999999998622221 346777762 235566766655
No 274
>COG2716 GcvR Glycine cleavage system regulatory protein [Amino acid transport and metabolism]
Probab=21.03 E-value=1.1e+02 Score=26.59 Aligned_cols=31 Identities=19% Similarity=0.301 Sum_probs=25.0
Q ss_pred EEEEEecCCCCCcccHHHHHHHHHHhCCCcEEEE
Q 020431 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMI 275 (326)
Q Consensus 242 a~IsivG~~~~~~~~i~a~if~~L~~~~I~v~~I 275 (326)
-.+.+++ .++||+..++...|..+||++.-.
T Consensus 93 v~v~v~a---~DrpgIv~~~T~lf~~~~inie~L 123 (176)
T COG2716 93 VWVYVDA---NDRPGIVEEFTALFDGHGINIENL 123 (176)
T ss_pred EEEEEEe---cCCccHHHHHHHHHHhcCCchhhc
Confidence 3456665 368999999999999999997644
No 275
>PRK10622 pheA bifunctional chorismate mutase/prephenate dehydratase; Provisional
Probab=20.95 E-value=5.3e+02 Score=25.31 Aligned_cols=51 Identities=8% Similarity=0.083 Sum_probs=36.5
Q ss_pred CCcccHHHHHHHHHHhCCCcEEEEEecCC---ccEEEEEEccc------cHHHHHHHHHH
Q 020431 252 AGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEK------EVKAVAEALES 302 (326)
Q Consensus 252 ~~~~~i~a~if~~L~~~~I~v~~Isq~~s---e~sIs~~V~~~------d~~~av~~Lh~ 302 (326)
.+.||.+.++++.|+.+|||...|---+. .-...|.|+=+ .+.+++..|.+
T Consensus 305 ~~~pGaL~~~L~~Fa~~giNLtkIeSRP~~~~~~~Y~Ffid~eg~~~d~~~~~aL~~l~~ 364 (386)
T PRK10622 305 GQQAGALVEALLVLRNHNLIMTKLESRPIHGNPWEEMFYLDVQANLRSAEMQKALKELGE 364 (386)
T ss_pred CCCCcHHHHHHHHHHHcCCCeeEEEeeecCCCCceEEEEEEEeCCCCCHHHHHHHHHHHH
Confidence 47899999999999999999988852111 35667776532 35566666655
No 276
>cd02133 PA_C5a_like PA_C5a_like: Protease-associated domain containing proteins like Streptococcus pyogenes C5a peptidase. This group contains various PA domain-containing proteins similar to S. pyogenes C5a, including, i) Vpr, a minor extracellular serine protease from Bacillus subtilis, ii) a large molecular mass collagenolytic protease from Geobacillus collagenovorans MO-1, and iii) PrtS, a cell envelope protease from Streptococcus thermophilus CNRZ 385. Proteins in this group belong to the peptidase S8 family. C5a peptidase is a cell surface serine protease which specifically inactivates C5a [a chemotactic peptide, which attracts polymorphonuclear leukocytes (PMNs)], by cleaving it to release a 7-residue carboxy-terminal fragment which contains the PMN binding site. The significance of the PA domain to these proteins has not been ascertained. It may be a protein-protein interaction domain. At peptidase active sites, the PA domain may participate in substrate binding and/or promotin
Probab=20.95 E-value=4.3e+02 Score=21.58 Aligned_cols=47 Identities=15% Similarity=0.155 Sum_probs=28.7
Q ss_pred HHHHHHhhccceEEEeeccCcccccCCCCCCCCeEEeeecHHHHHHHh
Q 020431 130 AAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMS 177 (326)
Q Consensus 130 A~~lA~~l~a~~~~~~tDV~Gv~~~dP~~~~~a~~i~~ls~~e~~~l~ 177 (326)
-+.-|...||.-++++.|.+|.....+.. ...-+.-.+++++..+|.
T Consensus 63 K~~~a~~aGA~gvIi~n~~~~~~~~~~~~-~~~iP~v~Is~~dG~~L~ 109 (143)
T cd02133 63 KIANAKAAGAVGVIIYNNVDGLIPGTLGE-AVFIPVVFISKEDGEALK 109 (143)
T ss_pred HHHHHHHCCCeEEEEeecCCCcccccCCC-CCeEeEEEecHHHHHHHH
Confidence 35557778999999999887743322111 111233456777777764
No 277
>PF13511 DUF4124: Domain of unknown function (DUF4124)
Probab=20.74 E-value=96 Score=21.34 Aligned_cols=28 Identities=36% Similarity=0.609 Sum_probs=20.1
Q ss_pred HHHHHhhccceEEEeeccCcc--cccCCCC
Q 020431 131 AIMGALLRAHQVTIWTDVDGV--YSADPRK 158 (326)
Q Consensus 131 ~~lA~~l~a~~~~~~tDV~Gv--~~~dP~~ 158 (326)
..++...-+..+.=|+|-+|. |++.|-.
T Consensus 4 l~l~~~a~aa~vYk~~D~~G~v~ysd~P~~ 33 (60)
T PF13511_consen 4 LLLAASAAAAEVYKWVDENGVVHYSDTPPP 33 (60)
T ss_pred HHHhHHHhhccEEEEECCCCCEEECccCCC
Confidence 344445555689999999996 8887763
No 278
>PRK07199 phosphoribosylpyrophosphate synthetase; Provisional
Probab=20.59 E-value=7.2e+02 Score=23.40 Aligned_cols=96 Identities=11% Similarity=0.098 Sum_probs=51.5
Q ss_pred hHHhHhhccchHHHHHHHHHHHHHcCCc-eEEEcccc--eeeccCCCCCCCCCCchhhHHHHHHHhhcCCCcEEEecCcc
Q 020431 34 SFTDFVVGHGELWSAQMLAAVVRKNGID-CKWMDTRE--VLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFI 110 (326)
Q Consensus 34 ~~~d~i~~~GE~~s~~~~~~~L~~~Gi~-a~~l~~~~--~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~ipVv~Gfi 110 (326)
.-.|+....||.+|+++++..|+. |.+ ...+|+.. ..-+ .+.| +..++.......+.+++........|+..+
T Consensus 93 aRqDr~~~~ge~isak~vA~ll~~-~~d~vit~DlH~~~~~~~-~~~f-~ip~~nl~~~~~la~~l~~~~~~~vVVsPd- 168 (301)
T PRK07199 93 MRQDIAFHPGEAISQRHFARLLSG-SFDRLVTVDPHLHRYPSL-SEVY-PIPAVVLSAAPAIAAWIRAHVPRPLLIGPD- 168 (301)
T ss_pred cccccccCCCCCccHHHHHHHHHh-hcCeEEEEeccchhhHHh-cCcc-cCCccccchHHHHHHHHHhcCCCcEEEEeC-
Confidence 335667778999999999999985 663 44566553 1111 1112 122333333444555554211233333222
Q ss_pred ccCCCCCcccccCCcchHHHHHHHHhhccceEEEee
Q 020431 111 ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWT 146 (326)
Q Consensus 111 ~~~~~g~~~~lgrggsD~~A~~lA~~l~a~~~~~~t 146 (326)
.. +=..|..+|..++....++.+
T Consensus 169 ---~g----------~~~~a~~la~~l~~~~~~~~K 191 (301)
T PRK07199 169 ---EE----------SEQWVAAVAERAGAPHAVLRK 191 (301)
T ss_pred ---CC----------hHHHHHHHHHHhCCCEEEEEE
Confidence 11 223467888889876655554
No 279
>PRK10629 EnvZ/OmpR regulon moderator; Provisional
Probab=20.41 E-value=2.7e+02 Score=22.87 Aligned_cols=47 Identities=15% Similarity=0.225 Sum_probs=35.3
Q ss_pred cHHHHHHHHHHhCCCcEEEEEecCCccEEEEEEcccc-HHHHHHHHHHHH
Q 020431 256 GTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKE-VKAVAEALESKF 304 (326)
Q Consensus 256 ~i~a~if~~L~~~~I~v~~Isq~~se~sIs~~V~~~d-~~~av~~Lh~~f 304 (326)
....++-+.|.++||.+..|.+. +.++-+.+++.+ --+|-+.|.+.+
T Consensus 50 ~~~~~v~~~L~~~gI~~ksi~~~--~~~~~irf~~~~~Ql~Ak~vL~~~L 97 (127)
T PRK10629 50 PDGFYVYQHLDANGIHIKSITPE--NDSLLIRFDSPEQSAAAKEVLDRTL 97 (127)
T ss_pred chHHHHHHHHHHCCCCcceEEee--CCEEEEEECCHHHHHHHHHHHHHHc
Confidence 34678999999999999999864 567777777764 555666666654
Done!